יומן הפטנטים 2007 02 - justice.gov.il · web viewרשומות. israel state records...

2/2007ח'/התשס"ז

רשומותISRAEL STATE RECORDS

June 3, 2007 התשס"ז בסיון י"ז

והמדגמים הפטנטים יומןPATENTS AND DESIGNS JOURNAL

PATENTSעמודפטנטיםPage

448Applications filedשהוגשו בקשות593Applications acceptedשקובלו בקשות803Patents grantedשניתנו פטנטים804Patents renewedשחודשו פטנטים805Patents not in forceפקעו שתוקפם פטנטים806Patents renewed for 20 yearsשנה לעשרים שחודשו פטנטים807Noticesהודעות810Corrigendaטעויות תיקוני811Country codesלמדינות קודים

iIndices of applications acceptedשקובלו לבקשות מפתחות

DESIGNSמדגמים813Designs registeredשנרשמו מדגמים825Designs renewedשחודשו מדגמים826Designs voidשבוטלו מדגמים

כלליות ידיעות

אל: לשלוח יש ומדגמים פטנטים מכתבים, מסמכים, וכו' בענייני, ירושלים4 והמדגמים, רח' הסדנא הפטנטים רשם

חול בימי לציבור פתוחה והיא , תלפיות, ירושלים4 ברח' הסדנא נמצאת הפטנטים לשכת.12:30 ו- 8:30 השעות בין מועד או שבת ערבי שאינם כל בעד שקלים2.50 של במחיר ושרטוטים פירוטים של תצלומים מספקת הפטנטים לשכתממנו. חלק או עמוד

מס' הדואר בבנק הלשכה לחשבון תשלום ידי על ורק אך מתקבלות הפטנטים ללשכת אגרות האגרה שעבורה לפעולה הבקשה עם יחד ללשכה הדואר בנק קבלת להציג . יש0-24145-2

שולמה.

GENERAL INFORMATION

Letters, documents, etc. concerning Patents and Designs should be addressed to:The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem

The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.

The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50 per page or part thereof.

Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together with the application for the action for which the fee has been paid.

שמורה אלה בתקצירים היוצרים זכותמת להעתיק ישראל, אין למדינתקצירים

הפטנטים. לשכת ברשות אלא אלה

Copyright by the State of Israel. No Extracts may be published except with the permission of the Patent Office.

.Price per single issue (incl. VAT) : NIS 96.₪ 96מ.ע.מ.( )כולל בודדת חוברת מחיר: לכל

:Annual subscription (incl. VAT).₪ 1,152מ.ע.מ.( )כולל לשנה חתימה דמיNIS 1,152.

אצל: להשיג אפשר ב' הממשלה, רחוב פרסומי של ההפצה שרות, הקריה, תל-אביב.29מס'

Available at the Distribution Service of Government Publications, 29 B-Street, Hakirya, Tel-Aviv.

NOTICE UNDER SECTION 16 OF THE הפטנטים לחוק16 סעיף לפי הודעה

June 3, 2007 446 –התשס"ז בסיון י"ז

1967PATENTS LAW, 5727-1967- תשכ"ז

חדשות בקשות רשימת להלןשנקבעו הדרישות אחר הממלאות

הפטנטים, )א( לתקנות32 בתקנה:1968תשכ"ח–

In the following there are listed newApplications complying with theProvisions of rule 32(a) of the PatentRegulations, 5728-1968

לפי מובאים הבקשות פרטיזה: סדר

Particulars of the applications aregiven in the following order:

הגשתה ותאריך – הבקשה מספרשל הראשונים הסמנים וארבעה

הבינלאומי הסיווג

Number and date of application And the first four symbols of theInternational Classification

ע"י שהוצע )כפי האמצאה שםהמבקש(

Title of invention(as proposed by applicant)

Applicantהמבקש– האיגוד קדימה: מדינת דין

ומספר תאריך החוץ בקשת

Priority right: Convention country – Number and date of Foreign application

International Application Numberבינלאומית בקשה מספר

International Publication Numberבינלאומי מס' פרסום

B09B16930921/06/2005

MEFHOD FOR COLLECLION OFמוחזרים מוצרים איסוף שיטתRETURNED ARTICLES

June 3, 2007447 –התשס"ז בסיון י"ז

ROZENTAL SHUNIAשוניה רוזנטל

G01S17473703/04/2006

במכ"ם תמונה לתצוגת והתקן שיטהאולטרה פס–רחב

SYSTEM AND METHOD FOR IMAGE DISPLAY IN ULTRA-WIDEBAND RADAR

.CAMERO-TECH LTDבע"מ קמרו-טק

F41H17592925/05/2006

המותקן חום ממקור חום לסילוק מערכתבקסדה

SYSTEM FOR TRANSFERRING HEAT AWAY FROM A HELMET MOUNTED HEAT EMITTER

.ELBIT SYSTEMS LTDבע"מ מערכות אלביט

B60K17624512/06/2006

MANUAL DRIVEN CONTROLSידניים נהוג לבקרי הפעלה סוכן מנגנוןACTUATION AGENT MACHANISM

YEFIM KERETHקרת יפים

G06K17636918/06/2006

A SYSTEM & METHOD FORצילומים למניעת ושיטה מערכתPREVENTING PHOTOGRAPHY

PHOTO FREE LTDבע"מ פרי פוטו

F41H17645421/06/2006

EXPLOSIVE MATERIAL SENSITIVITYנפץ לחומר רגישות בקרתCONTROL


RAFAEL ARMAMENTבע"מ לחימה אמצעי לפיתוח רשות רפא"לDEVELOPMENT AUTHORITY LTD.

A23L17947324/05/2005

ודלקות בגידולים לטיפול רפואיים תכשיריםPHARMACEUTICAL PRODUCTS FOR TREATING NEOPLASTIC DISEASE AND INFLAMMATIONKGK SYNERGIZE INC.

26/05/2004

60/574487US

PCT/IB/2005/001420WO/2005/115376

G01B18005113/12/2006

קוהרנטי אופטי טווח מדCOHERENT OPTICAL RANGE FINDER USING TRANSMITTED PULSE AS LOCAL OSCILLATOR

RAFAEL ARMAMENTבע"מ לחימה אמצעי לפיתוח רשות רפא"לDEVELOPMENT AUTHORITY LTD.

F03G18005214/12/2006

DEVICE FOR GENERATING ENERGYים מגלי לאנרגיה מתקןFROM SEA WAVES

ELAZAR TAGANSKYטגנסקי אלעזר

B41J18011117/12/2006

DUAL MODE PRINTERמצבים שתי בעלת מדפסת.MATAN DIGITAL PRINTERS LTD ( בע"מ2001) דיגיטליות מדפסות מתן

C07D18011214/07/2005


רוקחות ותכשירי דחוסות בנזאמיד תרכובותאותן המכילים

CONDENSED BENZAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMEJAPAN TOBACCO INC.

15/07/2004

2004-208334JP

22/07/2004

60/590180US

28/12/2004

2004-379551JP

06/01/2005

60/641874US

28/04/2005

2005-133724JP

12/05/2005

60/680072US

PCT/JP/2005/013446WO/2006/006741

G06F18011316/06/2005

הטעון מאובטח תוכנית גוש לעידכון שיטהאבטחה מודול בתוך

METHOD FOR SECURELY UPDATING A PROGRAM BLOCK LOADED IN A SECURITY MODULENAGRACARD S.A.

17/06/2004

04102768.1EP

PCT/EP/2005/052797WO/2005/124502

A61B18011423/06/2005

SYSTEMS AND METHODS FOR SPINEשידרה עמוד לייצוב ושיטות מערכותSTABILIZATIONYALE UNIVERSITY

23/06/2004

60/581716US

31/12/2004

11/027270US

31/12/2004

11/027246US


31/12/2004

11/027073US

31/12/2004

11/027082US

31/12/2004

11/027245US

31/12/2004

11/027269US

31/12/2004

11/027247US

PCT/US/2005/022346WO/2006/002333

A61K18011530/06/2005

ופולימר,IX גורם של קבוצה של צמדיםלהכנתם ושיטות אותם המכילים תכשירים

A CONJUGATE OF A FACTOR IX MOIETY AND A POLYMER, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOFNEKTAR THERAPEUTICS AL, CORPORATION

30/06/2004

60/584505US

PCT/US/2005/023745WO/2006/005058

H04B18011602/06/2005

בספקטרום חללים לאספקת שיטהאלקטרונית רשת גבי על אותות בשידור

METHOD OF OBTAINING SPECTRAL VOIDS IN THE TRANSMISSION OF SIGNALS OVER THE ELECTRIC NETWORKDISENO DE SISTEMAS EN SILICIO, S.A.

18/06/2004P200401502ES

PCT/ES/2005/000315WO/2006/000602


H04Q18011721/06/2005

במערכת מידע והעברת אסינכרוני איתותאלחוטית תקשורת

ASYNCHRONOUS SIGNALING AND DATA DELIVERY IN A WIRELESS COMMUNICATION SYSTEMQUALCOMM INCORPORATED

21/06/2004

60/581970US

31/05/2005

60/686132US

17/06/2005

11/156176US

PCT/US/2005/022022WO/2006/002214

A61K18011805/04/2000

וממיסי דו–נתרניים, חד–מיימניים מלחיםפעילים נשאים להעברת אתנול

DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTSEMISPHERE TECHNOLOGIES, INC.

05/04/1999

60/127754US

01/03/2000

60/186143US

01/03/2000

60/186142US

21/03/2000

60/191286US

PCT/US/2000/009390WO/2000/059863

C01B18011915/06/2005

CHEMICALLY ASSISTED MILLINGכימי בסיוע סיליקות טחינתOF SILICASW.R. GRACE & CO. CONN


15/06/2004

60/579694US

PCT/US/2005/021156WO/2006/002085

H04L18012007/06/2005

לולאה של כוח ובקרת אמין מחיקות גילוימחיקה קצב מבוססת סגורה

ROBUST ERASURE DETECTION AND ERASURE-RATE-BASED CLOSED LOOP POWER CONTROLQUALCOMM INCORPORATED

18/06/2004

60/580819US

13/07/2004

10/890717US

PCT/US/2005/020087WO/2006/007317

H04L18012114/06/2005

ספקטרלי אומדן בעזרת זמן סנכרוןתקשורת במערכת

TIME SYNCHRONIZATION USING SPECTRAL ESTIMATION IN A COMMUNICATION SYSTEMQUALCOMM INCORPORATED

18/06/2004

60/580811US

22/12/2004

11/021694US

PCT/US/2005/021053WO/2006/009713


H04L18012229/04/2005

מערכת עבור רדיו תקשורת פרוטוקולאלחוטית תקשורת

RADIO LINK PROTOCOLS FOR A WIRELESS COMMUNICATION SYSTEMQUALCOMM INCORPORATED

18/06/2004

60/580753US

22/12/2004

11/020410US

PCT/US/2005/014850WO/2006/007025

H04L18012314/06/2005

תקשורת מערכת עבור שדרים ריבובאותות מרובת סלולרית

MULTIPLEXING FOR A MULTI-CARRIER CELLULAR COMMUNICATION SYSTEMQUALCOMM INCORPORATED

18/06/2004

60/580810US

08/07/2004

10/887710US

PCT/US/2005/021056WO/2006/009715

H04B18012407/06/2005

על אלחוטית תקשורת במערכת כוח בקרתאורתוגונלי ריבוב ידי

POWER CONTROL FOR A WIRELESS COMMUNICATION SYSTEM UTILIZING ORTHOGONAL MULTIPLEXINGQUALCOMM INCORPORATED

18/06/2004

60/580819US


22/07/2004

10/897463US

PCT/US/2005/020092WO/2006/007318

C07C18012515/06/2005

METHODS FOR PRODUCINGביודיזל ליצור שיטותBIODIESELCARNEGIE MELLON UNIVERSITY

15/06/2004

10/867627US

PCT/US/2005/021173WO/2006/002087

A61B18012616/06/2005

METHOD AND APPARATUS FORבפלטה ברגים לשימור והתקן שיטהRETAINING SCREWS IN A PLATEWARSAW ORTHOPEDIC, INC.

17/06/2004

10/870026US

PCT/US/2005/021358WO/2006/009795

A61F18012715/06/2005

היגייני טמפון ליצור ושיטה היגייני טמפוןA HYGIENIC TAMPON AND A METHOD OF MANUFACTURING A HYGIENIC TAMPONJOHNSON & JOHNSON INDUSTRIAL LTDA

17/06/2004

PI0402403-6BR

PCT/BR/2005/000109WO/2005/122986

A61K18012817/06/2005

METHODS AND COMPOSITIONS FORפצעים להלחמת ותכשירים שיטותWOUND HEALING


THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION

18/06/2004

10/871158US

PCT/US/2005/021477WO/2006/009853

C12Q18012907/06/2005

בתאים כרומוזומליות חריגות של זיהויזקיקי מנוזל שהתקבלו

IDENTIFYING CHROMOSOMAL ABNORMALITIES IN CELLS OBTAINED FROM FOLLICULAR FLUIDRELIANCE LIFE SCIENCES PVT. LTD.

11/06/2004

642/MUM/2004IN

PCT/IN/2005/000185WO/2005/121365

E04H18013017/06/2005

A PREFABRICATED SHELTERטרומי מחסהCRAWFORD BREWIN LTD

17/06/2004

04253627.6EP

PCT/GB/2005/002406WO/2005/124063

A01G18013117/06/2005

של לניהול הניתנות משותפות תרביות מחלות במניעת השפעה בעלי אורגניזמים

בריאות ושיפור

MANAGED CO-CULTURES OF ORGANISMS HAVING PROPHYLACTIC AND HEALTH-PROMOTING EFFECTSVEGA, GABRIEL, CHAVEZ

17/06/2004

60/580983US

PCT/US/2005/021807WO/2006/002093


H01L18013317/12/2006

ומערכת חשמליים מעגלים לבחינת שיטהחשמליים מעגלים לבחינת

METHOD FOR INSPECTING ELECTRICAL CIRCUITS AND A SYSTEM FOR INSPECTING ELECTRICAL CIRCUITS

.CAMTEK LTDבע"מ קמטק17/12/2005

60/749052US

C07D18013607/07/2005

שלוש – מותמרים6,4,2 פירימידינים (PI) פוספוטידילאינוסיטול כמעכבי פעמים

בסרטן בטיפול בהם והשימוש –קינאז3

2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCERASTRAZENECA AB

09/07/2004

0415365.6GB

PCT/GB/2005/002664WO/2006/005914

C07D18013707/07/2005

פעמים שלוש –מותמרים6,4,2 פירימידינים–3( PI) פוספוטידילאינוסיטול כמעכבי

בסרטן בטיפול בהם והשימוש קינאז

2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCERASTRAZENECA AB

09/07/2004

0415364.9GB

PCT/GB/2005/002665WO/2006/005915

C07D18013807/07/2005


פעמים שלוש –מותמרים6,4,2 פירימידינים–3( PI) פוספוטידילאינוסיטול כמעכבי

בסרטן בטיפול בהם והשימוש קינאז

2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCERASTRAZENECA AB

09/07/2004

0415367.2GB

PCT/GB/2005/002678WO/2006/005918

B02C18013918/12/2006

פולימרים גריסת לצורך ושיטה מכונהמגופר גומי וחומרי

MACHINE AND METHOD FOR COMMINUTING OF POLYMER AND CURED ELASTOMER MATERIALS

INNOVERT INVESTMENTS A.L. LTDא.ל. בע"מ השקעות אינוברט

G06F18014028/06/2005

של ומיכון לאיחוד, אבטחת ושיטה מערכתנתונים ברשת לנודות לפס מחוץ גישה

SYSTEM AND METHOD FOR CONSOLIDATING, SECURING AND AUTOMATING OUT-OF-BAND ACCESS TO NODES IN A DATA NETWORKAVOCENT FREMONT CORP.

29/06/2004

10/881211US

PCT/US/2005/023719WO/2006/005047

B31B18014122/06/2005

SHEET MATERIAL AND METHODושיטה יריעה חומרELOPAK SYSTEMS AG

23/06/2004

0414029.9GB

PCT/IB/2005/001759WO/2006/000881


C07D18014206/07/2005

–אמינו–טריאזולופירימידנים7–פניל–6 בהם ליצורם, שימוש מותמרים, שיטה

וגורמים פתוגניות פטריות על לבקרהאלו תרכובות המכילים

SUBSTITUTED 6-PHENYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI, AND AGENTS CONTAINING THESE COMPOUNDSBASF AKTIENGESELLSCHAFT

08/07/2004

102004033239.8DE

PCT/EP/2005/007277WO/2006/005492

C07D18014312/07/2005

, שיטה2 בעמדה מותמרים פירימידינים על לבקרה בהם ושימוש להכנתםפתוגניות פטריות

2-SUBSTITUTED PYRIMIDINES, METHOD FOR THEIR PRODUCTION AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGIBASF AKTIENGESELLSCHAFT

14/07/2004

102004034197.4DE

PCT/EP/2005/007517WO/2006/005571

A61P18014424/06/2005

D וויטמין סטרונטיום המכילים תכשיריםושימושיהם

COMPOSITIONS COMPRISING STRONTIUM AND VITAMIN D AND USES THEREOFSTRONTIN APS

25/06/2004PA200400991DK

10/11/2004PA200401733DK

PCT/DK/2005/000425WO/2006/000224


B65D18014511/04/2006

IDENTIFICATION PANEL FOR PALLETמיכל עבור זיהוי לוחCONTAINERMAUSER-WERKE GMBH

20/04/2005

202005006351.7DE

PCT/EP/2006/003325WO/2006/111303

H01M18014618/12/2006

וציוד מצבר להכנסת ושיטות מצבר, ציודאחסון למצב כאלו

A BATTERY, EQUIPMENT, AND METHODS OF PUTTING SUCH A BATTERY AND SUCH EQUIPMENT INTO A STORAGE CONDITIONSAGEM DEFENSE SECURITE

19/12/20050512880FR

C07D18014720/06/2005

– – פניל4 – – בנזילN( 1( – 1 – תולדות1H2,2 – יל( – 2 – – אימידאזול–

ותרכובות דימתילפרופיל( בנזאמידבסרטן לטיפולKSP כמעכבות קשורות

N - (1 - (1 - BENZYL - 4 - PHENYL - 1H-IMIDAZOL - 2 - YL) - 2,2 - DYMETHYLPROPYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPIDLE PROTEIN (KSP) INHIBITORS FOR THE TREATMENT OF CANCERCHIRON CORPORATION

18/06/2004

60/580927US

PCT/US/2005/022062WO/2006/002236

G09F18014918/12/2006

ביחידות שימוש ידי על לפרסום שיטהמחשב של מסכים רב מוניטור

ADVERTISING METHOD WITH USE OF MULTI-SCREENED COMPUTER MONITOR UNITS

D. SIT TRADE L.T.Dבע"מ סחר ד.סיט


B67D18015018/12/2006

של אישיים פריטים להפקדת קיבול כליאוכל בשולחן סועד

RECEPTACLE FOR DEPOSITING PERSONAL ITEMS OF A DINER AT DINING TABLE

ZIV BEN ZVIחלבוני לירון

C07D18015105/07/2005

–2,1 של תרכובת לייצור שיטה–און2דיהידרופירידין–

METHOD FOR PRODUCING 1,2-DIHYDROPYRIDINE-2-ONE COMPOUNDEISAI R&D MANAGEMENT CO. LTD.

06/07/2004

2004-198709JP

PCT/JP/2005/012364WO/2006/004100

C07K18015230/06/2005

ומותאמים כימריים מונוקלונאליים נוגדנים13אינטלאוקין– נגד אדם לבני

CHIMERIC AND HUMANISED MONOCLONAL ANTIBODIES AGAINST INTELEUKIN-13GLAXO GROUP LIMITED

01/07/2004

0414799.7GB

25/10/2004

0423675.8GB

PCT/GB/2005/002581WO/2006/003407

A61B18015306/07/2005

COLORECTAL CELL SAMPLINGקולורקטלי תא לדגימת מכשירDEVICECOLONIX LIMITED

07/07/2004

0415277.3GB


PCT/GB/2005/002641WO/2006/003447

H04N18015422/04/2005

REAL-TIME STABILIZATIONאמת בזמן ייצובINTERGRAPH SOFTWARE TECHNOLOGIES COMPANY

21/06/2004

10/872767US

PCT/US/2005/013899WO/2006/007006

H04Q18015521/06/2005

תכני של שונים בסוגים להבחנה שיטה תקשורת במערכת דטה פקטות בתוך מידע

אלחוטית

METHOD FOR DISTINGUISHING DIFFERENT TYPES OF DATA CONTENT IN DATA PACKETS IN A WIRELESS COMMUNICATION SYSTEMQUALCOMM INCORPORATED

21/06/2004

60/581790US

31/05/2005

60/686131US

17/06/2005

11/156179US

PCT/US/2005/022025WO/2006/002217

H04Q18015721/06/2005

המשתמשת אלחוטית תקשורת מערכת תקשורת בקשות עבור מתמיד בערך

אחזור זמן קיצור לצורך קבוצתיות

WIRELESS COMMUNICATION SYSTEM UTILIZING A PERSISTENCE VALUE FOR GROUP COMMUNICATION REQUESTS TO REDUCE LATENCYQUALCOMM INCORPORATED

21/06/2004

60/581734US

31/05/2005

60/686141US

16/06/2005

11/155256US


PCT/US/2005/022026WO/2006/002218

H04Q18015820/06/2005

יצירת לצורך איתות בערוץ לשימוש שיטה PUSH TO בתקשורת לשיחה בקשהTALKאלחוטית תקשורת במערכת

METHOD FOR USING A SIGNALING CHANNEL TO SET UP A CALL REQUEST FOR A PUSH TO TALK

(PTT )COMMUNICATION ON A WIRELESS COMMUNICATION NETWORKQUALCOMM INCORPORATED

21/06/2004

60/581968US

31/05/2005

60/686147US

16/06/2005

Unknown yetUS

PCT/US/2005/022118WO/2006/002266

H04L18016011/07/2005

מפותל מוליכים זוג של אותות עבור מגברמסוכך בלתי

AMPLIFIER FOR UNSHIELDED TWISTED PAIR WIRE SIGNALSPHYLOGY, INC.

12/07/2004

10/889090US

PCT/US/2005/024576WO/2006/017236

F03G18016323/06/2005

מאגרים של וייצור לפיתוח שיטהעמוקים גיאותרמיים

METHOD OF DEVELOPING AND PRODUCING DEEP GEOTHERMAL RESERVOIRSCURLETT, HARRY, B.


23/06/2004

60/582626US

07/02/2005

60/650667US

PCT/US/2005/022305WO/2006/002325

E06B18016418/12/2006

WINDOW OR DOOR SHUTTER ANDעבורו ושלב דלת או לחלון תריסSLAT THEREFOR

.PROFILE GLASS LTDבע"מ גלס פרופיל

H02J18016521/04/2005

BI-DIRECTIONAL ENERGYדו–כוונית אנרגיה המרת מערכתCONVERSION SYSTEM

.LV POWER (2003) LTD ( בע"מ2003) אל.וי.פאוור08/07/2004

60/585830US

PCT/IL/2005/000438WO/2006/006142

E04B18016629/03/2005

קיר קשרי עם מבודדת בטון תבנית מערכתמשתנים באורכים

INSULATED CONCRETE FORM SYSTEM WITH VARIABLE LENGTH WALL TIESPJER-MISE VELICKOVIC

21/06/2004P20040578AHR

PCT/HR/2005/000021WO/2005/124046


C12N18016719/07/2005

המשתתף פוליפפטיד המקודד דנא פלאדיאינוליד, של בביו–סינתזה ושיטות הימנו המקודדים פוליפפטידים

בהם המשתמשות פלאדיאינוליד להכנת

DNA CODING FOR POLYPEPTIDE PARTICIPATING IN BIOSYNTHESIS OF PLADIENOLIDE, POLYPEPTIDES ENCODED THEREBY AND A METHOD FOR PRODUCING PLADIENOLIDE UTILIZING THE SAMEEISAI R&D MANAGEMENT CO, LTD.

20/07/2004

2004-211279JP

PCT/JP/2005/013541WO/2006/009276

G09F18016819/12/2006

על פרסומות להצגת נייד פרסום חבילותאישיים סלולרים מכשירים

MOBILE ADVERTISING PACKAGES FOR DISPLAYING ADVERTISEMENT DISPLAY MESSAGES ON PERSONAL CELLULAR TELECOMMUNICATIONS DEVICES

.CELLTICK TECHNOLOGIES LTDבע"מ טכנולוגיות סלטיק

G01N18016920/07/2005

חלבון של מבני לאפיון פרוצדורה רב תאים שורת או שבטי רב רקומביננטי

שבטית

A PROCEDURE FOR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT POLYCLONAL PROTEIN OR A POLYCLONAL CELL LINESYMPHOGEN A/S

20/07/2004PA200401133DK

22/12/2004PA200401991DK

PCT/DK/2005/000504WO/2006/007853


A61F18017016/06/2005

FLOW REGULATING IMPLANTSזרם המווסתים שתלים.OPTONOL LTDבע"מ אופטונול

25/06/2004

10/875571US

PCT/US/2005/021123WO/2006/012009

C07J18017104/07/2005

D–(–10)5, 3, 1– הומו–אסטרה 2 בעמדה המותמרים חדשים טריאנים

–17 של כמעכבים דהידרוגנאז בתא–הידרוקסיסטינואיד

1 מסוג

NOVEL 2-SUBSTITUTED D-HOMO-ESTRA-1,3,5(10)-TRIENES AS INHIBITORS OF 17?- HYDROXYSTEROID DEHYDROGENASE TYPE 1SCHERING AKTIENGESELLSCHAFT

02/07/2004

102004032673.8DE

PCT/EP/2005/007314WO/2006/003012

A61K18017201/07/2005

TOPICAL ANTIVIRALוירליים אנטי מקומיים הרכביםFORMULATIONSGILEAD SCIENCES, INC.

09/07/2004

60/586839US

PCT/US/2005/023492WO/2006/017044

B01D18017321/06/2005

עם משולבים עומק סינוני בסדרת שימוש תרביות להבהרת מתמשכת צנטריפוגה

יונקים תאי

USE OF DEPTH FILTRATION IN SERIES WITH CONTINUOUS CENTRIFUGATION TO CLARIFY MAMMALIAN CELL CULTURESBiogen Idec MA Inc.


21/06/2004

10/871261US

PCT/US/2005/021781WO/2006/007459

G06K18017424/06/2005

עם הקשור מיקום לקביעת והתקן שיטהדמות

METHOD AND APPARATUS FOR DETERMINING A LOCATION ASSOCIATED WITH AN IMAGEDIGITALGLOBE, INC.

25/06/2004

60/521729US

PCT/US/2005/022961WO/2006/078310

B02C18017505/07/2005

בנוכחות מינרליים חומרים לטחינת שיטה מיימיות סוספנסיות לקבלת מקשריםבהן והשימוש

METHOD FOR GRINDING MINERAL MATERIALS IN THE PRESENCE OF BINDERS, RESULTING AQUEOUS SUSPENSIONS AND USE THEREOFCOATEX S.A.S.

13/07/20040407805FR

PCT/FR/2005/001715WO/2006/016036

B02C18017605/07/2005

מינרליים חומרים של לטחינה שיטה לקבלת מסמיכים גורמים בנוכחות

בהן והשימוש מיימיות סוספנסות

METHOD FOR GRINDING MINERAL MATERIALS IN THE PRESENCE OF THICKENING AGENTS, RESULTING AQUEOUS SUSPENSIONS AND USES THEREOFCOATEX S.A.S.

13/07/20040407803FR

PCT/FR/2005/001716WO/2006/016037


C07D18017724/06/2005

בהן ושימוש טריאזולופירימידין תרכובותפתוגניות פטריות על לבקרה

TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGIBASF AKTIENGESELLSCHAFT

25/06/2004

102004030816.0DE

PCT/EP/2005/006855WO/2006/000436

A01N18017816/06/2005

פטריות על לבקרה מגן חומרפייטופתוגניות

PROTECTANT FOR CONTROLLING PHYTOPATHOGENIC FUNGIBAYER CROPSCIENCE AG

21/06/2004

102004029972.2DE

PCT/EP/2005/006483WO/2005/122770

G01N18017919/07/2005

תרכובת של נוכחות לקביעת שיטה הומוגנית בצורה המפוזרת כימית

קורלציה של באמצעים במדיום עם ספקטרום מדידת של מצולבתספקטרום רפרנס

METHOD FOR DETERMINING THE PRESENCE OF A CHEMICAL COMPOUND WHICH IS HOMOGENEOUSLY DISTRIBUTED IN A MEDIUM BY MEANS OF CROSS-CORRELATING A MEASURING SPECTRUM WITH REFERENCE SPECTRABASF AKTIENGESELLSCHAFT

23/07/2004

102004035948.2DE

PCT/EP/2005/007839WO/2006/010527

C07D18018013/07/2005


– פניל)תיאו( אורקילים3 לייצור שיטהודיתיאורקילים

METHOD FOR THE PRODUCTION OF 3 -PHENYL (THIO) URACILS AND DITHIOURACILSBASF AKTIENGESELLSCHAFT

22/07/2004

102004035656.4DE

PCT/EP/2005/007577WO/2006/010474

E05B18018119/12/2006

A LOCK PROTECTION SYSTEMמנעול על להגנה מערכתITZHAK COHEN-NEHEMIAנחמיה כהן יצחק

A43B18018219/12/2006

BOOTSמגפייםDORON MORADIמורדי דורון

F41G18018319/12/2006

מטרה לעבר קליע ניווט המאפשרת שיטהוהתקן

A PROCESS ENABLING A PROJECTILE TO BE NAVIGATED AND/OR GUIDED AND/OR STEERED TOWARDS A TARGET AND THE DEVICE THEREOFGIAT INDUSTRIES

19/12/200505.13205FR

F42B18018624/06/2005

מגן עם פגז, המצויד וקליע, כדוגמת מגןזה מסוג אחד

SHIELD AND A PROJECTILE, SUCH AS A SHELL, WHICH IS EQUIPPED WITH ONE SUCH SHIELDTDA ARMEMENTS S.A.S.

25/06/20040407009FR


PCT/EP/2005/052968WO/2006/000575

C07K18018729/06/2005

בהפרעות הטיפול עבור ושיטות תרכובותדלקתיות

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERSDOMANTIS LIMITED

30/06/2004

2004/002829GB

24/08/2004

10/925366US

04/04/2005

11/098758US

PCT/GB/2005/002553WO/2006/003388

G01R18018805/07/2005

מושהית ממברנה בעל בדיקה מכשיר ראשבדיקה מכשיר של

PROBE HEAD HAVING A MEMBRANE SUSPENDED PROBECASCADE MICROTECH, INC.

07/07/2004

60/586299US

PCT/US/2005/023806WO/2006/017078

C07C18018923/06/2005

–1–פאניל–1(–Z) ייצור עבור הליך–2דיאת'ילאמינוקרבוניל–

הידרוקסימת'ילציקלופרופאן

PROCESS FOR PRODUCING (Z)-1-PHENYL-1-DIETHYLAMINOCARBONYL-2-HYDROXYMETHYLCYCLOPROPANESUMITOMO CHEMICAL COMPANY, LIMITED.

25/06/2004

2004-188901JP

PCT/JP/2005/012020WO/2006/001498


B41J18019029/07/2005

עבור תשתית יצירת עבור ושיטה תשתיתנוזל פליטת מתקן

SUBSTRATE AND METHOD OF FORMING SUBSTRATE FOR FLUID EJECTION DEVICEHEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.

31/08/2004

60/606086US

07/12/2004

11/007103US

PCT/US/2005/027213WO/2006/026023

C07D18019228/06/2005

מזה, חדשות, מלח ארילאמידין תולדותאותן המכיל ואנטי–פטרייתי

NOVEL ARYLAMIDINE DERIVATIVE, SALT THEREOF, AND ANTIFUNGAL CONTAINING THESETOYAMA CHEMICAL CO., LTD.

30/06/2004

2004-193386JP

PCT/JP/2005/011809WO/2006/003881

C22C18019323/06/2005

DIE CAST MAGNESIUM ALLOYמגנזיום סגסוגת יציקתCAST CENTRE PTY., LTD.

24/06/2004

2004903446AU


25/11/2004

2004906768AU

PCT/AU/2005/000903WO/2006/000022

A61K18019521/06/2005

לשימוש ושיטות אקוורין מכילי תכשיריםבהם

AEQUORIN-CONTAINING COMPOSITIONS AND METHODS OF USING SAMEQUINCY BIOSCIENCE, LLC

21/06/2004

10/872795US

PCT/US/2005/021770WO/2006/010004

C07D18019722/06/2005

כאנטגוניסטים רבעוני מבנה בעלי מלחיםCCR2 ל–

QUATERNARY SALT CCR2 ANTAGONISTSJANSSEN PHARMACEUTICA, N.V.

25/06/2004

60/582929US

PCT/US/2005/022034WO/2006/012135

C07D18019821/06/2005

אינדולילאלקילאמין של מטבוליטים6 – – הידרוקסיטריפטאמין5 של כליגנדים

INDOLYLALKYLAMINE METABOLITES AS 5 - HYDROXYTRYPTAMINE - 6 LIGANDSWYETH

23/06/2004

60/582290US

PCT/US/2005/021852WO/2006/002125


C07F18028818/07/2005

ANTIVIRAL COMPOUNDSאנטיויראליים חומריםGILEAD SCIENCES, INC.

16/07/2004

60/588633US

27/07/2004

60/591635US

PCT/US/2005/025503WO/2006/020276

H04Q18028906/07/2005

ומערכת אלחוטית לתקשורת שיטהWLANב– הודעה להעברת

WIRELESS COMMUNICATION METHOD AND SYSTEM FOR ESTABLISHING A MULTIMEDIA MESSAGE SERVICE OVER A WLANINTERDIGITAL TECHNOLOGY CORPORATION

30/07/2004

60/592856US

15/06/2005

11/153207US

PCT/US/2005/023793WO/2006/023108

C07D18029007/07/2005

ביניים וחומרי אזולן נגזרות להכנת תהליךלהכנתם

PROCESS FOR PRODUCTION OF AZULENE DERIVATIVES AND INTERMEDIATES FOR THE SYNTHESIS OF THE SAME


KOTOBUKI PHARMAEUTICAL CO. LTD.

08/07/2004

2004-202437JP

PCT/JP/2005/012577WO/2006/006496

A61F18029130/06/2005

INTRAVAGINAL DEVICE WITHלניפוח הניתן ואגינלי מכשירCONTROLLED EXPANSIONMCNEIL-PPC, INC.

30/06/2004

60/584772US

PCT/US/2005/023812WO/2006/005069

A61M18029327/06/2005

A CREDIT CARD SIZED INJECTIONאשראי כרטיס בגודל הזרקה מכשירDEVICENOVO NORDISK A/S

05/07/2004

04015740.6EP

PCT/EP/2005/053001WO/2006/003130

A61K18029511/07/2005

בגורמים שימוש ע"י בסרטן לטיפול שיטותWNT16 סיגנל המעכבים

METHODS FOR TREATING CANCER USING AGENTS THAT INHIBIT WNT16 SIGNALINGTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA

09/07/2004

60/586564US

20/01/2005

60/645709US

PCT/US/2005/024759WO/2006/017318


A61F18029628/07/2005

HIGHLY DEFORMABLE TAMPONצורה משנה טמפוןTHE PROCTER & GAMBLE COMPANY

28/07/2004

10/900950US

PCT/US/2005/026832WO/2006/015139

A61F18029706/07/2005

רב מספר ובעל בגז דחוס, מיוצב טמפוןקפלים של

A COMPRESSED, GAS-STABILIZED TAMPON HAVING MULTIPLE FOLDSTHE PROCTER & GAMBLE COMPANY

09/07/2004

10/887645US

PCT/US/2005/023975WO/2006/017098

A61F18029828/07/2005

פנימי מארז המכיל צורה משנה טמפוןחיצוני ומארז

DEFORMABLE TAMPON COMPRISING AN INNER WRAP AND OUTER WRAPTHE PROCTER & GAMBLE COMPANY

28/07/2004

10/900821US

PCT/US/2005/026833WO/2006/015140

F24J18029916/06/2005

SOLAR ENERGY COLLECTIONשמשית אנרגיה קליטת מערכותSYSTEMSHELIODYNAMICS LIMITED

24/06/2004

0414184.2GB


24/06/2004

0414183.4GB

PCT/GB/2005/050090WO/2006/000834

B23B18030225/12/2006

CUTTING TOOL INSERTחיתוך כלי תותבתSANDVIK INTELLECTUAL PROPERTY AB

30/12/2005

0502958-2SE

C07D18030329/06/2005

רוקחות ותכשירי אזאאינדול תולדותאותן המכילים

AZAINDOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMEVERTEX PHARMACEUTICALS INCORPORATED

30/06/200460/584383US

01/07/200460/584721US

04/04/200511/098751US

04/04/2005PCT/US05/11358US

PCT/US/2005/023429WO/2006/004984

G01N18030419/10/2001

רצפי קביעת עבור מסה פגמי התויתאוליגומרים

MASS DEFECT LABELING FOR THE DETERMINATION OF OLIGOMER SEQUENCESTARGET DISCOVERY, INC.

19/10/2000

60/242165US

19/10/2000

60/242398US


PCT/US/2001/049951WO/2002/066952

A61M18030525/12/2006

ADMINISTRATION SET WITH TWOמפתחות שני עם אינפוזיה סטKEYS

CAESAREA MEDICAL ELECTRONICSבע"מ רפואית אלקטרוניקה קיסריהLTD.

A61B18030625/12/2006

A DEVICE TO SHARE FEELINGSאנשים בין רגשות לשיתוף התקןAMONG PEOPLE

ISHAY PEREZפרץ ישי

A61H18030725/12/2006

INDIVIDUALLY ADAPTIVEאישית מותאמת החיאהRESUSCITATION

R. A. EREZ SYSTEMS LTDבע"מ מערכות ר.א.ארז

A23L18030825/12/2006

NATURAL SALT SUBSTITUTEלמלח טבעי תחליףGAN SHMUEL FOODS LTDבע"מ מזון שמואל גן

C07D18030913/07/2005

–2–)הטרואריל–אוקסי(–3 של נגזרות כליגנדים –אזא–ביציקלואלקיל1אלקיל–

של במחלות לטיפולNACHR–7 אלפא שלהמרכזית העצבים מערכת

3(-HETEROARYL-OXY-)2-ALKYL-1-AZA-BICYCLOALKYL DERIVATIVES AS ALPHA.7-NACHR LIGANDS FOR THE TREATMENT OF CNS DISEASESNOVARTIS AG

14/07/2004

0415746.7GB


PCT/EP/2005/007630WO/2006/005608

C02F18031018/07/2005

לטיהור מוצק קומפקטי דו–שכבתי מוצרמים

DOUBLE-LAYERED COMPACTED SOLID WATER-PURIFICATION PRODUCTEUROTAB

19/07/20040407968FR

PCT/FR/2005/001834WO/2006/016073

C07C18031113/07/2005

–4,4 חומצה של אסטרים להכנת תהליך–אוקסובוטנואית3דיפלואורו–

PROCESS FOR THE PREPARATION OF 4,4-DIFLUORO-3-OXOBUTANOIC ACID ESTERSSYNGENTA PARTICIPATIONS AG

14/07/2004

0415764.0GB

PCT/EP/2005/007635WO/2006/005612

C07D18031228/06/2005

קרבוקסאמיד של נגזרות להכנת תהליך של בסינתזה ביניים כחומרי לשימוש פירידין

NK–1 רצפטור של אנטגוניסטים

PROCESS FOR PREPARING CARBOXAMIDE PYRIDINE DERIVATIVES USED AS INTERMEDIATES IN THE SYNTHESIS OF NK-1 RECEPOR ANTAGONISTSF. HOFFMANN-LA ROCHE AG

06/07/2004

60/585779US

23/02/2005

60/655731US

PCT/EP/2005/006919WO/2006/002860


C07D18031323/06/2005

THIAZOLINONE UNSUBSTITUTEDתיאזולינון של בלתי–מותמרים קוינוליניםQUINOLINESF. HOFFMANN-LA ROCHE AG

01/07/2004

60/584746US

19/11/2004

60/629495US

PCT/EP/2005/006807WO/2006/002829

C07D18031411/08/2005

בנזואיק אמינו ציקליק חומצת של נגזרותחדשה

NOVEL CYCLIC AMINO BENZOIC ACID DERIVATIVE

KYORIN PHARMACEUTICAL CO., LTD.

11/08/2004

2004-234603JP

PCT/JP/2005/014718WO/2006/016637

B65D18031528/06/2005

FLOATING MULTI-CHAMBEREDנוזל מיכלי עבור צפה תאית רב תוספתINSERT FOR LIQUID CONTAINERSBALL PACKAGING EUROPE GMBH

09/07/2004

04016274.5EP

PCT/EP/2005/006955WO/2006/005440


C07D18031711/11/2005

AZAINDOLE CARBOXAMIDESאזאיינדולים קארבוקסאמידיםSCHWARZ PHARMA AG

12/11/2004

102004054634.7DE

PCT/EP/2005/012127WO/2006/050976

A01K18031828/06/2005

על המבוססת לסריקה כימרית מערכתיונקי ממקור שתלים והכוללת עופות

CHIMERIC AVIAN- BASED SCREENING SYSTEM CONTAINING MAMMALIAN GRAFTS

המרכז שליד תשתיות ופיתוח מחקרים קרןסוראסקי ע"ש אביב תל הרפואי

THE MEDICAL RESEARCH FUND AT THE TEL-AVIV SOURASKY MEDICAL CENTER

28/06/2004

60/582807US

PCT/IL/2005/000687WO/2006/001021

A61K18031913/07/2005

פצעים ריפוי עבור ושיטות תכשיריםדרמטולוגיים

COMPOSITIONS AND METHODS FOR DERMATOLOGICAL WOUND HEALING

MEDIWOUND LTDבע"מ מדיוונד13/07/2004

60/587057US

PCT/IL/2005/000744WO/2006/006167

F41G18034326/12/2006

הפעלה אפשרות לבדיקת בדיקה מערכת טילים מהתקרבות אזהרה מערכת של

מונחים

TEST APPARATUS FOR TESTING THE OPERABILITY OF A WARNING SYSTEM FOR APPROACHING GUIDED MISSILESRUAG AEROSPACE


12/01/2004

06075083.3EP

H04L18034411/05/2001

מהירה קצב להתאמת והתקן שיטה גבוה קצב בעל נתונים בשידור סגור במעגל

מארזים של

METHOD AND APPARATUS FOR FAST CLOSED-LOOP RATE ADAPTATION IN A HIGH RATE PACKET DATA TRANSMISSIONQUALCOMM INCORPORATED

12/05/2000

09/570210US

PCT/US/2001/015381WO/2001/089162

C07D18034519/07/2005

IMPROVED PROCESS FOR THEמירטאזאפין לייצור משופרת שיטהMANUFACTURE OF MIRTAZAPINEMEDICHEM, S.A.

22/07/2004

200401804ES

PCT/EP/2005/053493WO/2006/008302

F03G18034630/06/2004

TORQUE MULTIPLIERסיבובי מומנט מכפלGIL ALDRETE

28/06/2004PA/a/2004/006381MX

PCT/MX/2004/000041WO/2006/001686

A45D18034826/12/2006


עבור שיער לייבוש מרכזית מערכתמספרות

CENTRAL HAIR DRYING SYSTEM FOR HAIR SALONS

ELIYAHU SUISSAסוויסה אליהו

C07D18034915/07/2005

מוחלפי–אריל טטראהידרואיסוקוינולינים למנוע כדי בהם והשימוש והטרואריל

נוראפינפרין, דופאמין של מחודשת קליטהוסרוטנין

ARYL-AND HETEROARYL - SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONINBRISTOL-MYERS SQUIBB COMPANY

15/07/2004

60/588448US

PCT/US/2005/025193WO/2006/020049

A61K18035012/07/2005

מסיסות בעלי תרופות לאספקת תכשיריםבמים גבוהה

COMPOSITIONS FOR DELIVERING HIGHLY WATER SOLUBLE DRUGSSD PHARMACEUTICALS, INC.

12/07/2004

10/889226US

PCT/US/2005/024594WO/2006/017246

C07D18035130/06/2004

שאריתים אלכוהולים להפחתת תהליךקריסטליני הידרוכלוריד בוולציקלוויר

METHOD FOR REDUCING RESIDUAL ALCOHOLS IN CRYSTALLINE VALACYCLOVER HYDROCHLORIDE

TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.

PCT/US/2004/020903WO/2006/011874


C07C18035201/07/2005

–1,24( S) של קריסטליניות צורות2D ויטמין דיהידרוקסי

CRYSTALLINE FORMS OF 1,24(S) - DIHYDROXY VITAMIN D2


01/07/2004

60/584844US

23/09/2004

60/612914US

PCT/US/2005/023547WO/2006/025939

C07C18035328/06/2005

PROCESSES FOR THE PREPARATIONטומוקסטין להכנת תהליכיםOF TOMOXETINETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

28/06/2004

60/583641US

28/06/2004

60/583644US

28/06/2004

60/583643US

14/09/2004

60/609716US

25/10/2004

60/622065US

11/02/2005

60/652330US

11/02/2005

60/652331US

11/02/2005

60/652332US

30/03/2005

60/666666US

26/04/2005

60/675369US

09/06/2005

60/689778US

14/06/2005

60/690738US


PCT/US/2005/023412WO/2006/068662

C07C18035428/06/2005

הידרוכלוריד אטומוקסטין להכנת תהליךPROCESS FOR THE PREPARATION OF ATOMOXETINE HYDROCHLORIDETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

28/06/2004

60/583641US

28/06/2004

60/583644US

28/06/2004

60/583643US

14/09/2004

60/609716US

25/10/2004

60/622065US

11/02/2005

60/652330US

11/02/2005

60/652331US

11/02/2005

60/652332US

30/03/2005

60/666666US

26/04/2005

60/675369US

09/06/2005

60/689778US

14/06/2005

60/690738US

PCT/US/2005/023419WO/2006/004976

C07C18035528/06/2005

של ומיחזור אופטית לרזולוציה תהליךטומוקסטין

PROCESS FOR THE OPTICAL RESOLUTION AND RECYCLING OF TOMOXETINE


TEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

28/06/2004

60/583641US

28/06/2004

60/583644US

28/06/2004

60/583643US

14/09/2004

60/609716US

25/10/2004

60/622065US

11/02/2005

60/652330US

11/02/2005

60/652331US

11/02/2005

60/652332US

26/04/2005

60/675369US

30/05/2005

60/666666US

09/06/2005

60/689778US

14/06/2005

60/690738US

PCT/US/2005/023421WO/2006/004977

C07C18035628/06/2005

נקיים מנדלאט וטומוקסטין אטומוקסטיןאננטיומרית

ENANTIOMERICALLY PURE ATOMOXETINE AND TOMOXETINE MANDELATETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

28/06/2004

60/583641US

28/06/2004

60/583644US

28/06/2004

60/583643US

14/09/2004

60/609716US


25/10/2004

60/622065US

11/02/2005

60/652330US

11/02/2005

60/652331US

11/02/2005

60/652332US

30/03/2005

60/666666US

26/04/2005

60/675369US

09/06/2005

60/689778US

14/06/2005

60/690738US

PCT/US/2005/023273WO/2006/004923

C07C18035728/06/2005

אטומוקסטין, תהליכים של מבודד אי–נקיון אטומוקסטין, של אי–נקיונות להכנת

כסטנדרט ושימושם

AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDSTEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

28/06/2004

60/583641US

28/06/2004

60/583644US

28/06/2004

60/583643US

14/09/2004

60/609716US

25/10/2004

60/622065US

11/02/2005

60/652330US

11/02/2005

60/652331US

11/02/2005

60/652332US

30/03/2005

60/666666US


26/04/2005

60/675369US

09/06/2005

60/689778US

14/06/2005

60/690738US

PCT/US/2005/023423WO/2006/004979

C07D18035829/06/2005

CRYSTALLINE FORM IV OFלינזוליד שלV I קריסטלינית צורהLINEZOLID


29/06/2004

60/584371US

30/06/2004

60/584283US

12/08/2004

60/601086US

17/08/2004

60/602227US

07/12/2004

60/633887US

24/02/2005

60/656646US

24/02/2005

60/656778US

05/05/2005

60/678440US

24/05/2005

60/684410US

PCT/US/2005/023272WO/2006/004922

C07D18035929/06/2005

ותהליכים לינזוליד של מוצקות צורותלהכנתן

SOLID FORMS OF LINEZOLID AND PROCESSES FOR PREPARATION THEREOF


29/06/2004

60/584371US


30/06/2004

60/584283US

12/08/2004

60/601086US

17/08/2004

60/606227US

07/12/2004

60/633887US

05/05/2005

60/678440US

24/05/2005

60/684410US

PCT/US/2005/023066WO/2006/110155

C09C18036007/07/2005

יעד של זהה כמעט העתק לקביעת שיטהמידע

A METHOD FOR DETERMINING NEAR DUPLICATE DATA OBJECTS

EQUIVIO LTDבע"מ אקויויו21/07/2004

60/589596US

PCT/IL/2005/000726WO/2006/008733

A61K18036127/06/2005

ושליטה למניעה ושיטות תכשיריםאינסולין מושפעת בהיפוגליקמיה

COMPOSITIONS AND METHODS FOR THE PREVENTION AND CONTROL OF INSULIN-INDUCED HYPOGLYCEMIADIOBEX, INC.

29/06/2004

60/584449US

PCT/US/2005/022812WO/2006/004696

A61K18036308/07/2005

של אנלוגים עם וירטואלית קולונוסקופיה באופן המסומנים אתרים פוספוליפידים

רדיואקטיבי

VIRTUAL COLONOSCOPY WITH RADIOLABELLED PHOSPHOLIPID ETHER ANALOGS


CELLECTAR, LLC08/07/2004

60/521831US

PCT/US/2005/024259WO/2006/014589

C07K18036401/08/2005

המכיל פפטיד בתא נגד המכוונים נוגדניםבהם לשימוש ושיטות עמילן

ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAMERINAT NEUROSCIENCE CORPORATION

30/07/2004

60/592494US

14/02/2005

60/653197US

29/04/2005

60/676093US

PCT/US/2005/027295WO/2006/036291

A61B18036522/06/2005

CARBORANYLPORPHYRINS ANDושימושיהם קרבורנילפורפריניםUSES THEREOFBROOKHAVEN SCIENCE ASSOCIATES

28/06/2004

10/878138US

PCT/US/2005/022061WO/2006/012140


A61M18036628/06/2005

NASAL DILATOR AND USESושימושיו נחירי מרחיבTHEREOFALEXANDRE YAZDI

28/06/20040407085FR

PCT/FR/2005/001634WO/2006/010848

A61K18036729/06/2005

נפוצה טרשת של ומניעה לטיפול שיטהלפטוספירה בזיהום טיפול באמצעות

METHOD FOR MULTIPLE SCLEROSIS TREATMENT AND PROPHYLAXIS BY TREATMENT OF LEPTOSPIRA INFECTIONKOBENHAVNS UNIVERSITET

01/07/2004PA200401042DK

PCT/DK/2005/000444WO/2006/002631

A61B18036905/07/2005

של מכונה בעזרת לעיצוב ושיטה מכשירחולייתי צווארי גוף

INSTRUMENTS AND METHOD FOR MACHINING A CERVICAL VERTEBRAL BODYCERVITECH, INC.

23/07/2004

10/897404US

12/11/2004

10/897404US

PCT/EP/2005/007253WO/2006/010444

C07K18037013/07/2005

IMPROVED APROTININ VARIANTSאפרוטינין של משופרים וריאנטיםBAYER PHARMACEUTICALS CORPORATION

13/07/2004

60/587655US

PCT/US/2005/024951


WO/2006/017355

C07K18037121/07/2005

METHOD OF TREATING SJOGREN'Sסג'ורגן בסינדרום לטיפול שיטהSYNDROMEGENENTECH, INC.

22/07/2004

60/590302US

PCT/US/2005/026027WO/2006/012508

C03B18037223/06/2005

והתקן שיטה וכן גלים מנחה אופטי חומרלייצורו

OPTICAL WAVEGUIDE MATERIAL AS WELL AS METHOD AND DEVICE FOR PRODUCING ITLIEKKI OY

02/07/2004

20045264FI

PCT/FI/2005/050239WO/2006/003253

C07C18037327/06/2005

–3(–3 (–R 1 ,R 2)–(–) גבישיות צורות–מתילפרופיל(–2–אתיל–1דימתילאמינו–

כלוריד הידרו פנול

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDEGRUNENTHAL GMBH

28/06/2004

04015091.4EP

PCT/EP/2005/006884WO/2006/000441

B65C18037426/12/2006


בלחצים גזים לאחסון רב–תאי המיכלשונים

MULTICHAMBER TANK FOR GAS STORAGE UNDER DIFFERENT PRESSURE

ANGSTORE TECHNOLOGIES LTDבע" מ טכנולוגי אגנסטור

A23L18037526/12/2006

גורמת שצריכתו אופונטיה ממין קקטוס ומפחיתה משקל והפחתת התיאבון לוויסות

ולניקוטין לקופאין החשק את

THE OPUNTIA SPECIES OF THE CACTUS FAMILY WHICH ITS CONSUMPTION CAUSES A REDUCTION OF THE APPETITE AND THE EAGERNESS FOR CAFFEINE AND NICOTINE

MOTI SHEFERשפר מוטי

B65D18037626/12/2006

יש העליון שבחלקו כלים לניקוי לנוזל מיכלהספוג להנחת שקערורית

A TANK FOR LIQUID SOAP FOR CLEANING DISHES WHICH ON TOP OF IT THERE IS A CRATER FOR LEAVING THE SPONGE

MOSHE ABAROאברו משה

B65B18037730/06/2005

VACUUM PACKAGE SYSTEM ANDבריק לאריזה ושיטה מערכתMETHODWEST PHARMACEUTICAL SERVICES, INC.

01/07/2004

60/584826US

PCT/US/2005/023138WO/2006/028562


A61M18037812/07/2005

אבקתיות, ומערכת תרופות למתן משאףזה משאף עם לשימוש האבקה לאחסון

INHALER FOR THE ADMINISTRATION OF POWDERED PHARMACEUTICALS, AND A POWDER CARTRIDGE SYSTEM FOR USE WITH THIS INHALERLABORATORIOS ALMIRALL, S.A.

16/07/2004

60/588382US

PCT/EP/2005/007525WO/2006/008027

A61K18037913/07/2005

מדיספונקציה ההבראה לקידום גורם נוירולוגית מחלה של התקפה לאחר

מרכזית

AGENT FOR PROMOTING THE RECOVERY FROM DYSFUNCTION AFTER THE ONSET OF CENTRAL NEUROLOGICAL DISEASEASTELLAS PHARMA INC.

14/07/2004

2004-207234JP

PCT/JP/2005/012895WO/2006/006617

A61K18038006/07/2005

בוטולינום המכיל רוקחות תכשירניורוטוקסין

PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM NEUROTOXINIPSEN LIMITED

12/07/2004

0415491.0GB

PCT/GB/2005/002653WO/2006/005910


C07J18038101/08/2005

אסטרון של תולדות להכנת תהליך2 בעמדה המותמרים ואסטראדיאול

PROCESS FOR THE PREPARATION 2-SUBSTITUTED-DERIVATIVES OF ESTRONE AND ESTRADIOLN.V. ORGANON

04/08/2004

04103742.5EP

PCT/EP/2005/053732WO/2006/013196

C07D18038228/06/2005

מותמרים קווינאזולינון –אלקיל2 תולדותPARP כמעכבי

SUBSTITUTED 2-ALKYL QUINAZOLINONE DERIVATIVES AS PARP INHIBITORSJANSSEN PHARMACEUTICA N.V.

30/06/2004

04076887.1EP

PCT/EP/2005/053034WO/2006/003150

B65D18038320/06/2005

לשימוש ומוצר בוצי משקה להגשת שיטהזו בשיטה

METHOD OF SERVING A SLUSHY DRINK AND A PRODUCT FOR USE IN SUCHUNILEVER PLC

19/07/2004

04254314.0EP

PCT/EP/2005/006697WO/2006/007921

B23K18038814/06/2005


REDUCING PLASMA IGNITIONפלאזמה הצתת של בלחץ צמצוםPRESSURELAM RESEARCH CORPORATION

30/06/2004

10/883583US

PCT/US/2005/021098WO/2006/012003

H04B18038930/06/2005

METHOD OF VIDEO DATAוידיאו נתוני של לשידור שיטהTRANSMITTINGCOMET VIDEO TECHNOLOGY

30/06/2004

60/584364US

PCT/US/2005/023109WO/2006/004837

G06K18039030/06/2005

נתוני של דחיסה כולל וידיאו דחיסת שיטתוידיאו

METHOD OF DATA COMPRESSION INCLUDING COMPRESSION OF VIDEO DATACOMET VIDEO TECHNOLOGY

30/06/2004

60/584102US

PCT/US/2005/023133WO/2006/004847

B65D18039128/06/2005

של בצורה העשויה חד–פעמית אריזה עבור יציאה בפתח אוכל, מצויד כלי

ריחות

READY-MADE DISH DISPOSABLE PACKAGING, EQUIPPED OF VENT DEVICE FOR INNER VAPORSDEVELPACK S.R.L.

28/06/2004CS2004A000006IT

27/06/2005CZ2005A000011IT

PCT/IT/2005/000371June 3, 2007495 –התשס"ז בסיון י"ז

WO/2006/001048

G06Q18039227/12/2006

נכסים של חוזרת למכירה ומערכת שיטהתקשורת רשת דרך

METHOD AND SYSTEM FOR RESELLING OF ASSETS THROUGH COMMUNICATION NETWORK

YACOV KORMANוייסמן שמואל12/12/2006

11/609366US

G06F18039316/06/2005

A METHOD FOR DETECTING OFרצויים לא אקסקיוטבלים לזיהוי שיטהUNWANTED EXECUTABLES

ALADDIN KNOWLEDGE SYSTEMSבע"מ מידע מערכות אלדיןLTD.

14/07/2004

10/890170US

PCT/IL/2005/000648WO/2006/006144

A61C18039406/02/2006

הברגה, מקבל מסוג תוך–עצמיים שתלים ורכיבים אחת בחתיכה חיצונית מושחל

הקשורים ומשענות נוחות להעברה, כיסויילהם

ONE-PIECE, SCREW-RECEIVING, EXTERNALLY-THREADED ENDOSSEOUS DENTAL IMPLANTS AND RELATED TRANSFER COMPONENTS, COMFORT CAPS AND ABUTMENTSGERALD A. NIZNICK

11/02/2005

11/056578US

PCT/US/2006/004052WO/2006/088680

G01N18039601/06/2005

METHOD FOR DETECTING GLUTENגלוטן לזיהוי שיטהJune 3, 2007 496 –התשס"ז בסיון י"ז

ACADEMISCH ZIEKENHUIS LEIDEN30/06/2004

04076902.8EP

PCT/NL/2005/000400WO/2006/004394

C07C18039719/07/2005

פטריות קוטלי , תכשירים דיאמין תולדותלהכנתן ותהליכים אותן המכילים

DIAMINE DERIVATIVES, FUNGICIDAL COMPOSITIONS CONTAINING THE SAME, AND PROCESSES FOR THE PREPARATION THEREOFMITSUI CHEMICALS, INC.

21/07/2004

2004-213208JP

27/01/2005

2005-019032JP

PCT/JP/2005/013233WO/2006/009134

C09D18039907/07/2005

בעובדים קורוזיה לבקרת ציפוי תכשיר להכנתו, ועובדים מתכתיים, שיטות

איתו מצופים מתכתיים

CORROSION CONTROL COATING COMPOSITION FOR METAL WORKPIECES, METHODS FOR THE PRODUCTION THEREOF AND METAL WORKPIECES COATED THEREWITHEWALD DORKEN AG

16/07/2004

102004034645.3DE


PCT/EP/2005/007360WO/2006/007985

H01M18040028/12/2006

בבית חשמל לייצר שיטהMETHOD FOR PRODUCING ELECTRICITY IN HOME FROM WASTE

SARAH MOGRABIמוגרבי שרה

E05C18040128/12/2006

דלתות בין ידיים לאצבעות הגנה מנגנוןומשקופים

MECHANISM, ELEMENT FOR PROTECTION OF FINGERS IN DOORS AND GATES

VICTOR BEN DAVID YOSSEFיוסף דוד בן ויקטור

H04L18040222/07/2005

מרוחקת גישה לאבטחת ומערכות שיטהפרטיות לרשתות

A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKSCITRIX SYSTEMS, INC.

23/07/2004

60/590837US

13/08/2004

60/601431US

03/09/2004

60/607420US

07/12/2004

60/634379US

PCT/US/2005/026300WO/2006/012612

H04L18040322/07/2005


A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKS


CITRIX SYSTEMS, INC.23/07/2004

60/590837US

13/08/2004

60/601431US

03/09/2004

60/607420US

07/12/2004

60/634379US

PCT/US/2005/026300WO/2006/012612

H04L18040422/07/2005



23/07/2004

60/590837US

13/08/2004

60/601431US

03/09/2004

60/607420US

07/12/2004

60/634379US

PCT/US/2005/026300WO/2006/012612

H04L18040522/07/2005



23/07/2004

60/590837US

13/08/2004

60/601431US


03/09/2004

60/607420US

07/12/2004

60/634379US

PCT/US/2005/026300WO/2006/012612

E02D18040628/12/2006

SCREW-PILE SYSTEMSכלונס–בורגי מערכות (1975) הנדסיים ושות' שירותים ליפסקר

בע"מLIPSKER & PARTNERS ENGINEERING SERVICES (1975) LTD.

B25G18040719/10/2004

כלי או מכשיר עבור קבוע ידית של מערכתידני

HANDLE-FIXING SYSTEM FOR HAND TOOL OR UTENSILPEDRO JOSE ZUBIAURRE ALBERDI

01/10/2004

200402342ES

01/10/2004

200402343ES

PCT/ES/2004/000449WO/2006/045855

B65D18040827/07/2005

WATER STORAGE EVAPORATIONמאוחסנים מים נידוף על בקרהCONTROLWATER INNOVATIONS PTY LTD.

28/07/2004

2004904178AU

02/08/2004

2004904282AU

04/11/2004

2004906329AU

23/03/2005

2005901415AU

PCT/AU/2005/001094WO/2006/010204


C07D18040928/06/2005

PARPQUINAZOLINEDIONE DERIVATES AS כמעכבות קווינאזולינדיאון תולדותPARP INHIBITORSJANSSEN PHARMACEUTICA N.V.

30/06/2004

04076885.5EP

PCT/EP/2005/053031WO/2006/003148

C07D18041028/06/2005

PARPPHTHALAZINE DERIVATIVES AS כמעכבי פטאלזין תולדותPARP INHIBITORSJANSSEN PHARMACEUTICA N.V.

30/06/2004

04076886.3EP

PCT/EP/2005/053030WO/2006/003147

C07D18041128/06/2005

PARPQUINAZOLINONE DERIVATIVES AS כמעכבי קווינאזולינון תולדותPARP INHIBITORSJANSSEN PHARMACEUTICA N.V.

30/06/2004

04076887.1EP

PCT/EP/2005/053029WO/2006/003146

A47G18041228/12/2006

DREAM SHEETחלומית וסדינית סדיןANAT BEN-DOV TZABARIצברי בן-דוב ענת


C07C18041313/07/2005

METHOD OF CRYSTALLIZATION OFביקאלוטאמיד של התגבשות תהליךBICALUTAMIDESUMITOMO CHEMICAL COMPANY, LIMITED.

14/07/2004

2004-207709JP

PCT/JP/2005/013346WO/2006/006736

B32B18041529/06/2005

מבחינה יעילות מבודדות בניה מעטפותאנרגית

ENERGY EFFICIENT AND INSULATED BUILDING ENVELOPESASPEN AEROGELS, INC

29/06/2004

60/583940US

07/10/2004

60/616887US

PCT/US/2005/023677WO/2006/002440

A61J18041729/06/2005

TEATפטמהJACKEL INTERNATIONAL LIMITED

29/06/2004

0414560.3GB

08/02/2005

0502599.4GB

PCT/GB/2005/002532WO/2006/000816

C12Q18041830/06/2005

הכבד הצטלקות קצב לחיזוי וערכות שיטותC מסוג הכבד בדלקת כרוניים בחולים

METHODS AND KITS FOR PREDICTING LIVER FIBROSIS PROGRESSION RATE IN CHRONIC HEPATITIS C PATIENTS




01/07/2004

60/584179US

PCT/IL/2005/000700WO/2006/003654

C07K18041906/07/2005

CYCLIC PEPTIDES FOR TREATMENTבהתנוונות לטיפול ציקליים פפטידיםOF CACHEXIAPALATIN TECHNOLOGIES, INC.

06/07/2004

60/585971US

05/07/2005

11/174845US

PCT/US/2005/024125WO/2006/014552

C07K18042006/07/2005

CYCLIC PEPTIDES FOR TREATMENTבהתנוונות לטיפול ציקליים פפטידיםOF CACHEXIAPALATIN TECHNOLOGIES, INC.

06/07/2004

60/585971US

05/07/2005

11/174851US

PCT/US/2005/024138WO/2006/014559

C07F18042104/07/2005

קישור בעלי '–דיפוספינופרוצנים1,1 או אכיראלים ' לרדיקלים2, 2 בעמדה

כיראלים

1,1 -'DIPHOSPHINOFERROCENES HAVING 2, 2' - BOUND ACHIRALS OR CHIRAL RADICALSSOLVIAS AG

05/07/20041126/04CH

26/10/20041773/04CH


10/11/20041853/04CH

PCT/EP/2005/053171WO/2006/003196

C07C18042419/07/2005

הלומתיל תרכובות של סינתזהארומטיות פוליהלוגנטיות

SYNTHESIS OF AROMATIC POLYHALOGENATED HALOMETHYL COMPOUNDS

.BROMINE COMPOUNDS LTDבע"מ ברום תרכובות19/07/2004163101IL

PCT/IL/2005/000768WO/2006/008738

C07D18042617/06/2005

הטרואריל של מותמרות תרכובותופנילסולפמואיל

SUBSTITUTED HETEROARYL - AND PHENYLSULFAMOYL COMPOUNDSPFIZER PRODUCTS, INC.

29/06/2004

60/583721US

PCT/IB/2005/002007WO/2006/003495

B60R18042728/12/2006

SYSTEM FOR ENCOURAGING USINGבטיחות בחגורת השימוש לעידוד מערכתA SEATBELT

YOSSEF COHENפרידמן ליאור

C08J18042819/07/2005

NOVEL FLAME-RETARDANTחדשים בעירה – מונעי פוליסטיריניםPOLYSTYRENES

.BROMINE COMPOUNDS LTDבע"מ ברום תרכובות19/07/2004163100IL

PCT/IL/2005/000767June 3, 2007 504 –התשס"ז בסיון י"ז

WO/2006/013554

C07F18042904/07/2005

TETRADENTATE FERROCENEושימושם פרוצין טטרהדנטאט של ליגנדיםLIGANDS AND THEIR USESOLVIAS AG

05/07/20041126/04CH

26/10/20041773/04CH

10/11/20041853/04CH

PCT/EP/2005/053170WO/2006/003195

C07D18043012/07/2005

PYRIDINE DERIVATIVESפירידין של נגזרותPFIZER INC.

23/07/2004

0416524.7GB

21/01/2005

60/646077US

PCT/IB/2005/002214WO/2006/011050

C07F18043101/07/2005

המשמשות אמינו חומצות להכנת תהליךפפטיד של לרצפטור מודולטורים בהכנת

PROCESS FOR THE PREPARATION OF AMINO ACIDS USEFUL IN THE PREPARATION OF PEPTIDE RECEPTOR MODULATORSBRISTOL-MYERS SQUIBB COMPANY

02/07/2004

60/584968US


PCT/US/2005/023363WO/2006/014324

C07D18043201/07/2005

CETPCETP INHIBITORS מעכביMERCK & CO., INC.

02/07/2004

60/585274US

21/01/2005

60/646103US

PCT/US/2005/023546WO/2006/014357

C07F18043329/06/2005

HIVPRODRUGS OF HIV PROTEASE פרוטאזת מעכבי של פרודרגיםINHIBITORSABBOTT LABORATORIES

06/07/2004

60/585710US

PCT/US/2005/023047WO/2006/014282

C07K18043430/06/2005

גלוקאגון דמוי1 – פפטיד של מודולטורים ומצבים בסכרת בטיפול ושימושיהם אנושי

קשורים

HUMAN GLUCAGON - LIKE - PEPTIDE - 1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONSBRISTOL-MYERS SQUIBB COMPANY

02/07/2004

60/585358US

26/05/2005

60/684805US

PCT/US/2005/023076WO/2006/014287


H04M18043528/02/2001

בחשמל מאומת לא שימוש לגילוי שיטהכח קווי דרך מועבר

METHOD OF DETECTING UNAUTHORIZED USAGE OF ELECTRICITY TRANSMITTED OVER POWER LINESQUADLOGIC CONTROLS CORPORATION

29/02/2000

60/185832US

PCT/US/2001/006573WO/2001/065823

G06K18043630/06/2005

עזר – סוללת בעלRFID משיב – משדראחורי פיזור עם

BATTERY-ASSISTED BACKSCATTER RFID TRANSPONDER

POWERID LTDבע"מ פאואראיידי01/07/2004

60/584141US

18/08/2004

60/602342US

09/09/2004

60/608118US

01/10/2004

60/614552US

04/02/2005

60/649561US

PCT/IL/2005/000694WO/2006/003648

A61L18043730/06/2005

רכה רקמה שתל ומימדי צורה ניהולגזע תאי באמצעות

SHAPE AND DIMENSION MAINTENANCE OF SOFT TISSUE GRAFTS BY STEM CELLS


THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS

30/06/2004

60/584657US

PCT/US/2005/023318WO/2006/004951

A47K18043828/12/2006

AMENITIES CASEנוחות מארז

BR-GO INTERNATIONAL TRADEמוגבלת שותפות בינלאומי סחר בר-גוLIMITED PARTNERSHIP

B65H18043930/06/2005

חומר של בליפוף לשליטה ושיטות מערכותלינארי

SYSTEMS AND METHODS FOR CONTROLLING SPOOLING OF LINEAR MATERIALGREAT STUFF, INC.

01/07/2004

60/584797US

02/07/2004

60/585042US

PCT/US/2005/023652WO/2006/007582

G21K18044028/12/2006

COMPACT SOURCE WITH VERY בהירהX קרן עם דחוס מקורBRIGHT X - RAY BEAMALCATEL LUCENT

03/01/20060650007FR


C07D18044122/07/2005

– איל( – פירימידינים2– – )פירידין2 פטריות על לבקרה בהם ושימוש

פתוגניות

2( - PYRIDIN - 2 - YL - )PYRIMIDINES AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGIBASF AKTIENGESELLSCHAFT

23/07/2004

102004035736.6DE

PCT/EP/2005/008039WO/2006/010570

C09D18044214/07/2005

באמצעות לריפוי הניתנים להזרקה דיובהם לשימוש ושיטות לייצור קרינה, שיטה

RADIATION CURABLE INKJET INKS, METHOD OF MANUFACTURE, AND METHODS OF USE THEREOFHEXION SPECIALTY CHEMICALS, INC.

16/07/2004

60/588921US

04/10/2004

60/615756US

02/06/2005

60/686768US

PCT/US/2005/025074WO/2006/085992

H04L18044301/07/2005

MIMOADVANCED MIMO INTERLEAVING ל מתקדם אינטרליבינגQUALCOMM INCORPORATED

01/07/2004

60/585246US

19/07/2004

60/589390US

11/08/2004

60/600962US

PCT/US/2005/023594WO/2006/007571


H04N18044401/07/2005

קצב של בטכניקות לשימוש ומתקן שיטה לפי וידיאו בהצפנות למעלה המרה מסגרתסקלה

METHOD AND APPARATUS FOR USING FRAME RATE UP CONVERSION TECHNIQUES IN SCALABLE VIDEO CODINGQUALCOMM INCORPORATED

01/07/2004

60/585154US

22/03/2005

60/665816US

PCT/US/2005/023333WO/2006/007527

B29D18044516/07/2004

STRETCH FILMאלסטי פיליםMEGAPLAST S.A.

PCT/EP/2004/007965WO/2006/018028

G06F18044623/06/2005

לתהליך גרף אפליקציית של בקר–מציגאובייקט

OBJECT PROCESS GRAPH APPLICATION CONTROLLER-VIEWERGRAPHLOGIC INC.

16/07/2004

60/588465US

20/05/2005

10/908653US

PCT/US/2005/022192WO/2006/019506


C12N18044713/07/2005

MEDIUM FOR GROWING HUMANאדם בן עובר של גזע תאי לגידול מצעEMBRYONIC STEM CELLSGERON CORPORATION

13/07/2004

60/587843US

01/03/2005

60/657990US

PCT/US/2005/025179WO/2006/017370

B23B18044828/12/2006

CLAMPING APPARATUSמלחציים מתקןF-TOOL INTERNATIONAL AG

30/01/200600151/06CH

C07K18044911/12/1997

תרכובות המכילות פרמצבטיות נוסחאות תרופות להעברת במים מסיסה שאינה

מתמשכת

PHARMACEUTICAL FORMULATIONS COMPRISING A WATERINSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERYPRAECIS PHARMACEUTICALS INCORPORATED

11/12/1996

08/762747US

PCT/US/1997/022881WO/1998/025642

C07K18045011/12/1997

תרכובות המכילות פרמצבטיות נוסחאות תרופות להעברת במים מסיסה שאינה

מתמשכת

PHARMACEUTICAL FORMULATIONS COMPRISING A WATERINSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERYPRAECIS PHARMACEUTICALS INCORPORATED


11/12/1996

08/762747US

PCT/US/1997/022881WO/1998/025642

A61L18045107/07/2005

בשימוש גבוהה ברמה לחיטוי ותכשיר שיטהרביעוני אמוניום הרכבי

METHOD AND COMPOSITION FOR HIGH LEVEL DISINFECTION EMPLOYING QUATERNARY AMMONIUM COMPOUNDSNANOSONICS PTY LIMITED

09/07/2004

2004903796AU

PCT/AU/2005/000997WO/2006/005108

B60H18045231/12/2006

ACTIVE VENTILATING SYSTEM FORרכב עבור פעיל אוורור מערכתVEHICLE

GIL AVRAHAMאברהם גיל

B60H18045331/12/2006

A BATHTUBאמבטיהLIAV DAVIDדויד רונלי ליאב

G06Q18045431/12/2006

METHOD & SYSTEM FORאלקטרוני תשלום לניתוב ומערכת שיטהELECTRONIC PAYMENT ROUTING

EHUD ZIEGELMANציגלמן אהוד

A47G18045505/04/2002


לדברי קולב עבר להסרה הניתן גודל מצייןלבוש

REMOVABLE SIZE INDICATOR FOR A GARMENT HANGERSPOTLESS PLASTICS PTY. LTD.

05/04/2001827072US

PCT/US/2002/010750WO/2002/080741

A61M18045630/06/2005

SYRINGE DEVICE HAVING VENTINGאוורור מערכת עם הזרקה התקןSYSTEMWEST PHARMACEUTICAL SERVICES, INC.

01/07/2004

60/584893US

PCT/US/2005/023754WO/2006/007592

C07K18045801/07/2005

PEPTIDE ANTIBIOTICS ANDלהכנתה ושיטות מפפטיד אנטיביוטיקהMETHODS FOR MAKING SAMEBIOSOURCE PHARM, INC.

01/07/2004

10/881160US

PCT/US/2005/023343WO/2006/083317

C07K18045901/07/2005

TREATMENT OF BACTERIALבקטרייאלים בזיהומים טיפולINFECTIONSNEUTEC PHARMA PLC

02/07/2004

0414886.2GB

PCT/GB/2005/002607WO/2006/003426


A61K18046030/06/2005

TREATMENT OF CANCERבסרטן טיפולNEUTEC PHARMA PLC

02/07/2004

0414885.4GB

20/09/2004

0420845.0GB

30/09/2004

60/614423US

21/02/2005

0503566.2GB

22/02/2005

60/654458US

PCT/GB/2005/002545WO/2006/003384

A61L18046125/06/2005

המכילות תרחיף פורמולציות תרסיסEA 277 TGאו A 134 TGמניע כחומר

AEROSOL SUSPENSION FORMULATIONS CONTAINING TG 227 EA OR TG 134 A AS A PROPELLANTBOEHRINGER INGELHEIM INTERNATIONAL GMBH

02/07/2004

102004032322.4DE

17/05/2005

102005023334.1DE

PCT/EP/2005/006865WO/2006/002840

A47C18046231/12/2006

INTELLIGENT CHILD SAFETY SEATהילד לבטיחות חכם כסאASHER S. SABANש. סבן אשר

30/03/2006174634IL

A45D18046306/07/2004

SHAVER WITH HAIR PREHEATINGהשיער של מקדים חימום עם גילוח מכשירRADIANCY INC.


PCT/IL/2004/000603WO/2006/003642

A45D18046406/07/2004

להרחקת אלמנט עם חשמלי גילוח מכשירפסולת

ELECTRIC SHAVER WITH DEBRIS REMOVAL ELEMENTRADIANCY INC.

PCT/IL/2004/000602WO/2006/003641

A45D18046506/07/2004

IMPROVED ELECTRIC SHAVERמשופר חשמלי גילוח מכשירRADIANCY INC.

PCT/IL/2004/000604WO/2006/003643

B64C18046724/06/2005

HYBRID AIRCRAFTהיברידי מטוסSIMICON AS

02/07/2004

20042823NO

PCT/NO/2005/000228WO/2006/004416


A01H18046801/07/2005

WATERMELON WITH IMPROVEDמשופרות עיבוד תכונות בעל אבטיחPROCESSING QUALITIESSEMINIS VEGETABLE SEEDS, INC.

02/07/2004

60/584964US

22/10/2004

10/972190US

31/03/2005

2005201372AU

PCT/US/2005/023902WO/2006/014463

A61F18046931/12/2006

VASCULAR ACCESS SYSTEM ANDלווריד לחדירה ושיטה מערכתMETHOD

OFER SELAסלע עופר

A61K18047029/06/2005

שימוש נגד מוגנת פומית מינון צורתלרעה

ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSEGRUNENTHAL GMBH

01/07/2004

102004032049.7DE

14/07/200410/890763US

PCT/EP/2005/006984WO/2006/002884

A61K18047126/06/2005


שימוש נגד מוגנת פומית מינון צורת–3(–3 (–R 1 , R 2) הכוללת לרעה

–2–אתיל–1דימתילאמינו–מתיל–פרופיל(–פניל

ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE CONTAINING (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOLGRUNENTHAL GMBH

01/07/2004

102004032103.5DE

14/07/200410/890707US

PCT/EP/2005/006990WO/2006/002886

H01L18047201/01/2007

חשמל ליצירת הידראולית מערכתנפח שינויי באמצעות

A SYSTEM FOR ELECTRICITY CREATION BY HYDRAULIC VOLUMETRIC REPLACEMENT

KLUGERMAN VLADIMIRרומן קלוגרמן

A61M18047321/07/2005

להתקן ממשק לאספקת ומערכות שיטהאינפוזיה

METHOD AND SYSTEMS FOR PROVIDING AN INFUSION DEVICE INTERFACEANIMAS CORPORATION

21/07/2004

60/589623US

PCT/US/2005/025931WO/2006/012446

H05K18047501/01/2007

בלוח אופטי סיב של חלקי לקיבוע שיטהמודפס מעגלים

METHOD OF PARTIALLY EMBEDDING OPTICAL FIBER IN MULTILAYER PRINTED CIRCUIT BOARD

.ELTEK LTDבע"מ אלטק


H05K18047601/01/2007

דרך אופטיים אותות לשידור ישירה דרךמודפס מעגלים לוח

STRAIGHTFORWARD OPTICAL VIA FOR SIGNAL TRANSMISSION THROUGH A PRINTED CIRCUIT BOARD

.ELTEK LTDבע"מ אלטק

G09B18047701/01/2007

דיגיטלי ותיקון להגהה ושיטה מערכתפגישה בתוך ורב–צדדי

SYSTEM AND METHOD FOR DIGITAL MULTI-LATERAL PROOFREADING DURING A MEETING

D. SIT TRADE LTDבע"מ סחר די.סיט

C07C18047930/09/2005

IMPROVED SYNTHESIS SCHEME FORללקוסאמיד משופרת סינתזה סכימתLACOSAMIDESCHWARZ PHARMA AG

02/10/2004

04023556.6EP

PCT/EP/2005/010603WO/2006/037574

D01F18048014/07/2005

של מננוטובים מרוכב סיב לעשיית תהליך מולרית מסה בעל פחמן/פוליאתילן

גבוהה אולטרה

PROCESS FOR MAKING A CARBON NANOTUBES/ ULTRA-HIGH MOLAR MASS POLYETHYLENE COMPOSITE FIBREDSM IP ASSETS B.V.

27/07/2004

04077162.8EP

PCT/EP/2005/007816WO/2006/010521


C07D18048120/07/2005

ARYL-PYRIDINE DERIVATIVESאריל–פירידין של נגזרותF. HOFFMANN-LA ROCHE AG

28/07/2004

04103639.3EP

PCT/EP/2005/007894WO/2006/010546

G01N18048201/01/2007

באמצעות קטנים תווים של בדיקהרנטגן קרני של פלואורסצנזיה

INSPECTION OF SMALL FEATURES USING X - RAY FLUORESCENCE

JORDAN VALLEYבע"מ סמיקונדקטורס ואלי ג'ורדןSEMICONDUCTORS LTD.

G11C18048301/07/2005

ידי על דינמי ריענון לשיפור ושיטה מערכת מוליך זיכרון בהתקן טמפרטורה מדידת

למחצה

APPARATUS AND METHOD FOR IMPROVING DYNAMIC REFRESH IN A SEMICONDUCTOR MEMORY DEVICE BY TEMPERATURE MEASUREMENTQUALCOMM INCORPORATED

02/07/2004

60/585310US

10/06/2005

11/150649US

PCT/US/2005/023334WO/2006/014315

C07D18048420/07/2005


און, הכנתן3–ארילמורפולינ–4 תולדותהרפואי ושימושן

4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOFSANOFI-AVENTIS

23/07/20040408222FR

PCT/FR/2005/001852WO/2006/021654

H01S18048503/08/2005

SOLID-STATE SUSPENSION LASERמוצקה סוספנסיה לייזרRAYTHEON COMPANY

10/08/2004

10/915229US

PCT/US/2005/027472WO/2006/026037

C07D18048605/08/2005

אמינים עם בנזימידאזול תולדת של מלחיםלייצרה ותהליך

SALTS OF BENZIMIDAZOLE DERIVATIVE WITH AMINES AND PROCESS FOR PRODUCTION THEREOFEISAI R&D MANAGEMENT CO. LTD.

06/08/2004

2004-230094JP

PCT/JP/2005/014400WO/2006/013960

A61K18048708/07/2005

MEDICAMENTתרופהAIMSCO LIMITED

08/07/2004

0415359.9GB

21/10/2004

0423386.2GB

PCT/GB/2005/050108WO/2006/021814


C07D18048825/07/2005

מותמרות, הכנתן ציקליות אוריאה תולדותקינאז כמעכבי שלהן הפרמצבטי והשימוש

SUBSTITUTED CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF OF KINASE INHIBITORSAVENTIS PHARMA S.A.

27/07/2004

04291903.5EP

PCT/EP/2005/008722WO/2006/010643

H04Q18048904/07/2005

התקן של גאופרפי לאיתור ומערכת שיטהסלולרי

SYSTEM AND METHOD FOR GEOGRAPHICALLY LOCATING A CELLULAR DEVICEITIS UK LIMITED

09/07/2004

10/888631US

PCT/GB/2005/002637WO/2006/005906

C07K18049006/07/2005

CYCLIC PEPTIDESציקליים פפטידיםPALATIN TECHNOLOGIES, INC.

06/07/2004

60/585971US

05/07/2005

11/174851US

PCT/US/2005/024125WO/2006/014552

C07K18049106/07/2005

CYCLIC PEPTIDESציקליים פפטידיםPALATIN TECHNOLOGIES, INC.


06/07/2004

60/585971US

05/07/2005

11/174851US

PCT/US/2005/024138WO/2006/014559

B65D18049215/06/2005

דרגת עם חומרים להנפקת ושיטה התקןגבוהה נקיון

APPARATUS AND METHOD FOR DISPENSING HIGH PURITY MATERIALSMALLINCKRODT BAKER, INC.

06/07/2004

60/585663US

21/10/2004

60/621030US

PCT/US/2005/021234WO/2006/014225

C07D18049330/06/2005

–5,5–מתוקסימתיל–1 להכנת תהליךברביטורית דיפניל–חומצה

A PROCESS FOR PREPARING 1-METHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID

TARO PHARMACEUTICALבע"מ רוקחית תעשיה תרוINDUSTRIES LTD.

02/07/2004

60/584955US

PCT/IL/2005/000697WO/2006/003651

C07D18049520/07/2005

רברס כמעכבי טריאזולון תרכובותנוקלאוטידים שאינם טרנסקריפטאז

BENZYLTRIAZOLONE COMPOUNDS AS NIN-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORSF. HOFFMANN-LA ROCHE AG

27/07/2004

60/591311US

PCT/EP/2005/007893


WO/2006/010545

G01N18049607/07/2005

מטענים ריכוז מדידת ו/או לגילוי חיישן חשמליים

לייצורו והשיטה בו אטמוספירם, שימושים

SENSOR FOR DETECTING AND/OR MEASURING CONCENTRATION OF ELECTRIC CHARGES CONTAINED IN AN ATMOSPHERE, CORRESPONDING USES AND METHOD FOR MAKING SAMEUNIVERSITE DE RENNES 1

07/07/20040407583FR

PCT/FR/2005/001761WO/2006/013289

A61B18049730/06/2005

BIOLOGICAL TISSUE CLOSUREביולוגית רקמה של לסגירה ושיטה התקןDEVICE AND METHODBRUCE D. MODESITT

10/07/2004

10/888682US

PCT/US/2005/023107WO/2006/017023

C07J18049812/07/2005

PROCESS FOR PRODUCTION OFסטרואידים ליצירת תהליךSTEROIDS


MITSUBISHI CHEMICAL CORPORATION

13/07/2004

2004-205515JP

23/07/2004

2004-215304JP

PCT/JP/2005/013216WO/2006/006718

C09D18049905/07/2005

מים מסיסי אקריליים בקופולימרים שימושותמיסות צבעוניות מים בתמיסות

USE OF WATER-SOLUBLE ACRYLIC COPOLYMERS IN OPTIONALLY PIGMENTED AQUEOUS FORMULATIONS AND RESULTING FORMULATIONSCOATEX S.A.S.

08/07/20040407570FR

PCT/FR/2005/001714WO/2006/016035

A01G18050002/01/2007

השקיה מערכת באמצעות מנהרות הריסתבטפטוף

TUNNEL DISTRACTION WITH DRIP IRRIGATION SYSTEM

RONI BEN AVRAHAMספורטס( משפחת )לידי אברהם בן רוני

A47G18050102/07/2005

CROWN SIZERגודל ממינת כותרתMAINETTI S.P.A.

09/07/2004

VI 2004 A 000168IT

14/01/2005

VI 2005 A 000007IT

PCT/EP/2005/007172WO/2006/005467


C12Q18050213/12/2004

חומצות ללכידת מוצקה בפזה חומריםגרעין

SOLID PHASE MATERIALS FOR BINDING NUCLEIC ACIDSLUMIGEN, INC.

15/07/2004

10/891880US

PCT/US/2004/039762WO/2006/019388

C12Q18050330/06/2005

מחומרים גרעין חומצות לשחרור שיטותמוצקה בפזה מלכדים

METHODS FOR RELEASING NUCLEIC ACIDS FROM SOLID PHASE BINDING MATERIALSLUMIGEN, INC.

15/07/2004

10/891880US

PCT/US/2005/023916WO/2006/019568

C12Q18050413/12/2004

מפזות גרעין חומצות לבידוד שיטותלביקוע שניתנות מוצקות

METHODS FOR ISOLATING NUCLEIC ACIDS FROM CLEAVABLE SOLID PHASESLUMIGEN, INC.

15/07/2004

10/891880US

PCT/US/2004/039761WO/2006/019387

B65H18050504/07/2005

ELECTRIC HOSE WINDERחשמלי צינורות מגוללXU XIAOHUA

13/04/2005

200520101572.5CN

PCT/CN/2005/000974WO/2006/108327


B65D18050602/01/2007

A FOLDING, STORAGE ANDונשיאה קיפול, אחסון מתקןCARRYING DEVICE

SHAY DAGANדגן שי

H01B18050702/01/2007

ומכרסמים מים בפני ועמיד גמיש כבל תקשורת ככבל לשימוש במיוחד המתאים

אופטי

HIGHLY FLEXIBLE WATER-PROOF, RODENT-PROOF CABLES PARTICULARLY USEFUL AS OPTICAL COMMUNICATION CABLES

.TELDOR WIRES AND CABLES LTDבע"מ וכבלים מוליכים טלדור

C07D18050829/06/2005

לשימוש מותמרים פירימידינים של קולטנים של כמודולטורים

גלוקוקורטיקואיד

MODIFIED PYRIMIDINE GLUCOCORTICOID RECEPTOR MODULATORSCORCEPT THERAPEUTICS, INC.

02/07/2004

60/585018US

PCT/US/2005/023675WO/2006/014394

A61N18050905/07/2005

DELIVERY SYSTEM FORהעור דרך לחיסון הולכה מערכתTRANSDERMAL IMMUNIZATION

.TRANSPHARMA MEDICAL LTDבע"מ מדיקל טראנספארמה


06/07/2004

60/585081US

PCT/IL/2005/000710WO/2006/003659

G06F18051004/07/2005

CRUSH MODELLINGהתנגשות מודלENGENUITY LIMITED

02/07/2004

0414992.8GB

31/08/2004

0419292.8GB

PCT/GB/2005/002627WO/2006/003438

H01M18051108/07/2005

–דלק תא של לאלקטרודות זרזים שלה, הכנה וסגסוגות פלטינה מבוסס המכילים שלהם, ותאי–דלק ושימושאותם

CATALYSTS FOR FUEL CELL ELECTRODES BASED ON PLATINUM AND ITS ALLOYS, THE PREPARATION AND USE THEREOF, AS WELL AS FUEL CELLS CONTAINING THEMACTA S.P.A.

09/07/2004FI2004A000154IT

PCT/EP/2005/053270WO/2006/005724

C07C18051207/07/2004

–4) של וניקוי לסינתזה תהליך –4מתוקסיבוטיל( )

טריפלואורומתילפניל( מתאמנון

PROCESS FOR THE SYNTHESIS AND PURIFICATION OF (4-METHOXYBUTYL)(4-TRIFLUOROMETHYLPHENYL)METHANONELUNDBECK PHARMACEUTICALS ITALY S.P.A.

PCT/EP/2004/051390WO/2006/002691


C07C18051307/07/2004

' – דיאמינו–4 – 4 של לסינתזה תהליךסולפון – דיפניל

PROCESS FOR SYNTHESIS OF 4-4'-DIAMINO-DIPHENYL-SULFONELUNDBECK PHARMACEUTICALS ITALY S.P.A.

PCT/EP/2004/051389WO/2006/002690

C12N18051407/07/2005

ניזוק שלא חלבון של ביולוגי ארעי ביטויבצמחים

BIOLOGICALLY SAFE TRANSIENT PROTEIN EXPRESSION IN PLANTSICON GENETICS GMBH

07/07/2004

04016011.1EP

15/01/2005

60/593454US

PCT/EP/2005/007361WO/2006/003018

G01G18051502/01/2007

NETWORKED WEIGHT SCALEמרושתות מאזניםMICHAL LAORלאור מיכל

C07K18051807/07/2005

שעברEPO של חדשה תרכובתליצורה ושיטה קרבמילציה

NOVEL CARBAMYLATED EPO AND METHOD FOR ITS PRODUCTIONH. LUNDBECK A/S

07/07/2004

PA 2004 01075DK

07/07/2004

60/586370US

23/06/2005

60/693870US

PCT/DK/2005/000477WO/2006/002646


A61B18051902/01/2007

ביולוגית ברקמה לטיפול ושיטה מערכתפלזמה גז שחרור באמצעות

SYSTEM AND METHOD FOR TREATING BIOLOGICAL TISSUE WITH A PLASMA GAS DISCHARGE

ALMA LASERS LTDבע"מ לייזרס אלמה18/06/2006

11/333308US

G06Q18052010/08/2005

דינמית, להוספה ומערכת שיטה סטטיים לתכנים פרסומות בזמן–אמת, של

מורדים

METHOD AND SYSTEM FOR DYNAMIC, REAL-TIME ADDITION OF ADVERTISEMENTS TO DOWNLOADED STATIC CONTENT

.HIRO-MEDIA LTDבע"מ הירו-מדיה10/08/2004

60/599876US

PCT/IL/2005/000866WO/2006/016365

D06F18052103/01/2007

AN APPARATUS FOR DRYINGחיצוני כביסה מייבשCLOTHES

SHALOM REHAVIרחבי שלום

A61B18052203/01/2007

RESPIRATION MONITORנשימה מוניטורRONEN PADOWICZפדוביץ רונן


A61P18052324/05/2000

-COMPOSITIONS FOR IAPP ושימושםIAPP מעכבות תרכובותINHIBITION AND USES THEREONQUEEN'S UNIVERSITY AT KINGSTON

24/05/1999

60/135545US

09/07/1999

60/143123US

23/05/2000

09/576677US

PCT/CA/2000/000607WO/2000/071101

C07D18052405/07/2005

–}4–הידרוקסי–N להכנת משופר תהליך–3,1–מתיל–2–איסופרופיל–5–)4–]5

–איל(–פנוקסי[–פנטוקסי{–4תיאזול–בנזאמידין

AN IMPROVED PROCESS FOR PREPARING N-HYDROXY-4-{5-[4-(5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL)-PHENOXY]-PENTOXY}-BENZAMIDINEDONG WHA PHARMACEUTICAL IND. CO. LTD.

05/07/2004

10-2004-0052070KR

PCT/KR/2005/002137WO/2006/004368

B65H18052707/07/2005

Z מסוג נעילה מערכת עם עטיפה חומרבו ושימוש לייצורו ושיטות

A WRAPPING MATERIAL WITH A Z-LOCK SYSTEM AND METHODS OF MAKING AND USING THE SAME

TAMA PLASTIC INDUSTRYפלסטיק תעשיות תמה


07/07/2004

10/884966US

PCT/IB/2005/003691WO/2006/048779

C12P18052823/02/2000

במחלות לטיפול רוקחות תכשירימיטוכונדריאליות

PHARMACEUTICAL FORMULATIONS FOR TREATING MITOCHONDRIAL DISORDERSWellstat Therapeutics Corporation

23/02/1999

60/121588US

PCT/US/2000/004663WO/2000/050043

E06B18052903/01/2007

SLAT BLIND TILTING LEVERתריסים רפרפות לכוונון מנוףYEHUDA KOSTAקוסטה יהודה

C12Q18053107/07/2005

NOVEL SEQUENCE FOR IMPROVINGגרעין חומצת ביטוי לשיפור חדש רצףEXPRESSION OF NUCLEIC ACIDCHROMAGENICS B.V.

08/07/200460/587007US

08/07/2004PCT/EP2004/51405EP

PCT/EP/2005/053251WO/2006/005718


G03F18053201/02/2005

אל–מימיים מיקרואלקטרוניים ניקוי תכשיריפרוקטוז המכילים

NON-AQUEOUS MICROELECTRONIC CLEANING COMPOSITIONS CONTAINING FRUCTOSEMALLINCKRODT BAKER, INC.

15/07/2004

60/588248US

PCT/US/2005/003422WO/2006/019402

G01N18053311/07/2005

DROPLET DEPOSITION APPARATUSטיפונת לפליטת התקןXAAR TECHNOLOGY LIMITED

10/07/2004

0415529.7GB

PCT/GB/2005/002746WO/2006/005952

E03D18053415/06/2005

W.C. DISPENSER WITH PERFUMINGמבושם מיכל עם לאסלה דיספנסרCHAMBERRE.LE.VI-S.P.A.

14/07/2004RE2004A000084IT

PCT/EP/2005/006514WO/2006/005410

F24J18053506/07/2005

SOLAR ENERGY CONTROLסולארית אנרגיה בקרתSHEC LABS-SOLAR HYDROGEN ENERGY CORPORATION


06/07/20042473042CA

PCT/CA/2005/001048WO/2006/002545

A43B18053603/01/2007

PROTECTIVE GAITERולגרב לנעל מגןYUVAL SHORמקובר עינב

B65D18053804/01/2007

TRAYמגש.SARI KLEIN LTDבע"מ קליין שרי

A61B18053923/06/2005

לשימוש אופטי סיב בחון קצה לייצור שיטהרפואי בהתקן

METHOD OF MAKING A FIBER OPTIC PROBE TIP FOR USE IN A MEDICAL DEVICEONDINE INTERNATIONAL LTD.

22/07/2004

60/590420US

30/03/2005

11/094084US

PCT/US/2005/022336WO/2006/019510

A61N18054003/06/2005

יישומים עבור בסונופוטודינמיקה ריפוידנטליים

SONOPHOTODYNAMIC THERAPY FOR DENTAL APPLICATIONSONDINE INTERNATIONAL LTD.

22/07/2004

60/590421US

27/10/2004

60/622463US


PCT/US/2005/019707WO/2006/022970

A61N18054108/07/2005

ומניעת מינירלי חומר לסילוק מערכתמוליכים רפואיים התקנים עבור קרישה

ANTI-COAGULATION AND DEMINERALIZATION SYSTEM FOR CONDUCTIVE MEDICAL DEVICESATS MEDICAL, INC.

12/07/2004

10/889328US

PCT/US/2005/024502WO/2006/017213

C07D18054309/07/2005

כקוטלי מותמר –פירולידין2 תולדותחרקים וקולטי פטריות

SUBSTITUTED 2-PYRROLIDONE DERIVATIVES AS FUNGICIDES AND INSECTICIDESBAYER CROPSCIENCE AG

12/07/2004

04016320.6EP

PCT/EP/2005/007442WO/2006/005551

C07D18054427/07/2005

פיפרזין, הכנתן דיארילמתיל של נגזרותושימושן

DIARYLMETHYL PIPERAZINE DERIVATIVES, PREPARATIONS THEREOF AND USES THEREOFASTRAZENECA AB

02/08/2004

0401968-3SE

18/08/2004

60/602363US

PCT/SE/2005/001186WO/2006/014133

C07D18054526/07/2005


הינוQ בהן היבריד שלA Q מולקולות אנטיביוטי, משקע הינוAו– אמינוקוינולין

נגד כחומרים שלהן והשמושים והסינתזהחיידקים

HYBRID MOLECULES QA WHERE Q IS A AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, AND THE SYNTHESIS AND USES THEREOF AS ANTIBACTERIAL AGENTSPALUMED S.A.

30/07/20040408441FR

23/12/2004

11/019450US

PCT/FR/2005/001937WO/2006/024741

C07D18054627/07/2005

בדיכאון לטיפול פיפרידין של חדשה נגזרתNOVEL PIPERIDINE DERIVATIVE FOR THE TREATMENT OF DEPRESSIONASTRAZENECA AB

02/08/2004

0401969-1SE

PCT/SE/2005/001187WO/2006/014134

C07D18054727/07/2005

של כליגנדים פיפרידין של חדשות נגזרות קולטן

בדיכאון לטיפול3H היסטמין

NOVEL PIPERIDINE DERIVATIVES AS HISTAMINE

H3 RECEPTOR LIGANDS FOR TREATMENT OF DEPRESSIONASTRAZENECA AB

02/08/2004

0401970-9SE

PCT/SE/2005/001188June 3, 2007535 –התשס"ז בסיון י"ז

WO/2006/014135

C07D18054827/07/2005

קולטן של כלינגדים פיפרידין של נגזרות3H היסטמין

PIPERIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDSASTRAZENECA AB

02/08/2004

0401971-7SE

PCT/SE/2005/001189WO/2006/014136

G01N18054912/07/2005

FC איזור בעלי נוגדנים והנדסת זיהוילשימושם ושיטות משתנה

IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT FC REGIONS AND METHODS OF USING SAMEMACROGENICS, INC.

12/07/2004

60/587251US

28/07/2004

10/902588US

PCT/US/2005/024645WO/2006/088494

H05C18055006/07/2005

לתוך חשמלי זרם לאספקת ומערכת שיטהמדיום או אובייקט

METHOD AND APPARATUS FOR PROVIDING ELECTRIC CURRENT INTO AN OBJECT OR MEDIUM


THE COMMONWEALTH OF AUSTRALIA, C/O MINISTER FOR DEFENCE

07/07/2004

2004903724AU

PCT/AU/2005/000984WO/2006/002485

G01N18055208/09/2005

METHOD OF EXPLOSIVE DETECTIONנפץ חומרי וזיהוי לגילוי שיטהAND IDENTIFICATIONZAKRYTOE AKTSIONERNOE OBSCHESTVO "INTELLEKTUALNYE SKANIRUYUSCHIE SISTEMY"

09/09/2004

2004126993RU

PCT/RU/2005/000456WO/2006/031155

C07D18055306/07/2005

גידול גורם המאפננים קווינאזולין לטיפולMET –C / פעילות הפאטוציטי

בסרטן

QUINAZOLINE MODULATORS OF HEPATOCYTE GROWTH FACTOR C-MET ACTIVITY FOR THE TREATMENT OF CANCERANGION BIOMEDICA CORPORATION

06/07/2004

60/585734US

PCT/US/2005/023801WO/2006/014420


C07K18055403/08/2005

RAGE FUSION PROTEINS ANDשימוש ושיטותRAGE אחויים חלבוניםMETHODS OF USETRANSTECH PHARMA, INC.

03/08/2004

60/598555US

PCT/US/2005/027705WO/2006/017647

C12N18055503/08/2005

RAGE FUSION PROTEINS ANDשימוש ושיטותRAGE אחויים חלבוניםMETHODS OF USETRANSTECH PHARMA, INC.

03/08/2004

60/598362US

PCT/US/2005/027694WO/2006/017643

H01S18055620/12/2005

ושיטת לייזר רכיב עבור מגן שכבת זיגוגאנקפסולציה

ARTICULATED GLAZE CLADDING FOR LASER COMPONENTS AND METHOD OF ENCAPSULATIONRAYTHEON COMPANY

23/12/2004

11/021413US

PCT/US/2005/047624WO/2006/130180

A61K18055808/07/2005

המכילים ערכיים רבVLA–4 אנטגוניסטיםפולימריים חלקים

MULTIVALENT VLA-4 ANTAGONISTS COMPRISING POLYMER MOIETIESELAN PHARMACEUTICALS, INC.

08/07/2004

60/586975US

PCT/US/2005/024369


WO/2006/010054

H04N18055908/07/2005

מוזיקה עבור זכויות לניהול ומערכת שיטהדיגיטלית

METHOD AND SYSTEM FOR MANAGING RIGHTS FOR DIGITAL MUSICCATCH MEDIA, INC.

16/07/2004

10/893473US

PCT/US/2005/024212WO/2006/019608

H04L18056007/07/2005

מתוזמנת להעברה תוכן לריבוד מערכתתקשורת ברשת

SYSTEM FOR LAYERING CONTENT FOR SCHEDULED DELIVERY IN A DATA NETWORKQUALCOMM INCORPORATED

09/07/2004

60/586820US

21/06/2005

11/158662US

PCT/US/2005/023980WO/2006/017099

F24H18056104/01/2007

ברז הכולל חימום או שמש לדוד אוגןמהדוד המים לריקון

A FLANGE OF A TANK OF HEATING WATER THAT INCLUDES A TAP FOR EMPTYING THE WATER

UDI RAHMANIרחמני עודי

G09B18056204/01/2007


עם לילדים עצמי ללימוד אנגלית מקלדתדיסלקציה

A SELF TEACHING ENGLISH KEYBOARD FOR CHILDREN WITH DYSLEXIA

MARINA VIGODSKYויגודסקי מרינה

F04D18056304/01/2007

AUTOMATIC VACUUM PUMPאוטומטית ואקום משאבתDAN BRONברקוביץ( )אצל ברון דן

H01R18056404/01/2007

למכשיר שקע עם חשמלי מכשיר תקענוסף חשמלי

AN ELECTRICAL CONNECTION-REPRODUCING ELECTRICAL PLUG

YAIR MESHULAMמשולם יאיר

A61`18056504/01/2007

לתוך תרופות למתן משופר מפסיק ברזמטופל של הגוף

AN IMPROVED STOPCOCK FOR ADMINISTERING MEDICAMENTS INTO THE PATIENT'S BODY

.PLASTMED LTDבע"מ פלאסטמד

G06K18056704/07/2005

SYSTEM AND METHOD FORלהדמיה ושיטה מערכתIMAGING

.REAL IMAGING LTDבע"מ אימג'ינג ריל07/07/2004

60/586162US

PCT/IL/2005/000707WO/2006/003658


G01N18056806/07/2005

שקע דמות לאיתור ומכשירים שיטותשקעים נושא רכיב בתמונת

METHOD AND DEVICE FOR IDENTIFYING AN IMAGE OF A WELL IN AN IMAGE OF A WELL-BEARING COMPONENTSENG ENTERPRISES LTD.

07/07/2004

60/585571US

13/09/2004

10/938951US

15/10/2004

60/618585US

05/11/2004

60/625096US

PCT/IL/2005/000719WO/2006/003664

H04Q18056904/07/2005

אינטראקטיבית מולטימדיה שירות מערכתושיטה

AN INTERACTIVE MULTIMEDIA SERVICE SYSTEM AND METHOD THEREOFSK TELECOM CO., LTD.

05/07/2004

10-2004-0052129KR

PCT/KR/2005/002119WO/2006/004363


C07D18057002/07/2005

מותמר דיפנילאמין נגזרות קרובות ותרכובות סליצילתיאזול

–B1 פוספטאז פוספוטירוזין כמעכבותPTP1Bהמרכיבים בהפחתת לשימוש

טיפול במסגרת בדם סוכר של הפעיליםבסכרת

DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) INHIBITORS FOR USING AS BLOOD-SUGAR DECREASING ACTIVE INGREDIENTS FOR TREATING DIABETESSANOFI-AVENTIS DEUTSCHLAND GMBH

17/07/2004

102004034697.6DE

PCT/EP/2005/007151WO/2006/007959

C07C18057128/06/2005

של אננטיומרית צורה לייצור שיטה–דיאמינו3,2 פרופיונית חומצה נגזרות

METHOD FOR PRODUCING ENANTIOMERIC FROM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVESSANOFI-AVENTIS DEUTSCHLAND GMBH

10/07/2004

102004033406.4DE

PCT/EP/2005/006920WO/2006/005436

C12Q18057207/07/2005

ההגנה להגברת פעילים חומריםלמציאתם בצמחים, ושיטות הפתוגנית

ACTIVE INGREDIENTS FOR ENHANCING PATHOGEN DEFENSE IN PLANTS, AND METHODS OF FINDING THEMBAYER CROPSCIENCE GMBH

20/07/2004

102004035137.6DE

PCT/EP/2005/007344WO/2006/007981


A01N18057307/07/2005

SAFENING METHODלהגנה שיטהBAYER CROPSCIENCE GMBH

20/07/2004

102004035136.8DE

PCT/EP/2005/007345WO/2006/007982

A61K18057708/08/2005

הרפית לעידוד וזודילטור המכיל תכשירוסקולרי חלק שריר

A COMPOSITION CONTAINING A VASODILATOR FOR PROMOTING VASCULAR SMOOTH MUSCLE RELAXATIONFUTURA MEDICAL DEVELOPMENTS LIMITED

09/08/2004

0417675.6GB

PCT/GB/2005/003110WO/2006/016139

G06C18057807/01/2007

CREDIT PHONE SYSTEMקרדיט–פון מערכתSHLOMI AZRIELעזריאל מאיר שלמה

A61P18057907/01/2007

לקבלתם פיפירידין, תהליך נגזרותאותן הכוללים ריקחיים והרכבים

PIPERIDINE DERIVATIVES, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSANOFI AVENTIS

10/02/199999/01593FR

07/04/199999/04429FR

PCT/FR/2000/000284WO/2000/047572


E04C18058007/07/2005

BALLISTIC ABATEMENT BARRIERבליסטי מחסום להפחתת ומערכת שיטהMETHOD AND SYSTEMBLASHIELD, INC.

08/07/2004

10/886975US

PCT/US/2005/024073WO/2006/085980

C12Q18058114/07/2005

גרעיניות לחומצות אנליזה ושיטות מערכותקשורים ומרכיבים פולימריות

SYSTEMS AND METHODS OF ANALYZING NUCLEIC ACID POLYMERS AND RELATED COMPONENTSZS GENETICS, INC.

14/07/2004

60/587997US

PCT/US/2005/024979WO/2006/019903

G02B18058206/07/2005

INTELLIGENT INTERACTIVE LOCKנעילה ומערכת חכם הידודי מנעולAND LOCKING SYSTEM

SEGEV, EREZארז שגב06/07/2004

60/585089US

PCT/IL/2005/000715WO/2006/003661

G07F18058305/07/2004


ללא קופה במכונות מזומנים לקבלת שיטה תשלום בהוראת שימוש ע"י כרטיס

אס( אמ )אס טקסט הודעות באמצעות

METHOD FOR OBTAINING CASH AT CARDLESS TELLER MACHINES, USING A PAYMENT ORDER VIA SMSCAJA DE AHORROS DE GALICIA

PCT/ES/2004/000321WO/2006/013218

A61K18058412/07/2005

MSF–A תלויHIFלהורדת חומריםבסרטן לטיפול ושימושם

AGENTS CAPABLE OF DOWNREGULATING AN MSF-A-DEPENDENT HIF-1ALPHA AND USE THEREOF IN CANCER TREATMENT



12/07/2004

60/586697US

PCT/IL/2005/000736WO/2006/038208

G06F18058518/05/2005

הניתנת נמוכה עוצמה בעלת ארכיטקטורה של סימולטני ליישום מחדש לעיצוב

ברורים לתקשורת סטנדרטים

LOW-POWER RECONFIGURABLE ARCHITECTURE FOR SIMULTANEOUS IMPLEMENTATION OF DISTINCT COMMUNICATION STANDARDSASOCS LTD

08/07/2004

60/586353US


08/07/2004

60/586389US

08/07/2004

60/586390US

08/07/2004

60/586391US

PCT/IB/2005/002485WO/2006/006076

G06F18058608/07/2005

אורטוגונלים שינויים ליישום ומערכת שיטהמשתנים בגדלים מהירים

A METHOD OF AND APPARATUS FOR IMPLEMENTING FAST ORTHOGONAL TRANSFORMS OF VARIABLE SIZEASOCS LTD

08/07/2004

60/586390US

08/07/2004

60/586391US

08/07/2004

60/586389US

08/07/2004

60/586353US

25/08/2004

60/604258US

03/03/2005

11/071340US

PCT/US/2005/024063WO/2006/014528

C07D18058702/08/2005

HETEROCYCLIC COMPOUNDSהטרוציקליות תרכובותPALAU PHARMA S.A.

03/08/2004

200401971ES

PCT/EP/2005/008371WO/2006/013095


C07K18058804/08/2005

CMETHUMANIZED ANTI-CMET נוגדי אנושי ממקור אנטגוניסטיםANTAGONISTSGENENTECH, INC.

05/08/2004

60/598991US

PCT/US/2005/027626WO/2006/015371

A61K18058929/07/2005

בסרטן – לטיפול29IL ו–IL–28ב– שימושעצמי חיסון של סדרים ואי

USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERSZymoGenetics INC.

29/07/2004

60/592069US

19/11/2004

60/629702US

29/04/2005

60/676047US

PCT/US/2005/026951WO/2006/012644

G06K18059211/07/2005

DISAMBIGUATING AMBIGUOUSמעורפלים תווים של משמעית דו הבהרהCHARACTERSAOL LLC

09/07/2004

60/586502US

PCT/US/2005/024519WO/2006/010114

E01F18059311/07/2005

ANTI-VEHICLE SECURITY SYSTEMרכב כלי נגד ביטחון מערכתVAN BIBBER, MICHAEL


09/07/2004

10/888337US

PCT/US/2005/024537WO/2006/010122

A23B18059408/01/2007

METHOD OF PROCESSING GARLICשום לעיבוד שיטהZIVA MORENOמורנו זיוה

09/01/2006

60/757007US

G09G18059516/08/2005

תצוגה התקן מנהל מעגל של מאפייןחיי במצב הפעלה המאפשר

CURRENT MODE DISPLAY DRIVER CIRCUIT REALIZATION FEATUREIDC, LLC.

27/08/2004

60/604893US

15/07/2005

11/182389US

PCT/US/2005/029161WO/2006/026162

G09F18059622/07/2005

FIELD LABELED BUTTONשדה תיוג מתגLUTRON ELECTRONICS CO. INC.

23/07/2004

60/590627US

PCT/US/2005/026119WO/2006/012545

A61K18059725/07/2005


שחרור עבור שכבות רב פרמצבטית טבלית מסיסות בעלי פעילים מרכיבים של מבוקר

גבוההPHתלות– על

PHARMACEUTICAL MULTILAYER TABLET FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS WITH HIGHLY PH-DEPENDENT SOLUBILITYSANOFI-AVENTIS

29/07/2004

04291943.1EP

PCT/EP/2005/008719WO/2006/010640

G01N18060108/07/2005

שחלות סרטן לגילוי ותרכובות שיטותMETHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN CANCERTRIPATH IMAGING, INC.

09/07/2004

60/586856US

PCT/US/2005/024359WO/2006/010047

C07D18060327/03/2000

GLUCOCORTICOID RECEPTORגלוקוקורטיקואיד רצפטור של מודולטוריםMODULATORSPFIZER PRODUCTS, INC.

30/04/1999

60/132130US

PCT/IB/2000/000366WO/2000/066522

B65D18060509/01/2007

-CONTAINER WITH MULTIמשולב הושטה מכסה עם מיכלFUNCTION DISPENSING COVER

.ZEUS AVIV LTDבע"מ הטבע מן חממית


G06F18060605/07/2000

טכני חומר של וסינטזה הצגה, ניהול, סינוןREPRESENTATION, MANAGEMENT, FILTERING AND SYNTHESIS OF TECHNICAL CONTENTCOHESIA CORPORATION

08/07/1999

09/349753US

PCT/US/2000/018422WO/2001/004812

C12Q18060703/08/2005

בסימנים המשתמשים ושיטות בחניםביולוגיים

ASSAYS AND METHODS USING BIOMARKERSGENENTECH, INC.

06/08/2004

60/599425US

PCT/US/2005/027480WO/2006/017531

C07K18060815/07/2005

HER2HER2 ANTIBODY COMPOSITION נוגדן של תכשירGENENTECH, INC.

22/07/2004

60/590202US

PCT/US/2005/025084WO/2006/033700

G06F18060912/07/2005


אלקטרונים מעגלים לעיצוב והתקן שיטהאופטימיזציה באמצעות

METHOD AND APPARATUS FOR DESIGNING ELECTRONIC CIRCUITS USING OPTIMIZATIONKIMOTION TECHNOLOGIES

13/07/2004

10/890349US

PCT/US/2005/024595WO/2006/017247

A61B18061009/01/2007

GRIPPING TOOLלאחיזה מכשירSHERWOOD SERVICES AG

16/01/2006

2006-7828JP

H04B18061129/06/2005

איזוריות תקשורת במערכות שכן סריקתאל–חוטיות

NEIGHBOR SCANNING IN WIRELESS LOCAL AREA NETWORKSINTERDIGITAL TECHNOLOGY CORPORATION

12/07/2004

60/587159US

PCT/US/2005/023145WO/2006/017024

C08B18061211/07/2005

המערכת להמרצת ושיטות חומריםהחיסונית

MATERIALS AND METHODS FOR IMMUNE SYSTEM STIMULATIONVARIETY CHILDREN'S HOSPITAL d/b/a MIAMI CHILDREN'S HOSPITAL


09/07/2004

60/586548US

PCT/US/2005/024410WO/2006/010069

G05F18061305/07/2005

של האפשר ככל להקטנה ושיטות מערכותמשולב ממעגל קבוע ערך בעלת דליפה

SYSTEMS AND METHODS FOR MINIMIZING STATIC LEAKAGE OF AN INTEGRATED CIRCUITVIRTUAL SILICON TECHNOLOGY, INC.

09/07/2004

60/586565US

24/11/2004

10/996739US

PCT/US/2005/023839WO/2006/017082

B01D18061412/04/2005

Co2 הסרת הכולל בעירה גזי של ביתר ניקויULTRA CLEANING OF COMBUSTION GAS INCLUDING THE REMOVAL OF CO2EIG, INC.

06/08/2004

60/599228US

13/10/2004

60/617779US

PCT/US/2005/012794WO/2006/022885


G01N18061520/07/2005

פנאומטי מפעל עם להכוונה הניתן קטטרהידראולי או

STEERABLE CATHETER WITH HYDRAULIC OR PNEUMATIC ACTUATORST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.

20/07/2004

10/895510US

PCT/US/2005/025888WO/2006/012421

H04L18061728/07/2005

שידור רב שירות וקליטת להספקת שיטה גישה במערכת עבירה בזמן לקהל ושידור

רחב פס אלחוטית

METHOD OF PROVIDING AND RECEIVING MULTICAST AND BROADCASTING SERVICE DURING HANDOVER IN BROADBAND WIRELESS ACCESS SYSTEMLG ELECTRONICS INC.

29/07/2004

10-2004-0059932KR

PCT/KR/2005/002458WO/2006/011763

H04Q18061829/07/2004

נתונים תעבורת שרות של חוקי יירוט פס אלחוטית גישה במערכת מיקום מבוסס

רחב

LAWFUL INTERCEPTION OF LOCATION BASED SERVICE TRAFFICTELEFONAKTIEBOLAGET LM ERICSSON (PUBL)


PCT/IT/2004/000417WO/2006/011165

H04Q18061929/07/2004

IRIPROVISION OF LOCATION לתוך מיקום מידע של הספקהINFORMATION INTO IRITELEFONAKTIEBOLAGET LM ERICSSON (PUBL)

PCT/IT/2004/000418WO/2006/011166

F02K18062009/01/2007

טרוף סילון/סילון מגח קרה הצתה מערכתתכליתי רב גז גנרטור

MULTIPURPOSE GAS GENERATOR RAMJET/ SCRAMJET COLD START SYSTEMUNITED TECHNOLOGIES CORPORATION

31/01/2006

11/344764US

B60N18062111/11/2004

ממסרה, נועל לכיוון הניתן מושב מבנהדו–צירית שתי סינכרוני, שיבולת צילוב

BILATERAL, WARP-TOLERANT, CROSS-SYNCHRONIZED, GEAR-LOCK ADJUSTABLE SEAT STRUCTUREMJD INNOVATIONS, L.L.C.

18/08/2004

10/921051US

PCT/US/2004/038006WO/2006/022789

A61B18062307/07/2005

SURGICAL IMAGING DEVICEניתוח לדימות התקןPOWER MEDICAL INTERVENTIONS, INC.


09/07/2004

10/888285US

PCT/US/2005/024141WO/2006/017128

H04Q18062411/07/2005

או פרוטוקולים מרובתRFID מערכתהוראות מרובת

MULTI-PROTOCOL OR MULTI-COMMAND RFID SYSTEMTC LICENSE LTD.

09/07/2004

10/887320US

PCT/US/2005/024432WO/2006/010076

A61B18062510/07/2005

למדידת ושיטה לביש, מערכת מכשירחיוניים פרמטרים

WEARABLE DEVICE, SYSTEM AND METHOD FOR MEASURING VITAL PARAMETERS

.TADIRAN SPECTRALINK LTDבע"מ ספקטרלינק תדיראן09/07/2004

60/586241US

PCT/IL/2005/000732WO/2006/006158

A61B18062610/07/2005

לניטור ושיטה לביש, מערכת מכשירפיזיולוגיים פרמטרים

סביבתיים ו/או

A WEARABLE DEVICE, SYSTEM AND METHOD FOR MONITORING PHYSIOLOGICAL AND/OR ENVIRONMENTAL PARAMETERS


60/586243US

09/07/2004

60/586242US

21/07/2004

60/589599US

PCT/IL/2005/000733WO/2006/006159


B41J18062712/07/2005

הדפסה צפיפות שוני להפחתת שיטהדיו הזרקת במדפסות במדפסות, במיוחד

METHOD FOR REDUCING PRINT-DENSITY VARIATIONS IN PRINTERS, PARTICULARY IN INKJET PRINTERS

.JEMTEX INK JET PRINTING LTDבע"מ פרינטינג ג'ט אינק ג'מטקס12/07/2004

60/586712US

PCT/IL/2005/000737WO/2006/006162

C07F18062810/07/2005

מחומצנים פוספוליפידים להכנת תהליכיםIMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS

.VASCULAR BIOGENICS LTDבע"מ ביוג'ניק וסקולר09/07/2004

60/586219US

PCT/IL/2005/000735WO/2006/006161

G06K18062924/05/2000

IDENTITY CODED SURFACEמקודדת שזהותו משטחSILVERBROOK RESEARCH PTY. LTD.

25/05/1999PQ0559AU

30/06/1999PQ1313AU

15/10/1999PQ3457AU

01/12/1999PQ4392AU

PCT/AU/2000/000570WO/2000/072250

C07D18063030/07/2005

PYRROLE DERIVATIVES ASרוקחות כגורמי פירול תולדותPHARMACEUTICAL AGENTS


EXELIXIS, INC.30/07/2004

60/592469US

30/07/2004

60/592439US

PCT/US/2005/026916WO/2006/012642

B41J18063310/01/2007

EFFICIENT KEYBOARDיעילה מקלדתZIV FISHERפישר זיו

A61K18063513/07/2005

זיהוי לשם זריקתי רדיו–אקטיבי צבע שימושהשומרות הלימפה בלוטות

USE OF AN INJECTABLE RADIOACTIVE DYE FOR SENTINEL LYMPH NODE IDENTIFICATIONBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE

13/07/2004

10/890420US

PCT/US/2005/024786WO/2006/010144

H01T18063608/07/2005

במחוללי בו והשימוש גבוה מתח מפסקמיקרוגל

HIGH-VOLTAGE SWITCH AND USE THEREOF IN A MICROWAVE GENERATORDIEHL BGT DEFENCE GMBH & CO. KG

19/07/2004

102004034895.2DE

PCT/EP/2005/007426WO/2006/008000


C07D18063708/07/2005

פיראזול של טריציקליות תולדותקולטניקאנאבינואיד כמווסתי

TRICYCLIC PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORSCADILA HEALTHCARE LTD.

12/07/2004

745/MUM/2004IN

PCT/IN/2005/000237WO/2006/025069

A61K18063811/07/2005

באמצעות וכאב בדלקת לטיפול הרכבים COX–2 של סלקטיבי מעכב של שילוב

LTB4 קולטן של ואנטגוניסט

COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND PAIN USING A COMBINATION OF A COX-2 SELECTIVE INHIBITOR AND A LTB4 RECEPTOR ANTAGONISTPHARMACIA CORPORATION

22/07/2004

60/590076US

PCT/IB/2005/002203WO/2006/011048

B25B18063910/01/2007

חלקי והעמדת לתיקון הידוק מערכתעבודה

CLAMPING APPARATUS FOR POSITIONING AND FIXING WORK PIECESF-TOOL INTERNATIONAL AG

13/03/200600393/06CH

G06K18064008/07/2005

SYSTEM AND METHOD FORאשראי חשבון לאבטחת ושיטה מערכתSECURING A CREDIT ACCOUNT


DAVID, N. HARRIS12/07/2004

10/889227US

PCT/US/2005/024242WO/2006/017165

G01R18064114/07/2005

ורכיבים סדקים לקביעת ומערכת שיטהבשריון שבורים

METHOD AND SYSTEM FOR DETERMINING CRACKS AND BROKEN COMPONENTS IN ARMORSIMULA, INC.

16/07/2004

10/892357US

PCT/US/2005/024859WO/2006/019820

G09B18064211/01/2007

כלים יישום תוך זרה שפה להוראת שיטהרגשית אינטליגנציה מודעות של

A METHOD OF TEACHING A FOREIGN LANGUAGE BY APPLYING AWARENESS AND EMOTIONAL INTELLIGENCE TOOLS

GILA FRISCHERפרישר גילה

C07D18064324/06/2005

מצמחי פאקליטאקסל לקבלת שיטותטאקסוס

METHODS FOR OBTAINING PACLITAXEL FROM TAXUS PLANTSINDENA S.P.A.

13/07/2004

04016493.1EP

PCT/EP/2005/006846WO/2006/005429

G01N18064412/07/2005


של אוטומטית לאנליזה ושיטה התקןדם דגימות

DEVICE AND METHOD FOR AUTOMATICALLY ANALYSING BLOOD SAMPLESVDG-VON DER GOLTZ GMBH

12/07/2004

102004033654.7DE

PCT/DE/2005/001228WO/2006/005326

H04Q18064630/06/2005

תקשורת במערכת ויעילה מהירה העברהמקומית אלחוטית

ROBUST AND FAST HANDOVER IN A WIRELESS LOCAL AREA NETWORKINTERDIGITAL TECHNOLOGY CORPORATION

12/07/2004

60/587273US

PCT/US/2005/023756WO/2006/017064

C12Q18064703/08/2005

בסימנים המשתמשים ושיטות בחניםביולוגיים

ASSAYS AND METHODS USING BIOMARKERSGENENTECH, INC.

06/08/2004

60/599393US

PCT/US/2005/029045WO/2006/017859

C09K18064803/05/2005

OXYGEN-ABSORBING PACKAGINGחמצן הסופג אריזה חומרMATERIALMULTISORB TECHNOLOGIES, INC.

13/07/2004

10/889731US

PCT/US/2005/015236WO/2006/016916


A61K18065008/07/2005

INFUSION AND INJECTIONולהזרקה לאינפוזיה לבודופה תמיסתSOLUTION OF LEVODOPADIZLIN MEDICAL DESIGN AB

12/07/2004

0401842-0SE

PCT/SE/2005/001135WO/2006/006929

G08B18065217/10/2005

השראה מצמדי של משורשר ארגוןנתונים לתקשורת

ARRANGEMENT OF DAISY CHAINED INDUCTIVE COUPLERS FOR DATA COMMUNICATIONAMBIENT CORPORATION

14/12/2004

11/011574US

PCT/US/2005/037463WO/2006/065340

F25B18065313/07/2005

אופף מאוויר מים לעיבוי יחידי מחזור התקןSINGLE CYCLE APPARATUS FOR CONDENSING WATER FROM AMBIENT AIRGRAEME ALLAN COLLINS

13/07/2004

2004903841AU

PCT/AU/2005/001027WO/2006/005133

C07D18065413/07/2005


ותרופות מותמרות אוקסינדול נגזרותאותן המכילות

SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAMEABBOTT GMBH & CO. KG

13/07/2004

102004033834.5DE

13/07/200460/587407US

PCT/EP/2005/007631WO/2006/005609

A61F18065511/01/2007

בעל אטריאלי אלקטרוגרם של מיפוימורכבות חלוקות

MAPPING OF COMPLEX FRACTIONATED ATRIAL ELECTROGRAMBIOSENSE WEBSTER, INC.

12/01/2006

60/758317US

05/01/2007

11/620370US

B21D18065612/07/2005

חסין–עייפות לגליון חתכים להכנסת שיטההנוצר והגליון

FATIGUE-RESISTANCE SHEET SLITTING METHOD AND RESULTING SHEETINDUSTRIAL ORIGAMI, LLC

12/07/2004

60/587470US

PCT/US/2005/024693WO/2006/017290

B08B18065811/01/2007

EAR PROTECTIONאוזניים מגןEDRI OFERעופר אדרי

H04L18065913/07/2005


אובייקט על למידע גישה להשגת שיטה ,ONS מקומי, הרשאת תווית, שרת בעל

בעל תווית, התקן יצירת תוכנית, שיטת על לשליטה תווית, תווית, ותוכנית כתיבתהתווית כתיבת בעל ההתקן

METHOD FOR ACCESSING INFORMATION ON OBJECT HAVING TAG, LOCAL SERVER, ONS PROXY, PROGRAM, TAG CREATION METHOD, DEVICE HAVING TAG WRITER, TAG, AND PROGRAM FOR CONTROLLING DEVICE HAVING TAG WRITERIBM CORPORATION

15/07/2004

2004-208935JP

PCT/JP/2005/012938WO/2006/009040

B23B18066011/01/2007

CUTTING TOOL AND CUTTINGשיבוב וכלי שיבוב שימתINSERT

.ISCAR LTDבע"מ ישקר

A61M18066114/07/2005

MATERIAL DELIVERY SYSTEMחומר לשחרור מערכתBY-PASS, INC.

14/07/2004

60/587335US

10/08/2004

60/599884US

23/08/2004

60/603262US

28/04/2005

60/675477US

PCT/IL/2005/000749WO/2006/006169

B64D18066211/01/2007

SIZE ADJUSTABLE SAFETY ANDלקסדה נוח וריפוד מתכווננת גודל ניצרתCOMFORT LINER FOR A HELMETGENTEX CORPORATION


19/01/2006

11/337040US

F03D18066414/07/2005

מידה בקנה רוח אנרגיית אוגרת מערכתבים להתקינה שניתן תעשייתי

INDUSTRIAL-SCALE WIND-ENERGY-COLLECTION SYSTEM WHICH CAN BE INSTALLED IN THE SEAVICTORINO GONZALEZ DIAZ

14/07/2004P200401716ES

PCT/ES/2005/000403WO/2006/018467

C07D18066515/07/2005

VIRAL POLYMERASE INHIBITORSוירלי פולימראז מעכביBOEHRINGER INGELHEIM INTERNATIONAL GMBH

16/07/2004

60/588670US

PCT/CA/2005/001103WO/2006/007693

C12Q18066627/06/2005

גוונילאט פעילות לזיהוי ובחנים שיטותציקלאז

METHODS AND ASSAYS FOR DETECTING GUANYLATE CYCLASE ACTIVITYAXXAM S.R.L.

16/07/2004

04016774.4EP

PCT/EP/2005/006887WO/2006/007937


A01N18066713/07/2005

כחומרים פוספטים באלקנולים שימוש ליצירת המשמשים מפזרים, חומרים

הידרוטרופים, חומרי תחליבים, חומרים בתכשירים מתאימים וחומרים הרטבה

חקלאיים

USE OF PHOSPHATED ALCANOLS AS DISPERSANTS, EMULSIFIERS, HYDROTROPES, WETTING AGENTS AND COMPATABILITY AGENTS IN AGRICULTURAL COMPOSITIONSAKZO NOBEL N.V.

15/07/2004

04077043.0EP

08/09/2004

60/608167US

PCT/US/2005/024777WO/2006/019772

A23L18067027/06/2005

AERATED FOOD PRODUCTSהידרופובין המכילים מאווררים מזון תוצריCONTAINING HYDROPHOBINUNILEVER PLC

27/07/2004

04254483.3EP

03/03/2005

05251282.9EP

PCT/EP/2005/006996WO/2006/010425

A23L18067127/06/2005

AERATED FOOD PRODUCTSהידרופובין המכילים מאווררים מזון תוצריCONTAINING HYDROPHOBINUNILEVER PLC

27/07/2004

04254483.3EP

03/03/2005

05251282.9EP

PCT/EP/2005/006997WO/2006/010426

E04H18067211/01/2007


STRUCTURE AND ACCESSORIESעבורו ואביזרים מבנהTHEREFOR

AVRAHAM SORYASסוריאס אברהם

A61B18067411/01/2007

IMPROVED SURGICAL CASSETTEמשופרת כירורגית קלטתALCON, INC.

24/01/2006

11/338491US

A61K18067518/07/2005

הפרעות או במחלות לטיפול שיטות המתווכות

CCR2 על–ידי

METHODS OF TREATING CCR2 MEDIATED DISEASES OR DISORSERSPFIZER PRODUCTS, INC.

30/07/2004

60/592683US

PCT/IB/2005/002162WO/2006/013427

C07D18067627/07/2005

טבעת עם הטרוציקליים קינז מאפננימאוחדת

FUSED RING HETEROCYCLE KINASE MODULATORSSGX PHARMACEUTICALS, INC.

27/07/2004

60/591778US

27/07/2004

60/591886US

11/05/2005

60/680091US

PCT/US/2005/026794WO/2006/015124

C07C18067918/10/2001


רצפטור של מודולטורים להכנת תהליךגלוקוקורטיקואיד של לא–סטרואידלי

PROCESS FOR THE PREPARATION OF NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORSPFIZER PRODUCTS, INC.

27/10/2000

60/243873US

C07D18068026/07/2005

לטיפול המשמשות פיפרזין של נגזרותומעיים קיבה של בהפרעות

PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERSGLAXO GROUP LIMITED

28/07/2004

0416844.9GB

08/07/2005

0514029.8GB

PCT/EP/2005/008263WO/2006/010629

C07D18068120/07/2005

PYRIDINE DERIVATIVES, THEIRבהן והשימוש פירידין, הכנתן תולדותPREPARATION AND USEAPPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

21/07/2004

04103483.6EP

21/07/2004

60/589621US

PCT/EP/2005/053501WO/2006/008303

C07D18068225/07/2005


והשימוש –הידרוקסיאמיד, הכנתןN תולדותבהן

N-HYDROXAMIDE DERIVATIVES, THEIR PREPARATION AND USEAPPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

26/07/2004

04103574.2EP

26/07/2004

60/591111US

31/01/2005

05100641.9EP

01/02/2005

60/648924US

PCT/EP/2005/053616WO/2006/010751

B25J18068318/07/2005

הנע גלגילות עם רצועה של הנע מפעילשונה היקפית מהירות בעלות

DRIVE BELT ACTUATOR WITH DRIVE PULLEYS OF DIFFERENT CIRCUMFERENTIAL SPEEDTIMOTHY JOHN JONES

20/07/2004

0416186.5GB

PCT/GB/2005/002834WO/2006/008515

E02F18068422/07/2005

מטרה לעבר חפירה לניווט והתקן שיטהקבורה

METHOD AND DEVICE FOR NAVIGATING EXCAVATION TOWARDS A BURIED TARGETKEIBERG INTERNATIONAL INC.

22/07/2004

10/896333US

PCT/CA/2005/001160WO/2006/007732


C23C18068526/01/2006

CUTTING INSERT WITH EXCELLENTגבוהה קשיחות בעלת חיתוך תותבתTOUGHNESSSANDVIK INTELLECTUAL PROPERTY AB

31/01/2005

0500234-0SE

PCT/SE/2006/000117WO/2006/080888

C23C18068626/01/2006

עבור מודבק מקארביד מצופות תותבותחתוך מכשיר

COATED CEMENTED CARBIDE CUTTING TOOL INSERTSSANDVIK INTELLECTUAL PROPERTY AB

31/01/2005

0500235-7SE

PCT/SE/2006/000118WO/2006/080889

G06F18068814/07/2005

A METHOD AND APPARATUS FORמפתחות למסירת ומערכת שיטהDELIVERING KEYSQUALCOMM INCORPORATED

14/07/2004

60/588203US

PCT/US/2005/025151WO/2006/020015

G08B18068914/07/2005

-VEHICLE ACTIVATED MILLIMETERמכשיר מופעל מילימטרי בגל שידורWAVE INTERROGATINGSAFEVIEW, INC.


16/07/2004

10/893017US

PCT/US/2005/025115WO/2006/019994

A61L18069014/07/2005

ליצירת הזנה ושיטת מילוי, התקן אמצעיבעצם בחלל תומך מבנה

FILLER MEANS, FEEDING DEVICE AND METHOD FOR THE FORMING OF A SUPPORT STRUCTURE IN A BONE CAVITYSIDLER, BRUNO

14/07/2004

04405451.8EP

PCT/EP/2005/007936WO/2005/094735

A61K18069111/10/2005

ORGANO-GEL FORMULATIONS FORרפואיים ליישומים אורגנו–ג'ל תכשיריTHERAPEUTIC APPLICATIONSMEDIQUEST THERAPEUTICS, INC.

08/10/2004

10/960516US

28/02/2005

11/066485US

13/06/2005

11/150254US

PCT/US/2005/036064WO/2006/042059

A01N18069230/06/2005

HERBICIDAL AGENTSעשבים קוטל תכשירBAYER CROPSCIENCE GMBH

17/07/2004

102004034571.6DE

PCT/EP/2005/007041WO/2006/007947


C12N18069413/01/2005

פעילות בעל רעלים מסלק חומרהגנטי קידודו ואת אפלטוקסין המשנה

A DETOXIFIZYME HAVING ACTIVITY OF TRANSFORMING AFLATOXIN AND THE GENE ENCODES THEREOFGUANGZHOU CO-WIN BIOENGINEERING CO. LTD.

17/08/2004

200410051120.0CN

PCT/CN/2005/000050WO/2006/017960

G06K18069515/07/2005

תשלום התקני לבדיקת התייחסות מיכשורמגע ללא

REFERENCE EQUIPMENT FOR TESTING CONTACTLESS PAYMENT DEVICESMASTERCARD INTERNATIONAL INCORPORATED

15/07/2004

60/588270US

PCT/US/2005/025107WO/2006/019989

G06K18069615/07/2005

באמצעות עסקאות לביצוע ומערכת שיטהמגע ללא תשלום כרטיסי

METHOD AND SYSTEM FOR CONDUCTING CONTACTLESS PAYMENT CARD TRANSACTIONSMASTERCARD INTERNATIONAL INCORPORATED

15/07/2004

60/588270US

PCT/US/2005/025119WO/2006/019997

G06K18069715/07/2005

ממנה ולהימנעות התנגשות לגילוי מערכתמגע ללא תשלום כרטיסי מערכות עבור

COLLISION DETECTION AND AVOIDANCE SCHEME FOR CONTACTLESS CARD PAYMENT SYSTEMS


MASTERCARD INTERNATIONAL INCORPORATED

15/07/2004

60/588270US

PCT/US/2005/025317WO/2006/020144

G06K18069815/07/2005

בביטמפ המשתמשים ומערכת שיטה לעסקאות המתייחסים משתנים למסירת

במבני מגע ללא תשלום כרטיסי באמצעותתקניים נתונים

METHOD AND SYSTEM USING A BITMAP FOR PASSING CONTACTLESS PAYMENT CARD TRANSACTION VARIABLES IN STANDARDIZED DATA FORMATSMASTERCARD INTERNATIONAL INCORPORATED

15/07/2004

60/588624US

PCT/US/2005/025221WO/2006/020073

G06K18069915/07/2005

כרטיסי אותות עבור אפיון ומעגלי שיטותתשלום

PAYMENT CARD SIGNAL CHARACTERIZATION METHODS AND CIRCUITSMASTERCARD INTERNATIONAL INCORPORATED

15/07/2004

60/588270US

PCT/US/2005/025220WO/2006/020072

G06K18070015/07/2005


נפח עם מגע ללא תשלום כרטיסי קוראקונית–מקוטעת בצורה עבודה

CONTACTLESS PAYMENT CARD READER WITH A FRUSTO-CONICAL OPERATING VOLUMEMASTERCARD INTERNATIONAL INCORPORATED

15/07/2004

60/588270US

PCT/US/2005/025110WO/2006/019990

C07D18070213/07/2005

DIMERIC PIPERIDINE DERIVATIVESדימריים פיפרדין של תולדותJANSSEN PHARMACEUTICA N.V.

16/07/2004

60/588711US

16/07/2004

04103412.5EP

PCT/EP/2005/053351WO/2006/008260

C07D18070313/07/2005

פיפרדין, פיפראזין, של דימריות תרכובות המכילים שלהם אנלוגיים או מורפולין

המתאימות אטומים7 בעלות טבעותעצבי לניוון הקשורים סדרים באי לטיפול

DIMERIC COMPOUNDS OF PIPERIDINE, PIPERAZINE OR MORPHOLINE OR THEIR 7-MEMBERED ANALOGS SUITABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERSJANSSEN PHARMACEUTICA N.V.

16/07/2004

60/588446US

16/07/2004

04103413.3EP

PCT/EP/2005/053345WO/2006/008259


G05B18070414/07/2005

PROGRAMMABLE WALLBOXלתכנות הניתן תאורה למתג עמעםDIMMERLUTRON ELECTRONICS CO., INC.

15/07/2004

10/892510US

PCT/US/2005/025002WO/2006/019918

F01K18070518/07/2005

חומנית אנרגיה המרת עבור עבודה נוזלי באמצעות וזאת דלק מתאי נפלט חום של

מעגליות ראנקין מערכות

WORKING FLUIDS FOR THERMAL ENERGY CONVERSION OF WASTE HEAT FROM FUEL CELLS USING RANKINE CYCLE SYSTEMSHONEYWELL INTERNATIONAL INC.

16/07/2004

10/892913US

PCT/US/2005/025522WO/2006/014609

A61K18070626/07/2005

PHARMACEUTICAL DOSAGE FORMSראסג'ילין הכוללות רוקחיות מינון צורותINCLUDING RASAGILINE


26/07/2004

60/591359US

01/09/2004

60/606241US

PCT/US/2005/026517WO/2006/014973

C07C18070721/07/2005


POLYMORPHS OF ATOMOXETINEהידרוכלוריד אטמוקסטין של פולימורפיםHYDROCHLORIDETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

22/07/2004

60/590851US

PCT/US/2005/026008WO/2006/020348

C07D18070822/07/2005

של חדשות קריסטליניות צורות ותהליכים המי–קלציום אטורבסטטין

להכנתן

NOVEL CRYSTAL FORMS OF ATORVASTATIN HEMI-CALCIUM AND PROCESSES FOR THEIR PREPARATION


22/07/2004

60/590945US

PCT/US/2005/026015WO/2006/012499

A61K18071024/01/2001

שחרור בעל להזרקה ניתן פרמצבטי שתלמבוקר

CONTROLLED-RELEASE, INJECTABLE PHARMACEUTICAL IMPLANTARDANA BIOSCIENCE LIMITED

27/01/2000

09/491978US

PCT/EP/2001/000733WO/2001/054662

B23B18071115/07/2005

למתאם, כלי חיתוך כלי לחיבור מערכתואביזר חיתוך

SYSTEM FOR CLAMPING A CUTTING HEAD TO AN ADAPTER, A CUTTING HEAD AND A FIXTURETEENESS ASA

22/07/2004

20043161NO

PCT/NO/2005/000264


WO/2006/019305

H04S18071213/07/2005

קטעי ניתוח באמצעות אודיו אותות צירוףאודיו

COMBINING AUDIO SIGNALS USING AUDITORY SCENE ANALYSISDOLBY LABORATORIES LICENSING CORPORATION

03/08/2004

10/911404US

PCT/US/2005/024630WO/2006/019719

C12P18071315/07/2005

IMMUNE MODULATING COMPOUNDSמפטריות מתכווננים רכיבים חיסוןFROM FUNGIMEDIMUSH A/S

16/07/200410/892393US

15/06/2005PA200500881DK

15/06/200560/690477US

15/06/2005PA200500882DK

15/06/200560/690482US

15/06/2005PA200500880DK

15/06/200560/690496US

PCT/DK/2005/000498WO/2006/007848

A61K18071420/07/2005

מתחלבות תערובות של גלניים יישומיםליפידיים אקסיפיינטים של מעצמן

GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTSAVENTIS PHARMA S.A.


27/07/20040408269FR

PCT/FR/2005/001853WO/2006/018501

H01L18071515/01/2007

מפסקים של אוטומטי לייצור ותהליך שיטהאלקטרים פיאזו–

A METHOD FOR THE FULLY AUTOMATED PRODUCTION OF A PIEZOELECTRIC SWITCH AND A PROCESS THEREFOR

BARAN ADVANCED TECHNOLOGIES( בע"מ86) מתקדמות טכנולוגיות ברן(86) LTD.

B01J18071602/07/2005

של הדרגתי לייצור ומתקן שיטהעיבוי בהמסת שימוש על–ידי פולימרים

METHOD AND DEVICE FOR THE GRADUAL PRODUCTION OF POLYMERS USING MELT CONDENSATIONZIMMER AKTIENGESELLSCHAFT

17/07/2004

102004034708.5DE

PCT/EP/2005/007171WO/2006/007966

A61K18071704/08/2005

ILIL-17 ANTAGONISTIC ANTOBODIES – 17 אנטגוניסטים נוגדניםNOVARTIS AG

05/08/2004

0417487.6GB


PCT/EP/2005/008470WO/2006/013107

C07D18071801/11/2000

של אגוניסטים של חיוביים מודולטוריםניקוטיני רצפטור

POSITIVE MODULATORS OF NICOTINIC RECEPTOR AGONISTSASTRAZENECA AB

03/11/1999

9903997-6SE

PCT/SE/2000/002148WO/2001/032619

G02B18071906/07/2005

ומערך משתנה פוקלי מרחק עם עדשות הנשלטות מיקרו–מראות המכילות עדשותיחידני באופן

VARIABLE FOCAL LENGTH LENS AND LENS ARRAY COMPRISING DISCRETELY CONTROLLED MICROMIRRORSSTEREO DISPLAY, INC.

16/07/2004

10/893039US

PCT/US/2005/023920WO/2006/019571

B23K18072014/07/2005

SOLDER PASTE DISPENSER FOR Aתדמיות מדפסת עבור לחם משחת מנפקSTENCIL PRINTERSPEEDLINE TECHNOLOGIES, INC.

15/07/2004

10/891625US

PCT/US/2005/025071WO/2006/019966

C07D18072115/07/2005


לטיפול ניקוטין קולטני של אגוניסטיםדלקתיות במחלות

NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASESUNIVERSITE LAVAL

15/07/2004

10/890987US

PCT/CA/2005/001120WO/2006/005195

C07D18072215/07/2005

רוקחות ותכשירי תיאינופירימידין תולדותאותן המכילים

THIENOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMESUNESIS PHARMACEUTICALS, INC.

16/07/2004

60/588718US

01/12/2004

60/632568US

PCT/US/2005/025340WO/2006/036266

G01C18072304/01/2007

LEVELING DEVICEפלס.KAPRO INDUSTRIES LTDבע"מ תעשיות קפרו

C07K18072519/07/2005

,4דמוי–אנגיופיוטין– חלבון של מעכביםבהם ושימוש תצריפיהם

INHIBITORS OF ANGIOPOIETIN-LIKE 4 PROTEIN, COMBINATIONS, AND THEIR USEGENENTECH, INC.

20/07/2004

60/589782US

PCT/US/2005/025734


WO/2006/014729

B23K18072627/07/2005

והלחמת אוטומטית להרכבה ומכשיר שיטהרפואי מכשור של לייזר

METHOD AND APPARATUS FOR AUTOMATED ASSEMBLY AND LASER WELDING OF MEDICAL DEVICESMEDTRONIC, INC.

28/07/2004

10/900858US

PCT/US/2005/026691WO/2006/015068

C07K18072718/08/2005

המכילים מיקרוביאליים אנטי פפטידיםליזין ו/או ארגינין של מוטיב

ANTIMICROBIAL PEPTIDES COMPRISING AN ARGININE AND/OR LYSINE -CONTAINING MOTIFNOVABIOTICS LIMITED

18/08/2004

0418414.9GB

14/03/2005

11/079795US

PCT/GB/2005/003245WO/2006/018652

G02C18072822/02/2005


הכוללים מסגרת חסר מסוג משקפיים מניתנות ציר צידיות, נטולות תייל זרועותלכיפוף

FRAMELESS-TYPE SPECTACLES COMPRISING HINGE-FREE, BENDABLE WIRE SIDEARMSMINIMA

19/08/20040408983FR

PCT/FR/2005/000406WO/2006/027428

C07F18072915/07/2005

COMPOUNDS AND METHODS FORבסרטן לטיפול ושיטות תרכובותTREATMENT OF CANCERTHE TEXAS A&M UNIVERSITY SYSTEM

16/07/2004

60/588596US

PCT/US/2005/025192WO/2006/020048

C07K18073315/07/2005

APOLIPOPROTEIN A1 MIMETICS ושימושיהם1A אפוליפופרוטאין מחקיAND USES THEREOFTRUSTEES OF TUFTS COLLEGE

16/07/2004

60/588722US

PCT/US/2005/025182WO/2006/020040

C12N18073415/07/2005

ושיטות דיסטרופין רטינל של טרנסגןבו לשימוש

RETINAL DYSTROPHIN TRANSGENE AND METHODS OF USE THEREOFTHE CHILDREN'S MERCY HOSPITAL

16/07/2004

60/588700US

09/09/2004

60/608252US

24/09/2004

60/613026US

04/02/2005

11/050911US


PCT/US/2005/025375WO/2006/020184

A61L18073519/07/2005

מוליכים שטח לפני פעילים חומרים קישורשונים גופים של

MODIFIED CONDUCTIVE SURFACES HAVING ACTIVE SUBSTANCES ATTACHED THERETO

.ELUTEX LTDבע"מ אלוטקס19/07/2004

60/588749US

PCT/IL/2005/000769WO/2006/008739

C07D18073613/07/2005

במחלות לטיפול הידנטואין של נגזרותדלקתיות

HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERSSCHERING CORPORATION

16/07/2004

60/588502US

PCT/US/2005/024771WO/2006/019768

C07C18073726/08/2005

לטיפול ארילסולפונילסטילבין נגזרותקשורים ומצבים באינסומניה

ARYLSULPHONYLSTILBENE DERIVATIVES FOR TREATMENT OF INSOMNIA AND RELATED CONDITIONSMERCK SHARP & DOHME LTD

27/08/2004

0419192.0GB

PCT/GB/2005/003353WO/2006/021806

C07D18073815/07/2005

CINHIBITORS OF HCV REPLICATION הפטיטיס וירוס של שכפול מעכביBRISTOL-MYERS SQUIBB COMPANY


09/08/2004

60/608932US

11/03/2005

60/660555US

14/07/2005

11/181639US

PCT/US/2005/025234WO/2006/020082

A61K18073904/08/2005

ושיטות חדישות פנופיבראט פורמולציותקשורות טיפול

NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENTTRANSFORM PHARMACEUTICALS, INC.

06/08/2004

60/599320US

27/08/2004

60/604861US

24/02/2005

60/655762US

06/06/2005

60/687704US

PCT/US/2005/027806WO/2006/017692

A61K18074025/07/2005

מניעה או לטיפול תזונתיים והרכבים שיטותאוסטיאופרוזיס של

NUTRITIONAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSISABBOTT LABORATORIES

28/07/2004

60/591656US

PCT/US/2005/026342WO/2006/014878

B41J18074225/07/2005

METHOD OF MANUFACTUREייצור שיטתXAAR TECHNOLOGY LIMITED


23/07/2004

0416523.9GB

PCT/GB/2005/002923WO/2006/008555

H04Q18074318/07/2005

HANDOFF עם משתנה שידור קצבSOFT

VARIABLE RATE BROADCAST WITH SOFT HANDOFFQUALCOMM INCORPORATED

20/07/2004

60/589819US

15/07/2005

11/182232US

PCT/US/2005/025523WO/2006/014610

H04L18074418/07/2005

צלילי עם והפרעה ערוץ של חוזר אומדןPILOTל מוקצים OFDMA

ITERATIVE CHANNEL AND INTERFERENCE ESTIMATION WITH DEDICATED PILOT TONES FOR OFDMAQUALCOMM INCORPORATED

16/07/2004

60/588646US

22/12/2004

60/639157US

PCT/US/2005/025609WO/2006/010159

H04L18074515/07/2005

ערוץ לאומדןPILOT של הדרגתית החרדהוהפרעה

INCREMENTAL PILOT INSERTION FOR CHANNEL AND INTERFERENCE ESTIMATIONQUALCOMM INCORPORATED

16/07/2004

60/588686US

22/12/2004

60/638536US

13/05/2005

11/128976US


PCT/US/2005/025157WO/2006/020021

B22D18074616/01/2007

פיזור עם מתכת בהזרקת מעוצב פריטזהה לעשייה ושיטות לקרינה אטום

METAL INJECTION MOLDED ARTICLE WITH A RADIOPAQUE DISPERSION AND METHODS OF MAKING SAMEACCELLENT, INC.

27/01/2006

11/342182US

C09D18074730/06/2005

AN INK-JET PRINTING PROCESS ANDדיו הזרקת ותהליך דיוINKSUN CHEMICAL B.V.

23/07/2004

0416571.8GB

PCT/GB/2005/002589WO/2006/008441

H04S18074915/08/2005

כל למילוי קול ערבוב להרחבת שיטההפנויים היוצאים הערוצים

METHOD FOR EXPANDING AN AUDIO MIX TO FILL ALL AVAILABLE OUTPUT CHANNELSDOLBY LABORATORIES LICENSING CORPORATION

23/08/2004

10/924757US

PCT/US/2005/029164WO/2006/023509

B65D18075014/07/2005

CONTAINERמיכלMICHAEL JAMES WARWICK


19/07/2004

2004/5728ZA

PCT/IB/2005/052342WO/2006/011093

C07K18075219/07/2005

דמוי בחלבון לשימוש ושיטות תרכובות4 אנגיופויטין

COMPOSITIONS AND METHODS OF USING ANGIOPOIETIN-LIKE 4 PROTEINGENENTECH, INC.

20/07/2004

60/589875US

PCT/US/2005/025650WO/2006/014678

F41G18075317/01/2007

אדומה "נקודה מסוג משופר תצפית מתקןנעה"

IMPROVED "MOVING RED DOT" SIGHTING DEVICE

"FN HERSTAL" S.A.08/02/2006

2006/0078BE

A61B18075417/01/2007

לחיבור כירורגי, אליפטי, תוך–חללי מהדקרקמות

ELLIPTICAL INTRALUMINAL SURGICAL STAPLER FOR ANASTOMOSISETHICON ENDO-SURGERY, INC.

01/02/2006

11/344542US

C12N18075504/08/2005


לשימוש ושיטותAHASS מונוקוט רצפיבהם

MONOCOT AHASS SEQUENCES AND METHODS OF USEBASF PLANT SCIENCE GMBH

04/08/2004

60/598671US

PCT/US/2005/027729WO/2006/015376

C07D18075726/07/2005

[ פירימידינים, שימושיהםD–5 , 4אמידזו]להכנתם ושיטות

IMIDAZO[4,5-D] PYRIMIDINES, THEIR USES AND METHODS OF PREPARATIONGILEAD SCIENCES, INC.

27/07/2004

60/591726US

PCT/US/2005/026606WO/2006/033703

C07D18075901/08/2005

דם כלי במחלות לטיפול היעילים אינדזוליםולב

INDAZOLES USEFUL IN TREATING CARDIOVASCULAR DISEASESWYETH

03/08/2004

60/598573US

08/04/2005

60/669737US

PCT/US/2005/026970WO/2006/017284

C07D18076029/09/2005

ב או בהטרוציקליים מותמרים פירימידיניםHIV כמעכבי – קרבו5

HIV INHIBITING 5-CARBO- OR HETEROCYCLIC SUBSTITUTED PYRIMIDINESTIBOTEC PHARMACEUTICALS LTD.

30/09/2004

04104814.1EP


PCT/EP/2005/054931WO/2006/035068

C07K18076219/07/2005

אוליגומרי של קוניוגטים של פורמולציותבהן ושימוש אינסולין

INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOFNOBEX CORPORATION

19/07/2004

60/589058US

15/10/2004

60/619153US

02/12/2004

60/632578US

24/02/2005

60/655803US

24/02/2005

60/655838US

PCT/US/2005/025644WO/2006/014673

C07D18076327/12/2005

דיאזאפן פאניל קרבוקסאמידי פאניל קרבוקסאמידי ואנאלייטד

ובשימוש חמצן המכילים דיאזאפן כאנטגוניסטים

D 3 של

PHENYL DIAZEPANE CARBOXAMIDES AND ANNELATED PHENYL PIPERAZINE CARBOXAMIDES CONTAINING OXYGEN AND USED AS DOPAMINE D3 ANTAGONISTSSCHWARZ PHARMA AG

30/12/2004

102004063797.0DE

PCT/EP/2005/014047WO/2006/072430


C23C18076429/07/2005

של ( לשיקועII) נחושת של קומפלקסים של שיקוע ידי על נחושת של פילמיםאוטומיות שכבות

COPPER (II) COMPLEXES FOR DEPOSITION OF COPPER FILMS BY ATOMIC LAYER DEPOSITIONE.I. DU PONT DE NEMOURS AND COMPANY

30/07/2004

60/592785US

30/07/2004

60/592816US

PCT/US/2005/027019WO/2006/015225

B29C18076502/08/2005

לעשיית נמוכה בטמפרטורה עיצוב תהליךביולוגי לפירוק הניתנים מוצקים פריטים

LOW TEMPERATURE MOLDING PROCESS FOR MAKING SOLID BIODEGRADABLE ARTICLESR&D GREEN MATERIALS, LLC

05/08/2004

60/599215US

PCT/US/2005/027380WO/2006/017481

C07D18076620/07/2005

ושימושם אמינופיפרידין, הכנתם תולדותמלנוקורטין קולטני של כאגוניסטים

AMINOPIPERIDINE DERIVATIVES , PREPARATION THEREOF AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONISTSSANOFI-AVENTIS

29/07/20040408370FR

PCT/FR/2005/001855WO/2006/021656


H04N18076720/07/2005

FRAME מבוססת להמרה ומערכת שיטהRATE UPוידאו דחיסת עבור (FRUC–EA)

METHOD AND APPARATUS FOR ENCODER ASSISTED-FRAME RATE UP CONVERSION (EA-FRUC) FOR VIDEO COMPRESSIONQUALCOMM INCORPORATED

20/07/2004

60/589901US

PCT/US/2005/025813WO/2006/012384

C23C18076829/07/2005

של ( לשיקועII) נחושת של קומפלקסים של שיקוע ידי על נחושת של פילמיםאוטומיות שכבות

COPPER (II) COMPLEXES FOR DEPOSITION OF COPPER FILMS BY ATOMIC LAYER DEPOSITIONE.I. DU PONT DE NEMOURS AND COMPANY

30/07/2004

60/592785US

30/07/2004

60/592816US

PCT/US/2005/026953WO/2006/015200

G06F18076928/06/2005

SYSTEM FOR PROVIDING ACCESSתפעולי למידע גישה לאספקת מערכתTO OPERATION INFORMATIONNDS LIMITED

16/08/2004

60/601890US

16/08/2004

0418279.6GB

PCT/IL/2005/000685WO/2006/018827


C07D18077020/07/2005

והשימוש אוקסופיפרידין, הכנתן תולדותבהן הרפואי

OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOFSANOFI-AVENTIS

29/07/20040408369FR

PCT/FR/2005/001854WO/2006/021655

A61K18077119/07/2005

של נורוטוקסין המכיל רפואי תכשירבוטולינום

THERAPEUTIC COMPOSITION WITH A BOUTULINUM NEUROTOXINMERZ PHARMA GMBH & CO. KGAA

26/07/2004

60/591196US

PCT/US/2005/025408WO/2006/020208

A61K18077203/08/2005

CARRIER FOR ENTERALתוך–מעי למתן נשאADMINISTRATIONVITAL HEALTH SCIENCES PTY LTD.

03/08/2004

2004904366AU

07/04/2005

2005901723AU


PCT/AU/2005/001159WO/2006/012692

F26B18077319/07/2005

בחום וטיפול לייבוש ומערכת תהליךבחומרים

PROCESS AND SYSTEM FOR DRYING AND HEAT TREATING MATERIALSEARTHRENEW IP HOLDINGS LLC

19/07/2004

10/895030US

PCT/US/2005/025640WO/2006/014670

F26B18077418/07/2005

PROCESS AND APPARATUS OFלדישון גלם חומר לייבוש ומכשיר תהליךFEEDSTOCK DRYING FERTILIZEREARTHRENEW IP HOLDINGS LLC

19/07/2004

60/894645US

PCT/US/2005/025466WO/2006/020253

C07D18077519/07/2005

ניקוטיני אצטילכולין קולטן של מאפננים ? ושימושיהם7

MODULATORS OF ALPH7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOFSIENA BIOTECH S.P.A.

20/07/2004

60/589003US

PCT/EP/2005/007846WO/2006/008133

A63B18077615/08/2005

FREE STANDING BALLET BARעצמאי העומד בלט לתרגול קורה מתקןEXERCISE DEVICEFLUIDITY ENTERPRISES, INC.


16/08/2004

10/710975US

PCT/US/2005/028988WO/2006/023446

C07D18077728/09/2005

והשימוש חדשות –און2כרומן– תולדות של חוזרת ספיגה כמעכבי בהן

מונואמיניים נוירוטרנסמיטרים

NOVEL CHROMEN-2- ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORSNEUROSEARCH A/S

30/09/200460/614052US

30/09/2004PA200401491DK

PCT/EP/2005/054861WO/2006/035034

A61B18077818/01/2007

LANCING DEVICE WITH DAMPENEDמרסן קפיץ עם ניקוב התקןSPRINGLIFESCAN, INC.

20/01/2006

60/760497US

31/03/2006

11/395908US

A61B18077918/01/2007

LANCING DEVICE WITH DAMPENERמרין עם ניקוב התקןLIFESCAN, INC.

20/01/2006

60/760497US

31/03/2006

11/395757US


A61B18078018/01/2007

METHOD FOR DAMPENED LANCINGניקוב לריסון שיטהLIFESCAN, INC.

20/01/2006

60/760497US

31/03/2006

11/395756US

C07F18078126/07/2005

תרכובות של פוספונאטים אנלוגיםHIV מעכבות

PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDSGILEAD SCIENCES, INC.

27/07/2004

60/591811US

PCT/US/2005/026504WO/2006/110157

C12N18078222/07/2005

דופאמינרגיים נוירוניים אב לתאי סמניםCORIN /4 Lrp

Lrp4/CORIN DOPAMINERGIC NEURON PROGENITOR CELL MARKERSEISAI CO. LTD.

22/07/2004

2004-213743JP

29/10/2004

2004-315060JP

PCT/JP/2005/013453WO/2006/009241


F01D18078318/01/2007

CERAMIC MATRIX LAMINATESקרמיות מטריצה שכבותUNITED TECHNOLOGIES CORPORATION

20/01/2006

60/760990US

17/01/2007

11/654302US

C12Q18078425/07/2005

דלקת לגילוי אימונו בדיקת ומתקן שיטההתוספתן

A METHOD AND AN IMMUNOASSAY TEST DEVICE FOR DETECTING APPENDICITISASPENBIO PHARMA, INC.

23/07/2004

60/590631US

PCT/US/2005/026218WO/2006/012588

C12N18078603/08/2005

שינוי על–ידי גנים לביטוי אפנון שיטתCPG של תוכן

METHOD FOR MODULATING GENE EXPRESSION BY ALTERING THE CPG CONTENTGENEART AG

03/08/2004

102004037611.5DE

03/08/2004

102004037652.2DE

PCT/EP/2005/008423WO/2006/015789

C07D18078725/07/2005

חלבוני של כליגנדים מותמרים טריאזנים של הסרה או לזיהוי בהם והשימוש פריון

פריונים

SUBSTITUTED TRIAZINES AS PRION PROTEIN LIGANDS AND THEIR USE TO DETECT OR REMOVE PRIONSPROMETIC BIOSCIENCES LIMITED

27/07/2004

0416699.7GB


PCT/GB/2005/002910WO/2006/010915

C07D18078828/07/2005

וקולטןVEGF קולטן של איתות מעכביHGF

INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALINGMETHYLGENE, INC.

30/07/2004

60/592913US

20/05/2005

60/683038US

PCT/CA/2005/001177WO/2006/010264

C07K18078902/08/2005

IL –4 נגד מונוקלונליים אנושיים נוגדניםאנושי

HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN IL-4NOVARTIS AG

03/08/2004

0417301.9GB

03/08/2004

0417302.7GB

03/08/2004

0417303.5GB

03/08/2004

0417304.3GB

03/08/2004

0417305.0GB

03/08/2004

0417306.8GB

PCT/EP/2005/008361WO/2006/013087


C07D18079027/07/2005

PYRROLO-PYRIDINE KINASEפירולו–פירידין קינז מאפנניMODULATORSSGX PHARMACEUTICALS, INC.

27/07/2004

60/591888US

27/07/2004

60/591887US

19/05/2005

60/683510US

PCT/US/2005/026792WO/2006/015123

C07D18079127/07/2005

MAOBBENZYLOXY DERIVATIVES AS כמעכבי בנזילאוקסי נגזרותMAOB INHIBITORSF. HOFFMANN-LA ROCHE AG

02/08/2004

04103710.2EP

PCT/EP/2005/008143WO/2006/013049

A47B18079218/01/2007

תורה, תפילין )ספרי סת"ם לכתיבת שולחן גראפי, חופשית, רישום ומזוזות(, כתיבה

אפיון בעל כתיבה אופן וכל ידנית גראפיקהדומה

TABLE FOR "STAM" WRITING (TORA BOOKS, PHYLACTERIES, MEZUZAH), FREE WIRITING, GENERAL WRITING, GRAPHIC ARTS, DRAWING, WHICH HAVE SIMILAR CHARACTERISTICS.

ELIRAN ELDARאלדר אלירן

B61L18079318/01/2007

רכבת פסי על מכשולים לזיהוי שיטהרכבת תאונות ומניעת

A METHOD OF DETECTING OBSTACLES ON RAILWAYS AND PREVENTING TRAIN ACCIDENTS

TAL ISRAELIישראלי טלJune 3, 2007597 –התשס"ז בסיון י"ז

13/02/2006US60/760781US

A61B18079411/05/2005

עם מסגסוגות המיוצרים רפואיים מכשירים מרטינסיטי מעמד המופיעות צורתן זיכרון

לשימושם במאמץ, ושיטה ממושך

MEDICAL DEVICES FORMED FROM SHAPE MEMORY ALLOYS DISPLAYING A STRESS-RETAINED MARTENSITIC STATE AND METHOD FOR USE THEREOF

.NITI MEDICAL TECHNOLOGIES LTDבע"מ רפואיות טכנולוגיות ניטי30/07/2004

10/903823US

PCT/IL/2005/000492WO/2006/011127

C07D18079720/07/2005

ושימושים אמינו–טרופאן, הכנתם תולדותבהם רפואיים

AMINO-TROPANE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOFSANOFI-AVENTIS

29/07/20040408372FR

PCT/FR/2005/001856WO/2006/021657

G02B18079831/08/2005

מתח מאפייני קיזוז להתאמת תהליךאינטרפרומטרי מאפנן של חשמלי

PROCESS FOR MODIFYING OFFSET VOLTAGE CHARACTERISTICS OF AN INTERFEROMETRIC MODULATORIDC, LLC

27/09/2004

60/613499US

19/08/2005

11/208052US

PCT/US/2005/030962WO/2006/036439


H04L18079920/07/2005

בין סלולרית בתשורת שידור ערוצי מעברסלולרית תקשורת ומערכתSIP רשת

HANDOFF BETWEEN A SIP NETWORK AND A CELLULAR COMMUNICATION SYSTEMQUALCOMM INCORPORATED

20/07/2004

60/589821US

PCT/US/2005/025810WO/2006/012381

C12N18080220/07/2005

בררנייםSIRNAS A 5– EIFב– שימוש אנטיסנס ופולינוקלאוטידים לאפופטוזהדלקתית תגובה לעיכוב/דיכוי

USE OF APOPTOSIS-SPECIFIC EIF-5A SIRNAS AND ANTISENSE POLYNUCLEOTIDES TO INHIBIT/SUPPRESS AN INFLAMMATORY RESPONSESENESCO TECHNOLOGIES, INC.

20/07/2004

60/589073US

PCT/US/2005/025766WO/2006/014752

F41H18080308/06/2005

רכב כלי על להגנה מגנטי גלאי עם התקןמוקשים נגד אזרחי או צבאי

DEVICE FOR PROTECTING A MILITARY OR CIVILIAN VEHICLE AGAINST MINES WITH MAGNETIC DETECTIONGIAT INDUSTRIES

23/07/20040408212FR

PCT/FR/2005/001407WO/2006/021630

C07C18080402/02/2005

ZONE REACTORלמקטעים תגובה כורGRT, INC.


19/07/2004

10/894165US

PCT/US/2005/002829WO/2006/019399

G09B18080501/06/2005

SYSTEM AND METHOD FORנהיגה על למעקב ושיטה מערכתMONITORING DRIVING

,DRIVE DIAGNOSTIC LTDבע"מ דיאגנוסטיקה דרייב20/07/2004

10/894345US

PCT/IL/2005/000566WO/2006/008731

C07D18080620/07/2005

IMIDAZOPYRAZINE AS TYROSINEקינאז טירוזין כמעכבי אימידאזופיראזיניםKINASE INHIBITORSOSI PHARMACEUTICALS, INC.

20/07/2004

60/589514US

PCT/US/2005/025891WO/2006/012422

A61B18080720/07/2005

OBSTETRIC VACUUM EXTRACTORבלידה לסיוע וואקום שולפןMONTY MEDICAL LIMITED

20/07/2004

0416172.5GB

PCT/GB/2005/002863WO/2006/008532

H01K18080818/01/2007

A LAMP AND A METHOD FORלהארה ושיטה מנורהILLUMINATING

HERSHNZON GALIגלי הירשנזוןJune 3, 2007 600 –התשס"ז בסיון י"ז

B60J18080927/05/2005

עם שכבות לו שיש שקוף למינציה מבנה של רוח במגן לשימוש לקילוף הניתן פילם

טיס כלי

TRANSPARENT LAMINATED STRUCTURE HAVING PEEL-AWAY FILM LAYERS FOR USE ON AIRCRAFT WINDSCREENSUNITED PROTECTIVE TECHNOLOGIES, LLC

30/07/2004

10/909129US

PCT/US/2005/018771WO/2006/028532

C07D18081016/08/2005

מאוחים פירימידונים של אננטיומרים של ובמניעה בטיפול ושימושים נבחרים

סרטן

ENANTIOMERS OF SELECTED FUSED PYRIMIDONES AND USES IN THE TREATMENT AND PREVENTION OF CANCERASTRAZENECA AB

18/08/2004

60/602366US

PCT/GB/2005/003207WO/2006/018628

C07D18081116/08/2005

ושימושים נבחרים מאוחים הטרוציקליםבהם

SELECTED FUSED HETEROCYCLICS AND USES THEREOFASTRAZENECA AB

18/08/2004

60/602399US

PCT/GB/2005/003202WO/2006/018627


A61B18081320/07/2005

למדידת ושיטה לביש, מערכת מכשירסביבתיים ו/או פיסיולוגיים פרמטרים

WEARABLE DEVICE, SYSTEM AND METHOD FOR MEASURING PHYSIOLOGICAL AND/OR ENVIRONMENTAL PARAMETERS


60/589581US

21/07/2004

60/589572US

PCT/IL/2005/000772WO/2006/008740

B65D18081520/07/2005

של שטח לפיסול ושיטה מודולרי מנגנוןמפרק

MODULAR APPARATUS AND METHOD FOR SCULPTING THE SURFACE OF A JOINTALEXANDRIA RESEARCH TECHNOLOGIES LLC

20/07/2004

60/589320US

20/07/2005

11/186485US

PCT/US/2005/025794WO/2006/012370

A61K18081720/07/2005


ומחלות אוטואימוניות של ספציפי עיכובלאוטואנטיגנים קשורות

SPECIFIC INHIBITION OF AUTOIMMUNITY AND DISEASES ASSOCIATED WITH AUTOANTIGENSISOGENIS, INC.

20/07/2004

60/589707US

29/09/2004

60/614529US

PCT/US/2005/025878WO/2006/012416

F21L18081824/10/2005

RUGGEDIZED DIGITAL LOW -LIGHTנמוך באור לראיה קשיח דיגיטלי מכשירVIEWING DEVICEXENONICS, INC.

22/10/2004

60/621415US

18/02/2005

11/060903US

PCT/US/2005/038652WO/2006/047630

B60T18081921/01/2007

INTENCITY BREAKING INDCATORבלימה עוצמת חיוויעזר ארז

B23D18082021/01/2007

ROTATABLE HOUSING DEVICEלסיבוב הניתן מעטה התקןYEFIM KERETHקרת יפים

H04L18082123/06/2005

END USER RISK MANAGEMENTסופי משתמש סיכון ניהול


REFLECTENT SOFTWARE, INC.20/07/2004

10/894714US

PCT/US/2005/022352WO/2006/019513

F01D18082228/01/2005

FAN BLADES AND MODIFICATIONSותאומים מניפה להביDELTA T CORPORATION

21/07/2004

60/589945US

PCT/US/2005/002703WO/2006/022812

A62C18082313/06/2005

DISCHARGE OF FIREאש לכיבוי חומר של פריקהEXTINGUISHING AGENTKIDDE IP HOLDINGS LIMITED

21/07/2004

10/895729US

PCT/GB/2005/002398WO/2006/008436

H04L18082414/07/2005

במהלך פער אינדיקציית לאספקת שיטהדביקה משימה

A METHOD OF PROVIDING A GAP INDICATION DURING A STICKY ASSIGNMENTQUALCOMM INCORPORATED


21/07/2004

60/590112US

22/12/2004

11/022144US

PCT/US/2005/025168WO/2006/020030

H04L18082520/07/2005

תקשורת במערכות לפקטות מודע מתזמןאלחוטית

PACKET AWARE SCHEDULER IN WIRELESS COMMUNICATION SYSTEMSQUALCOMM INCORPORATED

20/07/2004

60/589820US

PCT/US/2005/025856WO/2006/012405

H04L18082611/07/2005

ערוץ אומדן לשיפור תדר תחום סינוןתקשורת אותות מרובות במערכת

FREQUENCY DOMAIN FILTERING TO IMPROVE CHANNEL ESTIMATION IN MULTICARRIER SYSTEMSQUALCOMM INCORPORATED

20/07/2004

60/589817US

22/12/2004

11/022360US

PCT/US/2005/024613WO/2006/019709

H04N18082721/07/2005

METHOD AND APPARATUS FORתנועה וקטור להעברת ומערכת שיטהMOTION VECTOR ASSIGNMENTQUALCOMM INCORPORATED

21/07/2004

60/590110US

PCT/US/2005/025897WO/2006/012428


H04L18082819/07/2005

CONTROLLING AND MANAGINGמרובות ורשתות גישה וניהול בקרהACCESS TO MULTIPLE NETWORKSQUALCOMM INCORPORATED

20/07/2004

60/589897US

26/04/2005

60/675337US

23/06/2005

11/165081US

PCT/US/2005/025804WO/2006/012377

H04B18082919/07/2005

במערכת חוזר חיבור של כוח בקרתאורטוגונלית

REVERSE LINK POWER CONTROL IN AN ORTHOGONAL SYSTEMQUALCOMM INCORPORATED

20/07/2004

60/589823US

22/12/2004

11/022348US

PCT/US/2005/025803WO/2006/012376

H04Q18083011/07/2005

EFFICIENT SIGNALING OVERגישה ערוץ מעבר יעיל איתותACCESS CHANNELQUALCOMM INCORPORATED

21/07/2004

60/590113US

22/12/2004

11/020457US

PCT/US/2005/024614WO/2006/019710


A47K18083121/01/2007

METHOD AND APPARATUS FORנוזל–נוזל למיצוי ומתקן שיטהLIQUID-LIQUID EXTRACTION

LAVIE, RAMרם לביא

C07H18083221/07/2005

–2–דאוקסי–2 של תכשיר מותמר–אלקיל פלואורו–די–ריבופוראנוסיל

ונגזרותיהם ופורינים פירידינים

PREPARATION OF ALKYL-SUBSTITUTED 2-DEOXY-2 FLURO-D-RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVESPHARMASSET, INC.

21/07/2004

60/589866US

09/09/2004

60/608320US

PCT/US/2005/025916WO/2006/012440

A23L18083422/07/2005

ANTI-HYPERTENSIVE FUNCTIONALדם לחץ יתר נגד פעילים מזון תוצריFOOD PRODUCTSGLOBUS EGG SCIENCES B.V.

22/07/2004

60/589902US

27/01/2005

05100544.5EP

PCT/NL/2005/000535WO/2006/009448

G01N18083521/07/2005

משטח דוגמת לבדיקת ומכשיר שיטהפלורסטיים בחמרים ושימוש

METHOD AND APPARATUS FOR INSPECTING A SPECIMEN SURFACE AND USE OF FLUORESCENT MATERIALS


NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO

23/07/2004

04077130.5EP

PCT/NL/2005/000529WO/2006/009444

A62C18083619/07/2005

THERMOSENSITIVE SPRINKLERחום רגיש ממטירKIL, JONG-JIN

28/07/2004

10-2004-0059444KR

04/07/2005

10-2005-0059693KR

PCT/KR/2005/002319WO/2006/011725

C12Q18083728/07/2005

החוזק, הייחודיות לקביעת שיטות סינטאז2D פרודטגלנדין של והרעילות

המטופויטי

METHODS FOR DETERMINING THE POTENCY, SPECIFICITY, AND TOXICITY OF HEMATOPOIETIC PROSTAGLANDIN D2 SYNTHASEAVENTIS PHARMACEUTICALS INC.

30/07/2004

60/592501US

PCT/US/2005/026945WO/2006/015195

B60C18083821/01/2007

טבעתי חרוזי גוף להכנת תהליך חיתוך עבור חיתוך לתיל– להקצעה

יחסית קשים חומרים

PROCESS FOR MAKING AN ANNULAR ABRASION BEAD ELEMENT FOR A CUTTING WIRE FOR CUTTING RELATIVELY HARD MATERIALS


AROS S.R.L.23/01/2006VR2006A000016IT

H01L18084020/07/2005

EXPOSURE METHOD AND DEVICEמתקן לייצר ושיטה חשיפה שיטתMANUFACTURING METHODNIKON CORPORATION

21/07/2004

2004-212756JP

29/06/2005

2005-190728JP

PCT/JP/2005/013311WO/2006/009169

F02B18084120/07/2004

עם הידראולי באופן מונעת משאבה–מזרקפנימיים בעירה מנועי עבור בקרה מנגנון

HYDRAULICALLY DRIVEN PUMP-INJECTOR WITH CONTROLLING MECHANISM FOR INTERNAL COMBUSTION ENGINES

.MAZREK LTDבע"מ מזרק

PCT/IL/2004/000656WO/2006/008726

F02M18084220/07/2004

עבור מחט–קפיץ מנגנון עם נעילה התקן בעירה למנועי המיועדת משאבה–מזרק

פנימיים

NEEDLE-SPRING LOCKING DEVICE FOR PUMP-INJECTOR (INJECTOR) FOR INTERNAL COMBUSTION ENGINES


PCT/IL/2004/000658WO/2006/008728

F02M18084320/07/2004


עם הידראולי באופן מונעת משאבה–מזרק בעירה מנועי עבור שלבית רב לחץ הגברתפנימיים

HYDRAULICALLY DRIVEN PUMP-INJECTOR WITH MULTISTAGE PRESSURE AMPLIFICATION FOR INTERNAL COMBUSTION ENGINES


PCT/IL/2004/000657WO/2006/008727

A61K18084422/07/2005

COMPOSITIONS AND METHODS FORיתר בדימום לטיפול ושיטות תכשיריםTREATING EXCESSIVE BLEEDINGALLAN D., PRONOVOST

22/07/2004

60/590214US

23/07/2004

60/590845US

PCT/US/2005/026105WO/2006/012541

G01N18084526/07/2005

VIBRATION SENSORתנודות חיישןSPIDER TECHNOLOGIES SECURITY LTD.

26/07/2004

60/590896US

PCT/IL/2005/000797WO/2006/011145

C07D18084625/07/2005

)הטרו( ארילאטאנים –טטרא2, 2, 1, 1 –טרי2,1,1 או

–הטרוציקלילאטאנים2)הטרו( אריל–אשלגן תעלות כמעכבי

1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORSMERCK & CO., INC.

29/07/2004

60/592181US

PCT/US/2005/026334


WO/2006/028590

G07D18084719/07/2005

DEVICE AND METHOD FOR VERIFYINGערך מסמכי לאימות ושיטה מכשירVALUE DOCUMENTSGIESECKE & DEVRIENT GMBH

22/07/2004

102004035494.4DE

PCT/EP/2005/007872WO/2006/010537

- תשכ"ז הפטנטים לחוק26 סעיף לפי הודעה1976

NOTICE UNDER SECTION 26 OF THE PATENTS LAW, 5727-1967

קובלו להלן מתפרסמים שפרטיהן הבקשות המעונין הפטנטים. כל לחוק17 סעיף לפי

מהבקשות בקשה פי על פטנט למתן להתנגד חדשים שלושה רשאי, תוך המתפרסמות

הפטנטים לרשם זה, להגיש יומן מתאריך לחוק30 סעיף לפי התנגדות הודעת

ואילך57 בתקנה הקבועה בדרך הפטנטים.1968 – הפטנטים, תשכ"ח לתקנות

The applications, particulars of which are set out below, have been accepted pursuant to Section 17 of the Patents Law. Any person wishing to oppose the grant of a patent on any of the applications published here, may, within three months from the date of this journal, give to the Commissioner of Patents notice under Section 30 of the Patents Law, in the manner prescribed in regulations 57 et seq of the Patents Regulations, 5728-1968

לפי מובאים ויישימים במידה הבקשות פרטיזה: סדר

Particulars of the applications, where applicable, are given in the following order:

Number of application [21] [11]הבקשה מספרTitle of invention [54]האמצאה שם

Application date [22]הבקשה תאריך מדינת – החוץ בקשות של ותאריך מספר


Number and date of foreign [33] [32] [31]האגודapplication – convention country.

.Int.Cl [51]*שביעית מהדורה – בינלאומי *סיווגApplication for patent of addition [61] מוסף לפטנט בקשהDivisional application [62]חלוקה בקשת

Applicant [71]המבקשInventor [72]הממציא

International Publication Number [87]הבינלאומית בקשה של מס' פרסום Address for service [74]מסמכים למסירת מען

Abridgement of invention (in the [57]הפירוט( ערוך בה )בשפה האמצאה תקצירlanguage in which the specification is drawn up)

מס' והמדגמים הפטנטים מיומן *הערה: החל לפי הסיווג פטנטים לבקשות ציון ניתן1/06

של הבינלאומי הסיווג של השמינית המהדורה(2006 )משנה פטנטים

*Note: As from Patents and Designs Journal No.1/06, patent applications are classified according to the Eighth Edition of the International Patent Classification (2006)


116223]21][11[

TELECENTRIC 3D CAMERAושיטה תלת-מימד טלצנטרית מצלמהAND METHOD

]54[

01.12.1995]22[Int. Cl.8 G01S 017/00]51[

]3DV SYSTEMS LIMITED]71בע"מ, יקנעם די.וי. מערכות3]GAVRIEL IDDAN, GIORA YAHAV]72יהב עידן, גיורה גבריאלבע"מ, רוחני ושות',קניין פנסטר

, ת.ד. אריה , קרית1 כניסה12 בזל תקוה , פתח10256

FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD,

12 BASEL STREETENTRANCE 1P.O.BOX 10256

PETACH TIKVA

]74[

]57 [Apparatus for creating an image indicating distances to objects (A, B) in a scene (11), comprising a modulated source of radiation (1), which directs radiation toward a scene, such that a portion of the radiation from the source is reflected from the scene and reaches the apparatus; a detector (12), which detects an image formed from the radiation that reaches the apparatus; a processor (22), which forms an image having an intensity value distribution indicative of the distance of objects from the apparatus, responsive to the intensity distribution of the detected image; and comprising a first telecentric optics comprising at least one lens (42) and an iris (40) located substantially at the

focal point of said at least one lens which receives and collimates the radiation reflected form the scene that reaches the apparatus; and a modulator (18), which modulates the collimated radiation, such that a part of the portion of the radiation which reaches the apparatus is passed by the modulator to a second telecentric optics comprising at least one image lens (44) that sends the light to pass through an iris (46) located substantially at the focal point of the image lens wherein light that passes through the iris forms the image detected by the detector, the part being dependent on the distance of respective portions of the scene from the apparatus.


__________124728]21][11[

AURORA–2AURORA-1 AND AURORA-2 – וAURORA–1 חלבוניPROTEINS

]54[

25.11.1996]22[US]33[18.12.1995]32[60/008809]31[US14.08.199660/023943

Int. Cl.8 C07K 014/435, 014/47, C12N 009/12, 015/54]51[SUGEN, INC., U.S.A.]71[

WO/1997/022702]87[ושותפיו, כהן ריינהולד

, תל4060 , ת.ד. 21 העם אחד רחוב אביב

REINHOLD COHN AND PARTNERS,

21 AHAD HA'AM ST ,.P.O.B. 4060 ,

TEL AVIV 61040

]74[

]57 [Isolated enriched or purified polypeptide, wherein said polypeptide comprises at least 100 contiguous amino

acids of the amino acid sequence depicted in SEQ IN NO:3 and SEQ.ID NO:4.

__________

124939]21][11[

בתאי המיוצרים הטרולוגיים חלבוניםלהכנתם ושיטות שמר

HETEROLOGOUS PROTEIN PRODUCTS FROM YEAST AND PROCESSES FOR PRODUCTION THEREOF

]54[

18.12.1996]22[DK]33[20.12.1995]32[1449/95]31[

Int. Cl.8 C07K 014/435, 014/62, C12N 001/19, 015/12, 015/62, 015/67, 015/81]51[NOVO NORDISK A/S, DENMARK]71[WO/1997/022706]87[

ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב

אביב



TEL AVIV 61040

]74[

]57 [DNA construct encoding a polypeptide and having the following

structure signal peptide-leader peptide-EEAEPK-heterologous protein.

__________


125855]21][11[

METHOD OF PRODUCINGמוקצפים קרמיים חומרים לייצור שיטהCERAMIC FOAMS

]54[

19.08.1998]22[IL]33[06.04.1998]32[123969]31[

Int. Cl.8 C04B 035/624]51[]CELLARIS LTD.]71בע"מ, נשר סלריס]72[גרדר גדעון


אביב



TEL AVIV 61040

]74[

]57 [A method of producing a ceramic foam based on foaming at least one precursor comprising a A1C13(Pri

2O) complex or a mixture of precursors comprising aluminium sec butoxide (ASB) and SiC14, the method comprising the steps of: placing said precursor or mixture

of precursors in a pressure vessel; heating and pressurizing said precursor or mixture of precursors to accelerate the transformation of the complex to a solution of isopropyl chloride and partially condensed Al-O-Al species.

__________

126552]21][11[

חכמים כרטיסים של אלחוטי שימושבטוחות גישה במערכת

REMOTE ADMINISTRATION OF SMART CARDS FOR SECURE ACCESS SYSTEMS

]54[

13.10.1998]22[Int. Cl.8 G06F 002/100000 012/14, G07F 007/10, H04L 009/32, 012/22]51[NDS LIMITED, UNITED KINGDOM]71[

]SHLOMO KIPNIS, RANNEN MEIR]72מאיר קיפניס, רענן שלמהושות', ט. קולב סנפורד

,2273, ת.ד. , מרמורק4 הגיא שער רחובות

SANFORD T.COLB & CO,. P.O.B. 2273 ,

REHOVOT

]74[

]57 [A system for remote administration of at least one smart card via a communication network, the system comprising: a remote administrator having administrator identification information; at

least one user unit; at least one smart card associated with said remote administrator by storing in the least one smart card said administrator identification information of the remote administrator; and a local


administrator other than the remote administrator, the local administrator being positioned in the communication network in a proximity to said at least one user unit and determined as a proxy administrator for administrating said at least one smart card by transmitting at least authorization information from the remote administrator to the local administrator, wherein said at least one smart card inserted in said at least

one user unit is operative to employ the administrator identification information to identify the remote administrator associated with said at least one smart card, and to establish communication via the communication network between the at least one smart card and the remote administrator in accordance with the administrator identification information.

__________

126918]21][11[

עצבי גידול להמרצתRET ליגאנדוכליני

RET LIGAND (RETL) FOR STIMULATING NEURAL AND RENAL GROWTH

]54[

07.05.1997]22[US]33[08.05.1996]32[60/017427]31[US07.06.199660/019300US16.07.199660/021859US11.04.199760/043533

Int. Cl.8 A61K 039/395, C07K 014/47, 016/18, 019/00, C12N 005/10, 015/12, 015/63]51[BIOGEN IDEC MA INC., U.S.A.]71[

WO/1997/044356]87[וגולר, וולף, ברגמן

,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים

WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .

P.O.B. 1352,JERUSALEM 91013

]74[

]57 [Isolated nucleic acid encoding a polypeptide with at least 80% sequence identity to an amino acid sequence selected from the group consisting of SEQ ID

NO:17 and SEQ ID NO:21, wherein said polypeptide interacts with a receptor protein Ret to trigger dimerization of the receptor protein Ret or


autophosphorylation of a tyrosine kinase domain of the receptor protein Ret.

__________

128058]21][11[

רוקחות ותכשירי אילודין של אנלוגיםאותם המכילים

ILLUDIN ANALOGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

]54[

14.07.1997]22[US]33[18.07.1996]32[08/683687]31[

Int. Cl.8 A61K 031/12, A61P 035/00, C07C 035/37, 039/225, 049/753, 049/757, 059/80, 062/38, 069/007, 205/45, 225/14, 225/20, 323/17, 323/22, 323/25, 323/52, C07D 233/60, 317/70, 317/72, C07F 007/08, C07H 015/18

]51[

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, U.S.A.

]71[





]74[

]57 [A compound of the formula

wherein R1 is (CH2)n-X-Y,where n is 0 to 4;

X is O or S or NH, andY is –CH2OC(O)(C1-C4) alkyl, (C1-C8) alkyl optionally substituted with 1 OH or 1-2 halo; a monosaccharide, -CH2C(O)-O-C(CH2)2-O-C(O)CH2SH,

)-CH2(2-O-(CH2)2W where W is halo; -(C1-C8) alkyl-O-(C1-C8) alkyl, (C6-C10) aryl, (C6-C10) aryl (C1-C4) alkyl, -C(O)O(C6-C10) aryl wherein the aryl group is optionally

substituted with 1-2 OH, halo, (C1-C4) alkyl, or O(C1-C4) alkyl; -CH2CO2(C1-C4) alkyl, - CH2CO2H, Si((C1-C4) alkyl)3 or an amino acid residue;

R3 is H or (C1-C4) alkyl; R4 is SCH2(C1-C4), -S-(C6-C10) aryl optionally substituted with halo, OH or (C1-C4) alkyl, or H;R5 is H, OH or absent;R6 is (C1-C4) alkyl;

R7 is OH or –O(Si((C1-C4) alkyl)3; orR6 and R7 together are ethylenedioxy;


R8 is (C1-C4) alkyl optionally comprising OH or halo;

the bond represented by ------ is present or absent; ora pharmaceutically acceptable salt thereof.

__________

128792]21][11[

רוקחות ותערובות הטרוציקלים קטוניםאותן המכילים

HETEROCYCLIC KETONES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

]54[

09.09.1997]22[US]33[25.09.1996]32[08/721765]31[US01.08.199708/904461

Int. Cl.8 A61K 031/40, 031/445, A61P 025/28, C07D 207/12, 207/16, 211/30, 211/60, 401/06, 409/06

]51[

GPI NIL HOLDINGS, INC., U.S.A.]71[WO/1998/013343]87[

ושותפיו, עו"פ, הס יצחק ד"ראביב , תל6451 , ת.ד. 279 הירקון רחוב

DR. YITZHAK HESS & PARTNERS, 279 HAYARKON STREET

P.O.B. 6451 TEL AVIV 61063

]74[

]57 [Compounds of the formula

or pharmaceutically acceptable salt thereof, wherein:n is 1 or 2;X is O;

Z is selected from the group consisting of CH2, CHR1 and C(R2)2;

R1 is C1-C5 straight or branched chain alkyl which is substituted with Ar1;

R2 is selected from the group consisting of:

-C1-C9 straight or branched chain alkyl,-C2-C9 straight or branched chain alkenyl,

-C3-C8 cycloalkyl,-C5-C7 cycloalkenyl, and,

-Ar1,Ar1 is phenyl, pyridyl, fluorenyl benzo[b] thiophen, or naphthyl, wherein said Ar1 is unsubstituted or substituted in one or more positions with halo, hydroxy, nitro, C1-C6 straight or branched chain alkyl, C2-C6 straight or branched chain alkenyl C1-C4 alkoxy, C2-C4 alkenyloxy, phenoxy, benzyloxy, amino, or a combination thereof.


מבקשה חלוקה בקשותפורסמו. שטרם זו

167896,The applications for division from this application have not yet been published

__________

129912]21][11[

PLANT COVER MATERIAL ANDבו שימוש ושיטה לצמחים כיסוי חומרMETHOD OF USING IT

]54[

19.11.1997]22[NZ]33[19.11.1996]32[299783]31[NZ18.09.1997328780

Int. Cl.8 A01G 013/02]51[JONATHAN DALLAS TOYE, NEW ZEALAND

]71[

WO/1998/021935]87[צדק, וכהן איתן, פרל, לצר

, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,

P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A reflective plant treatment material which reflects at least 55% of solar radiation in the UV (about 280-400 nm) range, which reflects more solar radiation than it transmits and absorbs in the UV,

visible (about 400-700 nm) and near infrared (about 700-800 nm) ranges, and which transmits at least 5% of solar radiation in the range about 800-20000 nm.

__________

131478]21][11[

בהכנתO בסטרפטוליזין שימושיםצלקת ברקמת לטיפול רפואים תכשירים

USES OF STREPTOLYSIN O IN THE PREPARATION OF MEDICAMENTS ADAPTED TO TREAT SCAR TISSUE

]54[

02.03.1998]22[US]33[04.03.1997]32[08/131478]31[

Int. Cl.8 A61K 038/00, 038/16, 038/43, 039/09, A61P 017/02, C07K 014/00, 014/315]51[MILKHAUS LABORATORY, INC., U.S.A.

]71[

WO/1998/039020]87[ושות', ט. קולב סנפורד

,2273, ת.ד. , מרמורק4 הגיא שער SANFORD T.COLB & CO,.

P.O.B. 2273 ,]74[


REHOVOTרחובות

]57 [Use of streptolysin O for the preparation of a medicament for

eliminating or reducing the appearance of scar tissue.

__________

133032]21][11[

גנים להעברת וירליים אדנו וקטורים ו/או שריר לתאי רקמתית זיקה בעליאנדותל תאי

ADENOVIRAL GENE DELIVERY VECTORS PROVIDED WITH A TISSUE TROPISM FOR SMOOTH MUSCLE CELLS AND /OR ENDOTHELIAL CELLS

]54[

18.11.1999]22[EP]33[20.11.1998]32[98203921.

6]31[

Int. Cl.8 A61K 048/00, A61P 009/00, C07K 014/075, C12N 005/10, 015/34, 015/62, 015/861

]51[

INTROGENE B.V., THE NETHERLANDS

]71[

צדק, וכהן איתן, פרל, לצר, הרצליה12688 , ת.ד. 7 שנקר רחוב

EITAN, PEARL, LATZER AND COHEN ZEDEK,

P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A recombinant adenoviral vector of a serotype from subgroup C, having been provided with at least a tissue tropism for smooth muscle cells and/or endothelial cells and having been deprived of at least a tissue tropism for liver cells, wherein said adenoviral vector comprises a capsid

comprising a tropism determining fragment of a fiber protein of an adenovirus of a serotype from subgroup B, and wherein said adenovirus serotype from subgroup B is selected from the group consisting of: adenovirus 11, adenovirus 16, adenovirus 35 and adenovirus 51.

__________

133693]21][11[

חדירות להגדלת ושיטות רוקחות תכשיריביולוגיות ממברנות של

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INCREASING PERMEABILITY OF BIOMEMBRANES

]54[

07.07.1998]22[IL]33[09.07.1997]32[121269]31[

Int. Cl.8 A61K 031/20, 031/21, A61P 025/00, 043/00, C07C 053/128, 057/03, 057/12, 069/003, 233/02

]51[


]D-PHARM LIMITED]71בע"מ, רחובות די-פארםWO/1999/002120]87[

בע"מ, די-פארם ,2313, ת.ד. ויצמן קרית המדע פארק

רחובות

D-PHARM LIMITED, KIRYAT WEIZMANN SCIENCE

PARK P.O.B. 2313

REHOVOT 76123

]74[

]57 [Use of a compound of the formula

A |

R-CH-R' (III)

wherein R denotes a saturated or unsaturated chain of between 1 to 10 carbon atoms and R' denotes a saturated or unsaturated chain of between 5 and 30 carbon atoms, and A is selected from the group consisting of COOH, COOR", CONH2, CONH-R", and COO-Y+, wherein R" is a lower alkyl group comprising 1-5 carbon atoms, and Y denotes any pharmaceutically acceptable counter-ion for the preparation of a pharmaceutical

composition for reversibly permeabilizing a biological membrane.A pharmaceutical composition for the permeabilization of biological membranes comprising a pharmaceutically effective amount of a compound of formula (III) wherein R denotes a saturated or unsaturated chain of between 4 to 10 carbon atoms, A, R', R" and Y as defined above and at least one pharmaceutically acceptable carrier is also claimed as novel.

__________

135288]21][11[

–טראיD של כרוני גלילה מתןמתילפנידט

CHRONIC BOLUS ADMINISTRATION OF D-THREO METHYLPHENIDATE

]54[

17.06.1998]22[US]33[29.09.1997]32[08/937684]31[

Int. Cl.8 A61K 031/445, A61P 025/00, C07D 211/34]51[CELGENE CORPORATION, U.S.A.]71[




REHOVOT

]74[

]57 [Use of D-threo methylphenidate or a pharmaceutically acceptable salt thereof, substantially free of both L-threo

methylphenidate and erythro methylphenidates, in the preparation of a


medicament for treating at least one of attention deficit disorder, attention deficit hyperactivity disorder, or AIDS-related dementia, wherein said medicament is

suitable for chronic administration in single, bolus dosage of said D-threo methylphenidate in each twenty-four hour period.

__________

135332]21][11[

מערכת אל להתקשרות ושיטה מתקן מחשב משאבי לבקרת שפועלת הפעלה מימדים3ב– הדמייה ממשק בעזרת

APPARATUS AND METHOD FOR INTERACTING WITH A SIMULATED 3D INTERFACE TO AN OPERATING SYSTEM OPERATIVE TO CONTROL COMPUTER RESOURCES

]54[

01.10.1998]22[US]33[02.10.1997]32[08/946106]31[

Int. Cl.8 G06F 009/45, 009/455]51[]CLOCKWISE TECHNOLOGIES LTD.]71בע"מ, תל- אביב טכנולוגיות קלוקוייז



P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A computer system comprising:computer resources (40); an operating system operative to control said computer resources; and a 3D interface (20) enabling a user generating camera motion to interact with the operating system and providing at least one screen display image (30) of a 3D

virtual scene including a simulated three-dimensional representation of at least a portion of the computer resources, said interface configured to be operative to monitor said camera motion and to determine which of said computer resources are visible in said display image.


__________

135345]21][11[

]HUMAN TOLL HOMOLOGUES]54 הומנייםTOLL הומולוגיי

07.10.1998]22[US]33[17.10.1997]32[60/062250]31[US13.11.199760/065311US28.04.199860/083322US26.06.199860/090863US26.06.199809/105413

Int. Cl.8 A61K 039/395, C07K 014/705, C12N 015/12]51[GENENTECH, INC., U.S.A.]71[





TEL AVIV 61040

]74[

] 57 [An isolated nucleic acid molecule comprising a polynucleotide sequence having at least a 95% sequence identity to

)a (a DNA molecule encoding a PRO285 polypeptide having amino acid residues 27 to 839 of Figure 1 (SEQ ID NO:1) as shown in the specification wherein the polypeptide has the ability to induce the

activation of NF-kB, or the complement of the DNA molecule; or

)b (a DNA molecule encoding the same mature polypeptide encoded by the human Toll protein cDNA in ATCC Deposit No. 209389 (DNA40021-1154) wherein the polypeptide has the ability to induce the


activation of NF-кB, or the complement of the DNA molecule.



__________

136310]21][11[

של ההפרשה יכולת לבדיקת שיטהפפטיד

METHOD FOR EXAMINING THE SECRETORY ABILITY OF A PEPTIDE

]54[

26.11.1998]22[JP]33[26.11.1997]32[9-324912]31[

Int. Cl.8 C12N 005/10, 015/12, 015/62, C12Q 001/68]51[CHUGAI SEIYAKU KABUSHIKI KAISHA, JAPANTOSHIO KITAMURA, JAPAN

]71[





TEL AVIV 61040

]74[

]57 [A method for examining whether a peptide encoded by a test cDNA contains the secretory ability, the method comprising:

)a (providing a vector wherein the test cDNA which encodes the peptide to be

examined whether it contains the secretory ability is ligated to the 5'-upstream of the DNA which encodes a peptide capable of inducing cell proliferation through dimerization on the cell surface and lacking the secretory ability;


)b (introducing the vector prepared in (a) into a cell; and

)c (culturing the transformant prepared in (b), and detecting the cell proliferation ability.

__________

136455]21][11[

ATTENUATED INVASIVEהחלשה שעברה חודרנית בקטריהBACTERIA

]54[

18.12.1998]22[US]33[29.12.1997]32[08/999391]31[

Int. Cl.8 A61K 048/00, C12N 001/21, 015/74, 015/85, 015/87]51[SCHERING AKTIENGESELLSCHAFT, GERMANY

]71[





]74[

] 57 [An attenuated invasive intracellular Listeria bacterium capable of infecting a mammalian host or host cell thereof, but having a decreased ability in intra-and intercellular movement in said host as

compared to a wild type bacterium, transformed with

)a (a promoter activated when said bacterium is present in the cytosol of a host cell, operably linked to a structural


gene or a biologically active fragment thereof encoding a Listeria bacteriphage lysine which is lethal to the bacterium;

)b (a host cell-compatible promoter, operably linked to a structural gene or fragment thereof, encoding a polypeptide.

__________

136647]21][11[

הכנה אכינוקנדין, שיטת תולדותפטריות נגד כתכשירים ושימוש

ECHINOCANDIN DERIVATIVES, PREPARATION METHOD AND APPLICATION AS ANTI-FUNGAL AGENTS

]54[

09.12.1998]22[FR]33[10.12.1997]32[97/15628]31[FR26.10.199898/13361

Int. Cl.8 A61K 038/12, A61P 031/10, C07K 007/56]51[NOVEXEL, FRANCE]71[OLIVIER COURTIN, PATRICK FAUVEAU, ASTRID MARKUS, DOMINIQUE MELON MANGUER, JEAN-MARC MICHEL, LAURENT SCHIO

]72[

WO/1999/029716]87[ דין, עורכי עורכי לצר צדק כהן פרל

ונוטריונים, פטנטים , ת.ד.5 , רח' שנקר1 גב-ים מרכז

PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET ,

P.O.B. 12704

]74[


HERZLIYA 46733, הרצליה12704

]57 [A compound selected from the group consisting of all possible stereoisomeric forms of a compound of the formula

whereinR1 and R2 are individually selected from the group consisting of hydrogen, -OH, alkyl and cycloalkyl of up to 8 carbon

atoms optionally interrupted with oxygen and optionally substituted by a member selected from the group consisting of halogen, - OH and

a and b are individually hydrogen or alkyl of 1 to 8 carbon atoms or taken together with the nitrogen form a heterocycle optionally containing at least one

heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, or R1 forms a double bond with the endocyclic carbon atom carrying the

wherein R2 is –XRa, X is selected from the group consisting of oxygen, -NH- and – N-alkyl radical, containing up to 8 carbon atoms, Ra is selected from the group consisting of hydrogen and alkyl and

cycloalkyl of up to 8 carbon atoms unsubstituted or substituted with at least one member of the group consisting of halogen, -OH-, -COOH, -COOAlk,


Alk is alkyl of 1 to 8 carbon atoms,a' and b' are individually selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms or taken with the nitrogen form a heterocycle optionally

containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen and/or substituted by a heterocycle containing at least one heteroatom or R2 is

d and e are hydrogen or alkyl of 1 to 8 carbon atoms, f and g are selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and acyl of an organic carboxylic acid of 1 to 8 carbon atoms or e and f together with –N=C-N- form a heterocycle optionally containing at least one other heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, R3 is selected from the group consisting of hydrogen, methyl and –OH,R4 is hydrogen or –OH,R representing either a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or several heteroatoms, one or several heterocycles or a linear, branched or cyclic

acyl radical containing up to 30 carbon atoms optionally containing one or several heteroatoms selected from the group consisting of oxygen, sulfur and nitrogen and/or one or several heterocycles, T is selected from the group consisting of hydrogen, methyl, -CH2 –CONH2, -CH2-CN, -(CH2)2-NH2 and –(CH2)2Nalk3

+X-, alk is alkyl of 1 to 8 carbon atoms, X is halogen,Y is selected from the group consisting of hydrogen, -OH, halogen and –SO3H and salts thereof,W is hydrogen, or –OH,Z is hydrogen or methyl or a non-toxic, pharmaceutically acceptable acid addition salt thereof.




__________

136833]21][11[

עצביים, פרקורסור תאי ליצירת שיטה אותם המכיל תומוריגני לא תאים הרכב

רוקחות תכשירי להכנת ושימושם

METHOD FOR GENERATING NEURAL PRECURSOR CELLS, NON-TUMORIGENIC CELL COMPOSITION CONTAINING THEM AND USES THEREOF IN PREPARATION OF PHARMACEUTICAL COMPOSITIONS

]54[


18.12.1998]22[DE]33[19.12.1997]32[19756864.

5]31[

Int. Cl.8 A61K 048/00, C12N 005/08, 005/10]51[OLIVER BRUESTLE, GERMANY]71[WO/1999/032606]87[

לוצאטו, את לוצאטושבע , באר5352, ת.ד. תעשייה, עומר גן

LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER

P.O.B. 5352BEER-SHEVA 84152

]74[

]57 [Non-tumorigenic cell composition obtained from mammalian embryonic stem cells, containing:

)a (at least 85% isolated neural precursor cells with the ability to differentiate into neuronal or glial cells, and

)b (no more than 15% primitive embryonic and non-neural cells, obtainable by the steps of:

)a (proliferation of ES cells;)b (cultivation of the ES cells from step (a)

into neural precursor cells;)c (proliferation of the neural precursor

cells in growth factor-containing serum-free medium;

)d (proliferation of the neural precursor cells from step (c) in another growth

factor-containing serum-free medium and isolation of the purified neural precursor cells; and

)e (proliferation of the neural precursor cells from step (d) in another growth factor-containing serum-free medium and isolation of the purified precursor cells with the ability to differentiate into neuronal or glial cells, wherein the growth factor-containing, serum-free medium in step (d) comprises bFGF and EGF, and wherein the growth factor-containing, serum-free medium in step (e) comprises bFGF and PDGF, with the proviso that the method does not include the destruction of human embryos.

__________

137257]21][11[

ותוקפנות בחרדה לטיפול חומר בלוטה סביב בעור מהפרשה המתקבל

אותו המכילה ותמידה ביונק

COMPOSITION FOR THE TREATMENT OF STRESS AND AGGRESSIVE BEHAVIOR OBTAINABLE FROM A SECRETION DERIVED FROM THE SKIN AROUND MAMMALIAN GLAND AND A SOLUTION COMPRISING SAME

]54[

21.01.1999]22[EP]33[21.01.1998]32[98400117.

2]31[

Int. Cl.8 A61K 035/00, 035/55]51[FIDELINE, FRANCE]71[WO/1999/037297]87[



אביב



TEL AVIV 61040

]74[

]57 [A composition for the treatment of stress, anxiety and/or aggressive behavior in a mammal, obtainable from a secretion derived from the skin around mammalian

gland, said secretion containing, as a main active ingredient, a mixture of at least the three fatty acids palmitic acid, linoleic acid and oleic acid or derivatives thereof.

__________

137292]21][11[

תופעות המציגים ביולוגים מודליםמחלות של משניות

BIOLOGICAL MODELS EXHIBITING SECONDARY DISEASE MANIFESTATIONS

]54[

13.07.2000]22[US]33[16.07.1999]32[09/356293]31[

Int. Cl.8 A01K 067/027, C12N 005/06]51[ENZO THERAPEUTICS, INC., U.S.A.]71[

וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב

ירושלים



]74[

]57 [A Tupaia animal model for a chronic disease caused by a human viral pathogen, wherein said Tupaia animal model infected by said pathogen exhibits analogous secondary disease manifestations that are

secondary to a viral infection caused by said pathogen and said secondary disease manifestations are similar to those seen in humans with said chronic disease.


__________

137299]21][11[


הניתנים צורה זיכרון בעלי פולימריםביולוגי לפירוק

BIODEGRADABLE SHAPE MEMORY POLYMERS

]54[

23.02.1999]22[US]33[23.02.1998]32[60/075523]31[

Int. Cl.8 A61L 027/00, C08L 101/12]51[MASSACHUSETTS INSTITUTE OF TECHNOLOGY, U.S.A.

]71[




REHOVOT

]74[

]57 [A degradable shape memory polymer composition having at least one shape in memory, the polymer comprising

)1 (hard and soft segments or)2 (at least one soft segment, which is

crosslinked covalently or ionically, or

)3 (polymer blends,wherein the original shape of the polymer is recovered by a change in temperature or by application of another stimulus.

__________

137455]21][11[

או בחשמל הגוף ברקמות לטפול מכשירתרופות

APPARATUS FOR TREATING BODY TISSUES WITH ELECTRICITY OR MEDICAMENTS

]54[

23.07.2000]22[US]33[26.07.1999]32[09/360893]31[

Int. Cl.8 A61N 007/00]51[]ZULI HOLDINGS LTD.]71השרון בע"מ, רמת החזקות זולי

איתן, מהולל, פאפו, קוגלר,, הרצליה11המנופים

EITAN, MEHULAL, PAPPO, KUGLER,

11 HAMENOFIM ST .HERZLIYA 46120

]74[

]57 [A device (3) to be inserted into the body for treating body tissue, comprising:

)a (a device (8) capable of generating electrical current at a therapeutic voltage and amperage, for treating body issue, in response to ultrasonic vibrations;

)b (sensor means (11), the sensor means adapted to receive preselected stimuli generated by the body tissue, and

)c (means (10) for selectively generating and transmitting ultrasonic vibrations to the device for a location outside the device,


)d (wherein the sensor means is adapted to communicate with and selectively energize the means for selectively generating and

transmitting ultrasonic vibrations to the device in response to the preselected stimuli generated by the body tissue.

__________

137617]21][11[

,1] – [ – טריאזולו4, 2, 1] – – פניל65 – a7 בקבוצה מותמרים [ פירימידינים

ציקלואליפטית, הכנתן או – אריל נגד למלחמה אותם המכילים ותכשירים

בצמחים פטוגניות פטריות

6 - PHENYL - [1, 2, 4] - TRIAZOLO - [1, 5 - A]-PYRIMIDINES SUBSTITUTED BY A 7 - ARYL OR (CYCLO) ALIPHATIC GROUP, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM FOR COMBATING PHYTOPATHOGENIC FUNGI

]54[

09.02.1999]22[US]33[11.02.1998]32[022288]31[US03.02.1999243851

Int. Cl.8 C07D 487/04]51[WYETH HOLDINGS CORPORATION, U.S.A.

]71[





TEL AVIV 61040

]74[



whereinR1 represents an optionally substituted alkyl, alkenyl, alkynyl, alkadienyl, or aryl group, or an optionally substituted cycloalkyl or cycloalkenyl group wherein one CH2 group of said cycloalkyl or cycloalkenyl group may also be replaced by O, S or NR2, in which R2 represents a hydrogen atom or an alkyl group; X

represents a hydrogen or halogen atom, or a hydroxy, alkoxy, aryloxy, aralkyloxy, haloalkoxy, alkylthio, cyano, amino, alkylamino, azido or dialkylamino group; L1, L2, L3, L4 and L5 each independently represent an hydrogen or halogen atom or an optionally substituted alkyl or alkoxy group or a nitro or cyano group.

__________

137893]21][11[

– ידי על זירוז באמצעות נוטקאטון יצורלקאז

PRODUCTION OF NOOTKATONE BY LACCASE CATALYSIS

]54[

16.08.2000]22[US]33[08.09.1999]32[09/391785]31[

Int. Cl.8 A23L 001/222, C07C 049/653, 409/14, C12P 007/26]51[GIVAUDAN SA, SWITZERLAND]71[


אביב



TEL AVIV 61040

]74[

]57 [A process for producing nootkatone comprising:

)a (reacting valencene and a composition having laccase activity, wherein valencene is at a concentration of greater than 0.1%,

in the presence of an oxygen source to form valencene hydroperoxide,

)b (degrading the hydroperoxide to form nootkatone, and

)c (recovering nootkatone.

__________June 3, 2007635 –התשס"ז בסיון י"ז

137954]21][11[

מותמרים פירידינו–אריפיפרזינים תאים התרבות ביתר בטיפול היעילים

בפרוסטטה סרטנית לא

SUBSTITUTED PYRIDINO ARYLPIPERAZINES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

]54[

19.02.1999]22[US]33[20.02.1998]32[60/075321]31[

Int. Cl.8 A61K 031/44, A61P 043/00, C07D 401/12]51[ORTHO-MCNEIL PHARMACEUTICAL, INC., U.S.A.

]71[





TEL AVIV 61040

]74[


R1 is hydrogen, halogen, C1-5 alkoxy, hydroxyl, or C1-5 alkyl;

R2 is C1-6 alkyl, substituted C1-6 alkyl where the alkyl substituents are independently selected from one or more halogens, phenyl, substituted phenyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy, and trihalo C1-5 alkyl, phenyl C1-5 alkyl, or substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, halogen, C1-5

alkoxy, and trihalo C1-5 alkyl; R3 is hydrogen, hydroxy or C1-5 alkoxy if the dashed line is absent or is oxygen if the

dashed line is present; R4 is hydrogen, C1-5 alkyl, phenyl C1-5 alkyl or substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy, and trihalo C1-5 alkyl;

R5 is C1-6 alkyl, substituted C1-6 alkyl where the alkyl substituents are independently selected from one or more halogens, phenyl, substituted phenyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy, C1-8 alkyl, substituted C1-8 alkyl where the alkyl substituents are independently selected from one or more


halogens, C1-5 alkoxy, amino, C1-5 alkylamino, di C1-5 alkylamino, C1-5 alkylcarbonyl, C1-5 alkoxycarbonyl, arylcarbonyl, nitrile, aminosulfonyl, C1-5 alkylsulfonyl, phenylsulfonyl, and substituted phenylsulfonyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy and nitro;

phenyl C1-5 alkyl, substituted phenyl C1-5 alkyl

where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy, C1-8 alkyl, substituted C1-8 alkyl where the alkyl substituents are independently selected from one or more halogens, C1-5 alkoxy, amino, C1-5 alkylamino, di C1-5 alkylamino, C1-5 alkylcarbonyl, C1-5 alkoxycarbonyl, and nitro; X is oxygen, sulfur or NH; pharmaceutically acceptable salts thereof; and stereoisomers, racemic mixtures, as well as enantiomers thereof.

__________

138090]21][11[

זימון בסביבת סתגלני מחדש רכישה זמןמקומות מרובת

ADAPTIVE REACQUISITION TIME IN A SLOTTED PAGING ENVIRONMENT

]54[

16.03.1999]22[US]33[16.03.1998]32[09/039985]31[

Int. Cl.8 H04B 007/216, H04Q 007/32]51[QUALCOMM INCORPORATED, U.S.A.

]71[




REHOVOT

]74[

]57 [A method for adaptively determining a pilot signal reacquisition time, the method comprising the steps of: measuring a magnitude of a shift in phase of said pilot signal; comparing said measured

magnitude to a shift threshold; and decreasing said reacquisition time if said measured magnitude is not greater than said shift threshold.


__________

138199]21][11[

LOW-PASS FILTER FOR Aדיפלקסר יחידה עבור איטי מעבר מסנןDIPLEXER

]54[

02.03.1999]22[DE]33[03.03.1998]32[19809021.

8]31[

Int. Cl.8 H03H 007/01]51[VACUUMSCHELZE GMBH, GERMANY

]71[

JORG PETZOLD, JOHANNES BEICHLER, DIRK HEUMANN

]72[

WO/1999/045643]87[לביא, שמעון

, ירושלים21 רח' הרצוג SIMON LAVIE,

21 HERZOG ST.JERUSALEM

]74[

]57 [Low-pass filter (8) for a diplexer for separating low-frequency signals of analogue communication systems from high-frequency signal of digital communication systems, comprising a plurality of series inductors (9) formed

with the aid of magnetic cores, characterised in that the magnetic cores are produced from an amorphous or manocrystalline alloy in such a manner that the series inductors display saturation induction of Bs > 0.6 T, a saturation to


remanence ratio of Br/Bs < 0.2 and substantially constant permeability to more than 10kHz.

__________

138336]21][11[

תימרוסל המכילים פרמצבטיים תכשיריםהרפס וירוס בזיהומי לטיפול

PHARMACEUTICAL COMPOSITIONS COMPRISING THIMEROSAL FOR TREATMENT OF HERPES VIRUS INFECTIONS

]54[

06.02.1998]22[Int. Cl.8 A61K 031/305, 031/555, 038/00, 039/20, A61P 009/10, 025/16, 025/28, 031/22, C07F 003/10, 003/12, C07K 014/00

]51[

DIVISION FROM 123206]62[MILKHAUS LABORATORY, INC., U.S.A.

]71[

ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער

רחובות


REHOVOT

]74[

]57 [Use of effective amount of thimerosal free of association with influenza virus and optionally in addition a rubella virus vaccine to make a pharmaceutical

composition for treating subjects suffering from herpes virus infections, wherein said composition is adapted to be administered systemically.


__________

138767]21][11[

המתחלבים טקסיין של טרום–תרכיזיםבאיחסון ויציבים

STORAGE-STABLE SELF- EMULSIFYING PRECONCENTRATES OF A TAXANE

]54[

30.03.1999]22[US]33[01.04.1998]32[60/080272]31[US01.04.199860/080273

Int. Cl.8 A61K 009/107, 045/00, 047/26, 047/44, A61P 035/00, C07D 305/14]51[RTP PHARMA INC., U.S.A.]71[

ISKANDAR MOUSSA, INDU PARIKH, ALAIN CARRIER

]72[

WO/1999/049848]87[ושות' בע"מ, מ. בן-דוד ירמיהו

,45087, ת.ד. חוצבים המרפא, הר רחוב ירושלים

JEREMY M. BEN-DAVID & CO. LTD,.

HAR HOTZVIM HI-TECH PARK ,P.O. B. 45087 ,

JERUSALEM 91450

]74[

]57 [A storage-stable, self-emulsifying preconcentrate of a taxane in a microemulsion, composed of:

)i (10 to 80% w/w of at least one hydrophobic component selected from triglyceride, diglyceride, monoglyceride, free fatty acid, fatty acid ester, fish oil, vegetable oil, or mixtures thereof;

)ii (20 to 80% w/w of a surfactant phase comprising at least one non-ionic surfactant;

)iii (0 to 35% w/w of diethylene glycol monoethylether; and

)iv (0 to 40% w/w of at least one hydrophilic component selected from hydroxyalkane, dihydroxyalkane, a polyethylene glycol having an average molecular weight of less than or equal to 1000, and mixtures thereof; said preconcentrate producing an average particle size of less than or equal to 10 μm when mixed with an aqueous medium.

__________

139297]21][11[

המעכבים פירידין אמידו של נגזרותגסטרית חומצה הפרשת

IMIDAZO PYRIDINE DERIVATIVES WHICH INHIBIT GASTRIC ACID SECRETION

]54[


23.04.1999]22[SE]33[29.04.1998]32[9801526-6]31[

Int. Cl.8 A61K 031/437, 045/00, A61P 001/04, C07D 471/04]51[ASTRAZENECA AB, SWEDEN]71[KOSRAT AMIN, PETER NORDBERG, INGEMAR STARKE, MICHAEL DAHLSTROM

]72[

WO/1999/055706]87[לוצאטו, את לוצאטו

שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,

INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152

]74[


or a pharmaceutically acceptable salt thereof, whereinR1 is H, CH3, or CH2 OH; R2 is CH3 or CH2

CH3; R3 is H, C1-C6 alkyl, hydroxylated

C1-C6 alkyl or halogen; R4 is H, C1-C6 alkyl, hydroxylated C1-C6 alkyl, or halogen;

R5 is H, or halogen, R6 and R7 are the same or different and selected from H, C1-C6 alkyl, hydroxylated C1-C6 alkoxy-substituted C1-C6 alkyl; and X is NH, or O.

__________

139813]21][11[

OLIGONUCLEOTIDEריריתית חסינות לגרימת ומוצרים שיטותCOMPRISING COMPOSITION FOR INDUCING MUCOSAL IMMUNITY

]54[

21.05.1999]22[US]33[22.05.1998]32[60/086393]31[

Int. Cl.8 A61K 039/39]51[


COLEY PHARMACEUTICALS, INC., U.S.A.

THE OTTAWA HEALTH RESEARCH INSTITUTE, CANADA

]71[




REHOVOT

]74[

]57 [A composition for inducing a mucosal immune response in a subject, also exposed to an antigen that is not encoded in a nucleic acid vector, on administration to a mucosal surface of the

subject, wherein the composition comprises an oligonucleotide having a sequence including at least the following formula:

5'X1X2CGX3X43;'

wherein C is unmethylated, and X1, X2, X3 and X4 are nucleotides; and a pharmaceutically acceptable carrier.

__________

140028]21][11[

]PATIENT SPECIFIC DOSIMETRY]54לחולה ספציפי מינון מדידת

04.06.1999]22[US]33[04.06.1998]32[60/088327]31[

Int. Cl.8 A61K 051/00, 051/12]51[THE REGENTS OF THE UNIVERSITY OF MICHIGAN, U.S.A.

SMITHKLINE BEECHAM CORPORATION, U.S.A.

]71[

WO/1999/062565]87[איתן, מהולל, פאפו, קוגלר,

, הרצליה11המנופים EITAN, MEHULAL, PAPPO, KUGLER,

11 HAMENOFIM ST .HERZLIYA 46120

]74[

]57 [A method of establishing a patient-specific optimally effective dose for

administration of a radiopharmaceutical to a patient, the method comprising: determining a maximum tolerated dose for


the radiopharmaceutical for the patient population; determining a desired total body dose of the radiopharmaceutical for the patient; determining the clearance profile for the radiopharmaceutical or radiopharmaceutical analog; determining the patient's mass and maximum effective mass; selecting the lower of the patient's mass and maximum effective mass; determining the activity hours for the radiopharmaceutical or radiopharmaceutical analog based on the

lower of the patient's mass or maximum effective mass and the desired total body dose; administering a tracer dose of the radiopharmaceutical or the radiopharmaceutical analog to the patient; determining the residence time for the radiopharmaceutical or the radiopharmaceutical analog; and establishing the optimally effective dose of the radiopharmaceutical for the patient by solving for therapeutic dose in the following equation:

Activity Hours desired total body dose therapeutic dose= –––––––––––––––– X––––––––––––––––––––

Residence time maximum tolerated dose.

__________

140367]21][11[

תקשורת עבור ושיטה התקן, מערכתגישה ובקרת מאובטחת

DEVICE, SYSTEM AND METHOD FOR SECURE COMMUNICATION AND ACCESS CONTROL

]54[

23.06.1999]22[US]33[24.06.1998]32[09/104014]31[US11.05.199909/309873

Int. Cl.8 G06F 007/58, H04L 009/12, 017/22]51[

אביב רון, תל בינימיןWARCOP INVESTMENT LTD., BRITISH VIRGIN ISLANDSBENYAMIN RON

]71[

]ADAM SHEFI]72שפי אדםWO/2000/067548]87[

( בע"מ,1995) ג'י.אי.ארליך בגין מנחם ,רחוב15 אילון, קומה מגדל

גן , רמת11

G.E. EHRLICH (1995) LTD,. AYALON TOWER 15TH FLOOR

11 MENACHEM BEGIN STREET

]74[


52521 RAMAT GAN

]57 [A method for generating a practically unlimited quantity of true random numbers, the true random numbers being identical in a plurality of locations, the method being operable by a data processor and the method comprising the steps of:

)a (providing an identical table of true random numbers, an identical pointer, an identical seed and an identical pseudorandom number generator at each of the plurality of locations;

)b (obtaining an obtained true random number from said identical table of true

random numbers according to said pointer, said obtained true random number being identical at the plurality of locations;

)c (generating a generated pseudorandom number by said pseudorandom number generator, said generated pseudorandom number being identical at the plurality of locations; and

)d (combining said obtained true random number and said generated pseudorandom number to form at least one of the quantity of true random numbers, said at least one of the quantity of true random numbers being identical at the plurality of locations.

__________

140429]21][11[


כסופגי השימושיים פוליאוריתן תכשירילהכנתן ושיטה אנרגיה

POLYURETHANE COMPOSITIONS USEFUL AS SHOCK ABSORBERS AND A METHOD FOR THEIR PREPARATION

]54[

20.12.2000]22[Int. Cl.8 C08G 018/48, 071/00, C08J 009/00, C08L 075/08]51[

]ORYCLE APPLICATIONS LTD.]71גת בע"מ, קרית יישומים אוריקלעו"פ, ברסלר דר' אייל

- גן , רמת11 תובל DR. EYAL BRESSLER,

11 TOVAL ST .RAMAT GAN 52522

]74[

]57 [A polyurethane foam composition comprising: at least one polyether polyol having an average molecular weight from

100-20,000; an aromatic polyisocyanate; a tackifying resin; a surfactant; a blowing agent, and a catalyst.

__________

140553]21][11[

דהידרוגנז לפורמאלדיהיד גניםמתילטרופיים משמרים

FORMALDEHYDE DEHYDROGENASE GENES FROM METHYLOTROPHIC YEASTS

]54[

02.07.1999]22[US]33[03.07.1998]32[60/091699]31[

Int. Cl.8 C12N 015/53]51[RESEARCH CORPORATION TECHNOLOGIES, INC., U.S.A.

]71[





]74[

]57 [An isolated nucleic acid comprising a promoter that is inducible by methanol, methylamine, and a mixture of both methanol and methylamine in a

methylotrophic yeast, wherein said isolated nucleic acid is derivable from Pichia pastoris.

__________

140669]21][11[

המכיל הרירית דרך למתן אבקתי תכשירפולימרית תרופה

POWDERY PREPARATION FOR MUCOSAL ADMINISTRATION CONTAINING

]54[


POLYMERICMEDICINE

01.07.1999]22[JP]33[08.07.1998]32[10-192722]31[JP25.03.199911-81549

Int. Cl.8 A61K 009/00, 009/14, 038/00]51[KIRIN-AMGEN INC., U.S.A.]71[




]74[

]57 [A preparation in powder form for administration through mucosa, comprising a medicine of high molecular weight selected from the group consisting

of bioactive peptides and proteins, antibodies, vaccines, and antigens, and aminoalkylmethacrylate copolymer or polyvinyl acetal diethylaminoacetate.

__________

141410]21][11[

להכנתם, ארילפיפראזינים, תהליך אותם המכילים רוקחות תכשירי

לטיפול תרופות להכנת בהם והשימוש ידי על המתווכים מחלה במצבי

(MMP) מטאלופרוטאינזות

ARYLPIPERAZINES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING DISEASE CONDITIONS MEDIATED BY METALLOPROTEINASES (MMP)

]54[

25.08.1999]22[EP]33[31.08.1998]32[98402144.

4]31[

EP04.06.199999401351.4Int. Cl.8 A61K 031/495, A61P 043/00, C07D 401/00, 403/12, 405/12, 409/12, 413/12, 417/12

]51[

ASTRAZENECA AB, SWEDEN]71[WO/2000/012478]87[

ושות', ש. הורוביץ , תל41-45 רוטשילד שדרות ציון בית

אביב

S. HOROWITZ & CO,. ZION HOUSE,

41-45 ROTHSCHILD BLVD,.TEL AVIV 65784

]74[



wherein ring B is a monocyclic or bicyclic alkyl, aryl, aralkyl, heteroaryl or heteroaralkyl ring comprising up to 12 ring atoms and containing one or more heteroatoms independently chosen from N, O, and S; alternatively ring B may be biphenyl; ring B may optionally be linked to ring A by a C1-4 alkyl or a C1-4 alkoxy chain linking the 2-position of ring B with a carbon atoms alpha to X2; each R3 is independently selected from hydrogen, halogen, NO2, COOR wherein R is

hydrogen or C1-6 alkyl, CN, CF3, C1-6 alkyl, -S-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-C1-6 alkyl, C1-6 alkoxy and up to C10 aryloxy, n is 1, 2 or 3; P is –(CH2)n- wherein n=0, 1, 2: or P is an alkene or alkyne chain of up to six carbon atoms; or P may be selected from –CO-N(R6)-, -N(R6)-CO-, -SO2-N(R6)- and- N(R6)-SO2-, and R6 is hydrogen, C1-6 alkyl, up to C10 aralkyl or up to C9 heteroalkyl; Ring A is piperazine and may optionally be mono- or di-substituted by optionally

substituted C1-6 alkyl or C1-6 alkoxy, each substituent being independently selected from halogen, C1-6 alkyl or an oxo group.X1 and X2 are each N;Y is selected from –SO2- and –CO;-

Z is –N(OH)HO and Q is selected from –CH(R6)-, -CH(R6)-CH2-, and- N(R6)-

CH2;-R1 is H, C1-6 alkyl, C5-7 cycloalkyl, up to C10 aryl, up to C10 heteroaryl, up to C12 aralkyl, or up to C12 heteroarylalkyl, all optionally substituted by up to three groups independently selected from NO2, CF3, halogen, C1-4 alkyl, carboxyl (C1-4) alkyl, up to C6 cycloalkyl, -OR4, -SR4, C1-4 alkyl substituted with –OR4, SR4 (and its oxidized analogues), or C1-4 alkyl-Y-NR4, or R1 is 2,3,4,5,6-pentafluorophenyl; R4 is hydrogen, C1-6 alkyl, up to C10 aryl or up to C10 heteroaryl or up to C9 aralkyl, each independently optionally substituted by halogen, NO2, CN, CF3, C1-6 alkyl, -S-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-C1-6 alkyl or C1-6 alkoxy;

R2 is H, C1-6 alkyl, or together with R1 forms a carbocyclic or heterocyclic spiro 5, 6 or 7 membered ring, the latter containing at least one heteroatom selected from N, O, and S; also the group Q can be linked to either R1 or R2 to form a 5, 6 or 7 membered alkyl or heteroalkyl ring comprising one or more of O, S and N; and wherein any alkyl groups outlined above may be straight chain or branched, or a pharmaceutically-acceptable salt or in vivo hydrolysable precursor thereof.

__________

141458]21][11[

MORPHOLOGICALמורפולוגית הבהרהDISAMBIGUATION

]54[


15.02.2001]22[US]33[29.06.2000]32[09/606326]31[

Int. Cl.8 G06F 017/27]51[IBM CORPORATION, U.S.A.]71[


רחובות


REHOVOT

]74[

]57 [A method for morphological disambiguation, comprising: building a statistical base by morphologically analyzing a corpus of text comprising multiple words having lemmas so as to find respective linguistic patterns of the words independently of the lemmas to which the linguistic patterns are applied, each pattern comprising a specification of at least one characteristic selected from a set of characteristics including a part of speech, prefix, number, gender and person,

and finding relative frequencies of occurrence of the linguistic patterns in the corpus; receiving an input string; morphologically analyzing the string to generate a list of candidate analyses of the string, each candidate analysis comprising a respective word, having a linguistic pattern and a lemma; and evaluating the

pattern in each of the analyses using the statistical base so as to determine a relative frequency of occurrence of the pattern in each of the analyses, independent of the

lemma to which the pattern is applied; and selecting from the list one or more of the analyses that comprise respective patterns whose frequency of occurrence is above a predetermined threshold.

__________

141710]21][11[

OBJECT DETECTION METHODאובייקט לגילוי ומערכת שיטהAND SYSTEM

]54[

28.02.2001]22[June 3, 2007 648 –התשס"ז בסיון י"ז

Int. Cl.8 G01S 017/02]51[ בע"מ, לחימה אמצעי לפיתוח רפאל-רשות

חיפהRAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD.

]71[


אביב



TEL AVIV 61040

]74[

]57 [A method for monitoring a region of interest, the method comprising:

)i (transmitting incident radiation towards the region of interest with a certain transmitting angle to define a plane of propagation of the incident radiation, and with a predetermined angular intensity distribution, I(θ), of the incident radiation, the region of interest being located within said plane;

)ii (collecting reflections of the incident radiation with a solid angle of collection intersecting with said plane, a region of intersection being a detecting window of a

predetermined geometry containing at least a portion of said region of interest; detecting the collected radiation coming from within said detecting window utilizing a detector having a sensing surface configured with a predetermined geometry and with a spatially variable sensitivity within this surface selected in accordance with the geometry of the detecting window and the angular intensity distribution of the incident radiation; and generating output signals indicative of the detected radiation.

__________

141743]21][11[

דימולטיפלקסר בקרת עבור ושיטה ציוד קצב להתאמת בשימוש ומולטיפלקסר

ניידת תקשורת במערכת

APPARATUS AND METHOD FOR CONTROLLING A DEMULTIPLEXER AND A MULTIPLEXER USED FOR RATE MATCHING IN A MOBILE COMMUNICATION SYSTEM

]54[

08.07.2000]22[KR]33[08.07.1999]32[1999/2740

7]31[

KR23.07.19991999/30095KR30.08.19991999/37496

Int. Cl.8 H03M 013/03, H04B 007/02, 007/216]51[SAMSUNG ELECTRONICS CO., LTD., REPUBLIC OF KOREA

]71[




REHOVOT

]74[


]57 [An uplink transmitting device in a mobile communication system, comprising: an encoder for receiving a first information bit stream and for outputting three streams, a second information bit stream, a first parity stream, and a second parity stream, by encoding the first information bit stream; an interleaver for interleaving the encoded streams by a predetermined interleaving rule; a radio frame segmenter for receiving the interleaved stream from the interleaver and mapping the received interleaved stream

onto at least one consecutive radio frame; a demultiplexer for separating each of the at least one radio frames received from the radio frame segmenter into a third information bit stream, and first and second parity streams from the demultiplexer; and a rate matcher for bypassing the third information bit stream and for puncturing a part of the first and second parity streams from the demultiplexer according to a given rate matching rule.



__________

141761]21][11[

CONTACTLESS ACCESS TICKETלייצורו ושיטה מגע ללא לגישה כרטיסAND METHOD FOR MAKING SAME

]54[

07.07.2000]22[FR]33[07.07.1999]32[99/08802]31[

Int. Cl.8 G06K 019/06]51[ASK, FRANCE]71[WO/2001/004834]87[


אביב



TEL AVIV 61040

]74[

]57 [A ticket (10) providing access to a zone with controlled access when said

ticket is presented without contact in front of a ticket reader authorizing access to the zone, said ticket having an Edmonson


format and comprising a paper ticket body (12) covered on both surfaces with a protective coating (18, 20), said paper ticket body being provided with a through-hole wherein is located an electronic module (14) comprising an integrated circuit (22) and an antenna (24), said antenna being formed by at least one turn obtained by screen printing with silvery powder in a polymerisable composition

before being heat-cured, wherein said electronic module also includes an overlay having a thickness slightly greater than that of said electronic circuit and provided with an opening whose dimensions are slightly greater than that of said electronic circuit such that said electronic circuit fits into said opening, so that said module has a substantially constant thickness.

__________

142265]21][11[

לא גישה בעלת נתונים עיבוד מערכת ( המקדימהNUMA) לזכרון אחידה על מרוחק עיבוד לענף קריאה בקשתמשוער בסיס

NON-UNIFORM MEMORY ACCESS (NUMA) DATA PROCESSING SYSTEM THAT SPECULATIVELY FORWARDS A READ REQUEST TO A REMOTE PROCESSING NODE

]54[

10.12.1999]22[US]33[15.12.1998]32[09/211351]31[

Int. Cl.8 G06F 012/08, 013/00]51[INTERNATIONAL BUSINESS MACHINES CORPORATION, U.S.A.

]71[

WO/2000/036514]87[ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער רחובות


]74[


REHOVOT

]57 [A computer system, comprising: a node interconnect; and at least a local node and a remote node that are each coupled to said node interconnect, said local node including a local interconnect and said local and remote nodes each including one or more snoopers, wherein said one or more snoopers of said local node include a node controller insterposed between said local interconnect and said node interconnect, wherein said node controller speculatively transmits a request transaction received from said local

interconnect to said remote node via said node interconnect prior to determination of a local response, wherein snoopers at the local node and the remote node independently process the request transaction to obtain the local node response at the local node and a remote node response at the remote node, and wherein said node controller of the local node handles the remote node response to said request transaction in accordance with the local node response.

__________

142572]21][11[

מודלים שני בין ההבדלים לקביעת שיטהיותר או

METHOD FOR DETERMINING DIFFERENCES BETWEEN TWO OR MORE MODELS

]54[

15.10.1999]22[US]33[16.10.1998]32[60/104682]31[

Int. Cl.8 G06F 017/30]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.

]71[



INDUSTRIAL PARK, OMER]74[



]57 [A method for comparing a first model and a second model, comprising: identifying metadata in the first model and in the second model; calculating a first set of signatures for objects of the metadata of the first model and a second set of signatures for objects of the metadata of the second model, wherein the objects to the first model and the objects of the second model corresponding with each

other have the same signatures; determining which signatures of the first set of signatures match signatures of the second set of signatures; and determining for the matched signatures whether the objects associated with the signatures of the first set of signatures equal the objects associated with the signatures of the second set of signatures.

__________

142650]21][11[

או מרה חומצת של קוניוגטים של שימוש או שומנית וחומצה מרה מלח של

רוקחות תכשירי להכנת שומניות חומצות שומני בכבד כולסטרול, לטיפול להורדתוסכרת בהיפרגליקמיה ולטיפול

USE OF BILE ACID OR BILE SALT FATTY ACIDS CONJUGATES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR REDUCING CHOLESTEROL, TREATING FATTY LIVER AND

]54[


TREATING HYPERGLYCEMIA AND DIABETES

17.04.2001]22[Int. Cl.8 A61K 031/575, C07J 009/00, 041/00]51[GALMED INTERNATIONAL LIMITED, MALTA

]71[


גן , רמת11


11 MENACHEM BEGIN STREET52521 RAMAT GAN

]74[

]57 [Use of a bile acid or bile salt fatty acid conjugate of the formula W-X-Gin which G is a bile acid or bile salt radical, which, if desired, is conjugated in position 24 with a suitable amino acid, W stands for one or two fatty acid radicals

having 14-22 carbon atoms, and X stands for a suitable bonding member or for a direct C=C bond between said bile acid or bile salt radical and the fatty acid(s) or of a pharmaceutical composition comprising same for the manufacture of a medicament for the reduction of the cholesterol in blood and body, wherein said suitable bonding member provides a solid bond that is not substantially deconjugated during the absorption process of the conjugate, with the proviso that said bond is not an ester bond.

__________

142787]21][11[

גבישי איבופרופאן של מצופים חלקיקיםמגורען

COATED PARTICLES OF GRANULATED CRYSTALLINE IBUPROFEN

]54[

03.11.1999]22[FR]33[06.11.1998]32[98/14033]31[

Int. Cl.8 A61K 009/28, 009/50, 031/19]51[ETHYPHARM, FRANCE]71[WO/2000/027368]87[


אביב



TEL AVIV 61040

]74[

]57 [Coated particles based on granulated microcrystals of ibuprofen, its isomers and its pharmaceutically acceptable salts,

characterized in that they have a coating consisting of a mixture comprising


)a (from 5 to 50% by weight, preferably from 10 to 30% by weight, of ethyl cellulose, based on the ibuprofen,

)b (from 10 to 60% by weight, preferably from 15 to 50% by weight, of hydroxypropyl methyl cellulose, based on the ethyl cellulose, and

)c (from 0.1 to 40% by weight, preferably from 3 to 25% by weight, of silica with antistatic and permeabilizing properties, based on the ethyl cellulose,

said coating – of which at least one of the constituents can be used for the granulation of the ibuprofen microcrystals to produce said particles – masking the unpleasant taste of the ibuprofen, significantly reducing its irritant effect on the throat after swallowing, and releasing the ibuprofen substantially immediately when the particles are placed in an aqueous medium.

__________

142876]21][11[

–חומצה5 של נאנו–אמולסיהאמינולוולינית

NANO-EMULSION OF 5-AMINOLEVULINIC ACID

]54[

12.11.1999]22[DE]33[12.11.1998]32[19852245.

2]31[

Int. Cl.8 A61K 009/107]51[BIOFRONTERA BIOSCIENCE GMBH, GERMANY

]71[




]74[

]57 [Composition characterized in that it contains a nanoemulsion which comprises an active substance selected from 5-aminolevulinic acid, or a salt, a complex or an addition compound thereof, and/or precursors and/or metabolites thereof

which can be converted into protoporphyrin IX, and a carrier in an aqueous phase, with the carrier being formed from one or more lipids and from one or more emulsifiers including soybean lecithin.

__________

143013]21][11[

בעל מעצמו המתיישרMOSFET שבבנפרדים שערים עם כפול שער

SELF-ALIGNED DOUBLE GATE MOSFET WITH SEPARATE GATES

]54[


07.05.2001]22[US]33[15.05.2000]32[60/204131]31[US07.07.200009/612260

Int. Cl.8 H01L 029/76]51[IBM CORPORATION, U.S.A.]71[


רחובות


REHOVOT

]74[

]57 [A transistor comprising: a channel region (5); a first gate (16) on top of said channel region; a second gate (22) below said channel region; and source and drain regions (8) laterally adjacent said channel region, wherein said channel region

includes an extension into said source and drain regions, and wherein said first gate comprises the same material as said second gate, and has a different doping concentration than said second gate.

__________


143014]21][11[

TRANSDERMAL DRUGתת–עוריים אנליט והוצאת תרופה מתןDELIVERY AND ANALYTE EXTRACTION

]54[

01.11.1999]22[US]33[09.11.1998]32[09/189170]31[

Int. Cl.8 A61N 001/30]51[]TRANSPHARMA MEDICAL LTD.]71בע"מ, יהוד מדיקל טראנספארמה




REHOVOT

]74[

]57 [A device (20) for ablating stratum corneum epidermidis of skin on the body of a subject, comprising; a plurality of electrodes (60), which are adapted to be applied to the skin of the subject at respective points; and a power source,

(52) which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area during a second time period, subsequent to the first time period.

__________

143202]21][11[

COMPUTERIZED ADAPTIVEמסתגלת ממוחשבת הדמיהIMAGING

]54[

30.11.1999]22[IL]33[01.12.1998]32[127359]31[US27.01.199909/238225


Int. Cl.8 G01N 021/17, 021/64, G02B 021/00, G06T 001/00]51[ YEDA RESEARCH ANDבע"מ, רחובות ופיתוח למחקר חברה ידע

DEVELOPMENT CO. LTD.THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, U.S.A.

]71[

WO/2000/033250]87[סקמסקי, אפרים

, ירושלים4500, ת.ד. EPHRAIM SECEMSKI,

P.O.BOX 4500JERUSALEM 91045

]74[

]57 [Apparatus for three-dimensional image processing, comprising: an imaging system reading a three dimensional map of variations in the refractive characteristics in a volume; a ray tracer, utilizing said three dimensional map to analytically trace a multiplicity of rays from a multiplicity of locations in said volume through said

volume, thereby providing a location dependent point spread function; and a three dimensional deconvolver, utilizing the location dependent point spread function, to provide an output image corrected for distortions due to three dimensional variations in the refractive characteristics in said volume.

__________

143229]21][11[

מבחינה פעילות נגזרות לייצור שיטה –4–אמינו–1 של אופטית

– אין2)הידרוקסימתיל(– ציקלופנט–

METHOD FOR PRODUCING OPTICALLY ACTIVE 1-AMINO-4-(HYDROXYMETHYL)-CYCLOPENT-2-ENE DERIVATIVES

]54[

23.12.1999]22[EP]33[23.12.1998]32[98124570.

7]31[


Int. Cl.8 C07C 235/30, 235/40, C12P 041/00]51[LONZA AG, SWITZERLAND]71[WO/2000/039324]87[




]74[

]57 [Process for preparing enantiomerically enriched 1-amino-4-

(hydroxymethyl) cyclopent-2-ene derivatives of the formulae

in which R1 is hydrogen or an optoionally substituted C1-8-alkyl radical, aryl radical

or cycloalkyl radical and R2 is an optionally substituted acyl, in that a racemic 1-amino-4-(hydroxymethyl) cyclopent-2-ene derivative of the formula

in which R1 is as defined above is reacted using a hydrolase in the presence of an acylating agent.

__________

143253]21][11[

נקודות בעל בטיפטוף להשקייה זרנוקשונה בקצב מים טיפטוף

DRIP IRRIGATION HOSE WITH EMITTERS HAVING DIFFERENT DISCHARGE RATES

]54[

19.11.1999]22[US]33[20.11.1998]32[60/109667]31[

Int. Cl.8 A01G 025/02]51[T-SYSTEMS INTERNATIONAL, INC., U.S.A.

]71[

WO/2000/030433]87[



רחובות


REHOVOT

]74[

]57 [A drip irrigation hose (10) having a water supply passage (26) and a plurality of flow regulating channels (24) manufactured into the hose that are smaller than the water supply passage, the flow regulating channels each comprising: a predesignated geometry to provide a desired discharge rate at a given pressure, an inlet section (32) comprising one or more openings connecting the water

supply passage to that flow regulating channel, and an outlet section (28) comprising one or more openings (36) connecting that flow regulating channel to the exterior of the hose, wherein the plurality of flow regulating channels have at least two different geometries to provide at least two different discharge rates at the given pressure.

__________

143270]21][11[

חיות של פעילות הגברת עבור שיטהמחמד

METHOD FOR INCREASING PET ACTIVITY

]54[

21.09.2000]22[US]33[22.09.1999]32[60/155451]31[

Int. Cl.8 A23K 001/14, 001/18]51[SOCIETE DES PRODUITS NESTLE S.A., SWITZERLAND

]71[


WO/2001/021008]87[ושותפיו, עו"פ, הס יצחק ד"ר

אביב , תל6451 , ת.ד. 279 הירקון רחוב DR. YITZHAK HESS & PARTNERS,

279 HAYARKON STREET P.O.B. 6451

TEL AVIV 61063

]74[

]57 [A method for improving activity in a pet, the method comprising administering to the pet a nutritional agent which

promotes the growth of bifido-and lactic-bacteria in the gastro-intestinal tract of the pet.

__________

143693]21][11[

לקבצים דינמית לגישה ומערכת שיטהשרת – לקוח במערכת

CLIENT-SERVER DYNAMIC FILE ACCESS SYSTEM AND METHOD

]54[

29.12.1999]22[US]33[31.12.1998]32[09/224622]31[

Int. Cl.8 G06F 015/173, 019/00]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.

]71[




]74[

]57 [A system for dynamically viewing updates to a data file, comprising: a file access client operable to request dynamic access to a data file; and a file access server coupled to the file access client, the file access server operable to transmit an

initial content of the data file to the file access client and data file modifications dynamically occurring over time, wherein the file access client is enabled to dynamically view the updates to the data file as they occur.


__________

143709]21][11[

ANDROGEN RECEPTORאנדרוגן לקולטני מעכביםSUPPRESSORS

]54[

12.11.1999]22[US]33[18.12.1998]32[09/215351]31[

Int. Cl.8 A61K 031/145, 031/165, 031/275, 031/40, C07C 237/04, 237/22, 255/56, 255/58, 275/30, 317/46, 323/51, 335/06, 335/16, C07D 207/40, 233/66

]51[

BIOPHYSICA, INC., U.S.A.]71[WO/2000/037430]87[


גן , רמת11



]74[

]57 [A compound of the formula:


wherein:X is nitro, cyano or halogen;V is CF3, halogen or H;

W is OH when T is H and is methyl when T and T1 are taken together to form a C=Z bridge; U is N when T and T1 are taken together to form a C=Z bridge or is taken together with T1 to form a bond or O or N; Q is a chalcogen; n is 1 or 2 and d is 0 or 1;when d is 0, T and T1 are hydrogen;when d is 1, then:

when n is 1, Y is a bond or linking group of from 1 to 10 carbon atoms and from 0 to 6 heteroatoms in the chain, where the

heteroatoms are N, O, or S; Z, when other than taken together with Y, is an aliphatic group of from 1 to 6 carbon atoms, a polyfluoroacylamido group of from 2 to 8 carbon atoms and having at least 2 fluorines and not more than 2m-1 fluorines, wherein m is the number of carbon atoms, or haloanilino, where halo is of atomic number 9 to 80; and when n is 2, Y and Z are taken together to form a bond or a linking group of from 1 to 10 carbon atoms and from 0 to 6 heteroatoms, with from 0 to 4 heteroatoms in the chain, where the heteroatoms are N,O, and S.

__________

143780]21][11[

PROCESS FORאלקטרודה לייצור תהליךMANUFACTURING ELECTRODE

]54[

14.06.2001]22[Int. Cl.8 H01G 009/052]51[

קרמיקה( בע"מ, יקנעם )טכנולוגיות קראלעילית

CEREL (CERAMIC TECHNOLOGIES) LTD.

]71[

צ'רניאק, טלי שוסטר, לודמילה ישראלכהן פלד, ניסים

ISRAEL SCHUSTER, LUDMILA CHERNIAK, TALI PELED, NISSIM COHEN

]72[




]74[


]57 [An electrophoretic process for producing a tantalum electrode having a substantially uniform layer of deposited tantalum particles thereon, comprising the steps:

)a (providing a suspension of tantalum particles in a polar organic solvent;

)b (immersing a temporary tantalum foil deposition electrode and a counter electrode in said suspension;

)c (providing an electric field to charge said particles using said temporary

deposition electrode and said counter electrode;

)d (replacing said temporary deposition electrode with a new deposition electrode; and,applying a suitable direct current to said new deposition electrode and said counter electrode, such as to cause electrophoretic homogeneous deposition of tantalum particles onto the surface of said deposition electrode.

__________

143886]21][11[

וגרירה גלילה מערכת הכולל תרמילאינטגרלית

RUCKSACK WITH INTEGRATED ROLLING AND TRACTION SYSTEM

]54[

01.10.1999]22[BE]33[02.10.1998]32[9800714]31[

Int. Cl.8 A45F 003/04]51[ROGER DE LATHOUWER, BELGIUM

]71[




HAR HOTZVIM HI-TECH PARK ,

]74[


P.O. B. 45087 ,JERUSALEM 91450

[57] Rucksack with supple material walls comprising a retractable handle (7) and an incurvated base plate, such plate made to be integrated with the base of at least one telescopic housing of the rod(s) of the retractable handle, said base plate comprising openings at the incurvation, openings receiving projecting wheels, characterized in that the upper extremity of the telescopic housing(s) is connected to a

supporting plate of the supple material extending perpendicular to the telescopic system and in that the base plate is an interior base plate and the telescopic housing provided internally in the baggage along one face, and in that the face in contact with the back and provided with straps (31) is opposite the face adjacent to the telescopic housing.

__________

143940]21][11[

של דינמית לקורלציה ושיטה מערכתאירועים

SYSTEM AND METHOD FOR DYNAMIC CORRELATION OF EVENTS

]54[

29.12.1999]22[US]33[31.12.1998]32[09/224487]31[


]71[



INDUSTRIAL PARK, OMERP.O.B. 5352

]74[


BEER-SHEVA 84152

[57] An event management system comprising: ane event manager, the event manager receiving on or more subscription requests for one or more event data from one or more subscribers, the event manager receiving one or more events and if the one or more events matches an existing condition, applying the one or more events as an update to the existing condition, the event manager further routing the one or more event data to the one or more subscribers; an alarm rule store, the alarm rule store storing alarm

rules; an event correlator coupled to the event manager and to the alarm rule store, the event correlator correlating the one or more event data provided by the event manager based on the alarm rules, the event correlator further dynamically determining whether a rule has changed, added or deleted to dynamically execute the added or modified rule; and a response engine coupled to the event manager, the response engine executing a response policy based on the correlation of events by the event correlator.

__________

143952]21][11[

רקבוביות, תכונות בעל אורגני דשןושימושו לייצורו שיטה

ORGANIC FERTILIZER HAVING HUMIC PROPERTIES, ITS METHOD OF PRODUCTION AND ITS USE

]54[

17.12.1999]22[DE]33[22.12.1998]32[19859068.

7]31[

Int. Cl.8 C05F 011/02, C05G 003/00]51[TECHNISCHE UNIVERSITAT DRESDEN, GERMANY

]71[

KLAUS FISCHER, RAINER SCHIENE, JOACHIM KATZUR

]72[


WO/2000/037394]87[בע"מ, פרידמן מרק ד"ר

אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.

BEIT SAMUELOFF, 7 HAOMANIM STREET,

TEL AVIV

]74[

[57] A method for the production of organic fertilizer having humic properties, comprising suspending lignite in an aqueous-ammoniacal medium of pH greater than about 9 and up to about 12, dissolving partially and oxidizing the lignite at a temperature of about 20 to

about 100oC, under atmospheric pressure thereby to obtain the organic fertilizer as a dispersion in aqueous medium and thickening or drying the dispersion, the organic fertilizer having a C/N ratio of about 9 to about 15.

__________

144067]21][11[

SYSTEM AND METHOD OFמתועלים נתונים להצגת ושיטה מערכתPRESENTING CHANNELIZED DATA

]54[

20.01.2000]22[US]33[20.01.1999]32[09/233870]31[


]71[




]74[

[57] A method of channelising data within a system having a user interface and a server, characterized by: identifying, at the user interface, data to be published as published content; sending a request to the server identifying the data to the server;

generating, at the server, an object key to the the data to be published; storing the object key into a content directory as a function of values stored in a virtual directory; associating the object key with a channel; and displaying the channel on the user interface.


__________

144290]21][11[

]ANTITACHYCARDIAL PACING]54אנטיטכיכרדיאלית הקצבה

14.01.2000]22[US]33[14.01.1999]32[231570]31[

Int. Cl.8 A61N 001/37]51[THE MOWER FAMILY CHF TREATMENT IRREVOCABLE TRUST, U.S.A.

]71[

MORTON M. MOWER]72[WO/2000/041766]87[

ושות' בע"מ, מ. בן-דוד ירמיהו ,45087, ת.ד. חוצבים המרפא, הר רחוב

ירושלים



JERUSALEM 91450

]74[

[57] A method for setting up an implantable cardiac stimulator preparatory to the stimulator's use on the human body

to perform cardioverting, the cardiac stimulator having output means for delivering electrical stimulation of a

predetermined polarity, amplitude, shape and duration, the method comprising: selecting a first intensity level for application of pulses of biphasic pacing

stimulation, upon sensing the onset of tachycardia, each pulse of biphasic pacing stimulation comprising a first stimulation phase with a first phase polarity, a first phase amplitude, a first phase shape and a first phase duration; and a second stimulation phase with a second phase polarity, a second phase amplitude, a second phase shape and a second phase duration wherein said first phase amplitude is less than said second phase amplitude, said selecting comprising selection from the group consisting of at the diastolic


depolarization threshold, below the diastolic depolarization threshold or above the diastolic depolarization threshold.

__________

144411]21][11[

]HUMAN LIVER PROGENITORS]54אנושי מכבד אב תאי

19.01.2000]22[US]33[19.01.1999]32[60/116331]31[

Int. Cl.8 A61K 035/407, C12N 005/08]51[UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, U.S.A.

]71[





TEL AVIV 61040

]74[

[57] A method of preparing a composition comprising a mixture of cells derived from human liver tissue, which mixture comprises an enriched population of human liver progenitors, the method comprising:(a) providing a cell suspension of human liver tissue comprising a mixture of cells of varying sizes, including immature cells and mature cells;(b) debulking the suspension based upon cell size, buoyant density, or a combination thereof to remove mature cells under conditions that permit the removal of mature cells and those of

relatively larger size, while retaining immature cells and those cells of less than about 15 micrometer in diameter; and(c) selecting those cells that express alpha-fetoprotein and one or more markers selected from the group consisting of CD14, CD34, CD38,ICAM, CD117, and albumin.

__________


144756]21][11[

METHOD FOR CONTROLLINGהליפוזום גודל על לשליטה שיטהLIPOSOME SIZE

]54[


03.02.2000]22[US]33[08.02.1999]32[60/119229]31[

Int. Cl.8 A61K 009/00, 009/127, 009/133]51[ALZA CORPORATION, U.S.A.]71[




]74[

[57] A method for preparing a liposome composition comprising liposomes having a desired size, the method comprising (i) determining an amount of lipid solvent required to achieve the desired liposome size from a profile of liposome size as a function of amount of lipid solvent in a hydration mixture of the lipid solvent and a

second solvent with which the lipid solvent is miscible, and (ii) hydrating a vesicle-forming lipid dissolved in said determined amount of lipid solvent with the second solvent to form the hydration mixture, said determined amount of lipid solvent being between 10-50 weight percent.

__________

144966]21][11[

פי על מחשב פעולות להפעלת שיטהלחוצים המחשב מקלדת מקשי בו הזמן

METHOD FOR EXECUTING COMPUTER OPERATIONS ACCORDING TO COMPUTER KEYBOARD'S KEYS DOWN TIME

]54[

19.08.2001]22[Int. Cl.8 G06F 003/02]51[

]ISRAEL ELIEZEROV]71אביב אליעזרוב, תל ישראלאליעזרוב, ישראל

אביב , תל16 רח' בלוך ISRAEL ELIEZEROV,

16 BLOCH ST. TEL AVIV]74[

[57] A method for enabling users of computer keyboards to generate different characters using the same keyboard keys said method comprising timing the keydown time of said key whereby a predetermined short duration results with

the character that a regular keystroke would generate being outputted, and a predetermined longer duration results with the character that would have been generated if the shift key was pressed while the key was pressed.


__________

145069]21][11[

משטח דרך לנתינה רוקחות תכשירהגוף של חלל או מעבר של חצוני

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO AN EXTERNAL WALL OF A BODY PASSAGEWAY OR CAVITY

]54[


23.02.2000]22[US]33[23.02.1999]32[60/121424]31[

Int. Cl.8 A61K 009/00, 009/70]51[UNIVERSITY OF BRITISH COLUMBIA, CANADAANGIOTECH INTERNATIONAL AG., SWITZERLAND

]71[





]74[

[57] Use of a factor that induces fibrosis for the manufacture of a medicament for improving or increasing body passageway or cavity integrity, when said factor is

delivered to a non-luminal surface of said body passageway or cavity substantially as described in the specification.

__________

145090]21][11[

בערוץ המתקבלים נתונים לעיבוד שיטהאריתמטית אפליקציה בצורת תקשורת

APPROACH FOR PROCESSING DATA RECEIVED FROM A COMMUNICATION CHANNEL IN FINITE PRECISION ARITHMETIC APPLICATIONS

]54[

02.01.2001]22[US]33[30.12.1999]32[60/173785]31[US30.12.199960/173778

Int. Cl.8 H04B 003/06, H04J 011/00, H04L 027/01, 027/26]51[BANDSPEED, INC., U.S.A.]71[





TEL AVIV 61040

]74[

[57] An apparatus for processing data received from a communications channel comprising: an equalizer configured to equalize received data from the

communications channel and generate equalized data, wherein the received data

is based upon both modulated data and distortion introduced by the communications channel, and the modulated data is the result of original data modulated onto one or more carriers, and wherein the equalizer is configured to use an algorithm with a set of one or more


coefficients selected to account for a frequency domain response of the equalizer and to reduce the distortion introduced by the communications

channel; and a demodulator configured to generation an estimate of the original data by demodulating the equalized data.

__________

145125]21][11[

ההעברה לצימצום ושיטה מערכתTCP/IP בסביבת הודעות של החוזרת

SYSTEM AND METHOD OF REDUCING RETRANSMISSION OF MESSAGES ON A TCP/IP ENVIRONMENT

]54[

27.08.2001]22[US]33[13.09.2000]32[661402]31[

Int. Cl.8 H04L 012/56, 029/06]51[HARRIS CORPORATION, U.S.A.]71[


אביב



TEL AVIV 61040

]74[

[57] In a radio network using TCP as the transport protocol for acknowledging message packets successfully received at a destination station and retransmitting message packets from the source station

which are not acknowledged within a predetermined period of time, a method of reducing the unnecessary retransmission of

message packets characterized by the steps of:(a) receiving a TCP retransmission packet at a source radio from a source station for retransmission to a destination station and maintaining the packet in a message queue until retransmission;(b) receiving a TCP acknowledgment packet at the source radio from a destination station;


(c) comparing the received acknowledgment packet from the destination station with the retransmission packet in the message queue; and

(d) discarding the retransmission packet from the message queue if the retransmission packet corresponds to the acknowledgment packet.

__________

145150]21][11[


–a10 , 8הקסאהידרו– נגזרותמתאנופירידו

אזפין,d–3,2]] ' פיראנו2',6,5:3]] ותכשיריאותן המכילים רוקחות

HEXAHYDRO-8, 10A-METHANO PYRIDO

[2,'3:'5,6 ]PYRANO [2,3-D] AZEPINE

DERIVATIVES AND PHARMACEUTICAL

COMPOSITIONS CONTAINING THEM

]54[

01.03.2000]22[FR]33[05.03.1999]32[99/02784]31[

Int. Cl.8 A61K 031/439, A61P 001/00, 025/30, 029/00, C07D 491/22]51[SANOFI AVENTIS, FRANCE]71[WO/2000/053608]87[


רחובות


REHOVOT

]74[

[57] A compound in the form of pure geometrical or optical isomers or a mixture of such isomers, of the formula

in whichR1 is a hydrogen atom, a (C1-C4) alkyl group, a phenyl (C1-C4) alkyl group, a phenylhydroxy (C1-C4) alkyl group, a furanyl (C1-C4) alkyl group, or a furanylhydroxy (C1-C4) alkyl group,R2 is either a hydrogen or halogen atom or a trifluoromethyl, cyano, hydroxyl, nitro, acetyl, (C1-C6) alkyl or (C1-C6) alkoxy group or a group of general formula NR4R5

in which R4 is a hydrogen atom or a (C1-C4) alkyl or (C1-C4) alkanoyl group and R5 is a hydrogen atom or a (C1-C4) alkyl

group, or else R4 and R5 form, with the nitrogen atom which carries them, a C4-C7 ring, or a phenyl or naphthyl group optionally subsituted by a halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, nitro, acetyl, (C1-C6) alkyl, (C1-C6) alkoxy or methylenedioxy group linked in the 2 and 3 positions of the phenyl ring, and R3 is a hydrogen or halogen atom or a (C1-C4) alkyl group, in the state of a base or an addition salt to an acid.

__________

145325]21][11[

]SYSTEM AND METHOD FOR ]54 אינדקס מפתח לחילוץ ושיטה מערכת


EXTRACTING INDEX KEY DATAנתונים שדות שלFIELDS

24.03.2000]22[US]33[26.03.1999]32[09/276994]31[


]71[




]74[

[57] A system (100) for extracting index key data fields, comprising: a definition interrogator (102) operable to extract index definitions and column definitions from a database; a code generator (104) coupled to the definition interrogator, the code generator operable to build computer code for extracting index key data fields based upon the index definitions and the column

definitions, the computer code including instructions to skip reading a selected number of characters in a data table (108) to read index key data fields; and a table analyzer (106) coupled to the code generator, the table analyzer operable to use the computer code to extract index data from a data table.

__________

145362]21][11[


מיצוי עבור סולפיד מחצבי גיפור ומתכות נחושת של הידרומטלורגי

אחרות

SULPHIDISATION OF SULPHIDE ORES FOR HYDROMETALLURGICAL EXTRACTION OF COPPER AND OTHER METALS

]54[

14.12.2000]22[DE]33[14.12.1999]32[19960132.

1]31[

Int. Cl.8 C22B 001/00, 015/00]51[ALEXANDER BECKMANN, GERMANY

]71[



REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.

P.O.B. 4060 ,TEL AVIV 61040

]74[

[57] A process for extracting metals from chalcopyrite-containing ores comprising leaching steps of microbiological or chemical nature for leaching out the metals, characterized in that(a) the ores are converted in an inert atmosphere to a reaction product

compriusing covelline, pyrite, and accompanying sulfides by adding sulfur and additives in a conversion step interposed prior to the leaching steps, and(b) copper and other metals, precious metals, and rare earths contained in the reaction product are extracted.

__________

145470]21][11[

ALKYLATED RESORCINOLאלקיל קבוצות עם ריסורצינול תולדותDERIVATIVES

]54[

22.03.2000]22[US]33[22.03.1999]32[60/125674]31[US30.08.199960/151595

Int. Cl.8 C07C 039/10, 039/19, 043/20, 043/23]51[IMMUGEN PHARMACEUTICALS, INC., U.S.A.

]71[





]74[


[57] An alkylated resorcinol derivativeof the formula:

wherein,R1 is: OH, OCH3

R2 is: HR3 is: 1, 1,5-trimethylhexyl, 1,1,5,5-tetramethylhexyl, or 1,1,5-trimethyl-hept-

4-enyl,R4 is: HR5 is: OH, or OCH3; andR6 is: H, OH, methyl, or ethyl.

__________

145483]21][11[

ביציקליות הטרוארומטיות תרכובות בטיפול לשימוש פעמים ארבע מותמרות

אותן הכוללים רוקחות תרופתי, תכשיריחדשות תרכובות וכמה

TETRASUBSTITUTED BICYCLIC HETEROAROMATIC COMPOUNDS FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME NOVEL COMPOUNDS

]54[

03.04.2000]22[EP]33[08.04.1999]32[99201152.

8]31[

Int. Cl.8 A61K 031/395, A61P 005/06, C07D 471/04, 487/04, 491/04, 495/00]51[N.V. ORGANON, THE NETHERLANDS

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

[57] A bicyclic heteroaromatic derivative compound of the formula


or a pharmaceutically acceptable salt thereof whereinR1 is NR5R6, OR5, SR5 or R7;R5 and R6 are independently selected from H, (1-8C) alkyl, (2-8C) alkenyl, (2-8C) alkynyl, (3-8C) cycloalkyl, (2-7C) heterocycloalkyl, alkyl (1-8C) carbonyl, (6-14C) arylcarbonyl, (6-14C) aryl or (4-13C) heteroaryl, or R5 and R6 together are joined in a (2-7C) heterocycloalkyl ring and wherein the alkyl group, alkenyl group or alkynyl group, if present in R5 and/or R6

optionally are substituted with one or more substituents selected from hydroxyl, (6-14C) aryl, (1-8C) alkoxy, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkoxycarbonyl, (6-14C) aryloxycarbonyl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, (1-8C) alkylaminocarbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylcarbonylamino, (6-14C) arylcarbonylamino, (6-14C)(di) arylamino and/or (1-8C) (di) alkylamino;R7 is (3-8C) cycloalkyl, (2-7C) heterocycloalkyl or (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted at the ortho and/or meta position with one or more substituents selected from R8, (6-14C) aryl, (4-13C) heteroaryl, (2-7C) heterocycloalkyl, (3-8C) cycloalkyl, NHR8, OR8 and/or SR8 in which R8 is (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, (1-8C) alkyl, (2-8C) alkenyl, (2-8C) alkynyl, the alkyl group of which may be optionally substituted with one or more substituents selected from hydroxyl, (1-8C) alkoxy, (2-7C) heterocycloalkyl (1-8C) alkoxy, (3-8C) cycloalkyl (1-8C) alkoxy, (6-14C) aryl (1-8C) alkoxy, (4-

13C) heteroaryl (1-8C) alkoxy, (2-7C) heterocycloalkyl, (3-8C) cycloalkyl, (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkoxycarbonyl, (6-14C) arylyloxycarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, 1-8C) alkylamino-carbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylarbonylamino, (6-14C) aryl-carbonylamino, (6-14C) (di) arylamino and/or (1-8C) (di) alkylamino; R2 is (1-8C) alkyl, (2-8C) alkenyl or (2-8) alkynyl, all optionally substituted with one or more substituents selected from (6-14C) aryl, (4-13C) hetdroaryl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (6-14C) aryloxcarbonyl and/or (1-8C) alkoxycarbonyl or R2 is (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted with one or more substituents selected from (1-8C) alkyl, (1-8C) alkylthio, (1-8C) (di) alkylamino, (1-8C) alkoxy, (2-8C) alkenyl, or (2-8C) alkynyl;R3 is (1-8C) alkyl, (2-8C) alkenyl or (2-8C) alkynyl, all optionally substituted with one or more substituents selected from hydroxyl, (1-8C) alkoxy, (6-14C) aryloxy, (3-8C) cycloalkyl (1-8C) alkoxy, (2-7C) heterocycloalkyl (1-8C) alkoxy, (6-14C) aryl (1-8C) alkoxy, (4-13C) heteroaryl (1-8C) alkoxy, (2-7C) heterocycloalkyl, (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkoxycarbonyl, (6-14C) aryloxycarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, (1-8C) alkylaminocarbonyl, (6-


14C) arylaminocarbonyl, (1-8C) alkylcarbonylamino, (6-14C) arylcarbonylamino, (6-14C)(di) arylamino or (1-8C)(di) alkylamino, or R3 is (3-8C cycloalkyl, (2-7C) heterocycloalkyl, or (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted with one or more substituents selected from (1-8C) alkyl, (1-8C) (di) alkylamino or (1-8C) alkoxy;X is S, O or N(R4);

R4 is H, (1-8C) alkyl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl or (6-14C) aryl (1-8C) alkyl;Y is CH or N;Z is NH2 or OH;A is S, N(H), N(R9), O or a bond;R9 can be selected from the same groups as described for R2;B is N(H), O, or a bond;for use in therapy.

__________

145553]21][11[

BONE SCREW FOR USE INאורטופדי בניתוח לשימוש עצמות בורגORTHOPAEDIC SURGERY

]54[

03.04.2000]22[EP]33[08.04.1999]32[99830204.

6]31[

Int. Cl.8 A61B 017/86]51[ORTHOFIX INTERNATIONAL B.V., THE NETHERLANDS

]71[

DANIELE VENTURINI]72[WO/2000/061022]87[

בע"מ, פרידמן מרק ד"ראביב , תל7 שמואלוב, רח' האומנים בית

DR. MARK FRIEDMAN LTD,. BEIT SAMUELOFF, 7 HAOMANIM

STREET, TEL AVIV

]74[

[57] A bone screw for use in orthopaedic surgery, in particular with external fracture fixation devices, comprising a head (3), a shank (4), and a threaded portion (5) tapering towards a tip (2) at the opposite end from the head, wherein said threaded portion has at least one constant pitch

section comprising threads (9) with an acute angle or cusp-like triangular profile in cross-section, characterised in that said threads are separated from each other by a shaped bottom land having a concave profile (10) defined by two countersloping planes.


__________

145572]21][11[

USER INTERFACE FORזמן של נתונים להזנת משתמש ממשקINPUTTING TIME-RELATED DATA

]54[

23.09.2001]22[Int. Cl.8 G04B 027/08, G04C 009/00]51[

שבע ברמן, באר ראובןשבע ברמן, באר אנה

REUBEN BERMANANNA BERMAN

]71[

ברמן, ראובןשבע , באר16 ארן זלמן

REUBEN BERMAN, 16 ZALMAN ARAN ST .

BEER-SHEBA

]74[

[57] A non-virtual apparatus for inputting time-related data, comprising: an analog clock whose notches and/or the surrounding thereof is sensitive to a touch of a rigid object, inputting said time via said apparatus being carried out by:(a) inputting the hour of said time by touching the corresponding notch or its surrounding with a rigid object;

(b) inputting the minute of said time by touching the corresponding notch or its surrounding with a rigid object;(c) optionally, setting the second of said time by touching the corresponding notch or its surrounding with a rigid object.


__________

145668]21][11[

]NEEDLELESS SYRINGE]54מחט חסר מזרק

14.04.2000]22[US]33[16.04.1999]32[293320]31[

Int. Cl.8 A61M 005/30]51[POWDERJECT RESEARCH LIMITED, UNITED KINGDOM

]71[





TEL AVIV 61040

]74[

[57] A needleless syringe device for accelerating particles into a target tissue of a vertebrate subject, said syringe comprising: an elongate, tubular duct (1) having a lumen (2) for delivering the particles towards the target tissue, the duct having an upstream end and a downstream

end; a receptacle (10) holding the particles to be accelerated; and a gas discharge chamber (4), upstream of the receptacle for the controlled discharge therefrom of pressurized gas to accelerate the particles from the receptacle down the duct lumen towards the target tissue; wherein the


pressurized gas discharged from the gas discharge chamber has a maximum total pressure which is less than 10 bar, and which is sufficient to accelerate the

particles down the duct such that the particles are configured to exit the duct with sufficient energy to penetrate into the target tissue.

__________

146058]21][11[

]FUSE SWITCH]54נתיך של מתג

20.04.2000]22[AT]33[20.04.1999]32[A702/99]31[

Int. Cl.8 H01H 085/54]51[MOELLER GEBAUDEAUTOMATION KG, AUSTRIA

]71[




TEL AVIV 61063

]74[

[57] A fuse switch with an insulating housing (1) in which two live housing contacts (14) are arranged in a stationary fashion and with a switching slide (22) which is guided in a displaceable or swivelable manner between an on position and an off or exchange position in the

insulating housing for receiving a cartridge fuse link (20), which switching slide is also formed from an insulating material and whose final contact caps (21) rest in the on position directly on the stationary housing contacts and in the off or exchange position are spaced from the


stationary housing contacts, characterized by a carriage (24) with a pin (27), which carriage is held displaceably in the switching slide and holds the cartridge fuse-link and engages in a connecting link (28) arranged on the insulating housing, with the connecting link being shaped in

such a way that the carriage is displaced during the displacement or swiveling of the switching slide to such an extent from the the same that the cartridge fuse-link projects in sections beyond the switching slide.

__________

146098]21][11[

של הפה דרך למתן מינון צורת12,7,6,3,2, 12a–2 – הקסאהידרו–

–4, 3 – )6 – דימתיל( –3, 2 מתיל)ו– :1,'2]' מתילנדיאוקסיפניל( פיראזינו

–4, 1 – [ אינדולb – 4,3] [ פירידו1,6דיאון

UNIT DOSAGE FORM OF 2,3,6,7,12, 12A - HEXAHYDRO - 2 - METHYL - (AND 2,3 - DIMETHYL) -6 - (3,4 - METHYLENEDIOXYPHENYL) PYRAZINO [2',1',: 1,6] PYRIDO [3,4-B] INDOLE - 1,4 - DIONE FOR ORAL ADMINISTRATION

]54[

26.04.2000]22[US]33[30.04.1999]32[60/132036]31[

Int. Cl.8 A61K 031/4985, A61P 015/10, C07D 471/14]51[LILLY ICOS LLC, U.S.A.]71[


, תל4060 , ת.ד. 21 העם אחד רחוב REINHOLD COHN AND PARTNERS,

21 AHAD HA'AM ST ,.]74[


, P.O.B. 4060אביבTEL AVIV 61040

[57] A pharmaceutical unit dosage composition comprising about 1 to about 20 mg of a compound of the formula

said unit dosage form being suitable for oral administration.

__________

146211]21][11[

רעלן כקושרי אניוניים פולימריםאנטיבקטריאליים וחומרים

ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS

]54[

11.05.2000]22[US]33[13.05.1999]32[60/133975]31[US03.04.200009/541268

Int. Cl.8 A61K 031/74, 047/00, A61P 001/12]51[GENZYME CORPORATION, U.S.A.]71[




]74[

[57] Use of a therapeutically effective amount of a polymer comprising pendant acid functional groups or a salt thereof with a pharmaceutically acceptable cation

in the preparation of a medicament for inhibiting a pathogenic toxin in a patient, said polymer being substantially free of acid anhydride groups.

__________


146232]21][11[

D3 דופאמין לקולטן בליגנדות שימושכליה במחלות לטיפול תרופות לייצור

USE OF DOPAMINE D3 RECEPTOR LIGANDS FOR PRODUCING MEDICAMENTS FOR TREATING KIDNEY DISORDERS

]54[

28.04.2000]22[DE]33[07.05.1999]32[19922443.

9]31[

Int. Cl.8 A61K 045/00, C07D 403/14]51[ABBOTT GMBH & CO. KG, GERMANY

]71[





TEL AVIV 61040

]74[

[57] Use of dopamine D3 receptor antagonists for the production of drugs for the treatment of renal function disorders.

__________

146276]21][11[

ספירואמידזולידין, הכנתם, של תולדות המכילות רפואיות והכנות שימושם

אותם

SPIROIMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

]54[

06.05.2000]22[DE]33[17.05.1999]32[19922462.

5]31[


Int. Cl.8 A61K 031/4184, A61P 009/00, 043/00, C07D 235/00, 235/02]51[SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY

]71[



, הרצליה12704


P.O.B. 12704 HERZLIYA 46733

]74[

[57] A compound of the formula

in whichR1 is hydrogen or methyl;R2 is unsubsituted phenyl, phenyl which is substituted by a methylenedioxy residue or an ethylenedioxy residue, phenyl which is substituted by one or two (C1-C4) – alkoxy groups, or (C1-C4) – alkyl; X is –CH2-CH2- or –CH2-CH2-CH2-, where one of the CH2 groups in these two residues can be replaced by a carbonyl group C=O;W is isopropyl or cyclopropyl;V is hydrogen or methoxy;E is –CO-R3, -CO-H, -CH2-O-R4, -CH2-O-CO-R4, -CH2-O-CO-O-R5 or 5-tetrazolyl; R3 is hydroxy, (C1-C10)-alkoxy, phenyl-(C1-C8) – alkoxy-, phenyloxy –,(C1-C8)- alkylcarbonyloxy-(C1-C6)-alkoxy-, phenylcarbonyloxy – (C1-C6)-alkoxy-, phenyl-(C1-C6)- alkylcarbonyloxy-(C1-C6)-alkoxy-, (C1-C8)-alkoxycarbonyloxy-(C1-C6)-alkoxy-phenyloxycarbonyloxy- (C1-

C6)-alkoxy-, phenyl-(C1-C6)-alkoxycarbonyloxy-(C1-C6)-alkoxy-, amino, mono-((C1-C10)-alkyl)-amino-, di-((C1-C10)-alkyl-amino-or R4R4N-CO-(C1-C6)-alkoxy-in which the residues R4 are independent of one another and can be identical or different;R4 is hydrogen, (C1-C10) – alkyl, phenyl or phenyl-(C1-C8)-alkyl-; R5 has one of the meanings of R4 with the exception of hydrogen; phenyl present in the groups R3, R4 and R5 is an unsubstituted phenyl residue or a phenyl residue which is substituted by one or more identical or different substituents from the group consisting of (C1-C4)-alkyl, (C1-C4)-alkoxy, methylenedioxy, ethylenedioxy, halogen, trifluoromethyl and trifluoromethoxy; in all its stereosiomeric forms and mixtures thereof in all ratios, and its physiologically tolerable salts.

__________


146420]21][11[

1,7,7[ – PHENYL – ]2 – [(ETHOXY – ( DIMETHYLAMINO – N, N) – '2)] – 2 – (–) –(4R, 2S, 1R) HEPTANE HIGH

PURITY [2.2.1]BICYCLO – [METHYL] – TRIתוספה ומלחי גבוהה –באיכות

שלהם, רפואיות למטרות חומציות ותרופות התרכיבים להכנת תהליך

אותם המכילות

HIGH PURITY (1R,2S,4R) - (-) - 2 - [(2' - (N, N - DIMETHYLAMINO) - ETHOXY)] - 2- [PHENYL] - 1,7,7 -TRI - [METHYL]-BICYCLO [2.2.1] HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AND MEDICAMENTS CONTAINING THEM

]54[

10.05.2000]22[HU]33[11.05.1999]32[P9901559]31[

Int. Cl.8 C07C 217/00]51[EGIS GYOGYSZERGYAR RT., HUNGARY

]71[

GYULA LUKACS, GYULA SIMIG, TIBOR MEZEI, ZOLTAN BUDAI, MARTA PORCS-MAKKAY, GYORGY KRASZNAI, KALMAN NAGY, GYORGYI DONATH VERECZKEY, TIBOR SZABO, NORBERT NEMETH, JANOS SZYLAGYI

]72[




TEL AVIV

]74[


[57] (1R, 2S, 4R)-(-)-2-[(2'-(N, N-dimethylamino)-ethoxy)]-2-[phenyl]-

1,7,7,-tri-[methyl]-bicyclo [2.2.1] heptane of formula

and pharmaceutically acceptable acid addition salts thereof, charactgerised by that they contain not more than 0.2% of

(1R, 3S, 4R)-3-[(2'-(N, N-dimethylamino)-ethyl)]-1,7,7-tri-[methyl]-bicyclo (2.2.1) heptane-2-one of formula

or of a pharmaceutically acceptable acid addition salt thereof.

__________

146432]21][11[

רוקחות ותכשירי טטראפפטידאותן המכילים

TETRAPEPTIDE AND PHARMACEUTICALCOMPOSITION CONTAINING THE SAME

]54[

20.01.2000]22[RU]33[11.05.1999]32[99108841]31[

Int. Cl.8 A61K 038/07, A61P 011/06, 039/06, 043/00, C07K 005/10, 005/103]51[OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "KLINIKA INSTITUTA BIOREGUL YATSII I GERONTOLOGII", RUSSIA

]71[


ב' , ת.ד.19 היסוד קרן רחוב , ירושלים1352


P.O.B. 1352,

]74[


JERUSALEM 91013

[57] A tetrapeptide L-alanyl-L-glutamyl-L-aspartyl-glycine of the general formula L-Ala-L-Glu-L-Asp-Gly.

__________

146471]21][11[

– איל3 – – אוקסולאןN אגוניסטים2,'3,'5( ,'Oאדנוזינים )מותמר–

בפה, הפעיליםA1 לאדנוזין לקולטניםאותם המכילים רוקחיים

ORALLY ACTIVE A1 ADENOSINE RECEPTOR AGONIST N- OXOLAN - 3 - YL - 2`,3`,5` - TRIS (O- SUBSTITUTED) ADENOSINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

19.05.2000]22[US]33[24.05.1999]32[09/317523]31[

Int. Cl.8 C07H 019/00]51[CV THERAPEUTICS, INC., U.S.A.]71[




REHOVOT

]74[

[57] A compound of the formula:


wherein R2, R2' and R2" are independently selected from the group of C1-5 alkyl, C3-6 cycloalkyl, and 2-, 3-, 4-pyridinyl, which alkyl, cycloalkyl, and pyridinyl are optionally substituted with 1 to 3 substituents independently selected from

the group consisting of OR20 and N(R20)2; and R20 is selected from the group consisting of hydrogen and C1-5 alkyl, which alkyl group is optionally substituted with 1 to 3 phenyl groups.

__________

146619]21][11[

METHOD AND SYSTEM FORפקס למשלוח ומערכת שיטהDELIVERY OF FACSIMILE

]54[

24.05.2000]22[AU]33[25.05.1999]32[PQ0559]31[AU30.06.1999PQ1313

Int. Cl.8 G06F 013/00, 015/00, H04N 001/00]51[SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA

]71[





TEL AVIV 61040

]74[

[57] A method of enabling composition of a facsimile by a user and delivery thereof, the method including the steps of:providing a form to the user, the form printed onto at least one paper surface, the form including visible information relating to the user and at least one area for the user to enter a message, the at least one paper surface having invisible coded data indicative of an identity of the form and of the at least one area, wherein the visible information and the invisible coded data are printed substantially simultaneously and wherein at the time of printing a computer system associates the type and spatial extent of the coded data with the spatial extent of at least some of the visible

information; receiving, in a computer system, interaction data from a sensing device used to compose the message, the interaction data being indicative of an identity of the form and a position of the sensing device relative to the area on the paper surface, the sensing device, when placed operatively relative to the area in order to compose the message, generating the interaction data based at least partially on sensing at least some of the coded data in the vicinity of the position; capturing electronically, in the computer system and from the interaction data, at least the message, and transmitting the message to a designated recipient address for facsimile delivery.


__________

146688]21][11[

METHOD AND APPARATUS FORדמויות והשוואת לחיפוש והתקן שיטהSEARCHING FOR AND COMPARING IMAGES

]54[

23.05.2000]22[US]33[04.06.1999]32[09/326362]31[

Int. Cl.8 G06K 009/68, G06T 007/00]51[LOOK DYNAMICS, INC., U.S.A.]71[





]74[

[57] A search method for locating particular content or similar content that has been converted to a digital format for storage in a digital file at a location somewhere in at least one of a plurality of database and/or server devices, which are connected to and accessible via a computer network, comprising: producing a reference image in an optical pattern that is characteristic of the particular content; accessing and downloading a plurality of digital candidate files from their respective storage locations in one or more of the plurality of database and/or server devices along with location information that is

indicative of said respective storage locations;producing a plurality of candidate images in optical patterns that are characteristic of content in the respective downloaded digital candidate files; comparing the candidate image to the reference image by optical correlation to detect degree of correlation between the reference image and the candidate images, and reporting results based on the degree of correlation for the digital candidate files from the storage locations that are determined by the degree of correlation to have content that is closest to or matches the particular content.


__________

146707]21][11[

– ציאנואינדול5 – )4 – ]1 של שימוש– YL– 3 – ]קרבמואיל2 – )4 (בוטיל – ( – פיפרזיןYL – 5 – בנזופורן –

שלו פיזיולוגית המקובלים והמלחיםתרופות להכנת

USE OF 1 - [4 - (5 - CYANOINDOL - 3 - YL) BUTYL] - 4 - (2 - CARBAMOYL - BENZOFURAN - 5 - YL) - PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF MEDICAMENTS

]54[

16.05.2000]22[EP]33[27.05.1999]32[99109295.

8]31[

Int. Cl.8 A61K 031/00, A61P 005/00, 009/10, 009/12, 025/00, 025/06, C07D 405/00]51[MERCK PATENT GMBH, GERMANY

]71[



P.O.B. 12688 ,HERZLIYA 46733

]74[

[57] Use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)- piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety disorders chosen from the the sub-

types: panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress indication and/or generalized-anxiety disorder.


__________

146758]21][11[

PROCESS FOR PRODUCTION OFאמית חומצת של אסטר לייצור תהליךAMIC ACID ESTER

]54[

02.04.2001]22[JP]33[03.04.2000]32[2000-

100786]31[

Int. Cl.8 C07D 277/64]51[IHARA CHEMICAL INDUSTRY CO., LTD., JAPAN

]71[

WO/2001/074795]87[ושות', גבריאלי זליגסון

אביב , תל1426 , ת.ד. 31 רח' יבנה SELIGSOHN GABRIELI & CO,.

31 YAVNE ST.P.O.B. 1426

TEL AVIV 61013

]74[

[57] A process for producing anamic acid ester of the formula:

(wherein A is a substituted or unsubstituted lower alkylene group, a substituted or unsubstituted cycloalkylene group, a substituted or unsubstituted arylene group, a substituted or unsubsituted cycloalkylalkylene group, or a substituted or unsubstituted aralkylene group; R1 is a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a

substituted or unsubstituted aryl group, a substituted or unsubstituted cycloalkylalkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic alkyl group; and R3 is a hydrogen atom or a lower alkyl group), which process comprises reacting, in the presence of water, an amino acid of the formula:


(wherein A has the same definition as given above) with a halogenated carbonic acid ester of the formula

(wherein R1 has the same definition as given above and X is a halogen atom) to

form a carbamate compound of the the formula

(wherein A and R1 have the same definitions as given above), then reacting the carbamate compound with a

halogenated carbonic acid ester of the formula

(wherein R2 is a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted cycloalkylalkyl group, a substituted or

unsubstituted aralkyl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic alkyl group; and X is a halogen atom) to form, in the system, a mixed acid anhydride of the formula

(wherein A, R1 and R2 and R2 have the same definitions as given above), and

reacting the mixed acid anhydride with an amine compound of the formula

(wherein R3 has the same definition as given above and Het is a substituted or unsubstituted heterocyclic group).


__________

146810]21][11[

–10,11 של נגזרות להכנת תהליךמתנובנזוסבראן

PROCESS FOR PREPARING 10,11-METHANOBENZOSUBERANE DERIVATIVES

]54[

26.05.2000]22[US]33[03.06.1999]32[60/137283]31[

Int. Cl.8 C07D 241/12, 295/088, 401/12]51[ELI LILLY AND COMPANY, U.S.A.]71[




]74[

[57] A process for preparing a compoundof the formula

wherein A is –CH2-CH2-, -CH2-CHRa-CH2-, -CH2-CHRa-CH2-CH2-, and Ra is OH;R1 is H, F, Cl, or Br;R2 is H, F,Cl, or Br; and

R3 is heteroaryl or phenyl, each optionally substituted with F, Cl, Br, CF3, CN, NO2, or OCHF2; or the pharmaceutically acceptable salts thereof, comprising the steps of:


(a) reacting a compound of the formula

with a nucleophile source to form a compound of the formula

wherein X is a leaving group;(b) reacting a compound of formula (5) with pyrazine to provide a compound of the formula

(c) reducing the compound of formula (6) to provide a compound of the formula


(d) reacting a compound of formula (8) with either:

(i) an epoxy compound of the formula

wherein R3 is as defined above, and n is an integer 1 or 2; or

(ii) a halo compound of the formula

X1-(CH2)m-O-R3

wherein R3 is as defined above, X1 is halo, and m is 2, 3 or 4; and(e) optionally forming a pharmaceutically acceptable salt from the compound produced in step (d).

Claimed as novel are intermediate compounds of formula (6)wherein R1 and R2 are as above defined and X is selected from the group consisting of I, Br, Cl, OMs, and OTs.

__________

146923]21][11[

חומצות של פולימרים ו– אוליגומריםציקליות אימנו קרבוקסיליות

OLIGOMERS AND POLYMERS OF CYCLIC IMINO CARBOXYLIC ACIDS

]54[

13.06.2000]22[US]33[14.06.1999]32[60/138972]31[

Int. Cl.8 A61K 031/40, 031/445, 031/495, A61P 043/00, C07D 207/16, 211/00, 211/60, 241/04, 401/06, 403/06, G01N 033/53

]51[

WISCONSIN ALUMNI RESEARCH FOUNDATION, U.S.A.

]71[

SAMUEL H. GELLMAN, BAYARD R. HUCK, MICHELE R. RICHARDS

]72[





TEL AVIV

]74[

[57] Compound of the formula:

X-{A}n-Y

wherein n is an integer greater than 1; andeach A, independent of every other A, is selected from the group consisting of:

wherein R1, R2, and R5 are independently selected from the group consisting of hydrogen, linear or branched C1-C6-alkyl, alkenyl, or alkynyl; mono-or di-C1-C6 alkylamino, mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic aryl-C1-C6-alkyl, mono-or bicycle heteroaryl- C1-C6-alkyl, -(CH2)1-

6-OR3, -(CH2)1-6-SR3,-(CH2)1-6-S(=O)-CH2-R3, -(CH2)1-6-S(=O)2-CH2-R3, -(CH2)1-6-NR3R3,-(CH2)1-6-NHC(=O)R3, -(CH2)1-6-NHS(=O)2-CH2-R3, -(CH2)1-6-O-(CH2)2-6-R4,-(CH2)1-6-S-(CH2)2-6-R4, -(CH2)1-6-S(=O) -(CH2)2-6-R4, -(CH2)1-6-S(=O)2-(CH2)2-6-R4,-(CH2)1-6-NH-(CH2)2-6-R4, -(CH2)1-6-N- {(CH2)2-6-R4}2, -(CH2)1-6-NHC(=O) -(CH2)2-6-R4,and -(CH2)1-6 –NHS=(=O)2-(CH2)2-6-R4; whereinR3 is independently selected from the group consisting of hydrogen, C1-C6-alkyl, alkenyl, or alkynyl; mono- or bicyclic aryl,

mono-or bicyclic heteraryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic aryl- C1-C6-alkyl, mono- or bicyclic heteroaryl- C1-C6 – alkyl; and R4 is selected from the group consisting of hydroxy, C1-C6-alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6- alkylthio, C1-C6

- alkylsulfinyl, C1-C6 – alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono-or di- C1-C6 – alkylamino, mono – or diarylamino, mono-or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-aryl-N-heteroarylamino, aryl- C1-C6 – alkylamino, carboxylic acid, carboxamide, mono- or di- C1-C6 – alkylcarboxamide, mono- or diarylcarboxamide, mono- or diheterarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide, sulfonic acid, sulfonamide, mono- or di- C1-C6

alkylsulfonamide, mono- or diarylsulfonamide, mono- or diheteroarylsulfonamide, N-alkyl-N-


arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea; mono- di- or tri-substituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6 - alkyl, aryl, heteroaryl; O-alkylurethane, O-arylurethane, and O-heteroarylurethane;R6 is selected from the group consisting of hydrogen, linear or branched C1-C6 – alkyl, alkenyl, or alkynyl; mono-or di- C1-C6

alkylamino, mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic heteroaryl- C1-C6 – alkyl, -S(=O)2-(CH2)1-6-(CH2)1-6-R3, -C(=O)R3, -S(=O)2-(CH2)2-6R4, and –C(=O)-(CH2)1-6-R4;wherein R3 and R4 are as defined above; R7

and R8 are selected from the group listed above for R1, R2, and R5, and are further selected from the group consisting of hydroxy, C1-C6 – alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6 – alkylthio, C1-C6 – alkylsulfinyl, C1-C6 –alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono – or di-

C1-C6 – alkylamino, mono- or diarylamino, mono-or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-aryl-N-heteroarylamino, aryl- C1-C6 - alkylamino, carboxylic acid, carboxamide, mono-or di- C1-C6 - alkylcarboxamide, mono – or diarylcarboxamide, mono- or diheteroarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide,sulfonic acid, sulfonamide, mono- or di- C1-C6 – alkylsulfonamide, mono- or diarylsulfonamide, mono- or diheteroarylsulfonamide, N-alkyl-N-arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea; mono-di- or trisubstituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6 – alkyl, aryl, heteroaryl; O-alkylurethane, O-arylurethane, and O-heteroarylurethane; one of X or Y is hydrogen or an amino-terminal capping group; the other of X or Y is hydroxy or a carboxy-terminal capping group; and salts thereof.

לתקנות35 לתקנה בהתאם נבחן זה פירוט1968 – הפטנטים, תשכ"ח

This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968

__________

146993]21][11[

וכבל גבוהים ביצועים בעל נתונים כבל מעטה בעל גבוהים ביצועים נתוניםפלאור מכיל שאינוUL 910 קיבול

HIGH PERFORMANCE DATA CABLE AND A UL 910 PLENUM NON-FLUORINATED JACKET HIGH PERFORMANCE DATA CABLE

]54[

14.06.2000]22[US]33[22.07.1999]32[60/144998]31[

Int. Cl.8 H01B 007/18]51[BELDEN WIRE & CABLE COMPANY, U.S.A.

]71[






]74[

[57] An individual bound lateral shielded twisted pair data cable comprising:an insulated twisted pair cable (10); a shielding tape selected from the group consisting of a metal tape (16), a first composite tape having a non-metal base and a layer of metal on one side of said base, and a second composite tape having a non-metal base and a layer of metal on both sides of said base; said shielding tape being laterally wrapped with at least a 10% overlap around said individual twisted pair cable; a fabric or metal binder (18) being wrapped around said shielding tape to provide a bound lateral shielded twisted

pair cable; said shielding tape having a metal thickness of 0.33 to 2.00 mils; said shielding tape and binder being wrapped around said twisted pair at a tension to eliminate a substantial amount of the air and to leave a cross-sectional void area of less than 25% of the cross-sectional area of the shielded twisted pair cable to provide said bound lateral shielded twisted pair data cable, and to provide said bound lateral shielded twisted pair data cable with an adjusted to 20o C standard impedance deviation of 4.5 or less when said standard deviation is calculated around a mean or average impedance of 50 to 200 ohms.

__________

147012]21][11[

רוקחות אינדול, תכשירי של תולדות תרופה בהכנת ושימושן אותן המכילים יתר לפעילות הקשורות במחלות לטיפול

אוסטאוקלאסטס של

INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OVER ACTIVITY OF OSTEOCLASTS

]54[

16.06.2000]22[GB]33[18.06.1999]32[9914371.1]31[

Int. Cl.8 A61K 031/404, 031/435, A61P 019/10, C07D 401/12, 403/12]51[NIKEM RESEARCH S.R.L., ITALY]71[





]74[

[57] Compounds selected from the list consisting of:4-(5,6-dichloro-1H-indol-2-yl) 3-ethoxy-N(2,2,6,6-tetramethylpiperidin-4-yl)-benzamide;4-(5,6-dichloro-1H-indol-2-yl)-3-benzyloxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)-benzamide;4-(5,6-dichloro-1H-indol-2yl)-3-propoxy-N-(2,2, 6,6-tetramethylpiperidin-4-yl) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-[3-[4-(3-methoxyphenyl) piperazin-1-yl]propyl]-3-methoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-[3-[4-(2-pyrimidiyl) piperazin-1yl]propy]-3-methoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-methoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)-3-ethoxybenzamide;4-(5, 6-dichloro-1H-indol-2-yl)-N(3-pyridyl)-3-ethoxybenzamide,4-(5,6,-dichloro-1H-indo-2-yl)-N-(3-(6-methoxypyridyl)-3-ethoxybenzamide;4-(5,6-dichloro-1H-indol-2yl)-N-(1-benzylpiperidin-4-yl)-3-ethoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-2,5-dimethoxybenzamide;

4-(5, 6-dichloro-1H-indol-2-yl)-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)2,5-dimethoxybenzamide;4-(5-methoxy-6-chloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-ethoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-3-methoxy-N-((1-ethoxycarbonylpentyl) piperidin-4-yl) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-3-methoxy-N-((carboxybutyl) piperidin-4-yl)benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(hydroxycarbonylmethoxy) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethypiperidin-4-yl)-3-(2-hydroxyethoxy) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(3-aminopropoxy) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(2-dimethylamino-ethoxy) benzamide, and;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(2, 3-dihydroxypropoxy) benzamide;or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof.


__________

147091]21][11[

משטח לקילוף משוב בקרת מערכת מים ניהול של משולבת מערכת עם אויר

חומצה ומיחזור

FEEDBACK CONTROLLED AIRFOIL STRIPPING SYSTEM WITH INTEGRATED WATER MANAGEMENT AND ACID RECYCLING SYSTEM

]54[


13.12.2001]22[US]33[15.12.2000]32[09/738449]31[

Int. Cl.8 B22D 029/00]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.

]71[


ירושלים



]74[

[57] A coating removal system comprising: a stripping tank (12) containing an electrolyte bath stripping solution for removing a coating from at least one workpiece immersed in said electrolyte bath while a controlled absolute electrical potential is maintained on said at least one workpiece with respect to a reference electrode immersed in said electrolyte bath; a rinse tank (14)

containing a rinse solution for rinsing said at least one workpiece after completion of removal of said coating from said at least one workpiece; and a distillation unit (16) for receiving electrolyte from said stripping tank containing dissolved metals, for purifying said electrolyte received from said stripping tank, and for returning said electrolyte in a purified form to said stripping tank.

__________

147118]21][11[

בשרת מקור שרתי למספר דינמי חיבורמעבר מקודד פרוקסי

DYNAMIC CONNECTION TO MULTIPLE ORIGIN SERVERS IN A TRANSCODING PROXY

]54[

28.06.2000]22[US]33[30.06.1999]32[09/343454]31[


Int. Cl.8 H04L 009/08, 012/22, 012/66, 029/00, 029/06]51[INTERNATIONAL BUSINESS MACHINES CORPORATION, U.S.A.

]71[




REHOVOT

]74[

[57] A method of enabling a proxy (15) to participate in secure communication between a client (10') and a first origin server (12a'), comprising the step of:(a) establishing (20, 22) a first secure session between the client and the proxy;(b) upon verifying the first secure session, establishing (24, 26) a second secure session between the client and the proxy, the second secure session requesting the proxy to act as a conduit to the first origin server;(c) having the client and the first origin server negotiate (30) a session master secret;

(d) having the client deliver (32) the session master secret to the proxy using the first secure session to enable the proxy to participate in the secure communication;(e) responsive to a client request to the first origin server, establishing a third secure session between the client and the proxy, the third secure session requesting the proxy to act as conduit to the second origin server;(f) having the client and the second origin server negotiate a new session master secret; and(g) having the client deliver the new session master secret to the proxy using the first secure session generated in step (a).


__________

147169]21][11[

לשם קוד בר ליצירת אוטומטית שיטהנתונים והעברת איחזור

AUTOMATIC BARCODE CREATION FOR DATA TRANSFER AND RETRIEVAL

]54[

11.06.2000]22[US]33[18.06.1999]32[335838]31[

Int. Cl.8 G06K 007/10]51[]I.C. CODE LTD.]71בע"מ, מתן איי.סי. קוד




]74[

[57] A system for automatically printing an at least two-dimensional barcode onto a printable substrate (24); the barcode featuring a pattern of a plurality of marks, the system comprising:(a) an output device (16) for receiving a plurality of printing commands and for printing a printable substrate according to said plurality of printing commands;(b) a computational device (12) for receiving data to be printed; and(c) a printer driver module (14) for being operated by said computational device and for automatically translating into the at

least two dimensional barcode, at least a portion of said data to be printed including at least one selected from a group including: substantially all text and substantially all graphical images, and for automatically determining at least one command for printing the barcode onto said printable substrate to form a printed barcode, said printer driver module passing said at least one command to said output device, so that said output device is enabled to print the barcode in addition to said data to be printed.


__________

147199]21][11[

המשוקעים יסודות לאריזת שיטהאלקטרוכימית

METHOD FOR PACKING ELECTROCHEMICALLY-DEPOSITED ELEMENTS

]54[

20.12.2001]22[Int. Cl.8 A61N 005/10, G21G 004/06]51[

למחקר בנגב, הרשות בן-גוריון אוניברסיטתשבע ופיתוח, באר

BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

]71[

שני, משה לסטר, גד גולן, ברנדה יובלטולמן פרג'י, רוברטו

YUVAL GOLAN, BRENDA H. LASTER, GAD SHANI, MOSHE FARAGGI

]72[

עו"פ, רוטמן פיירניק ,10012 , ת.ד. 91 רח' הרצל עציון בית

שבע באר

PYERNIK RUTMAN, BEIT ETSION

HERZL ST. 91P.O.B. 10012

BEER SHEVA

]74[

[57] A method for densely packaging an element inside a casing, such that the element-containing casing is suitable for use in the preparation of a radiation source, comprising providing a solution containing ions of said element, positioning a working electrode and at least one counter electrode in contact with said solution, connecting said working electrode and said at least one counter electrode to the negative and

positive poles of a power source, respectively, passing an electrical current between said electrodes to electrochemically deposit said element on said working electrode in a geometrical form corresponding to the form of the interior of the casing and concurrently or sequentially loading said casing with said element.

__________June 3, 2007 708 –התשס"ז בסיון י"ז

147265]21][11[

דרך למתן תכשיר המספק התקן אורגנוסילוקסאן שרף הפה, המכיל

להסרה ניתן בפסתומך ומשתמש

DELIVERY SYSTEM FOR ORAL CARE COMPOSITIONS COMPRISING ORGANOSILOXANE RESINS USING A REMOVABLE BACKING STRIP

]54[

30.06.2000]22[WO]33[02.07.1999]32[PCT/US99/15131]31[WO02.07.1999PCT/US99/15130WO09.06.2000PCT/US00/15890WO09.06.2000PCT/US00/15891

Int. Cl.7 A61K 000/889000 009/00]51[THE PROCTER & GAMBLE COMPANY, U.S.A.

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

[57] A delivery system for delivering an oral care substance to the oral cavity, the delivery system comprising:(a) a removable backing strip having sufficient flexibility so as to be readily conformable to an oral surface when the delivery system is placed thereagainst; and

(b) an oral care composition applied to the backing strip such that when the delivery system is placed on the oral surface the oral care composition contacts the oral surface, the oral care composition comprising:(i) an organosiloxane resin;


(ii) a rheology modifier; and(iii) at least one oral care substance;

wherein the oral care composition remains on the oral surface after the backing strip is removed.

__________

147319]21][11[

פגמים של אל–הרס לגילוי והתקן שיטהחבויים

METHOD AND APPARATUS FOR NON-DESTRUCTIVE DETECTION OF HIDDEN FLAWS

]54[

10.05.2000]22[US]33[14.05.1999]32[09/311442]31[

Int. Cl.8 G01B 015/06]51[SCANNEX TECHNOLOGIES, LLC, U.S.A.

]71[




REHOVOT

]74[

[57] A method for non-destructive examination a test sample comprising the steps of:(a) directing radiation into said test sample;(b) directing radiation into an unflawed standard sample;(c) detecting radiation emanating from said test sample to obtain a set of responses R;

(d) detecting radiation emanating from said standard sample to obtain a set of responses S;(e) utilizing said set of responses R and said set of responses S to obtain a single figure-of-merit; and(f) determining the deviation of said single figure-of-merit from a reference value.


__________

147327]21][11[

ואימידאזופירידינים, בנזאימידיאזולים להכנתם, תכשירי ביניים וחומר תהליך

בהם והשימוש אותם המכילים רוקחות זיהום מניעת או לטיפול תרופות להכנתסינסיציאלי נשמתי ויראלי

BENZIMIDAZOLES AND IMIDAZOPYRIDINES, A PROCESS AND AN INTERMEDIATE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS

]54[

20.06.2000]22[EP]33[28.06.1999]32[99202088.

3]31[

Int. Cl.8 A61K 031/395, A61P 031/00, C07D 401/00, 471/02, 491/02, 495/02]51[JANSSEN PHARMACEUTICA N.V., BELGIUM

]71[





TEL AVIV 61040

]74[



a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein-a1=a2-a3=a4-represents a bivalent radical of formula-CH=CH-CH=CH- (a-1);-N=CH-CH=CH- (a-2);-CH=N-CH=CH- (a-3);-CH=CH-N=CH- (a-4); or

-CH=CH-CH=N- (a-5);wherein each hydrogen atom in the radicals (a-1), (a-2), (a-3), (a-4) and (a-5) may optionally be replaced by halo, C1-6 alkyl, nitro, amino, hydroxy, C1-6 alkyl-oxy, polyhalo C1-6 alkyl, carboxyl, amino C1-6 alkyl, mono- or di(C1-4 alkyl)- amino C1-6 alkyl, C1-6 alkyloxycarbonyl, hydroxy C1-6 alkyl, or a radical or formula

wherein =Z is =O, =CH-C(=O)-NR5aR5b, =CH2, =CH-C1-6 alkyl, =N-OH or =N-O-C1-6 alkyl;

Q is a radical of formula

wherein Alk is C1-6 alkanediyl;Y1 is a bivalent radical of formula –NR2- or –CH(NR2R4)-;

X1 is NR4, S, S(=O), S(=O)2, O, CH2, C(=O), C(=CH2), CH(OH), CH(CH3),CH(OCH3), CH(SCH3), CH(NR5aR5b), CH2-NR4 or NR4-CH2;


X2 is a direct bond, CH2, C(=O), NR4, C1-4 alkyl-NR4, NR4 –C1-4 alkyl;t is 2, 3 4 or 5;u is 1, 2, 3, 4 or 5;v is 2 or 3; andwhereby each hydrogen atom in Alk and the carbocycles and the heterocycles defined in radicals (b-3), (b-4), (b-5), (b-6), (b-7) and (b-8) may optionally be replaced by R3; with the proviso that when R3 is hydroxy or C1-6 alkyloxy, then R3 can not replace a hydrogen atom in the α position relative to a nitrogen atom;G is C1-10 alkanediyl substituted with one or more hydroxy, C1-6 alkyloxy, aryl C1-6 alkyloxy, C1-6 alkylthio, aryl C1-6 alkylthio, HO(-CH2-CH2-O)n-, C1-6 alkyloxy-(-CH2-CH2-O)n- or aryl C1-6 alkyloxy (-CH2-CH2-O)n-;R1 is a monocyclic heterocycle or aryl; said heterocycle being selected from piperidinyl, piperazinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydrofuranyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazoly l, isoxazolyl, oxadiazolyl; and each heterocycle may optionally be substituted with1 or where possible more, such as 2, 3 or 4, substituents selected from halo, hydroxy, amino, cyano, carboxy, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio, C1-6 alkyloxy C1-6 alkyl, aryl, aryl C1-6 alkyl, aryl C1-6 alkyloxy, hydroxy C1-6 alkyl, mono-or di(C1-6 alkyl) amino, mono-or di(C1-6 alkyl) amino C1-6 alkyl, polyhalo C1-6 alkyl, C1-6 alkylcarbonylamino, C1-6 alkyl-SO2-NR5c-, aryl-SO2-NR5c-, -C1-6 alkyloxycarbonyl, -

C(=O)-NR5cR5d, HO(-CH2-CH2-O)n-, halo (-CH2-CH2-O)n-, C1-6 alkyloxy (-CH2-CH2-O)n-,aryl C1-6 alkyloxy (-CH2-CH2-O)n- and mono-or di(C1-6 alkyl) amino (-CH2-CH2O)n-;each n independently is 1, 2, 3 or 4;

R2 is hydrogen, formyl, C1-6 alkylcarbonyl, Hetcarbonyl, pyrrolidinyl, piperidinyl, homopiperidinyl,C3-7 cycloalkyl substituted with N(R6)2, or C1-10 alkyl substituted with N(R6)2 and optionally with a second, third or fourth substituent selected from amino, hydroxy, C3-7 cycloalkyl, C2-5 alkanediyl, piperidinyl, mono-or di(C1-6 alkyl) amino, C1-6

alkyloxycarbonylamino, aryl and aryloxy;R3 is hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aryl C1-6 alkyl or aryl C1-6 alkyloxy;R4 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl;R5a, R5b, R5c and R5d each independently are hydrogen or C1-6 alkyl; orR5a and R5b, or R5c and R5d taken together form a bivalent radical of formula –(CH2)s- wherein s is 4 or 5;R6 is hydrogen, C1-4 alkyl, formyl, hydroxy C1-6 alkyl, C1-6 alkylcarbonyl or C1-6 alkyloxycarbonyl;aryl is phenyl or phenyl substituted with 1 or more, such as 2, 3 or 4, substituents selected from halo, hydroxy, C1-6 alkyl, hydroxy C1-6 alkyl, polyhalo C1-6 alkyl, and C1-6 alkyloxy;Het is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl.

__________

147328]21][11[

ואימידזופירידין בנזימידזול תרכובות או לטיפול תרופה להכנת בהן והשימוש

וירליים זיהומים מניעת

BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS AND THEIR USE FOR PREPARING A MEDICINE FOR TREATMENT OR

]54[


PREVENTION OF VIRAL INFECTIONS

20.06.2000]22[EP]33[28.06.1999]32[99202089.

1]31[

Int. Cl.8 A61K 031/395, A61P 031/00, C07D 401/00, 471/02, 491/02, 495/02]51[JANSSEN PHARMACEUTICA N.V., BELGIUM

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[


a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein-a1=a2-a3=a4-represents a bivalent radical of formula-CH=CH-CH=CH- (a-1);-N=CH-CH=CH- (a-2);-CH=N-CH=CH- (a-3);

-CH=CH-N=CH- (a-4); or-CH=CH-CH=N- (a-5);wherein each hydrogen atom in the radicals (a-1), (a-2), (a-3), (a-4) and (a-5) may optionally be replaced by halo, C1-6 alkyl, nitro, amino, hydroxy, C1-6 alkyl-oxy, polyhalo C1-6 alkyl, carboxyl, amino C1-6 alkyl, mono- or di(C1-4 alkyl)- amino C1-6 alkyl, C1-6 alkyloxycarbonyl, hydroxy C1-6 alkyl, or a radical of formula

wherein =Z is =O, =CH-C(=O)-NR5aR5b, =CH2, =CH-C1-6 alkyl, =N-OH or =N-O-C1-6 alkyl;

Q is a radical of formula


wherein Alk is C1-6 alkanediyl;Y1 is a bivalent radical of formula –NR2- or –CH(NR2R4)-;X1 is NR4, S, S(=O), S(=O)2, O, CH2, C(=O), C(=CH2), CH(OH), CH(CH3),CH(OCH3), CH(SCH3), CH(NR5aR5b), CH2-NR4 or NR4-CH2;X2 is a direct bond, CH2, C(=O), NR4, C1-4 alkyl-NR4, NR4 –C1-4 alkyl;t is 2, 3 4 or 5;u is 1, 2, 3, 4 or 5;v is 2 or 3; andwhereby each hydrogen atom in Alk and the carbocycles and the heterocycles defined in radicals (b-3), (b-4), (b-5), (b-

6), (b-7) and (b-8) may optionally be replaced by R3; with the proviso that when R3 is hydroxy or C1-6 alkyloxy, then R3 can

not replace a hydrogen atom in the α position relative to a nitrogen atom;G is C1-10 alkanediyl substituted with one or more hydroxy, C1-6 alkyloxy, aryl C1-6 alkyloxy, C1-6 alkylthio, aryl C1-6 alkylthio, HO(-CH2-CH2-O)n-, C1-6 alkyloxy-(-CH2-CH2-O)n- or aryl C1-6 alkyloxy (-CH2-CH2-O)n-; aryl C1-6 alyloxy (-CH2-CH2-O)n-, amino, mono-or-di(C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino and aryl; R1 is a bicyclic heterocycle selected from quinolinyl, quinoxalinyl, benzofuranyl,

benzothienyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, pyridopyridyl, naphthiridinyl, 1H-imidazo [4, 5-b] pyridinyl, 3H-imidazo [4,5] pyridinyl, imidazo [1,2-a] pyridinyl, 2, 3-dihydro-1,4-dioxino [2,3-b] pyridyl or a radical of the formula


and said bicyclic heterocylces may optionally be substituted in either of the two cycles with 1 or where possible more, such as 2, 3 or 4, substituents selected from halo, hydroxy, amino, cyano, carboxyl, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio, C1-6 alkyloxy-C1-6 alkyl, aryl, aryl C1-6 alkyl, aryl C1-6 alkyloxy, hydroxy C1-6 alkyl, mono-or di(C1-6 alkyl)-amino, mono-or di(C1-6 alkyl) amino C1-6 alkyl, polyhalo C1-6 alkyl, C1-6 alkycarbonylamino, C1-6 alkyl –SO2-NR5c-, aryl-SO2-NR5c-, C1-6 alkyloxycarbonyl, -C(=O)-NR5CR5d, HO(-CH2-CH2-O)n-, halo (-CH2-CH2-O)n-, C1-6 alkyloxy (-CH2-CH2-

O)n-, aryl C1-6 alkoxy (-CH2-CH2-O)n- and mono-or di(C1-6 alkyl) amino(-CH2-CH2-O)n-; each n independently is 1, 2, 3 or 4; each m independently is 1 or 2; each p independently is 1 or 2;each R2 indepdnently is hydrogen, formyl, C1-6 alkylcarbonyl, Hetcharbonyl, pyrrolidinyl, piperidinyl, homopiperidinyl, C3-7 cycloalkyl substituted with N(R6)2, or C1-10 alkyl substituted with N(R6)2 and

optionally with a second, third or fourth substituent selected from amino, hydroxy, C3-7 cycloalkyl, C2-5 alkanediyl, piperidinyl, mono-or di (C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino, aryl and aryloxy; R3 is hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aryl C1-6 alkyl or aryl C1-6 alkyloxy; R4 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl;R5a, R5b, R5c and R5d each independently are hydrogen or C1-6 alkyl; orR5a and R5b, or R5c and R5d taken together form a bivalent radical of formula –(CH2)s-wherein s is 4 or 5; R6 is hydrogen, C1-4 alkyl, formyl, hydroxy C1-6 alkyl, C1-6 alkylcarbonyl or C1-6 alkyloxycarbonyl; aryl is phenyl or phenyl substituted with 1 or more, such as 2, 3 or 4, substituents selected from halo, hydroxy, C1-6 alkyl, hydroxy C1-6 alkyl, polyhalo C1-6 alkyl, and C1-6 alkyloxy;Het is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl.Intermediates of formula


with P being a protective group, and Q1 being defined as, Q above defined but

being devoided of the R2 or R6 substituent, and of the formula

with (O=)Q3 being a carbonyl derivative of Q provided that it is devoided of the NR2R4

or NR2 substituent.

and of the formula

with (O=)G2 being a carbonyl derivative of G are claimed as novel.

__________

147418]21][11[

כיסוי קצה לזיהוי ושיטה מערכתאלחוטי תקשורת במכשיר

SYSTEM AND METHOD FOR EDGE OF COVERAGE DETECTION IN A WIRELESS COMMUNICATION DEVICE

]54[

06.07.2000]22[US]33[07.07.1999]32[09/348442]31[

Int. Cl.8 H04Q 007/38]51[QUALCOMM INCORPORATED, U.S.A.

]71[




REHOVOT

]74[

[57] In a wireless telephone communication system having more than one service provider system a method to enhance performance of a mobile phone,

comprising: when the mobile phone that is communicating with a first service provider system is in an idle mode, monitoring a first performance level and a second performance level;


if the first performance level falls below a first threshold and the second performance level falls below a second threshold. starting a timer; if, while the timer is running, either the first or second performance levels exceed their respective thresholds, resetting the timer and continue

monitoring the first and second performance levels; and if the timer exceeds a predetermined duration, switching the mobile telephone from the first service provider system to a second service provider system.

__________

147441]21][11[

[N-[4-(1-SUBSTITUTED ]54[June 3, 2007 718 –התשס"ז בסיון י"ז

[פנילN[–4(–1– תולדות–5–איל[אלקיל[–1מותמר(פיפראזין–

[פיראן–B–2,3–אוקסו–תיאנו]7מותמר– רוקחות ותכשירי –קרבוקסאמיד3

אותן המכילים

PHENYL)PIPERAZIN-1-YL]ALKYL-]5-SUBSTITUTED-7-

OXO-THIENO[3,2-B]PYRAN-3-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

28.07.2000]22[IT]33[30.07.1999]32[MI99A001704]31[

Int. Cl.8 A61K 031/396, A61P 013/00, 025/00, 027/02, C07D 495/00, 495/04]51[RECORDATI IRELAND LIMITED, IRELAND

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[


whereinR represents an aryl, cycloalkyl or polyhaloalkyl group,R1 represents an alkyl, alkoxy, polyfuoroalkoxy, hydroxy or trifluoromethanesulphonyloxy group, each

of R2 and R3 independently represents a hydrogen or halogen atom or an alkoxy or polyfluoroalkoxy group, and n is 0, 1 or 2, or an N-oxide or a pharmaceutically acceptable salt of such a compound.

__________


147510]21][11[

TASTE MASKEDמוסווה טעם בעל נוזלי רוקחות תכשירPHARMACEUTICAL LIQUID FORMULATIONS

]54[


21.06.2000]22[US]33[09.07.1999]32[60/143019]31[

Int. Cl.8 A61K 009/00, 009/14, 009/16]51[ORTHO-MCNEIL PHARMACEUTICAL, INC., U.S.A.

]71[





TEL AVIV 61040

]74[

[57] An orally consumable liquid composition comprising a pharmaceutically active agent wherein the active agent is levofloxacin in particle form contained in a liquid suspension having a pH greater than about 6.0, each particle comprising a core of the pharmaceutically active agent, optionally associated with inactive pharmaceutical adjuvants; the core being coated with a

taste masking effective amount of a polymer blend of (a) dimethylaminoethyl methacrylate and neutral methacrylic acid ester (MM/MAE) and (b) a cellulose ester, in an aqueous vehicle, wherein the cellulose ester and the MM/MAE are present in a polymer weight ratio of the cellulose ester to the MM/MAE of about 40:60 to about 90:10.

__________

147628]21][11[

בקרה ערוץ של ניידת תחנה פיקוחמקוטע שידור במצב יעודי קדמי

MOBILE STATION SUPERVISION OF THE FORWARD DEDICATED CONTROL CHANNEL WHEN IN THE DISCONTINUOUS TRANSMISSION MODE

]54[

20.07.2000]22[US]33[21.07.1999]32[09/358634]31[

Int. Cl.8 H04B 007/185, H04J 003/12, H04Q 007/20, 007/38]51[QUALCOMM INCORPORATED, U.S.A.

]71[




REHOVOT

]74[

[57] An apparatus used to supervise a dedicated control channel transmitted operating in a discontinuous transmission (DTX) mode, comprising: transceiver

means for transmitting and receiving transmissions; count means communicatively coupled to said transceiver means for counting a number


of bad, good, and empty frames received in a transmission, wherein said count means is reset when a new transmission is received, and wherein said count means counts the number of bad frames received (COUNT1), the number of good frames received (COUNT2), and the number of empty frames received (COUNT3), and where said COUNTs may be incremented when:COUNT1 is incremented if a bad frame is received;COUNT2 is incremented if a good frame is received, and reset to zero if a bad frame is received; andCOUNT3 is incremented if an empty frame is received, and reset to zero if a

good frame is received; a fade timer, wherein said fade timer is set for a designated period if COUNT2 exceeds a third threshold (TH3); disabling/enabling means for disabling said transceiver, wherein said transceiver is enabled if COUNT2 exceeds a second threshold (TH2), and wherein said transceiver is disabled if said fade timer expires before COUNT1 is reset to zero, and wherein said transceiver is disabled if COUNT3 exceeds a fourth threshold (TH4); and terminating means for terminating a transmission, wherein said transmission is terminated if said fade timer expires before COUNT1 is reset to zero, or if COUNT3 exceeds a fifth threshold (TH5).




__________

147672]21][11[

ושיטת הקלטה וידאו, מערכת מצלמתמשופר דינמי טווח בעלות הקלטה

DYNAMIC RANGE VIDEO CAMERA, RECORDING SYSTEM AND RECORDING METHOD

]54[


16.08.2000]22[US]33[17.08.1999]32[60/149237]31[

Int. Cl.8 G03B 007/00, H04N 003/14, 005/225, 005/235, 005/238]51[APPLIED VISION SYSTEMS, INC., U.S.A.

]71[

WO/2001/013171]87[ושות', ש. הורוביץ

, תל41-45 רוטשילד שדרות ציון בית אביב

S. HOROWITZ & CO,. ZION HOUSE,

41-45 ROTHSCHILD BLVD,.TEL AVIV 65784

]74[

[57] A method of producing a video recording with improved dynamic range comprising: providing a video camera comprising a video detector capable of converting an optical image into a sequence of video fields or frames, and an electronic shutter for adjusting the amount of light received by said detector from an optical image viewed by said camera; operating said camera to capture an optical image; commanding said electronic shutter to vary the amount of light received by said video detector from said captured optical image whereby to produce from said detector an output video signal constituting a sequence of video fields or frames representing the captured optical image, with said sequence comprising at least first and second fields or frames representing different exposure values of

the captured image occurring repetitively in said sequence according to a predetermined repetition frequency; recording said output video signal in a recording medium; subsequently playing said output video signal out of said recording medium; processing said output video signal played out of said recording medium so as to produce a modified video signal consisting of a continuous sequence of said first fields or frames or a continuous sequence of said second fields or frames; and selectively applying said modified video signal as an input signal to a video display apparatus whereby to cause said apparatus to display said captured optical image according to the first or second fields or frames contained in said modified video signal.


__________

147761]21][11[

שידור אנרגיית לבקרת ומערכת שיטה שמבקר שער בעלת תקשורת במערכת

משתנה מהירות על

METHOD AND SYSTEM FOR CONTROLLING TRANSMISSION ENERGY IN A VARIABLE RATE GATED COMMUNICATION SYSTEM

]54[

27.07.2000]22[US]33[29.07.1999]32[09/363545]31[

Int. Cl.8 H04B 007/005, 007/216, 007/26]51[QUALCOMM INCORPORATED, U.S.A.

]71[




REHOVOT

]74[

[57] In a wireless communication device, a method for controlling transmission energy of a remote station in response to received closed loop power control commands, comprising the steps of:(a) identifying ones of said received closed loop power control commands generated based upon gated out portions of a reverse link signal wherein said step of identifying is performed by receiving a predetermined number of power control bit estimates

requesting said remote station to increase its transmission energy in a set of said received closed loop power control commands consisting of alternating power control commands; and(b) adjusting transmission energy in response to said step of identifying ones of said received closed loop power control commands generated based upon gated out portions of a reverse link signal.

__________


147767]21][11[

– ארילויניל2 תרכובות להכנת תהליכים –2 – – דיאריל1, 4 ו– אתר אלקיל

– בוטן2 – פלורורו

PROCESSES FOR THE PREPARATION OF 2 - ARYLVINYL ALKYL ETHER AND 1,4 - DIARYL - 2 - FLUORO - 2 - BUTENE COMPOUNDS

]54[

07.08.2000]22[US]33[12.08.1999]32[373262]31[

Int. Cl.8 C07C 017/263, 022/08, 025/24, 041/01, 041/28, 041/30, 043/00, 043/176, 043/215, 043/225, 043/29, 069/773, C07D 213/24, 213/62

]51[

BASF AKTIENGESELLSCHAFT, GERMANY

]71[





TEL AVIV 61040

]74[

[57] A process for the preparation of a 2-arylvinyl alkyl ether compound of the formula

whereinR is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl or C3-C6 halocycloalkyl;R1 is C1-C6 alkyl; andAr is phenyl optionally substituted with any combination of from one to three halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, 1-or 2-naphthyl optionally substituted with any

combination of from one to three halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, or a 5- or 6-membered heteroaromatic ring optionally substituted with any combination of from one to three halogen, C1-C4 alkyl, C1-C4

haloalkyl, C1-C4 alkoxy or C1-C4

haloalkoxy groups, in the absence of phosphonium halide compounds, which process comprises reacting a first acid with either(a) an aldehyde compound of the formula


wherein R and Ar are as described above and an alkanol compound of the formula

R1OHwherein R1 is as described above, or(b) an acetal compound of the formula

in the presence of an aprotic solvent at an elevated temperature.

__________

147791]21][11[

של רבים בתים לייצור והתקן שיטה על שעון דופק בכל רעש דמויי רצפים

במקביל הבתים חישוב ידי

METHOD AND APPARATUS FOR GENERATING MULTIPLE BITS OF A PSEUDONOISE SEQUENCE WITH EACH CLOCK PULSE BY COMPUTING THE BITS IN PARALLEL

]54[

30.08.2000]22[US]33[31.08.1999]32[09/386600]31[

Int. Cl.8 G06F 007/58, H04B 007/216]51[QUALCOMM INCORPORATED, ]71[


U.S.A.WO/2001/016699]87[


רחובות


REHOVOT

]74[

[57] An apparatus for generating multiple bits of a pseudonoise sequence by computing the bit in parallel, comprising:(a) a state memory;(b) a next state generator communicatively connected with said state memory, said

next state generator being configured to provide next state pre-determined number of states apart from a current state by a single operation; and(c) an output generator communicatively connected with said state memory.

__________

147795]21][11[

חיפוש זמני להפחתת והתקן שיטה תחנות איכון מידע באמצעות ראשוניים

ניידות

METHOD AND APPARATUS FOR REDUCING PILOT SEARCH TIMES UTILIZING MOBILE STATION LOCATION INFORMATION

]54[

30.08.2000]22[US]33[31.08.1999]32[09/387102]31[

Int. Cl.8 H04B 001/707, H04J 013/00, H04Q 007/22, 007/32, 007/34, 007/38]51[QUALCOMM INCORPORATED, U.S.A.

]71[

WO/2001/017125]87[



רחובות


REHOVOT

]74[

[57] A method for conducting pilot signal search in a wireless communications system, comprising: determining a location of a mobile station within said wireless

communications system; determining a plurality of search window sizes corresponding to a plurality of pilot signals.



__________

147916]21][11[

בעלת אלחוטית לתקשורת והתקן שיטהמשתנים מידע קצבי

METHOD AND APPARATUS FOR WIRELESS COMMUNICATIONS HAVING VARYING DATA RATES

]54[

28.07.2000]22[US]33[04.08.1999]32[09/368637]31[

Int. Cl.8 H04B 007/005, H04J 003/16, H04L 001/00, 012/28, H04Q 007/00]51[ATHEROS COMMUNICATIONS, INC., U.S.A.

]71[

WO/2001/011815]87[



רחובות


REHOVOT

]74[

[57] A method of dynamically allocating a data rate for wireless communication between a first transceiver and a second transceiver, the method comprising: transmitting initial first data at a first predetermined power level and at an initial first data rate from a first transceiver to a second transceiver; receiving the initial first data at the second transceiver; sensing the received power level of the received initial first data; determining a modified

first data rate greater than said initial first data rate at which to transmit further first data, said modified first data rate having a maximum data rate that is determined based upon the received power level of the received initial first data; transmitting the further first data at the modified first data rate and at the first predetermined power level from the first transceiver to the second transceiver; and receiving the further first data at the second transceiver.

__________

148003]21][11[

פעולה המכיל מורחף רוקחות תכשירפעילה לא ופאזה

FLOATING PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PHASE AND A NON-ACTIVE PHASE

]54[


02.08.2000]22[FR]33[06.08.1999]32[99/10285]31[

Int. Cl.8 A61K 009/00, 009/20, 009/50]51[GALENIX DEVELOPPEMENT, FRANCE

]71[





TEL AVIV 61040

]74[

[57] Floating pharmaceutical composition characterized in that is it constituted by at least:(a) a first phase, termed active phase, comprising at least one active ingredient and at least one disintegrating agent selected from hydroxypropylmethylcellulose, highly substituted hydroxy propylcellulose and ethylcellulose, the at least one disintegrating agent being in quantities less

than 15% by weight of the active phase and in a form making it possible to obtain a disintegrating effect while preventing the formation of a continuous network;(b) a second phase, termed inactive phase, comprising at least one gas-generating system and at least one hydrophilic polymer or a porous mineral compound,the active phase comprising a quantity of active ingredient(s) constituting at least 80% by weight of the active phase.

לתקנות35 לתקנה בהתאם נבחן זה פירוט1968 – הפטנטים, תשכ"ח


__________

148042]21][11[

METHOD FOR PREPARING–דיאונים5,8קינולין– להכנת שיטהQUINOLINE-5,8-DIONES

]54[

10.08.2000]22[FR]33[13.08.1999]32[99/10491]31[

Int. Cl.8 C07D 215/20]51[LABORATOIRE L. LAFON, FRANCE]71[WO/2001/012597]87[


אביב



TEL AVIV 61040

]74[


[57] A process for preparing quinoline-5, 8-diones of the formula:

in which:R1, R2 and R3 are chosen from hydrogen, a halogen atom, a C1-C6 alkyl group, -CHO,

-OH, -OR, -COOH, -CN, -CO2R, -CONHR, -CONRR'-, -NH2, -NHCOR,

morpholino and SO3H, Rand R' being chosen from C1-C6 alkyl groups and Ar being a C6-C14 aryl group, in

which an 8-hydroxyquinoline of the formula:

in which R1, R2 and R3 have the meaning given above, is oxidized with oxygen under the action of actinic radiation in solution in an organic solvent and in the

presence of a catalytic amount of a sensitizer, and the hydroperoxide formed, of the formula:


is then decomposed to a compoundof formula I.

__________

148068]21][11[

או ליפואית אלפא– בחומצה שימוש בתרופות פעיל כמרכיב בנגזרותיה

מיגרנה מניעת או לטיפול

USE OF ALPHA- LIPOIC ACID OR DERIVATIVES THEREOF AS AN ACTIVE INGREDENT IN THE MANUFACTURE OF MEDICAMENTS FOR TREATING OR PREVENTING MIGRAINE

]54[

26.08.2000]22[DE]33[30.08.1999]32[19941217.

0]31[

Int. Cl.8 A61K 031/385, 031/405, A61P 025/06, C07D 209/04, 339/00, 339/04]51[MEDA PHARMA GMBH & CO. KG, GERMANY

]71[

JEAN SCHOENEN, JURGEN ENGEL, KLAUS WESSEL, MANFRED PEUKERT, MICHAEL LOBISCH, HARALD BORBE

]72[

WO/2001/015693]87[( בע"מ,1995) ג'י.אי.ארליך

בגין מנחם ,רחוב15 אילון, קומה מגדל גן , רמת11



]74[

[57] Use of racemic α-lipoic acid or its enantiomers or pharmaceutically

acceptable salts, amides, esters or thioesters thereof, in reduced or oxidized


form, as an active ingredient for the manufacture of a medicament for prevention or treatment of migraine.

__________

148137]21][11[

באמצעות מסונכרנת מעגל סינתזהאסינכרוני פירוט

SYNCHRONOUS CIRCUIT SYNTHESIS USING AN ASYNCHRONOUS SPECIFICATION

]54[

18.08.2000]22[US]33[19.08.1999]32[377372]31[US09.11.199960/164201

Int. Cl.8 G06F 017/50, H04L 012/66]51[MASSACHUSETTS INSTITUTE OF TECHNOLOGY, U.S.A.

]71[





TEL AVIV 61040

]74[

[57] A method for designing a synchronous digital system according to an asynchronous system specification for a first system comprising:accepting the asynchronous system specification, including accepting specifications of a plurality of data elements whose values define a state of the first system and accepting specifications of a plurality of state transition rules, wherein application of any of the state transition rules atomically updates values of the data element according to the specification of said state transition rule; and processing

the asynchronous system specification to form a specification of the synchronous digital system; wherein: processing the asynchronous system specification includes identifying a sequence of two or more of the state transition rules of the asynchronous system specification for application in a single state transition of the synchronous digital system; and at least some state transition of said synchronous digital system corresponds to sequential application of two or more of the state transition rules of the identified sequence.


__________

148162]21][11[

באמצעות אדמה בחרקי להלחם שיטהפניל–פירזולים

METHOD FOR FIGHTING SOIL INSECTS WITH PHENYL-PYRAZOLES

]54[

07.09.2000]22[FR]33[07.09.1999]32[99/11312]31[

Int. Cl.8 A01N 043/56, C07D 231/14, 401/02]51[BAYER CROPSCIENCE S.A., FRANCE

]71[



INDUSTRIAL PARK, OMER]74[



[57] Insecticidal compositions comprising:(a) between 0.001 and 5%, preferably between 0.05 and 1% and still more

advantageously between 0.05 and 0.5% of a compound of the formula

in which:R1 is a halogen atom or a CN group or a methyl group or a CH3CO group;R2 is S(O)nR3;R3 is alkyl or haloalkyl;R4 represents a hydrogen or halogen atom, or an NR5R6, S(O)mR7, C(O)R7 or C(O)-R7, alkyl, haloalkyl or OR8 radical or an –N=C(R9)(R10) radical; R5 and R6 independently represent a hydrogen atom or an alkyl, haloalkyl, C(O) alkyl or S(O) rCF3 radical, or R5 and R6 can together form a divalent alkylene radical which may be interrupted by one or two divalent heteroatoms such as oxygen or sulphur; R7 represents an alkyl or haloalkyl radical; R8 represents an alkyl or haloalkyl radical or a hydrogen atom; R9 represents an alkyl radical or a hydrogen atom; R10 represents a phenyl or heteroaryl group optionally substituted with one or more halogen

atoms or groups such as OH, -O-alkyl, -S-alkyl, cyano or alkyl; X represents a trivalent nitrogen atom or a C-R12 radical; R11 and R12 represent, independently of each other, a hydrogen or halogen atom; R13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O)qCF3 or SF5 group; m, n, q, r represent, independently of each other, an integer equal to 0, 1 or 2; with the proviso that when R1 is methyl, then R3 is haloalkyl, R4 is NH2, R11 is Cl, R13 is CF3 and X is N;(b) between 0.05 and 10%, preferably between 0.1 and 5% of one (or more) moisture-retaining agents, preferably a moisture-retaining agent of an organic nature; and(c) between 40 and 99%, preferably between 50 and 98% (and more preferably between 70 and 97%) of vegetable meal.

__________

148325]21][11[

של רצפטור של אנטגוניסטיםויטרונקטין

VITRONECTIN RECEPTOR ANTAGONISTS

]54[


07.09.2000]22[US]33[07.09.1999]32[60/152780]31[

Int. Cl.8 A61K 031/4375, 031/4439, A61P 003/14, 009/00, 019/10, 035/00, C07D 213/74, 401/06, 413/12, 417/12, 471/04

]51[

SMITHKLINE BEECHAM CORPORATION, U.S.A.

]71[




]74[

[57] A compound of the formula:

wherein:R1 is Het-or Ar;R2 is

or a pharmaceutically acceptable salt thereof.

__________

148375]21][11[

]AIR DUCT DAMPER]54אויר לתעלת אויר וסת

25.02.2002]22[Int. Cl.8 F24F 007/06]51[

]TWITOPLAST LTD.]71בע"מ, פתח-תקוה טויטופלסטצדק, וכהן איתן, פרל, לצר


P.O.B. 12688 ,HERZLIYA 46733

]74[


[57] An air damper particularly useful in air conditioning ducts, comprising a plurality of radial blades, each blade being pivotally supported between an outer housing ring and a central hub member, said blades being rotatable about a radial pivot axis between a fully closed position blocking air flow in a duct containing said

damper to a fully open position allowing substantially free air flow in said duct, and including any desired intermediate position, said radial blades being interlinked so that the rotation of one blade causes the same degree of rotation in all remaining blades.

__________

148406]21][11[

PHARMACEUTICAL TRAMADOLרוקחי לשימוש טרמדול מלחיSALTS

]54[

03.08.2000]22[DE]33[31.08.1999]32[19940740.

1]31[

Int. Cl.8 C07D 215/00]51[GRUNENTHAL GMBH, GERMANY]71[WO/2001/015682]87[



אביב


P.O.B. 4060 ,TEL AVIV 61040

]74[

[57] A pharmaceutically acceptable salt of tramadol and a sugar substitute, wherein

the solubility of the salt in water or aqueous body fluids is <100 mg/ml.

__________

148521]21][11[

הודעות סידרת לשידור ומערכת שיטהנתונים בסיס עבור

METHOD AND SYSTEM FOR TRANSMITTING A CHAIN OF MESSAGES FOR DATABASE

]54[

14.09.2000]22[CH]33[17.09.1999]32[1713/99]31[

Int. Cl.8 G06F 009/445, H04L 012/18, 029/06, H04N 007/24]51[NAGRACARD S.A., SWITZERLAND]71[WO/2001/022684]87[


ירושלים



]74[

[57] Method of transmission of chain of database managing messages between a management centre and a plurality of subscriber databases, each management message comprising a chain header (HD), a chain identifier (FM) allowing the simultaneous transmission of several chains and a chain index (FI) allowing to identify the message in the chain,

characterized in that it consists in adding to each message a conditional block (CD) which determines if this message is to be processed without references to all or part of elements of the chain or to be processed according to the conditions linked to the previous processing of all or part of elements of the chain.


__________

148568]21][11[

במערכת לשימוש דבק, במיוחד סרטיטרנסדרמלית או דרמלית

PLASTIC FILMS, ESPECIALLY FOR USE IN A DERMAL OR TRANSDERMAL THERAPEUTIC SYSTEM

]54[


26.08.2000]22[DE]33[10.09.1999]32[1994317.8]31[

Int. Cl.8 A61K 035/00]51[LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY

]71[




]74[

[57] Dermal or transdermal therapeutic system comprising a sheet-like substrate or reservoir containing readily volatile auxiliary agents or active agents, which substrate or reservoir is covered on one of its sides with a backing layer impermeable to the ingredients and on the opposite side

with a detachable, likewise impermeable protective layer to prevent loss of ingredients during prolonged storage, characterized in that both the backing layer and the protective layer are made of plastic film which is impermeably coated on both sides with vapour-deposited metal.

__________

148619]21][11[

לזכרון לאפשר ושיטה מערכת תפקוד כדי תוך קוד בצע לא–וולטיליל

מידע ועיבוד אגירה כמתקן

SYSTEM AND METHOD FOR ENABLING NON-VOLATILE MEMORY TO EXECUTE CODE WHILE OPERATING AS A DATA STORAGE/PROCESSING DEVICE

]54[

18.06.2001]22[US]33[31.07.2000]32[09/629966]31[

Int. Cl.8 G06F 012/00, 015/78]51[


M-SYSTEMS FLASH DISKבע"מ פיונירס דיסק פלאש אם-סיסטמסPIONEERS LTD.

]71[

,AMIR BAN, MOSHE GEFENזרנוויצקי גפן, שוקה בן, משה אמירSHUKA ZERNOVIZKY

]72[




TEL AVIV

]74[

[57] A method for executing code while processing data on a non-volatile memory device, comprising the following steps:(i) adding at least one logic circuit to the non-volatile memory device;(ii) sensing a read request while the device is in program/erase mode/operation, by said at least one logic circuit;(iii) in response to said sensing, entering of program and/or erase operations into suspended mode, by said at least one logic circuit;(iv) signaling to CPU/Bus to delay executing said read request, by said at least one logic circuit;

(v) turning off signal to allow CPU/Bus to execute said read request, by said at least one logic circuit; and(vi) exiting of said device from said suspended mode to continue program/erase operation, by said at least one logic circuit.A single flash memory device comprising:a suspend logic circuit for enabling hardware initiated suspending of data processing operations in response to at least one read request received by the memory device from a host; and a resume logic circuit for enabling hardware initiated resuming of data processing operations.

__________

148683]21][11[

נמתח, מחיצה בד לקיבוע מסילה מקטע קיר או מדומה תקרה כגון מדומהממנו המורכב מדומה

RAIL SECTION FOR FIXING A STRETCHED WEB, FALSE PARTITION SUCH AS A FALSE CEILING OR FALSE WALL COMPRISING SAME

]54[


11.07.2001]22[FR]33[13.07.2000]32[00/09186]31[

Int. Cl.8 E04B 009/30]51[NEWMAT, S.A., FRANCE]71[WO/2002/006604]87[




]74[

[57] A rail section (3) for stretched fabric false partitions affixed to a mounting surface (4), said rail section comprising: a groove (3) defined by an internal wing (7), an external wing (5) and a base (6); an interval adjacent to the external wing and separating the external wing from a mounting surface; a joint (12) including a lip (13), and a flap (14) outside the groove, said flap extending outward from said

external wing toward said mounting surface; said lip being shaped and configured to pinch the fabric of the false partition between said lip and said internal wing; wherein the lip is approximately flat, an internal face (16) of the lip being approximately parallel to an external face of the lip; wherein the lip has a free edge that is disposed inside the groove.

__________

148953]21][11[

]HORMONAL COMPOSITION AND ]54בו ושימוש הורמונלי תכשיר


USE THEREOF

24.10.2000]22[WO]33[25.10.1999]32[PCT/FR99/02588]31[

Int. Cl.8 A61K 045/00, C07J 005/00]51[LABORATOIRE THERAMEX, MONACO

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

[57] Use of a combined estroprogestative association to be administered by the oral route for the preparation of a medicament intended to correct estrogen deficiencies in women, more particularly in menopausal women, wherein the association contains an estrogen at a dose ranging from 0.3 to 3

mg, and a progestative selected from nomegestrol and esters thereof at a dose ranging from 0.3 to 1.25 mg, in combination or admixture with one or more non-toxic, inert, pharmaceutically acceptable excipient(s).

__________

149209]21][11[

Nאלקילאמידים, הכנתם, –גואנידינו המכילים רוקחות ותכשירי בהם השמוש

אותם

N-GUANIDINOALKYLAMIDES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

]54[

21.10.2000]22[EP]33[30.10.1999]32[99121623.

5]31[

Int. Cl.8 A61K 031/16, 031/395, A61P 007/02, 009/00, C07C 279/14, C07D 213/30, 213/40, 215/48, 239/28

]51[

SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY

]71[



P.O.B. 12688 ,HERZLIYA 46733

]74[

[57] Compounds of the formula


in whichone or two of the groups Y are carbonatoms carrying a group of the formula

Ro-(CH2)n-O-

and zero, one, two or three of the groups Y are nitrogen atoms, and the remaining groups Y are carbon atoms carrying a group R1, where the groups Y are independent of each other and can be identical or different; L is chosen from hydrogen, (C1-C6)-alkylcarbonyl, (C6-C14)-aryl-(C1-C4) – alkylcarbonyl, (C6-C14)-arylcarbonyl, (C1-C6)-alkyloxycarbonyl,

(C6-C14)-aryl-(C1-C4)- alkyloxycarbonyl and (C6-C14)-aryloxycarbonyl, where the aryl groups present in L are unsubstituted or substituted by one or more identical or different substituents R13, and where all groups L are independent of each other and can be identical or different;A is chosen from R3O- and R4R6N-;k is 1, 2, 3 or 4;

n is 0, 1, 2, 3 or 4;Ro is chosen from phenyl and monocyclic 6-membered heteroaryl containing one or two nitrogen atoms as ring heteroatoms, where the group Ro is unsubstituted or substituted by one or more identical or different groups R2;R1 is chosen from hydrogen, halogen, nitro, hydroxy, (C1-C6)-alkyloxy-, (C6-C14)-

aryl, (C1-C8)-alkyl, hydroxycarbonyl-(C1-C8)-alkylureido-, (C1-C8)-alkyloxycarbonyl-(C1-C8)-alkylureido-, (C1-C8)-alkylsulfonyl-and R11R12N-, where the groups R1 are independent of each other and can be identical or different, and where alkyl and aryl groups present in R1 are unsubstituted or substituted by one or more identical of different substituents R13,or two groups R1 bonded to adjacent ring carbon atoms together with the carbon atoms to which they are bonded form an aromatic ring condensed to the ring depicted in formula l, where the ring formed by the two groups R1 is unsubstituted or substituted by one or more identical or different substituents R13;R2 is chosen from halogen, nitro, (C1-C8)-alkyl, cyano, hydroxy, amino and (C1-C8)- alkyloxy-, where alkyl groups present in R2 are unsubstituted or substituted by one or more identical or different halogen atoms; R3, R4 and R5 are chosen from hydrogen, (C1-C12)-alkyl, (C6-C14)-aryl-(C1-C4)-alkyl-, (C6-C14)-aryl-, Het-and Het-(C1-C4)-alkyl, where R4 and R5 are independent of each other and can be identical or different, and where the groups alkyl, aryl and Het present in R3, R4 and R5 are


unsubstituted or substituted by one or more identical or different substituents R13, or R4

and R5 together with the nitrogen atom to which they are bonded form a saturated 3-membered to 8-membered monocyclic ring which in addition to the nitrogen atom carrying R4 and R5 can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen; R11 and R12 which are independent of each other and can be identical or different, are chosen from hydrogen, (C1-C8)-alkyl, (C6-C14)- (C1-C4)-alkyl, -Het-(C1-C4)-alkyl-, hydroxycarbonyl-(C1-C8)-alkyl-, (C1-C8)-alkyloycarbonyl-(C1-C8)-alkyl-, hydroxycarbonyl-(C1-C8)-alkyloxcarbonyl-(C1-C8)- alkylcarbonyl- and (C1-C8)-alkylcarbonyl-, where alkyl and aryl groups present in R11 and R12 are unsubstituted or substituted by one or more identical or different substituents R13,or R11 and R12 together with the nitrogen atom to which they are bonded form a

saturated or unsaturated 5-membered to 8-membered monocyclic heterocyclic ring which in addition to the nitrogen atom carrying R11 and R12 can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen, and in which one or two of the ring carbon atoms can be substituted by oxo to form C=O group(s); R13 is chosen from halogen, nitro, cyano, hydroxy, (C1-C8)-alkyl, (C1-C8)-alkyloxy, trifluoromethyl and amino; Het is a residue of a saturated, partially unsaturated or aromatic monocyclic or bicyclic, 3-membered to 10-membered heterocyclic ring system containing one, two, three or four identical or different heteroatoms chosen from nitrogen, oxygen and sulfur; in all their stereoisomeric forms and mixtures thereof in any ratio, and their physiologically tolerable salts.

__________

149324]21][11[

דיספרסיה של סימן לאיתור שיטהאופטיים תקשורת בקווי אופטית

TECHNIQUE FOR DETERMINING SIGN OF OPTICAL DISPERSION IN OPTICAL COMMUNICATION LINES

]54[

24.04.2002]22[Int. Cl.8 G02B 006/34]51[

]ECI TELECOM LTD.]71תקוה בע"מ, פתח אי.סי.איי. טלקוםבע"מ, אי. סי. איי. טלקום

תקוה , פתח30הסיבים רחוב ECI TELECOM LTD,

30 HASIVIM ST.PETACH TIKVA 49517

]74[

[57] A method for determining the sign of chromatic dispersion in an optical communication line suitable for transmitting an optical signal at a

predetermined optical wavelength, the method comprising steps of: introducing controlled changes of wavelength around said predetermined wavelength,


monitoring the optical signal that has passed said line, and obtaining a first signal reflecting changes of the carrier wavelength of said optical signal, a second signal reflecting changes of delay of the optical signal transmitted via said line,

comparing the first signal with the second signal, and determining the chromatic dispersion sign based on the phase difference between the compared first and second signals.

__________

149356]21][11[

המאפשרת תקשורת מערכת רשת להשתמש רשת ספקי של רב למספרמשותף רשת במבנה

DISTRIBUTED NETWORK COMMUNICATION SYSTEM WHICH ENABLES MULTIPLE NETWORK PROVIDERS TO USE A COMMON DISTRIBUTED NETWORK INFRASTRUCTURE

]54[

03.11.2000]22[US]33[03.11.1999]32[433818]31[US18.04.2000551291

Int. Cl.8 H04L 012/14, 012/28, 029/06, 029/12]51[WAYPORT, INC., U.S.A.]71[





TEL AVIV 61040

]74[

[57] A method for providing access to a network system, wherein the network system includes a plurality of access points coupled to a network, the method comprising: a first access point receiving identification information from a portable computing device, wherein the identification information indicates a

network provider of a plurality of possible network providers; determining the network provider for the portable computing device after receiving the identification information; the first access to the portable computing device through the network provider determined in said determining.


__________

149439]21][11[

יותר או אחת לבקרת ושיטה מערכת כיחידה כניסות מרובות בקרה יחידותאחת כניסות מרובת

SYSTEM AND METHOD FOR CONTROLLING ONE OR MORE MULTIPOINT CONTROL UNITS AS ONE MULTIPOINT CONTROL UNIT

]54[

08.11.2000]22[US]33[08.11.1999]32[60/164298]31[

Int. Cl.8 H04L 012/18, 029/06, H04N 007/00, 007/15]51[]POLYCOM ISRAEL LTD.]71תקווה בע"מ, פתח ישראל פוליקום



P.O.B. 12688 ,HERZLIYA 46733

]74[

[57] A method for multimedia communication, comprising the steps of:communicatively interconnecting a plurality of multimedia terminals to a plurality of corresponding multipoint control units, wherein each multimedia terminal is connectable to two or more of said plurality of multipoint control units; communicatively interconnecting the plurality of corresponding multipoint control units to a central control unit; identifying capability factors for each of the plurality of multimedia terminals and

each of the plurality of corresponding multipoint control units; responsive to a command to initiate a multimedia communication between at least two of the plurality of multimedia terminals, evaluating the capability factors for each of the at least two multimedia terminals;comparing the capability factors for each of the at least two multimedia terminals to the capability factors of the multipoint control units communicatively interconnected to the central control unit to determine an optimum assignment of


resources for a multimedia interconnection between the at least two participating multimedia terminals and responsive to the comparing of capability factors, the central control unit assigning the multimedia control unit to be used for the multimedia interconnection of the participating

multimedia terminals to one of said plurality of multimedia control units and directing a communicative interconnection between the at least two multimedia terminals via at least one of the plurality of multipoint control units.

__________

149538]21][11[

של הדדי אופטי לחיבור אפיק תצורתחישוב יחידות מספר

BUS CONFIGURATION FOR OPTICALLY INTERCONNECTING A PLURALITY OF CALCULATION UNITS

]54[

29.09.2000]22[


US]33[11.11.1999]32[09/438345]31[Int. Cl.8 G02B 006/28]51[INTEL CORPORATION, U.S.A.]71[





]74[

[57] A method for optically interconnecting a plurality of devices, comprising: splitting a first optical signal beam received from a first device; optically coupling a second device and a third device to receive the first optical signal beam; splitting a second optical signal beam received from the second device; optically coupling the first device and the third device to receive the second

optical signal beam; splitting a third optical signal beam received from the third device; optically coupling the first device and the second device to receive the third optical signal beam, and deflecting a portion of at least one of the first, second, and third optical signal beams directed from a first beam splitter back to the first beam splitter.

__________

149659]21][11[

SYSTEM FOR TRACKING Aכלי אחרי למעקב מערכתCRAFT

]54[

17.10.2001]22[FR]33[20.10.2000]32[00/13484]31[

Int. Cl.8 G01S 001/04, 005/14]51[THALES, FRANCE]71[WO/2002/033437]87[


רחובות


REHOVOT

]74[

[57] A system for tracking a craft from a monitoring station by means of signals transmitted by satellites of a positioning system and frequency-transposed and relayed by a transponder placed onboard the craft, said signals transmitted by the satellites of the positioning system each resulting from the modulation of a carrier by a spreading code, this craft tracking system comprising: onboard the craft, a transponder retransmitting the signals from the satellites of the positioning system

after an infradyne frequency transposition by means of a transposition carrier of higher frequency KFQ than F0 of the satellite signals, by associating a transposition driver FQ representative of the phase and frequency of the carrier used for the transposition KFQ, and at the monitoring station; a receiver responsive to the signals retransmitted by the transponder, with: a signal processing part incorporating a demodulation stage with a spreading code recovery loop nested within a carrier recovery loop each slaved


to its own error signal, the error signal of the code recovery loop being representative of the delay affecting, on reception, the spreading code of the signal undergoing demodulation and the error signal of the carrier recovery loop being representative of the frequency gap affecting, on reception, the carrier of the signal undergoing demodulation; a part for determining the frequency gap K∆F2, with respect to its preset value, of the transposition carrier used by the transponder, operating on the basis of the transposition driver received from the transponder; means for correcting the error signal of the carrier recovery loop, of the bias caused by the frequency gap ∆F2 determined by the part for determining frequency gap, and a part for signal utilization, extracting information regarding the position and the speed of the

craft from the error signals of the code recovery loop and of the carrier recovery loop of the processing part, the error signal of the carrier recovery loop being corrected beforehand of the frequency gap K∆F2 delivered by the frequency gap determining part, said craft tracking system being characterized in that it comprises: at the level of the monitoring station, means for interpreting the error signal of the carrier recovery loop, after correction of the bias caused by the frequency gap K∆F2 determined by the frequency gap determining part (40, 41) as a measurement representative of the Doppler effect caused, on the initial frequency F0 of the signal relayed by the transponder, by an approach speed corresponding to the sum of the craft/satellite Vos and craft/receiver VOR relative retreat speeds.

__________

149730]21][11[

מסוג וירטואלי מסך רקע עיצובVMEbusלפגמים עמיד

FAULT TOLERANT VIRTUAL VMEBUS BACKPLANE DESIGN

]54[

15.11.2000]22[US]33[18.11.1999]32[442702]31[

Int. Cl.8 G06F 011/20, 013/40]51[


HONEYWELL INC., U.S.A.]71[WO/2001/037102]87[


אביב



TEL AVIV 61040

]74[

[57] A fault tolerant virtual VMEbus backplane for computer systems, the apparatus comprising: at least two VMEbus backplanes, each VMEbus backplane comprising a power supply and

a fault detection apparatus; and at least two bridge modules, each bridge module comprising a switch for connecting and disconnecting each of said VMEbus backplanes.

__________

149738]21][11[

רוטור על להבים של צורה שינוירוחבי סאונד אולטרה באמצעות

TRANSVERSE ULTRASOUND PEENING OF BLADES ON A ROTOR

]54[

20.09.2001]22[FR]33[21.09.2000]32[00/12017]31[

Int. Cl.8 B24B 039/00]51[June 3, 2007 752 –התשס"ז בסיון י"ז

SNECMA MOTEURS, FRANCE]71[BENOIT JEAN HENRI BERTHELET, GERARD MICHEL ROLAND GUELDRY, CLAUDE MARCEL MONS, MARIE-CHRISTINE NTSAMA-ETOUNDI

]72[



, הרצליה12704



]74[

]57 [A method for ultrasonic peening of parts lying radially at a periphery of a wheel, comprising: setting the wheel in rotation about its geometric axis; creating a mist of microbeads in a fixed active chamber arranged to a side of said wheel, by a first vibrating surface arranged in a lower part of said active chamber, said active chamber comprising an opening

shaped to allow the parts to be put in and removed as the wheel rotates and being sized to accommodate at least three adjacent parts; wherein the wheel is rotated about said geometric axis which is substantially vertical, and the first vibrating surface is arranged under a path of the parts in the active chamber.

__________

149748]21][11[

3 ,1 – –ניטרוגואנידינים2 להכין שיטה– דימותמרים

METHOD FOR PRODUCTION OF 1,3 - DISUBSTITUTED 2-NITROGUANIDINES

]54[

08.12.2000]22[DE]33[21.12.1999]32[19961604.

3]31[


Int. Cl.8 C07D 213/36, 213/61, 277/28, 277/32, 307/14]51[BAYER AKTIENGESELLSCHAFT, GERMANY

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

]57 [A process for the preparation of a compound of the formula

wherein R1 is hydrogen or alkyl,R2 is hydrogen, alkyl, cycloalkyl or –CH2R3,R3 is alkenyl, alkinyl, or aryl or heteroaryl each of which is optionally substituted,

Het is an unsubstituted or substituted aromatic or non-aromatic, monocyclic or bicyclic heterocyclic radical, comprising the step of: reacting a compound of the formula

wherein R1, R2 and Het are as defined above, and R4 is alkyl, cycloalkyl, aryl, arylalkyl or heterocyclylalkyl, each of which may be unsubstituted or substituted,

with anhydrous hydrogen chloride or with one or more compounds which can generate hydrogen chloride in the presence or absence of a diluent.


__________149812]21][11[

טרנסדרמליות תרופתיות מערכותוייצורן משופרת יציבות בעלות

TRANSDERMAL THERAPEUTIC SYSTEMS HAVING IMPROVED STABILITY AND THEIR PRODUCTION

]54[

24.11.2000]22[DE]33[29.11.1999]32[19957401.

4]31[


DE04.11.200010054713.3Int. Cl.8 A61K 009/00, 009/70]51[LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY

]71[

WALTER MULLER]72[WO/2001/039753]87[



P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A transdermal therapeutic system (TTS) in which the formation of oxidative degradation products of at least one active substance present in this system and oxidizable by hydroperoxides is reduced during storage of the TTS, wherein the

sum of the peroxide numbers (PON) of the formulation constituents in contact with the active substance or substances in the proportionate weighting dictated by the formula for the TTS is not more than 20.

__________

149816]21][11[

מוזיקה תצוגת לתיאום ושיטה מערכתבתזמורת נגנים בין

SYSTEM AND METHOD FOR COORDINATING MUSIC DISPLAY AMONG PLAYERS IN AN ORCHESTRA

]54[

22.11.2000]22[US]33[23.11.1999]32[447916]31[

Int. Cl.8 G09B 015/00, 015/02]51[HARRY CONNICK, JR., U.S.A.]71[

WO/2001/039158]87[ושות', גבריאלי זליגסון

אביב , תל1426 , ת.ד. 31 רח' יבנה SELIGSOHN GABRIELI & CO,.

31 YAVNE ST.P.O.B. 1426

TEL AVIV 61013

]74[


]57 [In a network of computerized devices each containing programming for displaying music on a display device, the computerized devices being used by each of a plurality of players in an orchestra under direction of a conductor, a method for facilitating leading of the orchestra, the method comprising: registering an identity of an instrument in use by each player and the corresponding computerized device being used by the player; receiving at a computerized device in use by the conductor a change to a musical arrangement represented in a handwritten format, the conductor's format to electronic

music type format; allowing the conductor to select whether the change is to be sent to all players in the orchestra or only to one or more players using an instrument impacted by the change; if the conductor selects to send the change only to the player or players using an instrument impacted by the change, determining which instrument or instruments are impacted by the change and identifying the corresponding computerized device or devices registered for that instrument; allowing the conductor to select whether the change should be converted to electronic music type format before transmission to the one or more players; and transmitting the change to one or more players in accordance with the conductor's selections.

__________


149822]21][11[

MULTI-SERVER FILEשרתים ממספר קובץ הורדתDOWNLOAD

]54[

23.11.2000]22[US]33[24.11.1999]32[09/448179]31[

Int. Cl.8 G06F 011/00, 013/00]51[]SPEEDBIT LTD.]71בע"מ ספידביט

WO/2001/039002]87[עו"פ, בע"מ עמיתים אלפאפטנט

שמש , בית55 רח' ראובן ALPHAPATENT LTD,.

55 REUVEN ST,.BET-SHEMESH 99544

]74[

]57 [A method for downloading a file to a client, the method comprising the steps of:

)a (determining the presence of said file on each of a plurality of secondary servers;

)b (retrieving a plurality of portions of said file from any of said servers, wherein at

least a first of said portions is retrieved from a first on any of said servers and at least a second of said portions is retrieved from a second on any of said servers; and

)c (assembling said file at said client from said plurality of portions.

__________


149823]21][11[

METHODS AND APPARATUS FORמשרת קובץ להורדת והתקן שיטהDOWNLOADING A FILE FROM A SERVER

]54[

18.01.2001]22[US]33[19.01.2000]32[09/487338]31[

Int. Cl.8 G06F 011/00, 013/00]51[]SPEEDBIT LTD.]71בע"מ ספידביט

WO/2001/053953]87[עו"פ, בע"מ עמיתים אלפאפטנט

שמש , בית55 רח' ראובן ALPHAPATENT LTD,.

55 REUVEN ST,.BET-SHEMESH 99544

]74[

]57 [A method for downloading files, the method comprising the steps of: at a client:

)a (requesting a proxy server to initiate a first download of a file from a first server, said first server determined by said client to lack download resume capability and said proxy server possessing download resume capability; at said proxy server:

)b (initiating said first download of said file from said first server; and at said client:

)c (initiating at least a second download of at least a portion of said file from said proxy server, said portion not being downloaded to said client directly from said first server.


__________

149880]21][11[

ELECTRONIC PARKING METERאלקטרונית חניה מד מערכתSYSTEM

]54[

28.05.2002]22[US]33[30.05.2001]32[09/866919]31[

Int. Cl.8 G07C 001/30, G08G 001/14]51[INNOVAPARK, LLC, U.S.A.]71[


ירושלים



]74[

]57 [An electronic parking meter system comprising: an electronic parking meter (4, 6) for determining the time a parking space associated with the parking meter is occupied by a vehicle and receiving coins denoting desired parking time and indicating said time; an inductive loop vehicle detection sensor (8, 10) located to detect both the physical presence or absence of a vehicle in said parking space and emitting a respective signal indicative

thereof, a microprocessor controller (14) coupled to the sensor and the electronic parking meter for selectively controlling the electronic parking meter and the controller responsive to the sensor signal; the electronic parking meter indicating time provided upon payment with a vehicle occupying said space to obtain a fixed amount of time in accordance with the amount of payment, said electronic parking meter decrementing the indicated


time; said controller initializing said electronic parking meter to zero when the sensor signals the controller that a vehicle no longer occupies the parking space; said detection sensor includes a variable oscillator circuit oscillating at a base frequency and responsive to the inductance of the inductive loop for providing said signals to the microprocessor indicating the presence or absence of a vehicle in the parking space; said microprocessor controller including a crystal oscillator producing pulses and operating at approximately 50 times the base frequency of the variable oscillator circuit and initiating a 12.5 ms long charge to said variable oscillator circuit every 2.5 seconds for the purpose of measuring the operating frequency of said circuit while conserving power as needed for the practical application of the technology in

parking control; the presence or absence of a vehicle in the parking space causing a respective decrease or increase in the inductance of the inductive loop and a respective commensurate increase or decrease in the operating frequency and a respective decrease or increase in the period of the variable oscillator circuit, thereby decreasing or increasing the number of crystal oscillator pulses in each period of the variable oscillator circuit; said oscillator providing an output signal including said crystal oscillator pulses to said microprocessor controller, and said microprocessor controller superimposes the signals received from the variable oscillator circuit during each 12.5 ms time frame in which the variable oscillator circuit is charged with the crystal oscillator pulses to determine the presence or absence of a vehicle in the parking space.

__________

149898]21][11[

BUTT-ENDED BAG WITH Aבולט סגירה אלמנט בעלת שקיתBUCKLE-OVER CLOSING ELEMENT

]54[


20.10.2000]22[DE]33[30.11.1999]32[19957563.

0]31[

Int. Cl.8 B65D 075/00, 075/58]51[SPS VERPACKUNGS-SYSTEM GMBH, GERMANY

]71[





TEL AVIV 61040

]74[

]57 [Stand-up pouch (1) made of heat-sealable or weldable plastic foil for receiving liquid and/or paste-like substances, having two side walls (2, 3), which are joined to one another at their longitudinal edges, wherein disposed at the bottom stand-up pouch end between the bottom transverse edges (8, 9) is a foldable bottom part, which lies between the side wall and serves as a standing base (10) ,

and situated at the top stand-up pouch end between the side walls is a foldable top part, and having a discharge opening (12)

between the upper transverse edge (13, 20) of a first side wall and the associated top-part edge (21, 22), wherein a closure element (20) is inserted into the discharge opening, the stand-up pouch in the first side wall in a region below the closure element comprising a means (33) of

stabilizing and supporting the closure element in a forward-tilted position, wherein the means of stabilizing and supporting the closure element is formed by at least one embossing (33, 34).

__________

149984]21][11[


TIOTROPIUM-CONTAININGטיאוטרופיום המכילה לשאיפה אבקהINHALATION POWDER

]54[

28.09.2001]22[DE]33[12.10.2000]32[10050635.

6]31[

Int. Cl.8 A61K 009/00, 009/72, C07D 451/02]51[BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, GERMANY

]71[





TEL AVIV 61040

]74[

]57 [Inhalable powder containing 0.04 to 0.8% by weight of tiotropium in admixture with a physiologically acceptable excipient, characterized in that the excipient consists of a mixture of coarser excipient with an average particle size of

15 to 80 μm and finer excipient with an average particle size of 1 to 9 μm, the proportion of finer excipient constituting 3 to 15% by weight of the total amount of excipient.

__________

150159]21][11[

בפולשנות פגע ללא רקמה הנצלתמזערית

MINIMALLY INVASIVE INTACT RECOVERY OF TISSUE

]54[

01.09.2000]22[US]33[27.12.1999]32[09/472673]31[

Int. Cl.8 A61B 010/00]51[NEOTHERMIA CORPORATION, U.S.A.

]71[

WO/2001/047409]87[( בע"מ,1995) ג'י.אי.ארליך

בגין מנחם ,רחוב15 אילון, קומה מגדל גן , רמת11



]74[

]57 [Apparatus (10) for retrieving a tissue volume of predetermined peripheral extent, comprising a delivery cannula (12) having an outer surface surmounting an interior channel and extending from a proximal end portion along a longitudinal axis to a

forward region, having a distal end positionable in confronting adjacency with said tissue volume; a capture component positioned within said delivery cannula interior channel, having an expansible forward portion extending to a forwardly


disposed electrically conducting electrosurgical cutting leading edge portion and being extendible and expandable toward an outer peripheral dimension selected for the circumscriptive engagement of said tissue volume peripheral extent when moved along said longitudinal axis to egress from said delivery cannula; and a deployment assembly (18) extending within said interior channel, drivably coupled with

said capture component and actuable to effect said movement of said capture component along said longitudinal axis, and for effecting a subsequent contraction of said leading edge portion to provide closure of said capture component leading edge portion, and including a terminal assembly for simultaneously effecting the conduction of electrical energy to said leading edge portion.

__________

150173]21][11[

METHOD FOR PRODUCTION OF–פוספונומתילגליציןN להכנת שיטהN-PHOSPHONOMETHYLGLYCINE

]54[

22.12.2000]22[DE]33[23.12.1999]32[19962601.

4]31[

Int. Cl.8 C07F 009/00, 009/28, 009/38, 009/40, 009/50]51[BASF AKTIENGESELLSCHAFT, GERMANY

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

]57 [A process for the preparation of N-phosphonomethylglycine, wherein

)a (a hexahydrotriazine derivative of the formula


in which X is CN, COOZ, CONR1R2 or CH2OY,Y is H or a radical which is readily exchangeable for H,Z is H, an alkali metal, alkaline earth metal, C1-C18-alkyl or aryl, which is

unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl,R1 and R2 can be identical or different and are H or C1-C4-alkyl, is reacted with a triacyl phosphate of the formula

P(OCOR3)3

in which the radicals R3, which can be identical or different, are C1-C18-alkyl or aryl, which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, and

)b (the product obtained is hydrolyzed, and, if X is CH2OY, oxidized.Claimed as novel is the phosphono compound of the formula

in which the radicals R3, which can be identical or different, are C1-C18-alkyl or aryl which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, andX is CN, COOZ, CONR1R2 or CH2OY,Y is H or a radical which is readily exchangeable for H:

Z is H, and alkali metal, alkaline earth metal, C1-C18-alkyl or aryl, which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl;

R1 and R2, which can be identical or different, are H or C1-C4-alkyl, or a salt thereof.

__________


150177]21][11[

המגבירים הידרוקסיד משחררי אמצעיםהעור חדירות את

HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS

]54[

15.12.2000]22[US]33[16.12.1999]32[465098]31[US11.05.2000569889


US30.06.2000607892US14.12.2000738410US14.12.2000738395

Int. Cl.8 A61K 009/70, 047/02]51[DERMATRENDS, INC.]71[





TEL AVIV 61040

]74[

] 57 [Use of (a) a drug selected from the group consisting of amino acids, analgesic agents, anesthetic agents, anti-acne agents, antiarthritic agents, antiarrhythmic agents, antiasthmatic agents, antibiotic agents, anticancer agents, anticholinergic agents, anticonvulsant agents, antidepressant agents, antidiabetic agents, antidiarrheal agents, antifugal agents, antiglaucoma agents, antihelminthic agents, antihistamines, antihyperlipidemic agents, antihypertensive agents, antimigraine preparations, antinauseants, antineoplastic agents, antiparkinsonism drugs, antipruritic agents, antipsoriatic agents,antipsychotic agents, antipyretic agents, antispasmodic agents, antitubercular agents, antiulcer agents, antiviral agents, anxiolytic agents, appetite suppressants, attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) drugs, beta-blockers, calcium channel blockers, central nervous system stimulants, decongestants, diuretics, fatty acids, genetic materials, herbal remedies, hormonolytics, hypnotic agents, hypoglycemic agents, immunosuppressive agents, leukotriene inhibitors, mitotic inhibitors, muscle relaxants, narcotic antagonists, nicotine, parasympatholytic agents, peptide drugs, psychostimulants, sedatives, steroids, sympathomimetics,

tranquilizers, vasodilators, vitamins, and combinations thereof, wherein the drug is

)i (a basic drug in the form of a free base,)ii (an acidic drug in the form of a free

acid,)iii (an acidic drug in the form of a basic

addition salt, or)iv (a nonionizable compound; and

)b (an amount of an inorganic hydroxide effective to enhance the flux of the drug through the body surface without causing damage thereto, wherein the inorganic hydroxide is selected from the group consisting of monovalent metal hydroxides, divalent metal hydroxides, and ammonium hydroxide wherein the amount of inorganic hydroxide in the formulation applied to the body surface is the total of (a) the amount required to neutralize any acidic species in the formulation plus (b) an amount equal to 0.5 wt.% to 4.0% of the formulation;

for the preparation of a pharmaceutical formulation suitable for topical or transdermal drug administration for administering the drug to a localized region of a human patient's body surface for enhancing the flux of a drug through a body surface, and wherein following application to the body surface, the formulation provides a pH at the interface between the body surface and the


__________

150251]21][11[

SCREENING SYSTEM FORשינוע בתהליך פריטים בדיקת מערכתOBJECTS IN TRANSIT

]54[

16.06.2002]22[Int. Cl.8 B61J 001/02]51[

]SECURELOGIC LTD.]71בע"מ, נתניה ספייסלוג'יקצדק, וכהן איתן, פרל, לצר


P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [An automated security inspection and conveying system for in-transit objects, comprising means for identifying the sender of each object and to profile the security status data of said sender into said system, and a plurality of various cargo security screening machines in combination with conveying and storing components, to route and track said objects from a reception point through said screening machines to reach a storing junction, via a user-adjustable screening process, said conveying and storing components being interfaced with said

security status data for assigning a risk assessment factor to object of said sender, whereby each object is routed via an appropriate number of screening devices, the output of said screening devices being processed and said risk assessment factor being adjusted accordingly, the new risk assessment factor being sent to a control system of said conveying and storing components, whereby object is accordingly diverted to a track leading to a "reject" bay, or to a track for further screening of doubtful object, or to a loading track for objects cleared for transportation.

__________

150301]21][11[


METHOD AND SYSTEM FORלבלב מחלות של לבקרה ושיטה מערכתMONITORING PANCREATIC PATHOLOGIES

]54[

07.01.2001]22[US]33[06.01.2000]32[60/174663]31[

Int. Cl.8 A61B 005/04]51[ YEDA RESEARCH ANDבע"מ, רחובות ופיתוח למחקר חברה ידע

DEVELOPMENT CO. LTD.]71[

מרגלית, ליאור כהן, רענן דגני, ירון הדסהברוקר

HADASSA DEGANI, IRUN COHEN, RAANAN MARGALIT, LIOR BRUKER

]72[

WO/2001/049161]87[ושות', וב ד"ר

, רחובות2189 , ת.ד. 2 רח' פקריס WEBB & ASSOCIATES,

2 PEKERIS STREET P.O.B. 2189 REHOVOT 76121

]74[

]57 [A method for monitoring a pancreatic pathology in a patient comprising the steps of: obtaining a first magnetic resonance image of an internal body organ using defined sequence parameters; injecting a contrast agent to the patient; obtaining a plurality of subsequent contrast enhancement images of the internal body organ using the defined sequence parameters; creating an intensity curve, by plotting intensity over time, from the

plurality of subsequent contrast enhancement images, converting the intensity curve to an enhancement curve, said enhancement curve having a linear portion and a plateau portion; extracting an enhancement value at plateau from the enhancement curve; and comparing the enhancement value at plateau to a standard, thereby monitoring the pancreatic pathology in the patient.

__________

150306]21][11[

לטיפול ושיטות פרוסטגלנדין תרכובותגברית זיקפה באי–תפקוד

PROSTAGLANDIN COMPOSITIONS AND METHODS OF TREATMENT FOR MALE ERECTILE DYSFUNCTION

]54[

10.01.2001]22[US]33[10.01.2000]32[09/480738]31[

Int. Cl.8 A61K 031/5575, A61P 015/10, C07C 405/00]51[NEXMED HOLDINGS, INC., U.S.A.]71[




REHOVOT

]74[


]57 [Use of prostaglandin E1; a skin penetration enhancer which is a member of the group consisting of an alkyl-2-(N, N-disubstituted amino)-alkanoate, an (N, N-disubstituted amino)-alkanol alkanoate, pharmaceutically acceptable salts thereof and a mixture thereof; a polysaccharide gum or a polyacrylic acid polymer; a lipophilic compound which is a member of the group consisting of an aliphatic C1 to

C8 alcohol, an aliphatic C8 to C30 ester, and a mixture thereof; and an acidic buffer system for the preparation of a pharmaceutical composition for treating erectile dysfunction in a patient needing such treatment, whereby the pharmaceutical composition is to be supplied in the fossa navicularis of the patient.

__________

150403]21][11[

–4–2אלפא–) להכנת תהליך בוטילניטרון –טרט–Nדיסולפופניל(–

שלהם מקובלים רוקחות ומלחי

PROCESS FOR THE PREPARATION OF ALPHA-(2-4-DISULFOPHENYL)-N-TERT- BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

]54[

04.01.2001]22[SE]33[10.01.2000]32[0000055-4]31[

Int. Cl.8 C07C 303/02, 303/32, 309/46]51[ASTRAZENECA AB, SWEDENCENTAUR PHARMACEUTICALS,

]71[


INC., U.S.A.JORGEN BLIXT, HENRY KRUK, JOHN MCGINLEY, SERGEI POUHOV, JOHN VAJDA

]72[




]74[

]57 [A process for the preparation of a compound of the formula

wherein each R independently represents SO3H or a salt thereof, which process

involves reaction of an aldehyde of the formula

wherein R is as defined above, with N-tert-butylhydroxylammonium acetate in a liquid reaction solvent.

__________

150549]21][11[

בהזרקה להושטה רוקחות תכשירביפוספונאט המכיל

PHARMACEUTICAL PARENTERAL COMPOSITION CONTAINING A BIPHOSPHONATE

]54[

16.01.2001]22[EP]33[20.01.2000]32[00101044.

6]31[

Int. Cl.8 A61K 031/66, 031/675, A61P 019/00, C07F 009/00, 009/38, 009/572, 009/58, 009/6558

]51[

F. HOFFMANN-LA ROCHE AG, SWITZERLAND

]71[





]74[

]57 [A parenteral composition having pH from about 6 to about 8 comprising (1) a bisphosphonate, selected from the group consisting of

)a (N-methyl-4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid,

)b (4-(N,N-dimethylamino)-1-hydroxybutylidene-1,1-bis-phosphonic acid,

)c (3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid (pamidronate),

)d (3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-bisphosphonic acid (ibandronic acid),

)e (3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-bisphosphonic acid, monosodium salt, monohydrate (ibandronate),

)f (1-hydroxy-3-(N-methyl-N-pentylamino) propylidene-1,1-bisphosphonic acid,

)g (1-hydroxy-2-[3-pyridinyl] ethylidene-1,1-bisphosphonic acid (risedronate),

)h (4-(hydroxymethylene-1,1-bisphosphonic acid) piperidine,

)i (cycloheptylaminomethylene-1,1-

bisphosphonic acid (cimadronate),

)j (1,1-dichloromethylene-1,1-diphosphonic acid and the disodium salt (clodronate),

)k (1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonic acid (EB-1053),

)l (1-hydroxyethane-1,1-diphosphonic acid (etidronic acid),

)m (6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid (neridronate),

)n (3-(dimethylamino)-1-hydroxypropylidene-1,1-bisphosphonic acid (olpadronate),

)o] (2-(2-pyridinyl) ethylidene-[1,1-bisphosphonic acid (piridronate),

)p) (4-chlorophenyl (thiomethane-1,1-diphosponic acid (tiludronate),

)q (1-hydroxy-2-(1H-imidazol-1-yl) ethylidene-1,1-bisphosphonic acid (zolendronate),

)r)] (cycloheptylamino-(methylene-[bisphosphonic acid (icadronate), and

)s] (1-hydroxy-2-imidazo-(1,2-a) pyridine-3-ylethylidene-[bisphosphonic acid and

pharmaceutically acceptable salts thereof;)2 (a pharmaceutically acceptable

chelating agent selected from EDTA and DTPA and pharmaceutically acceptable salt thereof; and

)3 (a pharmaceutically acceptable excipient.

__________

150560]21][11[

תרכובות של פולימרים נושאים מצעים קשורות קואורדינציה סנדוויץ צמודות

בהן לשימוש ותהליכים

SUBSTRATES CARRYING POLYMERS OF LINKED SANDWICH COORDINATION COMPOUNDS AND METHODS OF USE THEREOF

]54[


05.01.2001]22[US]33[14.01.2000]32[09/483500]31[US28.06.200009/605587

Int. Cl.8 C08F 026/06, G11C 013/00]51[NORTH CAROLINA STATE UNIVERSITY, U.S.A.

]71[




TEL AVIV 61063

]74[

]57 [An apparatus for storing data, said apparatus comprising: a fixed electrode (103, 101) electrically coupled to a storage medium (102) having a plurality of different and distinguishable oxidation states wherein data is stored in said oxidation states by the addition or withdrawal of one or more electrons from said storage medium via the electrically

coupled electrode; said storage medium comprising a polymer; said polymer comprising a plurality of covalently joined monomeric units, each of said monomeric units comprising an independently selected sandwich coordination compound; and wherein said storage medium comprises a plurality of double-decker or triple-decker sandwich coordination compounds.

__________

150669]21][11[

תאי המכיל אלקטרוכימי בדיקה פסלשימושו ושיטות רבים תגובה

ELECTROCHEMICAL TEST STRIP HAVING A PLURALITY OF REACTION CHAMBERS AND METHODS FOR USING THE SAME

]54[

09.07.2002]22[Int. Cl.8 G01N 027/327]51[LIFESCAN, INC., U.S.A.]71[



רחובות


REHOVOT

]74[

]57 [An electrochemical test strip (20) comprising:

)a (a plurality of reaction zones (22) defined by opposing working and reference electrodes separated by a spacer layer, wherein each of said reaction zones is defined by a bore through said spacer layer and further wherein each of said

reaction zones has its own fluid ingress channel to provide for fluid communication between said reaction zones and the external environment of said test strip; and

)b (a reagent composition present in each of said reaction zones.

__________

150811]21][11[

נצנוץ מבני לשיוור ושיטה מערכת ממוחשבת הדמיה עבור גבישיים

טומוגרפית

SYSTEM AND METHOD OF ALIGNING SCINTILLATOR CRYSTALLINE STRUCTURES FOR COMPUTED TOMOGRAPHY IMAGING

]54[

18.12.2001]22[US]33[19.12.2000]32[09/681067]31[

Int. Cl.8 G01T 001/00]51[GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC,

]71[


U.S.A.WO/2002/050569]87[

ושות', גבריאלי זליגסוןאביב , תל1426 , ת.ד. 31 רח' יבנה

SELIGSOHN GABRIELI & CO,. 31 YAVNE ST.

P.O.B. 1426 TEL AVIV 61013

]74[

]57 [A method of CT imaging comprising the steps of: providing a plurality of scintillators forming a scintillator array wherein each scintillator comprises a plurality of crystallites; aligning the crystallites of each scintillator in a uniform direction to receive high frequency electromagnetic energy from a projection

source; directing high frequency electromagnetic energy toward the scintillator array; converting the high frequency electromagnetic energy to light energy; transmitting signals indicative of light energy intensity to a data acquisition system; and generating a CT image from the transmitted signals.

__________

150855]21][11[

INTRATUBULAR ANASTOMOSISתוך–טובולרי אנסטומוזה מתקןAPPARATUS

]54[

22.07.2002]22[Int. Cl.8 A61B 017/11]51[

NITI MEDICAL TECHNOLOGIESבע"מ, נתניה רפואיות טכנולוגיות ניטיLTD.

]71[

ספנסר, מיכאל מונסביץ, בנימין לאונידנאמן ערד, רונן

LEONID MONASSEVITCH, BENJAMIN SPENSER, MICHAEL ARAD, RONEN NE'EMAN

]72[

ושות' בע"מ, מ. בן-דוד ירמיהו ,45087, ת.ד. חוצבים המרפא, הר רחוב

ירושלים



JERUSALEM 91450

]74[

]57 [An intratubular anastomosis apparatus for joning organ portions of a hollow organ after intussusception thereof, said apparatus including:

)a (an anastomosis ring (50), and)b (a crimping support element (52) for use

therewith, wherein said anastomosis ring includes a length of a wire having a predetermined cross-sectional configuration and formed of a shape memory alloy defining a closed generally

circular shape, having a central opening, and having overlapping end portions, said anastomosis ring for crimping adjacent organ portions against said crimping support element so as to cause anastomosis therebetween, wherein said anastomosis ring and said shape memory alloy assume

)i (a plastic state, when at a first, lower temperature and

)ii (an elastic state, when reaching at least a second, higher temperature, thereby enabling said anastomosis ring to retain a


preselected configuration at the first, lower temperature, and an elastic crimping configuration upon reverting to the second, higher temperature; and wherein said crimping support element for intratubular insertion so as to provide a support for crimping said organ portions against said support element, said crimping support element having

)i (a generally cylindrical side-wall (54);)ii (proximal and distal end walls formed

generally transversely to said side-wall,

thereby to define therewith said crimping support element;

)iii (a generally axial aperture (60) for providing flow communication therethrough; and

)iv (attachment means for operationally engaging said crimping support element to a crimping applicator member so as to position said crimping support element adjacent to said anastomosis ring for facilitating crimping of preselected wall portions of a hollow organ therebetween.

__________

150880]21][11[

ממכשיר שידור לשינוי ושיטה מערכתגופית תוך לחישה

SYSTEM AND METHOD FOR CHANGING TRANSMISSION FROM AN IN VIVO SENSING DEVICE

]54[

23.07.2002]22[US]33[23.07.2001]32[60/306872]31[

Int. Cl.8 A61B 005/05]51[]GIVEN IMAGING LTD.]71בע"מ, יקנעם אימג'ינג גיוון


ARKADY GLUKHOVSKY, BARUCHארליך ארקדי, ברוך גלוקחובסקיERLICH

]72[

דין, עורכי עורכי לצר צדק כהן פרלונוטריונים, פטנטים

, ת.ד.5 , רח' שנקר1 גב-ים מרכז , הרצליה12704



]74[

]57 [A system for obtaining in vivo data, the system comprising: a swallowable capsule; and a receiving unit; said swallowable capsule comprising at least one in vivo sensor, or at least one signal transmitter and at least one power level

receiver to receive a command to adjust the power level of said at least one signal transmitter; and said receiving unit comprising at least one receiver and at least one power level transmitter.

__________

150888]21][11[

ידי על מזיקים חרקים לסילוק שיטהכימי אידוי

DEBUGGING METHOD OF EXPELLING HARMFUL INSECTS BY CHEMICAL VOLATILIZATION

]54[

30.01.2001]22[JP]33[13.04.2000]32[2000-

111596]31[

Int. Cl.8 A01N 025/18, 053/00, 061/00]51[FUMAKILLA LIMITED, JAPAN]71[WO/2001/078508]87[


אביב



TEL AVIV 61040

]74[

]57 [A method for repelling or expelling a harmful or noxious insect comprising:

)a (providing a pyrethroid chemical, said pyrethroid chemical having the following characteristics:

)i (a higher vapour pressure than d,d-T80-prallethrin, determined when the

pyrethroid chemical is heated at 60 to 250˚ C, the retention time of the pyrethroid chemical in minutes being 24.5 to 26.4; and

)ii (a higher debugging potency than transfuluthrin, determined when the pyrethroid chemical is spontaneously volatilized for 70 days in a room having a volume of 33m3, the pyrethroid chemical having an average KT50 in minutes of 7.92 to 10.86; and


)b (contacting the pyrethroid chemical with the harmful or noxious insect or a locus thereof.

__________

151000]21][11[

DEVICE FOR EXTRACTINGמרימונים מיץ שקיקי למיצוי התקןJUICE SACS FROM POMEGRANATES

]54[

31.07.2002]22[Int. Cl.8 A47J 019/02]51[

]ITZHAK GVILI]71גוילי, נתניה יצחקושותפיו, כהן ריינהולד




TEL AVIV 61040

]74[

]57 [A device for extracting juice sacs from at least a portion of a pomegranate, comprising:

)a (a mallet having a mallet arm and a mallet head;

)b (a driving mechanism operatively connected to the mallet configured to position the mallet at one or more positions and to swing the mallet when the mallet is positioned at each of the one or more positions.

__________

151011]21][11[


FOREIGN BODY RETRIEVALזר גוף לשליפת התקןDEVICE

]54[

02.02.2001]22[US]33[02.02.2000]32[09/496482]31[

Int. Cl.8 A61B 017/50]51[BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, U.S.A.

]71[



, הרצליה12704



]74[

]57 [A retrieval device comprising: a first catheter having a distal end, a proximal end, a lumen system configured to accept at least one wire such that the at least one wire may extend beyond either end of the first catheter, and an opening system through which a loop may be formed, the opening system positioned between the distal end and the proximal end, the lumen system having an opening separate from the opening system, the opening of the

lumen system configured to accept the at least one wire such that the at least one wire may extend beyond the distal end of the first catheter; and a wire having a distal end attached to the first catheter, and a proximal end; wherein the proximal end of the wire may be manipulated to cause a portion of the wire to form a loop external of the first catheter, the loop being capable of grasping foreign bodies within a patient.


__________

151182]21][11[

ותנורים עמיד–בחום חומרבו המשתמשים גבוהי–טמפרטורה

HEAT-RESISTANT MATERIAL BASED ON SILICIDES AND HIGH-TEMPERATURE HEATERS USING SAID MATERIAL

]54[

30.01.2001]22[RU]33[17.02.2000]32[200010364

9]31[

Int. Cl.8 C04B 035/505, C22C 029/02, H05B 003/14]51[INSTITUT FIZIKI TVERDOGO TELA ROSSIISKOI AKADEMII NAUK, RUSSIA

]71[

BORIS ABRAMOVICH GNESIN, PAVEL ARTEMOVICH GURZGIYANTS

]72[




TEL AVIV

]74[

]57 [A heat-resistant material comprising molybdenum and tungsten silicides Me5Si3

and MeSi2 and silicon carbide, characterized in that it comprises silicides in the form of solid solutions (Mo, W)5Si3,

(Mo, W)5Si3C and (Mo, W)Si2 with the following ratio of the components (in vol. %):

)Mo, W(5Si3 and/or (Mo, W)5Si3C 5-98,)Mo, W (Si2 2-95, the ratio of

molybdenum and tungsten in the total mass of the refractory metals in the heat-resistant material ranging within (in wt. %)Mo 2-90,W 10-98,the material comprising silicon carbide 0-

55 vol.%

__________

151212]21][11[

]FOAMED STARCH SHEET]54מוקצף עמילן גליון

14.02.2001]22[IT]33[15.02.2000]32[TO2000A000141]31[

Int. Cl.8 B32B 017/12, C08J 009/12, C08L 003/12]51[


NOVAMONT S.P.A., ITALY]71[WO/2001/060898]87[

לוצאטו, את לוצאטו , באר5352, ת.ד. תעשייה, עומר גן

שבע



]74[

]57 [A foamed article, in particular in the form of a foamed sheet useful as a partly-finished product adapted to be further processed into a finished article of manufacture, comprising destructured or complexed starch foamed as a continuous phase, having a density lying between 20 and 150 kg/m3, cell dimensions in a range

lying between 20 and 700 μm with a cell distribution such that at least 80% of them have, in the absence of stretching, a dimension lying between 20 and 400 μm, in which the material from which the foam is made has an intrinsic viscosity in DMSO at 30˚ lying between 1.5 and 0.3 dl/g.

__________

151314]21][11[

ותכנתן להכנתן מיצלות, שיטותאותן המכילים רוקחות ותכשירי

MICELLES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

]54[

20.02.2001]22[US]33[18.02.2000]32[60/183768]31[

Int. Cl.8 A61K 031/70, 038/00, A61P 043/00, C07D 407/12, C07F 009/00, 009/655, C07H 005/00, 019/00, 021/00

]51[

EISAI CO.,LTD., JAPAN]71[WO/2001/060382]87[


אביב


]74[



TEL AVIV 61040

]57 [A method for preparing at least one micelle comprising Compound (1), a pharmaceutically acceptable salt thereof, and/or a stereoisomer thereof, which method comprises: adding an amount of Compound (1), a pharmaceutically

acceptable salt thereof and/or a stereoisomer thereof to a first aqueous alkaline solution comprising at least one basic metal salt, at least one neutral salt, and a predetermined concentration of metal ion; wherein Compound (1) is:

thereby forming a second aqueous alkaline solution comprising at least one micelle having a preselected hydrodynamic diameter, wherein the at least one micelle

comprises Compound (1), a pharmaceutically acceptable salt thereof, and/or a stereoisomer thereof.

__________

151390]21][11[

סילאן, על המבוססים ציפויים הרכבי ושיטות מהם המופקים מצופים פריטיםבהם לשימוש

SILANE-BASED COATING COMPOSITIONS, COATED ARTICLES OBTAINED THEREFROM AND METHODS OF USING SAME

]54[

08.02.2001]22[US]33[28.02.2000]32[60/185354]31[US29.02.200060/185367US29.09.200060/236158

Int. Cl.8 C09D 183/06]51[ADSIL, LC, U.S.A.]71[

WO/2001/064804]87[


ושות', כהן שלמה ד"ראביב , תל11490 , ת.ד. 124 גבירול אבן

DR. SHLOMO COHEN & CO,. 124 IBN GABIROL ST,.

P.O.B. 11490 ,TEL AVIV 62038

]74[

]57 [An aqueous coating composition formed by admixing

)A (at least one silane of the formula

R1Si(OR2)3

wherein R1 is a C1-C6 alkyl group, a phenyl group or a functional group containing at least one of vinyl, acrylic, amino, mercapto, or vinyl chloride functional group; andR2 is a C1-C6 alkyl group;

)C (acid component comprising a member selected from the group consisting of water-soluble organic acids, H3BO3 and H3PO3; and

)D (water and further comprising a silane compound of the formula

X[R1Si(OR2)3]2

wherein R1 and R2 are as defined above, and X represents an amino group or keto group

O||

C >

__________

151586]21][11[

-PREPARATION OF 4,4'-DIKETO–קרוטןβ'–דיקטו–4,4 נגזרות הכנתΒ-CAROTENE DERIVATIVES

]54[

03.09.2002]22[US]33[13.09.2001]32[953007]31[

Int. Cl.8 C07C 403/24]51[DSM IP ASSETS B.V., THE NETHERLANDS

]71[


אביב



]74[


TEL AVIV 61040

]57 [A method of preparing 4,4'-diketo derivatives from β-carotene or β-carotene derivatives comprising contacting the β-carotene or β-carotene derivatives in an organic solvent with a solution of an oxidizing agent, wherein said oxidizing

agent is formed by mixing acidified aqueous solutions of the sodium or potassium salts of sulfite, hydrogen sulfite, or bisulfite solutions and sodium or potassium bromate solutions in water to produce 4,4'-diketo derivative products.

__________

151789]21][11[

CONTAINER FOR LINEZOLIDתוך–ורידית לינזוליד לתמיסת מיכלINTRAVENOUS SOLUTION

]54[

15.03.2001]22[US]33[22.03.2000]32[60/191383]31[

Int. Cl.8 A61J 001/00, A61L 002/16]51[PHARMACIA & UPJOHN COMPANY LLC, U.S.A.

]71[



P.O.B. 12688, HERZLIYA 46733

]74[

] 57 [A container containing an IV aqueous solution of a Gram-positive oxazolidinone agent, wherein the container

surface that contacts the solution is made of at least 50% polyolefin.



__________

151825]21][11[

OXYGEN REDUCED NIOBIUMחמצן מופחתות הניוביום תחמוצותOXIDES

]54[

22.03.2001]22[US]33[23.03.2000]32[09/533430]31[US01.09.200060/229668US11.01.200109/758705

Int. Cl.8 G01G 001/02, H01G 009/04]51[CABOT CORPORATION, U.S.A.]71[

WO/2001/071738]87[


ושות', גבריאלי זליגסוןאביב , תל1426 , ת.ד. 31 רח' יבנה

SELIGSOHN GABRIELI & CO,. 31 YAVNE ST.

P.O.B. 1426 TEL AVIV 61013

]74[

]57 [The method of forming an anode comprising the steps of pressing a mixture of niobium oxide powder with at least one binder or lubricant to form the pressed

anode, wherein the niobium oxide has an atomic ratio of niobium to oxygen of 1:less than 2.5.

__________

151953]21][11[

ACCESSORY MOUNT FOR Aנשק כלי עבור אביזרים מחברFIREARM

]54[

26.09.2002]22[Int. Cl.8 F41A 029/00]51[

]T.D.I. ARMS SYSTEMS LTD.]71בע"מ, יבנה נשק טי.די.אי. מערכותושות', בלום, גדור עו"ד גדור דבורה

, גבעתיים23 , קומה53 השלום דרך DEBORAH GADOR, BLUM,

GADOR & CO,. 53 DERECH HASHALOM

23 RD FLOORGIVATAYIM 53454

]74[

]57 [An accessory mount for a hand held firearm having a barrel and a mounting rail coupled beneath the barrel, the accessory mount comprising: a frame, defining a substantially flattened bottom surface, and a track for mounting along the mounting

rail, the frame having a cavity for receiving a light, and a bipod mount coupled adjacent the track and behind the light cavity and arranged to hold a bipod having legs which can be folded substantially adjacent the barrel.


__________

152305]21][11[

ושיטה מחוזק רב–שכבתי אריגלהכנתו

REINFORCED MULTILAYER FABRIC AND METHOD OF PREPARATION

]54[

12.04.2001]22[IT]33[17.04.2000]32[MI2000A000860]31[

Int. Cl.8 B32B 005/08, D04H 003/04, F41H 005/04]51[F. LLI CITTERIO S.P.A., ITALY]71[WO/2001/078975]87[


שבע



]74[

]57 [A finished reinforced multilayer fabric (18), comprising at least a first layer (12) of threads (13) parallel with each other, superimposed on at least one second layer (12) of threads also parallel with each other, the threads of said first layer being set in various directions as regards the threads of the second layer; a binding layer (14) interposed between said first and second layer to keep said layers together

and to prevent one layer sliding over the other, wherein the binding layer impregnates only a portion of a single thread which is placed on the upper layer and next to each thread of the lower layer, the remaining portion of said threads are made up of fibrils which are impregnated with a resin matrix which keeps said fibrils firmly together.

__________


152333]21][11[

]COATING COMPOSITION]54לציפוי תכשיר

20.04.2001]22[AU]33[20.04.2000]32[PQ7079]31[

Int. Cl.8 C09D 005/00, 007/12]51[WORLDWIDE THERMAL MANAGEMENT IP PTY LTD., AUSTRALIAWORLDWIDE FIRE RETARDANT IP PTY LTD., AUSTRALIAWORLDWIDE COATINGS IP PTY LTD, AUSTRALIA

]71[



P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A coating composition comprising)i (a supporting medium, and

)ii (a plurality of cellulose particles, having an average dry particle size of less than 10

μm, dispersed in the supporting medium in an amount of less than about 10 g/L, excluding aqueous coating compositions adapted for application to paper.

__________

152972]21][11[

]FULL-CALIBER PROJECTILE]54מלא קוטר בעל קליע

20.11.2002]22[DE]33[23.11.2001]32[10157563.

7]31[

Int. Cl.8 F42B 014/00]51[RHEINMETALL W & M GMBH, GERMANY

]71[



P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A full-caliber projectile (1) comprising: a projectile body having a cylindrical guide region (5) and an ogival

projectile tip (7), connected to a front end of the guide region; a cylindrical guide ring (8), which is divided at its


circumference into at least two shell-like guide-ring segments (9), mounted on an outer surface of the projectile tip, with an outer diameter of the ring being smaller than an inner diameter of a gun barrel (2) of the same caliber as the projectile; and means (10) securing the guide ring to the outer surface of the projectile tip such that the guide-ring segments detach from the

projectile and move rapidly outwardly when a predetermined firing acceleration is attained in the corresponding gun barrel, so that the guide-ring segments are pushed rearwardly toward the cylindrical guide region of the projectile in an axial direction until the guide ring segments rest against the inside wall of the gun barrel and against the projectile.

__________

153136]21][11[

]PIPE REPAIR CLAMP]54צינורות תיקון חבק

27.11.2002]22[Int. Cl.8 F16L 021/06]51[

KRAUSZ METAL INDUSTRIESאביב בע"מ, תל מתכת תעשיות קראוסLTD.

]71[

ELIEZER KRAUSZ, AVIצ'יפרוט קראוס, אבי אליעזרCHIPROOT

]72[



P.O.B. 12688 ,HERZLIYA 46733

]74[


]57 [A wide-range pipe repair clamp (10) for temporary or permanent repair of pipes (12, 12') comprising:

)a (a metal clamping band (14) to surround said pipe, said band being extended at both ends to form a hollow shape (16) including a flat base (18), a wedge-shaped section (20) and a convex rounded section (22), elongated apertures (24) being provided to allow passage for screw fasteners (26) through said hollow shape, narrow edges of said wedge-shaped sections being in contact with each other to form a substantially triangularly shaped space (28) between said formed ends;

)b (a flexible inner sealing sleeve (30) disposed inside said clamping band;

)c (a pair of profile strips (32) each having a major face for contacting the outer

surface of said convex rounded section, and an opposite seating face for shoulder support of a plurality of screw fasteners, said strips having apertures (40) to allow passage of said fasteners, said profile strips sliding over said convex rounded section when said fasteners are tightened or loosened to maintain said seating face perpendicular to the axes of said fasteners; and

)d (said plurality of screw fasteners inserted into said apertures wherein the tightening of said screw fasteners reduces the size of said triangularly shaped space and tightens said metal clamping band to compress said flexible inner sleeve sealingly against the outer diameter of said pipes.

__________

153892]21][11[

KIT FOR MOISTURIZING THEהעין שטח פני של הליחלוח עבור ערכהSURFACE OF THE EYE

]54[

06.07.2001]22[US]33[12.07.2000]32[09/614790]31[US30.03.200109/823385


Int. Cl.8 A61K 009/00, A61P 027/02, C07D 311/00]51[ROGUE VALLEY NATURAL SPRINGS, INC., U.S.A.

]71[




TEL AVIV 61063

]74[

]57 [A kit for moisturizing the surface of the eye comprising a sealed container, an aqueous fluid within said container, and an

actuator that sprays a mist of said fluid from said container.

__________

154133]21][11[

COMPRESSOR COOLER AND ITSהרכבתו ותהליך מדחס מקררASSEMBLY PROCEDURE

]54[

26.01.2003]22[NL]33[29.01.2002]32[1019858]31[

Int. Cl.8 F04B 017/04]51[THALES NEDERLAND B.V., THE NETHERLANDS

]71[


רחובות


REHOVOT

]74[

]57 [Assembly procedure of a cooler compressor comprising the following steps:

coating at least one piston with a material; placing each piston in a cylinder; and raising the temperature to a predetermined

temperature so that the coated piston expands to occupy substantially all the cylinder; wherein each piston is fixed in the cylinder in this position until the temperature returns to ambient temperature.


__________

154303]21][11[

סוספנסיה תרכיז להכנת רציף תהליך תכשיר בצורת עשבים קוטלת מימית

יציב

CONTINUOUS PROCESS FOR THE PREPARATION OF A STABLE HERBICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITION

]54[

24.08.2001]22[US]33[25.08.2000]32[60/228316]31[

Int. Cl.8 A01N 025/04, 033/18]51[BASF AKTIENGESELLSCHAFT, GERMANY

]71[





TEL AVIV 61040

]74[


]57 [A process for the preparation of a stable aqueous suspension concentrate composition which comprises mixing a molten pendimethalin stream having a temperature of about 57˚ to 75˚C with an

aqueous stream containing coformulants plus seed crystals of orange pendimethalin, said aqueous stream having a temperature of about -3˚C to 5˚C.

__________

154360]21][11[

גז התרחבות אנרגיות של לשימוש שיטהזו שיטה לממש כח במתקן ושימוש

METHOD FOR UTILIZATION OF GAS EXPANSION ENERGY AND UTILIZATION OF POWER INSTALLATION FOR IMPLEMENTATION OF THIS METHOD

]54[

15.08.2001]22[RU]33[16.08.2000]32[200012136

1]31[

Int. Cl.8 F02C 001/02, F25B 011/02]51[ALLA PAVLOVNA TUZOVA, RUSSIA

]71[

VLADIMIR YAROSLAVOVICH VASILEV, OLEG MICHAILOVICH KISELEV

]72[




TEL AVIV

]74[

]57 [Method of utilization of the natural gas expansion energy during the process of reduction of gas pressure from high to the required one by conversion of natural gas expansion energy to mechanical energy with the aid of the gas cooled down in the process of pressure reduction as a cooling

agent characterized in that natural gas pressure is reduced in two or more successive stages (1, 2) simultaneously, wherein at least a part of natural gas after the first and/or each successive stage of natural gas pressure drop is used as a cooling agent for generation of cold.


__________

154569]21][11[

טורבינת למערכת אוויר לסינון שיטותגז

METHODS FOR FILTERING AIR FOR A GAS TURBINE SYSTEM

]54[

10.08.2001]22[US]33[05.09.2000]32[60/230138]31[US31.05.200109/871169

Int. Cl.8 B01D 039/16, 046/24, 046/52]51[DONALDSON COMPANY, INC., U.S.A.

]71[




]74[

]57 [A filter structure for filtering air in a gas turbine intake system, the turbine operating at an intake air demand greater than 8000 cu.ft./min. the intake air having an ambient temperature and a humidity of at least 50% RH, the structure comprising, in an air intake of a gas turbine system, at least one filter element (242), the filter element having a media pack (260, 262) forming a tubular construction defining a open filter interior (268, 276), the open filter interior being a clean air plenum, the

media pack including a pleated construction of a media composite, the media composite including a substrate at least partially covered by a layer of fine fibers, the fine fibers comprising a polymeric composition comprising an addition polymer or a condensation polymer other than a copolymer formed from a cyclic lactam and a C6-10 diamine monomer or a C6-10 diacid monomer combined with an additive material.


__________

154570]21][11[

שכבות יותר או שתיים בעל מסנן מבנה שימושי חיים אורך בעל עדין סיב של

משופר

FILTER STRUCTURE WITH TWO OR MORE LAYERS OF FINE FIBER HAVING EXTENDED USEFUL SERVICE LIFE

]54[

21.08.2001]22[US]33[05.09.2000]32[60/230138]31[US31.05.200109/871156

Int. Cl.8 B01D 039/00, 046/12]51[DONALDSON COMPANY, INC., U.S.A.

]71[




]74[

]57 [A fine filter media comprising a single layer of filter substrate, the substrate having a first surface and a second surface,

the substrate having a permeability of about 0.03 to 15 m/sec and an efficiency greater than 10%, the first surface and the second surface each comprising a layer of fine fiber having a diameter of about 0.001

to 0.5 microns, the layer of fine fiber having a thickness of less than 5 microns, the layer of fine fiber formed in an amount effective to obtain a pore size of about 0.0001 to 5 microns, an overall efficiency under ASTM-1215-89 with monodisperse 0.78 micron polystyrene latex particles at 6.1 m/min velocity of about 50% to 90% in any one layer and to obtain an efficiency


of greater than 90% in the layers combined.

__________

154653]21][11[

מפולימרים סטריליים פריטים הכנת פולי על המבוסס מייצב המכילים

)אוקסיאלקילין(

PREPARATION OF STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE)

]54[

30.08.2001]22[US]33[01.09.2000]32[09/654359]31[

Int. Cl.8 A61L 002/14, C08K 005/12]51[OCCIDENTAL CHEMICAL CORPORATION, U.S.A.

]71[




REHOVOT

]74[

]57 [A method of preparing a sterile article comprising:

)A (preparing a polymer having a halogen-containing repeating unit, where said polymer contains about 0.005 to about 65 phr (as defined in the specification) of a stabilizer having the general formula TGOT', where each T is independently selected from R-, R-CO-, -P(OR)2, -Si(OR)3 or –Si(OR)3, T' is T or A[GOT]n, each A is independently selected from LS-Sn(R)3-q(SLJ)q, L-O-Sn(R)3-q (OLJ)q, (CH2)pS-Sn(R)3-q(S(CH2)p-J)q, LCO2SN(R)3-q(OLCO-J)q, or LSn(Y)3-

q(LJ)q when n is 0, from CO, E ,

CO-E-CO, Si(R)2, Si(OR)2, (Si(R)2G)r, (CO-E-CO-G)r, or (E-G)r when n is 1, and from P, PO, and trimellitate when n is 2, Y

is –SLJ, -SLOR, -OLJ, -OLR, -S(CH2)p-J, -S(CH2)pR, OLCO-J, or OLCOOR, G is (O-CH2-R'CH)n, J is O-(CH2CR'HO)T, L is CO(CH2)p, each R is independently selected from R', aralkyl from C6 to C12, and alkaryl from C6 to C12 each R' is independently selected from hydrogen, alkyl from C1 to C12 and aryl from C6 to C12, E is alkylene from C1 to C12, aralkylene from C6 to C12, alkarylene from C6 to C12, arylene from C6 to C12, m is 1 to

20 ,n is 0 to 2, p is 0 to 10, q is 0 to 3 and r is 1 to 20;

)B (making said article from said polymer; and

)C (sterilizing said article with ionizing radiation.


__________

154957]21][11[

אטומים למצנחים גמישה חיבור מערכתאחרים בטיחות ומתקני מהסביבה

FLEXIBLE LINKAGE SYSTEM FOR ENVIRONMENTALLY SEALED PARACHUTES AND OTHER SAFETY DEVICES

]54[


21.09.2001]22[US]33[22.09.2000]32[09/667678]31[

Int. Cl.8 B64D 017/40]51[SIMULA, INC., U.S.A.]71[




REHOVOT

]74[

]57 [A flexible linkage system for removably connecting an environmentally sealed apparatus (40) to an external apparatus, said flexible linkage system comprising:

)a (a flexible internal link (10) attachable at a first end to the environmentally sealed apparatus, said flexible internal link comprising an internal loop at a second end; and

)b (a flexible external link (20) comprising an external loop (23) at a third end and a removable fastener (24) anchored to a mid-section of the external link, wherein said flexible external link is attachable to the external apparatus at a fourth end, and wherein the external loop is routed through the internal loop and removably connected to the removable fastener.

__________

155006]21][11[

יעילות בעלי פולימריים הרכביםלאופרוליד למתן משופרת

POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY

]54[

21.09.2001]22[June 3, 2007797 –התשס"ז בסיון י"ז

US]33[21.09.2000]32[09/666174]31[US13.11.200009/711758

Int. Cl.8 A61K 009/00, 038/09, 047/34]51[QLT USA, INC., U.S.A.]71[





TEL AVIV 61040

]74[

]57 [A flowable composition suitable for use as a controlled release implant, the composition comprising: (a) a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid; (b) a biocompatible polar aprotic solvent

selected from the group consisting of an amide, an ester, a carbonate, a ketone, an ether, and a sulfonyl; wherein the biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid; and (c) leuprolide acetate.

__________

155138]21][11[

GEL TRAP FORאלקטרופורזיס עבור ג'ל מלכודתELECTROPHORESIS

]54[

29.10.2001]22[IL]33[02.11.2000]32[139446]31[IL02.11.2000139447

Int. Cl.8 G01N 027/447]51[]GENE BIO-APPLICATION LTD.]71בע"מ בביולוגיה יישומים גן




]74[

]57 [Apparatus for electrophoresis comprising a suitable housing (100) accommodating a first gel matrix (38) adapted for performing an electrophoretic process on at least one sample of interest therein in a first direction, characterized in comprising at least a first trap (90) comprising a second gel matrix (48) having at least one suitable absorption material capable of trapping and retaining

therein at least one target substance migrating thereto from the first gel matrix in an opposite direction to said first direction when an electrophoretic process is performed in said first matrix in said first direction, wherein said first gel matrix is in ionic communication with said second gel matrix, and wherein said target substance is different from said at least one sample of interest.


__________

155357]21][11[

]LOADING MEMBER]54העמסה יחידת

13.11.2001]22[DK]33[13.11.2000]32[PA200001694]31[

Int. Cl.8 B65D 019/40, 071/00, B65G 001/00]51[INTER IKEA SYSTEMS B.V., THE NETHERLANDS

]71[





]74[

]57 [A loading member (7), which is adapted to be handled by a fork lift truck, which further has a substantially L-shaped cross section and which jointly with a corresponding loading member may be arranged at the bottom of a box (3), each member being provided at one of two respective parallel lower edges (3a, 3b) of

the box and retained in close abutment with the box by means of circumferential straps (5) or packaging film, whereby the members may form the feet of the box, one web (2) of the L-section being provided with at least two pressed hollow projections (7', 7'', 7''') on the surface intended to face a supporting surface of the


loading member, characterized in that the two outermost of these projections (7', 7''), which are arranged in one row, have an interspacing of at least half the length of the member and a width being less than or equal to half the width of the web and

further that the projections substantially abut the edge (4), at which the web (2, 6) of the L-section converge, and that the interspacing between the projections is such as to allow the insertion therebetween of forks of a fork-lift truck.

__________

155372]21][11[

מידע לרכישת פריפריאלי מכשיר להכנת אישי, במיוחד ביומטריומזהים מסמכים

PERIPHERAL DEVICE FOR ACQUIRING BIOMETRIC AND PERSONAL DATA, PARTICULARLY FOR PREPARING RECOGNITION DOCUMENTS

]54[

11.10.2001]22[IT]33[16.10.2000]32[RM2000A000549]31[IT29.01.2001RM2001U000012

Int. Cl.8 G07C 009/00]51[ITALDATA INGEGNERIA DELL'IDEA S.P.A., ITALY

]71[


, באר5352, ת.ד. תעשייה, עומר גן שבע



]74[

]57 [Peripheral device for acquiring biomertric and personal data, which, in particular, acts as an interface device with a main computer for the preparation of recognition documents such as identity cards, comprising, in a single casing: a smart card reader/writer device (20); a first

video camera (3) for the live photography of a person requesting the document; an external lighting unit (63) adjacent to the first video camera; a second video camera (4), acting as a scanner, located inside the casing, for the acquisition of personal characteristics shown on a backing card for


video digitization, which can be inserted into a guide and support frame in front of the second camera, through an entry slot formed in the casing; an internal lighting unit (69) adjacent to the second video camera, for illuminating the backing card; a video source switch (65), for switching the signals from the first video camera and the second video camera; a power supply unit (60) operated by a switch (61) and

connected to a distributor of power (6) to the first and second video cameras; one USB data connector (1) for the connection to the main computer; characterized in that: said video source switch receives signals from said first video camera and said second video camera, said signals are sent to said USB data connector through a video digitizer (7).

__________

155408]21][11[

DUAL-STAGE FILTRATIONדו–שלבית סינון מחסניתCARTRIDGE

]54[

30.10.2001]22[US]33[30.10.2000]32[60/244317]31[US02.01.200160/259889

Int. Cl.8 A61M 001/34, B01D 061/14, 063/00]51[NEPHROS, INC., U.S.A.]71[




REHOVOT

]74[

]57 [In a blood dialysis system including a source of substitution fluid and a blood

dialysis machine, a hemodiafiltration cartridge (10) comprising: a housing (12) including a blood inlet (20) which receives blood, a blood outlet (60) which discharges


diafiltered blood, a dialysate inlet (12) for receiving a dialysate fluid and a dialysate outlet (64) for discharging the dialysate fluid, the housing further including a plurality of semi-permeable filtering elements; a member for dividing the housing into a first hemodiafiltration stage (14) and a second hemodiafiltration stage (16) a first portion of the plurality of semi-permeable filtering elements being associated with the first stage and a second portion of the plurality of semi-permeable filtering elements being associated with the second stage, the blood inlet being in fluid communication only with the first stage, while the blood outlet is in fluid communication only with the second stage;

and an inter-stage section for providing fluid communication between the first and second stages, the inter-stage section including an inlet for receiving a substitution fluid, wherein blood entering the blood inlet is partially diafiltered as it flows within the semi-permeable filtering elements of the first stage before being discharged into the inter-stage section where it is mixed with substitution fluid to form a blood/substitution mixture which then flows within the semi-permeable filtering elements of the second stage where further diafiltration occurs, wherein the housing includes only one dialysate fluid compartment that is common to both the first and second stages.

__________

155700]21][11[

]CONTAINER AND CONTAINER ]54למיכל ואביזר מיכלJune 3, 2007 802 –התשס"ז בסיון י"ז

ACCESSORY

21.11.2001]22[GB]33[06.12.2000]32[0029752.3]31[GB10.08.20010119484.4GB28.08.20010120767.9

Int. Cl.8 B65D 023/08, 077/04]51[ELI LILLY AND COMPANY, U.S.A.]71[




]74[

]57 [A protective container (1) for housing a fragile article (100) comprising: a container portion (3) and a base portion (5), said container portion comprising: an upper end, a lower end, and a generally cylindrical side surface extending lengthwise along a longitudinal axis from said upper end to said lower end, said cylindrical side surface forming a cavity therein for housing the fragile article, wherein said cylindrical side surface comprises an inner wall surface and an outer wall surface, said inner wall surface comprising a configuration of inner wall ribs and inner wall depressions, said outer wall surface comprising a configuration of

outer wall ribs (37) and outer wall depressions (39), wherein said outer wall depressions correspond with said inner wall ribs and said outer wall ribs correspond with said inner wall depressions, and wherein said container portion further comprises an upper end collar (45) and a lower end collar (47), both extending laterally beyond the outer wall ribs; wherein each collar is adapted to absorb impact energy in the event of an impact thereon to protect the fragile article from breakage; and wherein said base portion is releasably securable to said container portion.


__________

155711]21][11[

תרתיל של ופליטה להוצאה מכשירירי מכלי כדור של

DEVICE FOR EXTRACTING AND EJECTING A CARTRIDGE CASE AWAY FROM A FIREARM

]54[

01.05.2003]22[IT]33[13.05.2002]32[MI2002A001016]31[

Int. Cl.8 F41A 015/12]51[FABBRICA D'ARMI PIETRO BERETTA S.P.A., ITALY

]71[


שבע



]74[

]57 [Device for extracting and ejecting a cartridge case in a firearm applied to a breechblock equipped with windows (17) on opposite sides, characterized in that it comprises an extraction element (19), equipped with an engagement means (28) suitable for holding a cartridge case (15), and an ejector element (20), equipped with a thrusting plane (33) suitable for taking

away said cartridge case from the firearm through one of said windows, as well as in that it comprises a removable retainer element (27) of said extraction and ejector element, said extraction and ejector elements being housed equally effectively on opposite sides of a breechblock (12) in seats (18).


_________

156103]21][11[

VALVE MECHANISM FORנוזלים עירוי למערכות שסתום מנגנוןINFUSION FLUID SYSTEMS

]54[

07.12.2001]22[US]33[08.12.2000]32[60/254230]31[

Int. Cl.8 A61L 002/24, B01D 012/00, 017/12, 061/24]51[NEPHROS, INC., U.S.A.]71[




REHOVOT

]74[

]57 [A method of ensuring sterility and preventing contamination of a first fluid delivered through a first conduit (90) from a supply source that contains fresh, unused fluid to a point of use, wherein the first fluid is filtered before the point of use to produce sterile first fluid, the method comprising: disposing valve mechanism (110) along the first conduit, the valve mechanism being positionable between an open position in which the first fluid flows through the first conduit to the point of use and a closed position in which the first fluid is prevented from flowing through the valve mechanism to the point of use; sensing a first flow pressure of the fresh, unused first fluid in the first conduit at a location upstream of the valve mechanism; combining the first fluid with a second fluid to form a third fluid at a location

downstream of the valve mechanism; opening the valve mechanism when the first flow pressure exceeds a reference flow pressure by a predetermined value; and closing the valve mechanism under a preselected condition to prevent the first fluid from flowing to the point of use, the closing of the valve mechanism also preventing retrograde flow of the second and third fluids from the point of use to a location upstream of the valve mechanism, thereby ensuring that the first fluid is sterile and substantially free of contamination, wherein the fluid in the first conduit is divided into a first stream that delivers fresh, unused first fluid to a location where the first fluid is filtered and a second stream that delivers the first fluid directly to the point of use and the valve mechanism is disposed along the first


stream of the first conduit between a location where the first fluid is filtered and the point of use of the sterile first fluid such that the valve mechanism acts on and

controls flow of the sterile first fluid in the first conduit downstream of the location where the first fluid is filtered.

__________

156952]21][11[

FOLDABLE PUSHCHAIR FORתינוקות עבור מתקפלת טיול עגלתBABIES

]54[

16.07.2003]22[ES]33[10.09.2002]32[20020218

9]31[

Int. Cl.8 B62B 007/06]51[JANE, S.A., SPAIN]71[



P.O.B. 6451 TEL AVIV 61063

]74[


]57 [A foldable pushchair for babies comprising: a central front wheel (1) being a castoring wheel, and a footrest (5) being formed by a plate, wherein said footrest is linked by a pin-jointed connection to a lower portion of converging front legs (3, 4) by a cross pin (8), said footrest comprising: a rearward portion of said footrest defining two recesses (6), the front legs being fitted to said recesses by the

cross-pin, an extension (9) provided with a cylindrical bore at a forward portion of said footrest to fit a fork (12) to which the castoring wheel is fitted, and means (15) for locking the footrest in a position when in use and allowing for folding said footrest, said means being gripped to a plate (26) being fixed to the lower portion of the front legs.

__________

157258]21][11[

METHOD FOR REMOVING Aממעטפתו כבל מרכז להסרת שיטהCABLE CORE FROM A CABLE SHEATH

]54[

20.02.2002]22[AT]33[20.02.2001]32[PCT/AT01/00041]31[AT28.06.2001A 1010/2001

Int. Cl.8 H01B 015/00, H02G 001/08]51[ALOIS PICHLER, AUSTRIA]71[WO/2002/067397]87[


אביב


P.O.B. 4060 ,TEL AVIV 61040

]74[

]57 [A method for removing a cable core from a cable sheath of a cable, which cable core comprises an envelope, wherein, at an end of the cable – the so-called proximal

cable end – a flowable medium is introduced under pressure into the cable tube so as to reduce friction,and a tensile


force is exerted on the cable core at an end of the cable, characterized in that the flowable medium is introduced precisely

targeted into an annular space between the inner side of the cable sheath and the envelope of the cable core.

__________

157290]21][11[

CHEMICAL MECHANICALפנים שטח וגימור מכני כימי עיבודMACHINING AND SURFACE FINISHING

]54[

07.02.2002]22[US]33[08.02.2001]32[60/267756]31[

Int. Cl.8 B24B 037/04]51[REM TECHNOLOGIES, INC., U.S.A.]71[



P.O.B. 12688 ,HERZLIYA 46733

]74[

]57 [A process comprising:)a (providing a tool;

)b (introducing an active chemistry onto a workpiece, the active chemistry being capable of reacting with the workpiece to form a conversion coating on the workpiece, the conversion coating being insoluble in the active chemistry such that the conversion coating protects the workpiece from further reaction; and

)c (contacting the tool with the workpiece with a relative motion therebetween, until a desired surface property of the workpiece is reached; wherein the contact between the tool and the workpiece removes the conversion coating from the workpiece, thereby exposing the workpiece to further reaction with the active chemistry such that the conversion coating is allowed to re-form on the workpiece.


__________

157506]21][11[

דיאלקטריות שכבות לייצור שיטה נמוך, עבור דיאלקטרי מקדם בעלות

בעלות סיליקון, שהן שבבי על מוליכיםנמוכה פגמים וצפיפות משופרת אדהזיה

METHOD OF FABRICATING LOW-DIELECTRIC CONSTANT INTERLEVEL DIELECTRIC FILMS FOR BEOL INTERCONNECTS WITH ENHANCED ADHESION AND LOW-DEFECT DENSITY

]54[

19.02.2002]22[US]33[21.02.2001]32[09/789422]31[

Int. Cl.8 H01L 021/312]51[IBM CORPORATION, U.S.A.]71[

WO/2002/069381]87[יבמ, מעבדות

הכרמל, חיפה הר חיפה אוניברסיטת IBM LABORATORIES,

HAIFA UNIVERSITYHAIFA 31905

]74[

]57 [A method of fabricating an integrated circuit comprising the steps of: (a) applying a silane coupling agent containing at least one polymerizable group to a surface of a substrate to provide a substantially uniform coating of said silane-coupling agent on said substrate; (b) heating said substrate containing said coating of said silane-coupling agent at a

temperature of about 90º or above to provide a modified surface layer to said substrate containing Si—O bonds, said modified surface layer having a greater water contact angle than a non-heated substrate containing a coating of said silane-coupling agent; (c) rinsing said heated substrate with a suitable solvent that is effective in removing any unreacted


silane-coupling agent to provide a modified surface that is substantially free of particular matter; and (d) applying a

dielectric material to said rinsed surface containing said Si—O.

__________

157663]21][11[

במערכת נע גוף של מיקום לזיהוי התקןלכך ושיטה ניווט

APPARATUS FOR DETECTING LOCATION OF MOVABLE BODY IN NAVIGATION SYSTEM AND METHOD THEREOF

]54[

29.08.2003]22[KR]33[14.03.2003]32[16090/200

3]31[

Int. Cl.8 G01C 021/26, G08G 001/0968]51[SAMSUNG ELECTRONICS CO., LTD., REPUBLIC OF KOREA

]71[


רחובות


REHOVOT

]74[


]57 [An apparatus for detecting location of a movable body in a navigation system, the apparatus comprising: a map data detector (420) for detecting a width of a road, road linear information, and map information of a region corresponding to a location information in an external digital map storage on the basis of location information of the movable body, said location information being transmitted by sensors sensing location coordinates and traveling direction information of the movable body; a memory (430) for storing said width of the road, road linear information, and map information detected from the map data detector; a filter (440)

for computing an optimum location information of the movable body including the width of a road and the road linear information included in said map information on the basis of the location coordinates and traveling direction information of the movable body transmitted by said sensors; and a map-matching unit (450) for receiving the optimum location information of the movable body from the filter and correcting the optimum location information by matching the optimum location information and the map information stored in the memory.

__________

157691]21][11[

קו פרופיל של א–סימטרית מדידהסקטרומטריה בעזרת

LINE PROFILE ASYMMETRY MEASUREMENT USING SCATTEROMETRY

]54[

28.02.2002]22[US]33[02.03.2001]32[60/273039]31[

Int. Cl.8 G01B 011/02]51[ACCENT OPTICAL TECHNOLOGIES, INC., U.S.A.

]71[



P.O.B. 12688 ,HERZLIYA 46733

]74[


]57 [A method of measuring line profile asymmetries in microelectronic devices, the method comprising the steps of: directing light at an array of microelectronic features of a microelectronic device; detecting light scattered back from the array comprising

one or more features selected from the group consisting of one or more angles of reflection and one or more wavelengths; and comparing one or more characteristics of the back-scattered light by performing an operation comprising examining data from complementary angles of reflection.

__________

157789]21][11[

METHODS AND APPARATUSחומרים לעיבוד והתקן שיטותFOR MATERIALS PROCESSING

]54[

21.02.2002]22[US]33[07.03.2001]32[802037]31[

Int. Cl.8 B01F 007/12, B01J 019/10]51[KREIDO LABORATORIES, U.S.A.]71[





TEL AVIV 61040

]74[


]57 [A method for processing materials, comprising: passing materials to be processed in a flow path through an annular processing passage (44) between two closely spaced smooth surfaces provided by respective cylindrical apparatus members (30), at least one rotating relative to the another; wherein the material forms material boundary layers

against both the surfaces; wherein the radial spacing between the two surfaces is equal to or less than the back-to-back radial thicknesses of the two boundary layers; and wherein the smoothnesses of the surfaces are such that formation of Taylor vortices in the processing passage is inhibited.

__________

158429]21][11[

METHOD FOR CROSS-LINKING Aפולימרי פריט לצילוב שיטהPOLYMER ARTICLE

]54[

21.03.2002]22[EP]33[11.05.2001]32[01111570.

6]31[

Int. Cl.8 C08F 008/42]51[BOREALIS TECHNOLOGY OY, FINLAND

]71[




]74[



TEL AVIV 61040

]57 [Method for cross-linking a polymer article comprising a cross-linkable polymer which has been produced by the use of a single-site catalyst with hydrolysable silane groups and a

crystallinity level of at least 30% wherein the cross-linking is performed in the presence of a silanol condensation catalyst comprising a compound of the formula

ArSO3H

or a precursor thereof, Ar being a hydrocarbyl substituted aromatic group comprising at least 14 carbon atoms.

__________

158662]21][11[

התפרצות מקטעי קובץ תגובת מערכותמעורבים אנוקסית

SURGE ANOXIC MIX SEQUENCING BATCH REACTOR SYSTEMS

]54[

03.03.1999]22[US]33[04.03.1998]32[09/034512]31[US02.10.199860/102864

Int. Cl.8 C02F 003/12, 003/20, 003/30]51[DIVISION FROM 138198]62[MIKKEL G. MANDT, U.S.A.]71[




REHOVOT

]74[

]57 [A surge anoxic mix sequencing batch reaction method for treating wastewater to reduce its solids content, biological oxygen demand (BOD) and nitrogenous content in an overall sequencing batch-reaction treatment cycle time of less than 20 hours, comprising the steps of: providing an anaerobic pretreatment zone, an anoxic waste liquid treatment zone and one or more separate aerobic sequencing waste liquid treatment zones wherein the ratio of the volume of the anoxic waste liquid treatment zone to

the volume of the one or more aerobic sequencing waste liquid treatment zones is in the range of from about 0.2: to about 1:1; and wherein the anaerobic treatment zone has a treatment volume in the range of from about 20 percent to about 300 percent of the treatment volume of the anoxic treatment zone; introducing influent wastewater containing wastewater solids content, BOD and nitrogenous content to be treated into the anaerobic pretreatment zone containing waste solids including treatment microorganisms under


anaerobic conditions; introducing waste water from said anaerobic treatment zone into the anoxic waste liquid treatment zone containing waste solids including treatment microorganisms under anoxic conditions; introducing wastewater and treatment microorganisms from said anoxic waste liquid treatment zone in to the one or more aerobic sequencing waste liquid treatment zones containing waste solids including treatment microorganisms under aerobic conditions; mixing and aerating the waste liquid in the one or more aerobic sequencing batch aeration treatment zones to reduce the biological oxygen demand of the wastewater and to convert at least a portion of the nitrogenous wastewater content to inorganic nitrate or nitrite components; introducing and mixing waste liquid and treatment microorganisms from the one or more aerobic sequencing waste liquid treatment zones into the anoxic waste liquid treatment zone at a rate of at least about 0.1 of the total volume of anoxic zone per hour during an interaction time period, to provide nitrate or nitrite oxidizing components from the one or more aerobic sequencing batch reaction treatment zones for the anoxic treatment microorganism metabolism and to convert the nitrate or nitrite components to nitrogen for removal from the wastewater in the anoxic mix treatment zone; subsequently to said mixing and aeration steps, maintaining the waste liquid in the one or more aerobic sequential batch wastewater treatment zones in a quiescent state without said mixing and aerating, to form in the respective one or more sequencing batch aeration zones, a clarified upper layer and a stratified lower waste liquor layer containing waste solids including treatment microorganisms; recycling waste solids from the stratified lower waste liquor layer including treatment microorganisms from said one or

more aerobic sequential batch waste water treatment zones directly into the anaerobic pretreatment zones or indirectly into the anoxic zone and subsequently into the anaerobic pretreatment zone at a flow rate in the range of from about 50/1 to about 1/300 of the influent wastewater flow rate to the anaerobic treatment zone, wherein at least a portion of the total suspended solids of the influent wastewater to be treated is settled to an anaerobic settled solids zone in the lower portion of the anaerobic treatment zone, wherein at least 50 percent by weight of the microbial and other solids content (TSS) of the waste liquor directly or indirectly recycled to the anaerobic zone is settled to the anaerobic settled solids zone in the lower portion of the anaerobic treatment zone together with settled influent wastewater solids, wherein at least about 10 percent by weight of the organic solids which settle in the settled solids zone are anaerobically biologically digested to produce anaerobically digested solid, soluble and gas components, wherein wastewater from the anaerobic treatment zone which includes both influent wastewater and recycled waste liquor wastewater, is conducted from the anaerobic zone to the anoxic zone, and wherein at least the soluble anaerobic digestion components produced by anaerobic digestion in the anaerobic treatment zone are conducted in the wastewater flow from the anaerobic treatment zone to the anoxic treatment zone for anoxic biotreatment, and to the aerobic treatment zone for aerobic biotreatment; and removing a predetermined portion of the clarified upper layer from the respective one or more sequencing aeration treatment zones as a treated effluent stream having reduced solids content BOD and nitrogenous content with respect to said influent wastewater.

The applications for division,178656 מבקשה חלוקה בקשות


from this application haveפורסמו. שטרם זוnot yet been published

__________

159091]21][11[

HIGH TEMPERATUREגבוהה בטמפרטורה סיכה חומר הרכבLUBRICANT COMPOSITION

]54[

31.05.2002]22[US]33[01.06.2001]32[09/872191]31[

Int. Cl.8 C10M 169/04]51[ANDEROL, INC., U.S.A.]71[

MICHAEL A. MCHENRY, DALE D. CARR, JEFFREY A. HUTTER

]72[

WO/2002/099021]87[בע"מ, רוחני ושות',קניין פנסטר

, ת.ד. אריה , קרית1 כניסה12 בזל תקוה , פתח10256

FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD,

12 BASEL STREETENTRANCE 1P.O.BOX 10256

PETACH TIKVA

]74[

]57 [A synthetic polyol ester based lubricant, comprising

)A (a polyol ester base stock that is the reaction product of:

)i (a polyol mixture including a major proportion of dipentaerythritol, and

)ii (at least one C5 to C12 monocarboxylic acid, wherein the resulting mixture of esters has a viscosity at 40˚C of at least about 120 cSt, and

)B (an additive package including an effective amount of at least one oligomeric amine antioxidant, extreme pressure/anti-wear agents and a minor effective amount of a corrosion inhibitor.

__________

159109]21][11[

–4–אמינו–3–)7 של נגזרות–Aארילבוטנואיל(טטרהידרואימידזו)

–3,4וטטרהידרוטריאזולו) (פיראזין2,1Aפפטידז דיפפטידיל של כמעכבים (פיראזין

אותן המכילים רוקחות ותכשירי

DIPEPTIDYL PEPTIDASE INHIBITING 7-(3-AMINO-4-ARYLBUTANOYL)TETRAHYDROIMIDAZO (1,2-A) PYRAZINE AND TETRAHYDROTRIAZOLO (4,3-A) PYRAZINE DERIVATIVES AND PHARMACEUTICAL

]54[


COMPOSITIONS CONTAINING THEM

05.07.2002]22[US]33[06.07.200

1]32[60/303474]31[

Int. Cl.8 A61K 031/4985, A61P 001/00, 003/00, 003/10, 005/00, 009/00, 015/16, 019/10, 025/00, 031/18, 035/00, 037/06, C07D 487/04, 519/00, C12P 017/18

]51[

MERCK & CO., INC., U.S.A.]71[WO/2003/004498]87[

ושות', כהן שלמה ד"ר , תל11490 , ת.ד. 124 גבירול אבן

אביב

DR. SHLOMO COHEN & CO,. 124 IBN GABIROL ST,.

P.O.B. 11490 ,TEL AVIV 62038

]74[


wherein: Ar is phenyl which is unsubstituted or substituted with 1-5 of R3, wherein R3 is independently selected from the group consisting of:

)1 (halogen,)2 (C1-6 alkyl, which is linear or branched

and is unsubstituted or substituted with 1-5 halogens,

)3 (OC1-6 alkyl, which is linear or branched and is unsubstituted or substituted with 1-6 halogens, and

)4 (CN;X is selected from the group consisting of:

)1 (N, and)2 (CR3;

R1 and R2 are independently selected from the group consisting of:

)1 (hydrogen,)2 (CN,

)3 (C1-10 alkyl, which is linear or branched and which is unsubstituted or substituted with 1-5 halogens or phenyl, which is unsubstituted or substituted with 1-5

substituents independently selected from halogen, CN, OH, R4, OR4, NHSO2R4, SO2R4, CO2H, and CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched,

)4 (phenyl which is unsubstituted or substituted with 1-5 substituents independently selected from halogen, CN, OH, R4, OR4, NHSO2R4, SO2R4, CO2H, and CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched, and

)5 (a 5- or 6-membered heterocycle which may be saturated or unsaturated comprising 1-4 heteroatoms independently selected from N, S and O, the heterocycle being unsubstituted or substituted with 1-3 substituents independently selected from oxo, OH, halogen, C1-6 alkyl, and OC1-6 alkyl, wherein the C1-6 alkyl and OC1-6 alkyl are linear or branched and optionally substituted with 1-5 halogens;

R4 is C1-6 alkyl, which is linear or branched and which is unsubstituted or substituted


with 1-5 groups independently selected from halogen, CO2H, and CO2C1-6

alkyl, wherein the CO2C1-6 alkyl, wherein the

CO2C1-6 alkyl is linear or branched; and pharmaceutically acceptable salts thereof and individual diastereomers thereof.

35 לתקנה בהתאם נבחן זה פירוט1968 – הפטנטים, תשכ"ח לתקנות


חלוקה בקשות שטרם זו מבקשהפורסמו.


__________

160163]21][11[

מעגל מיקרו טורבינה של להב קצהלצינון

TURBINE BLADE TIP WITH MICROCIRCUIT COOLING

]54[

02.02.2004]22[US]33[05.02.2003]32[10/358646]31[

Int. Cl.8 F01D 005/18]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.

]71[


אביב



TEL AVIV 61040

]74[

]57 [A turbine blade (24) comprising: a hollow airfoil (54) into which cooling flow is flowable from an end of said airfoil, said airfoil including pressure (42) and suction (44) sidewalls joined together at leading (46) and trailing (48) edges and extending from a root (50) to a tip (36);

at least one micropassage (80) disposed within said tip, said micropassage includes an inlet (70) and an outlet (72), said inlet

and said outlet in flow communication with said micropassage; a means for providing cooling flow to said airfoil wherein said cooling flow enters said inlet from said airfoil, transitions through said micropassage and exits at said outlet into a region outside said airfoil; and at least one pedestal (88), said pedestal radially extends at least in part in the path of said cooling flow flowing in said micropassage.


__________

161371]21][11[

PANEL WITH SOUNDייצור ושיטת קול בידוד שכבת עם לוחINSULATION LAYER AND PRODUCTION METHOD

]54[

28.06.2002]22[DE]33[23.10.2001]32[10151614.

2]31[

Int. Cl.7 B32B 021/08, 025/04, E04F 015/20]51[M. KAINDL, AUSTRIA]71[WO/2003/035396]87[


ירושלים



]74[

]57 [A method for the production of a panel (P) having a sound insulation layer (5) mounted thereon, in which several layers are pressed in a press by supplying pressure and heat, wherein single layers

are made of wood, derived timber product or paper, at least one layer being provided with aminoplast, characterized in that: the layers are pressed together with the sound insulation layer; wherein the sound insulation layer is connected to the paper


that is impregnated with aminoplast, and after pressing, the panel is provided with locking elements (6, 7).

__________

161917]21][11[

מערכת עבור קרינה מפני מגן–חוםסולרית

RADIATION HEAT SHIELD FOR SOLAR SYSTEM

]54[

13.11.2002]22[US]33[13.11.2001]32[987106]31[

Int. Cl.8 F24J 002/05, 002/10]51[]SOLEL SOLAR SYSTEMS LTD.]71בע"מ, ירושלים סולריות מערכות סולל





TEL AVIV 61040

]74[

]57 [A solar system (60) comprising a reflector and a heat collecting element (HCE) received at the focus of the reflector, said HCE having a longitudinal axis extending between a first end and a second end; the HCE comprising a coated tube (16) received within a coaxial evacuated enveloping glass tube (24); said enveloping glass tube being secured at respective ends thereof to the coated tube by a coaxially deformable connector element (30) having a distal end thereof

sealingly secured to the coated tube and a proximal end thereof sealingly attached to a respective end of the enveloping glass tube by a glass to metal connection (46) (GMC), wherein a radiation shield assembly (62, 64) extends over the connector element and over the GMC; said radiation shield assembly is secured to the connector element by support legs (70, 72) engaging the connector element adjacent the proximal end.


__________

163286]21][11[

–2מותמר(פירולידין– –)גליציל1 רוקחות ותכשירי קרבוניטרילים, הכנתם

אותם המכילים

1(-SUBSTITUTED GLYCYL)PYRROLIDINE-2-CARBONITRILES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

04.03.2003]22[HU]33[06.03.2002]32[P0200849]31[

Int. Cl.8 A61K 031/395, A61P 001/00, 003/00, 009/00, 015/06, 017/00, 025/00, 029/00, 035/00, 037/00, C07D 401/14, 413/14, 417/14, 451/04, 451/14

]51[

SANOFI AVENTIS, FRANCE]71[WO/2003/074500]87[



P.O.B. 6451 TEL AVIV 61063

]74[

]57 [Dipeptidyl peptidase –IV- enzyme inhibition compounds of the formula


wherein R1 means a nitrogen-containing aromatic moiety consisting of one or two aromatic rings, preferably a pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxidazolyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, benzimidazolyl, indazolyl, benzthiazolyl, benzisothiazolyl, benzoxazolyl or benzisoxazolyl, tetrazolyl, triazinyl ring; which is, in a given case, independently from each other mono- or disubstituted by one or two of the following groups: C1-4 alkyl groups, C1-4 alkoxy groups, halogen atom, trihalogenomethyl group, methylthio group, nitro group, cyano group, amino group or phenyl group; or thienyl, furyl or

benzyl group; or p-toluenesulfonyl group; or acyl group of formula R1a-CO, wherein R1a means C1-4 alkyl group, phenyl group; phenyl, pyridyl or phenylethenyl group substituted with one or more alkyl- and/or alkoxy- or nitro-group or halogen atom; phenylethenyl or phenylethyl group substituted with alkylene-dioxy group; piperidin-1-yl, 4-methylpiperazin-1-yl, pyrrolidin-l-yl group,B stands for a group of formula (1) or (2) or (3) or (4) or (5) or (6) or (7) as shown in the specification;

R2 stands for hydrogen atom or fluorine atom;R3 stands for fluorine atom ;

and salts, isomers, tautomers, solvates and hydrates thereof.

__________

163398]21][11[

MICROCIRCUIT COOLING FORטורבינה של להב עבור קירור מערכתA TURBINE BLADE

]54[

05.08.2004]22[US]33[08.08.2003]32[637448]31[

Int. Cl.8 F01D 005/18]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.

]71[


אביב



TEL AVIV 61040

]74[

]57 [A turbine rotor blade (27) comprising: an external wall (24), said external wall including an inner surface (65); an internal cavity (32a-c) into which cooling air is flowable; a first cooling circuit (22) embedded within said wall, said first cooling circuit including: a first inlet (61c), said first inlet connects said first cooling circuit with said cavity and provides a cooling air flow path into said

first cooling circuit; and an exit aperture (63), said exit aperture provides a cooling air flow path out of said first cooling circuit, said first cooling circuit configured to increase the temperature of the cooling air as it travels from said inlet to said exit aperture of said second cooling circuit; and a third cooling circuit (22) embedded within said wall, said third cooling circuit


includes: a first inlet (61a), said first inlet of said second cooling circuit connects said second cooling circuit with said cavity and provides a cooling air flow path into said second cooling circuit; and an exit aperture (63), said exit aperture of said third cooling circuit provides a cooling air flow path out of said third cooling circuit, said third cooling circuit configured to increase the temperature of the cooling air

as it travels from said inlet of said third cooling circuit to said exit aperture of said third cooling circuit; wherein said first inlets are aligned with the direction of counter-rotating flow circulations (104, 106) experienced by said inner surface of said wall of said cavity caused by Coriolis forces on the cooling air flow inside said cavity.

__________


163443]21][11[

-INNER AIR SEAL ANTIפנימי אטם של סיבוב המונע התקןROTATION DEVICE

]54[

10.08.2004]22[US]33[13.08.2003]32[10/640225]31[

Int. Cl.8 F01D 009/04, 011/00, F04B 017/00, F16B 039/00]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.

]71[


ירושלים



]74[

]57 [An anti-rotation device for preventing rotation of a damper spring and an inner air seal (1) in a stator assembly (10), said device comprising a lug (8) positioned within a slot at a center of an inner air seal arc segment, said lug

engaging a slot in said damper spring and a cutout (18) in a stator segment so as to prevent rotation of said damper spring and said inner air seal in either direction relative to the stator assembly.

__________


163624]21][11[

QUICK DISCONNECT WITHעוצר קפיץ בעל מהיק מנתקRETAINING SPRING

]54[

19.08.2004]22[US]33[29.08.2003]32[60/499166]31[

Int. Cl.8 H01R 004/00, 004/50]51[TRIUMPH BRANDS, INC., U.S.A.]71[


ירושלים



]74[

]57 [A quick disconnect (100), comprising: a front coupling (10, 70) and a rear coupling (10) each for connection to a respective cable end; a hinge latch (20) comprising at least one finger pivotally mounted at a first end (18) of the rear coupling, the finger having a retention

groove (24) disposed at a second end and having a coupling groove for receiving the front coupling; a compression sleeve (40) slidably disposed over the hinge latch; a biasing member disposed at a first end of the compression sleeve for engagement with the retention groove of the finger.

__________


164542]21][11[

BALER GATE LINKAGE ANDהסגר ומבנה חבילה שער חיבורLATCH STRUCTURE

]54[

13.10.2004]22[US]33[15.10.2003]32[687256]31[

Int. Cl.8 A01D 046/08]51[DEERE & COMPANY, U.S.A.]71[


אביב



TEL AVIV 61040

]74[

]57 [A baler having a bale forming chamber with first and second upright frame sections (46, 48), the second frame section movable relative to the first frame section for releasing a formed bale from the chamber, linkage structure (50) connecting the first and second frame sections including a control linkage having an upper link (82) connecting an upper portion of the first frame section with an upper portion of the second frame section, a second link (86) pivotally connected between first and second frame sections at a location below the upper link, and cylinder structure (76) connected between the frame sections and rocking the second frame section relative to the first frame section between a closed position for

forming a bale and an open position for releasing the bale, wherein in the closed position, the upper portions of the frame sections generally abut, wherein the upper link moves the second frame section over the upper portion of the first frame section as the cylinder rocks the second frame member towards the open position; and further including a latch member (100) connected to the second frame section and securing the second frame section to the first frame section in the closed position, wherein the operation of the cylinder structure with the frame sections in the closed position initially moves the first frame section to release the latch member without need for a separate unlatching mechanism.


__________

164842]21][11[

COTTON FEEDING ROLLERכותנה להזנת מגלל מבנהSTRUCTURE

]54[

26.10.2004]22[US]33[28.10.2003]32[695096]31[

Int. Cl.8 A01D 046/08]51[DEERE & COMPANY, U.S.A.]71[


אביב



TEL AVIV 61040

]74[

]57 [In a mobile cotton harvester having selectively operable processing structure connected to the harvester for processing harvested cotton in a field, accumulator structure comprising: an upright storage area having side walls (30g) and having a lower discharge area (124), the upright storage area receiving the harvested cotton and facilitating continuous harvester operation; a cotton metering structure (32) including upper and lower rotatable spaced rollers (92, 96), the metering structure defining an inclined accumulator floor

angling downwardly towards the lower discharge area; a drive (14) connected to the metering structure for rotating the spaced rollers in a same direction to urge the received cotton from the storage area towards the lower discharge area; and a discharge roller (120) located above the lower roller and discharge area, the discharge roller intercepting the cotton urged towards the lower discharge area to break up cotton clumps and meter cotton to the discharge area.


__________

164924]21][11[

דיו דוחף הכולל דיו הזרקת נחיר מכלולהזזה בר

INK JET NOZZLE ASSEMBLY INCLUDING DISPLACEABLE INK PUSHER

]54[

21.08.2002]22[US]33[28.06.2002]32[10/183175]31[

Int. Cl.8 B41J 002/05]51[SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA

]71[




]74[

]57 [An ink jet printhead chip that comprises a substrate (116); drive circuitry (156) positioned in the substrate; and a plurality of nozzle arrangements (122) positioned on the substrate, each nozzle arrangement comprising nozzle chamber walls (150) and a roof wall (130) that define a nozzle chamber and an ink ejection port in the roof wall in fluid communication with the nozzle chamber; an ink pusher that is operatively positioned

with respect to the nozzle chamber and is displaceable through a range of between 1 micron and 5 microns to eject ink from the ink ejection port; and an actuator (128) that is connected to the drive circuitry and the ink pusher to displace the ink pusher on receipt of an electrical signal from the drive circuitry, each nozzle arrangement being the product of a MEMS fabrication technique.


__________

165463]21][11[

MULTI-LAYER CARBONLESSפחם נטול רב–שכבתי דף מוצרSHEET PRODUCT

]54[

19.05.2003]22[GB]33[29.05.2002]32[0212358.6]31[

Int. Cl.8 B41M 005/00]51[ARJO WIGGINS LIMITED, UNITED KINGDOM

]71[

DAVID JOHN TAYLOR, RICHARD DAVID SAUNDERS, MICHAEL ERIC HOBSON

]72[





JERUSALEM 91450

]74[

]57 [A magnetically-activatable sheet product comprising a pair of laminated outer sheets between which is a magnetic layer comprising magnetically-activatable particles in a binder matrix, the outer sheets having sufficient opacity to mask the appearance of the magnetic layer; at least one of the outer sheets being provided

on its outward facing surface with a coating which comprises either microcapsules containing a solution of at least one chromogenic material, or dispersed droplets containing at least one chromogenic material in a pressure-rupturable matrix, or a colour developer composition, or both microcapsules


containing at least one chromogenic

__________

165884]21][11[

METHOD FORמשטחים שלUV לטיהור שיטהPHOTOSENSITIZED ULTRAVIOLET DECONTAMINATION OF SURFACES

]54[

08.11.1999]22[US]33[09.11.1998]32[60/107617]31[

Int. Cl.8 A61L 002/10]51[DIVISION FROM 143058]62[CLEAN EARTH TECHNOLOGIES, LLC, U.S.A.

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

]57 [A method of decontaminating a contaminated surface, the method comprising: spraying a photosensitizer onto the contaminated surface, the photosensitizer comprising an aqueous

solution containing hydrogen peroxide and peracetic acid; and applying UV light in an intensity sufficient to destroy contaminants on the surface.


__________

165885]21][11[

METHOD FORמשטחים של לטיהור והתקן שיטהPHOTOSENSITIZED DECONTAMINATION OF SURFACES

]54[

08.11.1999]22[US]33[09.11.1998]32[60/107617]31[

Int. Cl.8 A61L 002/10]51[DIVISION FROM 143058]62[CLEAN EARTH TECHNOLOGIES, LLC, U.S.A.

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

]57 [A method of decontaminating the surface of a contaminated object, the method comprising: surrounding the contaminated object with a barrier having an entrance and an exit therein;

establishing an air flow into the exit and out of the entrance; spraying a photo sensitizer onto the surface of the object; and illuminating the sprayed surfaces of the object with light.


__________

165886]21][11[

METHOD FORמשטחים של לטיהור שיטהPHOTOSENSITIZED DECONTAMINATION OF SURFACES

]54[

08.11.1999]22[US]33[09.11.1998]32[60/107617]31[

Int. Cl.8 A61F 002/10]51[CLEAN EARTH TECHNOLOGIES, LLC, U.S.A.

]71[




P.O.B. 4060 ,TEL AVIV 61040

]74[

]57 [A method of decontaminating a contaminated non-conducting surface, the method comprising: providing a conducting backing for the non-conducting surface; spraying photosensitizer onto the

contaminated surface, the photosensitizer being electrically charged so that it is attracted to the contaminated surface; and illuminating the sprayed surface with light.


__________

166724]21][11[

תכונות עם מיקרו–אלקטרומכני מפעילמתנגד אבזם של

MICRO-ELECTROMECHANICAL ACTUATOR WITH BUCKLE-RESISTANT PROPERTIES

]54[

30.06.2000]22[Int. Cl.8 B41J 002/45]51[SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA

]71[




]74[

]57 [A micro-electromechanical actuator (7) that includes a substrate (2); drive circuitry positioned on the substrate; an active beam member (10) that is anchored to the substrate at one end and electrically connected to the drive circuitry, the active

beam member defining an electrical heating circuit that is spaced from and overlies the substrate to heat resistively and expand when a current from the drive circuitry is set up in the active beam member; a passive beam member (12) that


is also anchored to the substrate at one end and electrically isolated from the drive circuitry, the active beam member being interposed between the substrate and the passive beam member; a longitudinally extending lever arm (6) that is fast at one end to an opposite end of the active and

passive beam members, such that expansion and subsequent contraction of the active beam member causes reciprocal movement of the lever arm away from and towards the substrate; and a working member fast with an opposite end of the lever arm.

__________

167283]21][11[

מודפסים וספרים ספרים להדפסת שיטותאלו בשיטות

METHODS FOR PRINTING BOOKLETS AND BOOKLETS PRINTED THEREBY

]54[

07.03.2005]22[Int. Cl.8 B42C 001/00, B42D 009/00]51[

מרמורשטיין, אשדוד ישראלכץ, אשדוד אליעזר

ISRAEL MARMORSTEINELIEZER KATZ

]71[


ירושלים

WOLFF, BREGMAN AND GOLLER,

19B KEREN HAYESOD ST .P.O.B. 1352,

JERUSALEM 91013

]74[

]57 [A method for preparing a protable booklet of multi-column textual material, comprising reformatting the textual layout of said material in order to create substantial alignment between the lines of text I all of the columns in an area

predetermined for horizontal subdivision of the sheet containing the same, creating at least one space horizontally extending across said predetermined area of said sheet, thereby subdividing each of said respective columns to form at least two


distinct areas of printed matter, and utilizing said subdivided sheets to form a booklet having pages of reduced height in the direction of its columns, while

substantially maintaining the original font size of the letters of said multi-column textual material.

__________


PATENTSפטנטים

שניתנו פטנטיםPATENTS GRANTED

13265113210113141813127513114712956112931911498214670214666414646014638414628714625413281313279314699214697714695614691714689714687214672114670514811614794414789514770314763414761414755714741314862914855114841414835514831614829014819414812814955614949914948914933814891014881614874314863715120415119215072615071515061615051215023015002315158115153615151115150415147115129315124415124112732512719312562812497712447110831610635799435142738142570142484142457142132142112127770127769143441143370143354143112142978142954142879142868143733143694143576143495143490143487143479143457144762144747144486144358144352144106144084143797145158145157145156145121145011144905144847144775145400145350145336145318145316145305145177145159145948145799145783145767145561145554145517145437134087133078123514122832121614121402146103145986135585135499135371135295135166134980134602134224152394152222152192137096136773136768136469135945154066153673153657153630153448153396153026152986156331156236155910155255155211155187154926154765158405158305158210157711157622156918156537156403138951138647138435138425116609116398158663158409140476140368140080139849139666139252139199139035141045141039140804140702140661140636140552140491159158141848141780141727141707141501141411141183162279161466160122159760159522159400159245159213164775164505164504164448164445163503163497163265

165038164931164930164834164782

שחודשו פטנטיםPATENTS RENEWED

8942889410893998935789311893038927789094896028957789545895418947789465894618944210482910482110480010478910477610477410450699435104891104881104880104868104853104844104835104830105017105009105003104995104970104965104930104896120249120213120157120121119944119417105048105036120325120295120280120279120260120257120255120251120380120361120354120352120351120348120345120332121790121614121218120455120442120430120425120407125214124977124850124760124572122647122315121981125598125590125504125492125483125392125361125356125748125735125711125688125649125645125622125615125856125848125841125838125822125819125805125796125975125968125954125945125926125911125909125861126153126096126086126054126050126028126022125986129319128592127325126358126331126303126180126179131716130941130447130368130229130169130168129760135499134536133610133609133469132793132651132425137548136811136773136768136469136125135893135523138690138647138577138435138277138094137970137757140476140458140423140379140080139910139387139035141591141557141522141411141320141045140933140702141848141814141763141758141752141740141672141632142570142132141989141970141964141942141939141889143354143086142978142879142784142738142687142645143645143637143602143601143590143556143495143479144199144100143998143997143739143733143698143694145158145157145156145121144847144775144465144229145767145745145606145437145393145305145219145159146664146562146219146204145993145948145799145783147089146958146956146910146897146872146759146705147668147663147634147422147413147374147339147226148743148637148414148316148128148116147895147703150512150230150023149651149556149489149485148816151416151281151107151103150989150715150647150519153026152488152286151581151549151511151504151464155934155499155498154944154926154153154013153657159222159158158305158210157622156851156476156331163497163485163484162279161466159999159522159396169917168934165038164931164930164834164775163501

June 3, 2007 –התשס"ז בסיון י"ז 838

חידוש אגרת תשלום אי בגלל פקעו שתוקפם פטנטיםPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

123446

שנה לעשרים שחודשו פטנטיםPATENTS RENEWED FOR 20 YEARS

146287142068


NOTICEהודעה הפטנטים, לחוק66 סעיף לפי

1967תשכ"ז-Under section 66 of the Patents Law, 5727-1967

רשות ניתנה כי בזאת מודעמס' הפטנט בקשת לבעלת

133835This is to notify that permission has been granted to the owner of Patent Application No.

7/2003Acceptance published in journalביומן פורסם הקיבול דבר בקשת של הפירוט את לתקן

האמורה הפטנטTo amend the specification of the said Patent Application.

למתן להתנגד רשאי אדם כל חודשים שלושה תוך הרשות

זה, כפי פטנטים יומן מתאריך ובתקנה לחוק67 בסעיף שנקבע

הפטנטים, התשכ"ח- לתקנות991968.

Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.

טעות תיקוןCorrigendum

Journal 10/2006יומן

P. 4206 Patent application 76608מס' פטנט בקשת4206ע' No 76608

Notice under section 64 of the Patents Law הפטנטים לחוק64 סעיף לפי הודעה. Delete the notice ההודעה את מחק

The notice had been published 9/2006ההודעה פורסמה קודם ביומן earlier in Journal 9/2006

ביומן המופיעים למדינת קודיםJune 3, 2007 –התשס"ז בסיון י"ז 844

COUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or OrganizationAR ArgentinaAT AustriaAU AustraliaBA HerzegovinaBE BelgiumBR BrazilCA CanadaCH SwitzerlandCN ChinaCU CubaCZ Czech RepublicDE GermanyDK DenmarkEC EcuadorEP European Patent OfficeES SpainFI FinlandFR FranceGB United KingdomGE GeorgiaGR GreeceGT GuatemalaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV LatviaMX MexicoMY MalaysiaNL The NetherlandsNO Norway

NZ New ZealandPL PolandPT PortugalRU Russian FederationSE SwedenSG SingaporeSI SloveniaSK SlovakiaTH ThailandTR TurkeyTW TaiwanUA UkraineUS United States of AmericaUY UruguayUZ UzbekistanWO World Intellectual Property Organization (W.I.P.O.)ZA South Africa

DESIGNS מדגמים


שנרשמו מדגמיםDESIGNS REGISTERED

36120, 40378, 40379Class 23(01) סוג

31.1.2002MIGAN LTD. בע"מ מיגןFast connector מהיר מחבר

39787Class 6(01) סוג

15.8.2004JESSICA COHEN כהן ג'סיקהModular children's pouff לילדים מודלרי פוף


18.11.2004TNUVA CENTRAL COOPERATIVE FOR THE MARKETING OF AGRICULTURAL PRODUCE IN ISRAEL LTD.

תוצרת לשווק שתופי מרכז תנובה בע"מ בישראל חקלאית

Bottle בקבוק

40022, 40024Class 6(01) סוג

6.12.2004RONEN YITZHAKI AND GLAMER DESIGN IN WOOD LTD.

בעץ עיצוב וגלמר יצחקי רונן בע"מ

Bed מיטה


21.12.2004KETER PLASTIC LTD. בע"מ פלסטיק כתרBucket for tools עבודה לכלי דלי


15.2.2005MOSHE LAVI לביא משה

Attachment assembly for road signs to a pole לעמוד תמרור להצמדת מערכת

40355Class 22(04) סוג

20.2.2005FAB MANUFACTURING & IMPORT OF INDUSTRIAL EQUIPMENT LTD.

תעשייתי ציוד ויבוא ייצור פאב בע"מ

Firearm grip נשק כלי של ידית40404

Class 22(04) סוג7.3.2005

FAB MANUFACTURING & IMPORT OF INDUSTRIAL EQUIPMENT LTD.

תעשייתי ציוד ויבוא ייצור פאב בע"מ

Accessory grip אביזרים עבור ידית


14.3.2005L.B. ORLY LTD. בע"מ ל.ב. אורליProfile

הברית( )ארצות אמנה תאריך פרופיל

40480Class 11(01) סוג

20.3.2005ELIYAHU RAM (FADIDA) )פדידה( רם אליהוPendant תליון

40707Class 23(01) סוג

1.5.2005ODIS IRRIGATION EQUIPMENT (2002) LTD. AND ODIS FILTERING LTD.

(2002) השקיה אביזרי אודיס בע"מ סינון מפעלי ואודיס בע"מ

Cover for filtering unit למסנן מכסה


20. 6.2005NIRIT DRORI AND ANAT NEVO נבו וענת דרורי ניריתBaby carrier לתינוק מנשא


41113Class 11(01) סוג

25. 7.2005H. STERN COMERCIO E INDUSTRIA S.A.

Jewelהברית( )ארצות אמנה תאריך

תכשיט

41507Class 21(02) סוג

12. 10.2005TAL COHEN כהן טלExercise bench להתעמלות ספסל


17.10.2005N.V. NUTRICIA

Container מיכלConvention date (OHIM)

הברית( )ארצות אמנה תאריך 26.11.2005 )אוהיים( האמנה תאריך


24. 11.2005ORION CORPORATION

Packageהברית( )ארצות אמנה תאריך

אריזה

41677, 43553Class 8(07) סוג

30. 11.2005SHULAMIT MEIRA BITTON ביטון מאירה שולמיתKey מפתח

41761Class 19(06) סוג

20.12.2005MERZ & KRELL GMBH & CO. KGAA

Writing instrument כתיבה כליConvention date (Germany) 15.7.2005 )גרמניה( האמנה תאריך

הברית( )ארצות אמנה תאריך

41862Class 28(03) סוג

11.1.2006UNILEVER PLC

Bottle בקבוקConvention date (U.S.A.)

הברית( )ארצות אמנה תאריך 26.7.2005 הברית( )ארצות האמנה תאריך


17.1.2006UNILEVER PLC

Bottle בקבוקConvention date (U.S.A.)



29. 1.2006MOSHE HAREL AND GABRIEL BEN HAIM

חיים בן וגבריאל הראל משה

Headgear ראש כיסוי

41928Class 15(09) סוג

30. 1.2006B. VARTICOVSCHI LTD. בע"מ ב. ורטיקובסקיKey יהלומים לליטוש מכונה


10.2.2006COLGATE-PALMOLIVE COMPANY

Electric toothbrush handle חשמלית שיניים מברשת של ידיתConvention date (U.S.A.)


42271Class 11(01) סוג

4. 4.2006BEN ZIDEL זידל בןBracelet צמיד


42294Class 11(01) סוג



תכשיט

42303Class 11(01) סוג


Jewelryהברית( )ארצות אמנה תאריך

תכשיטים

42412, 42413Class 11(01) סוג

27. 4.2006GERALDO LTD. בע"מ ג'ראלדוJewel חן אבן

42452Class 19(04) סוג

14.5.2006KING JIM CO. LTD.

Pocket folder כיס אוגדןConvention date (Japan)

הברית( )ארצות אמנה תאריך 15.11.2005 )יפן( האמנה תאריך

42520, 42521Class 21(02) סוג

25. 5.2006GREENFIELD B.G LTD. ב.ג. בע"מ גרינפלדGymnastic apparatus להתעמלות מתקן

42594Class 11(01) סוג

12. 6.2006

DIAMINTANGIBLES INTERNATIONAL, LTD.Diamond

הברית( )ארצות אמנה תאריך יהלום

42597, 42598Class 11(01) סוג

13. 6.2006DIAMINTANGIBLES INTERNATIONAL, LTD.

Diamondהברית( )ארצות אמנה תאריך

יהלום


14. 6.2006AMISHAY MARKETING COMPANY LTD.

(1980) לשיווק חברה עמישי בע"מ

Door stop דלת מעצור

42662Class 11(01) סוג

3. 7.2006JAFA SHAVIT שביט יפהOrnament קישוט

42679, 42680, 42681,42682, 42683

Class 6(06) סוג4. 7.2006

XI MODULAR DESIGN LTD. בע"מ מודולארי עיצוב קסאיProfile פרופיל

42698, 42699Class 6(01) סוג

5.7.2006NICOLETTI S.P.A.

Sofa ספהConvention date (Italy)

הברית( )ארצות אמנה תאריך 13.1.2006 )איטליה( האמנה תאריך

42797, 42800, 42801, 42802

Class 11(01) סוג




תכשיט


25. 7.2006HISHTIL LTD. בע"מ חישתילForm for seedling שתילים לגידול תבנית

42808, 42809, 42812,42813

Class 25(01) סוג25. 7.2006

EXTAL LTD. בע"מ אקסטלProfile פרופיל


1. 8.2006KETER PLASTIC LTD. בע"מ פלסטיק כתרCollapsible table מתקפל שולחן

42836Class 11(01) סוג

2. 8.2006JACOB SIMAN-TOV AND ITZHAK SIMAN-TOV

סימן-טוב ויצחק סימן-טוב יעקב

Gemstone חן אבן


9. 8.2006DIGRIS IMPORT LTD. בע"מ יבוא דיגריסPants מכנסיים

42922, 42923, 42924Class 2(04) סוג

20. 8.2006PAPAYA FASHION LTD. בע"מ אופנה פאפאיהSole סוליה

42935

Class 19(06) סוג27. 8.2006

OMEGA CREATIVE INDUSTRIES KFAR GLICKSON, (1975) LIMITED PARTNERSHIP

) גליקסון כפר תעשיות אומגהמוגבלת (, שותפות1975

Painting assembly צביעה ערכת

42984, 42986Class 23(01) סוג

3. 9.2006ELGO IRRIGATION LTD. בע"מ השקייה אלגוIrrigator להשקיה מתקן

42989, 42990, 42991,42992, 42993

Class 8(06) סוג3. 9.2006

ARBRAHAM COHEN-HANDLES & PROFILES LTD.

ופרופילים כהן-ידיות אברהם בע"מ

Handle ידית42994

Class 8(07) סוג4. 9.2006

MUL-T-LOCK TECHNOLOGIES LTD.

בע"מ טכנולוגיות מולטילוק

Key head מפתח ראש

42998Class 25(01) סוג

4. 9.2006KOL CHEN LTD AND HAIM AZOULAY

אזולאי וחיים בע"מ חן כל

Profile פרופיל

43037, 43042Class 11(01) סוג



תכשיט


43073Class 24(04) סוג

17. 9.2006ILANIT SCHWAIZER PELEG פלג שוויצר אילניתPacifier מוצץ


18. 9.2006FORMASTER S.A.

Jug water filterהברית( )ארצות אמנה תאריך

מים מסנן קנקן

43094Class 20(03) סוג

21. 9.2006AVIV ZAGURI ADVERTISEMENT בע"מ פרסומאים זגורי אביבAdvertisement device פרסום מתקן

43157, 43158Class 9(03) סוג

5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.

בע"מ ובניו י. אריכא שחם

Trash container אשפתון

43159Class 25(03) סוג



Guard cabin לשומר מבנה

43160Class 23(01) סוג



Drinking fountain ברזיה

43161Class 20(03) סוג



Bulletin board מודעות לוח

43162, 43163, 43683Class 6(01) סוג



Sitting set ישיבה מערכת

43164, 43165Class 25(02) סוג



Barrier מחסום

43166, 43169Class 25(03) סוג



Pergola פרגולה

43168, 43171Class 6(01) סוג



Bench ספסל

43172Class 12(11) סוג



Bike device לאופניים מתקן

43174, 43175, 43176,43177


Class 23(01) סוג15. 10.2006

FORMASTER S.A.

Water filter cartridgeהברית( )ארצות אמנה תאריך

מים למסנן מחסנית

43198, 43200Class 11(01) סוג

15.10.2006H. STERN COMERCIO E INDUSTRIA S.A.


תכשיט

43222, 43223Class 11(01) סוג

22.10.2006H. STERN COMERCIO E INDUSTRIA S.A.


תכשיט

43244, 43245, 43246,43247, 43248

Class 11(01) סוג23.10.2006

H. STERN COMERCIO E INDUSTRIA S.A.


תכשיט

43271, 43272, 43273,43274, 43275, 43276,43277, 43278, 43279,

43280Class 27(03) סוג

2. 11.2006UNIQUE COMFORT ACCESSORIES LTD.

בע"מ נוחות אביזרי יוניק

Cigarette extinguisher סיגריות חונק

43290, 43291, 43292, 43293Class 2(04) סוג

7. 11.2006GAZIT SHOES T. VINER LTD. בע"מ ובניו ט. וינר גזית נעליShoe נעל

שחודשו מדגמיםDESIGNS RENEWED

27715 2771427713277122771127710275812744336366363053617236158361553608936088347943642936424364053640436403364023640136368

36495


שבוטלו מדגמיםDESIGNS VOID

26575265692655819128191261910319102190722664426639266382663326604266032659026589354643545435453354453544035438354362725235481354803547935474354733547235470354653550535502355013549335492354913548835482

368533685236851

Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks

נועם מאיר ד"רהפטנטים, המדגמים רשם

מסחר וסימני


בפנקס רשומים בפרטים שינוייםCHANGES IN PARTICULARS ENTERED IN REGISTER

שקובלו לבקשות מפתחותINDICES OF APPLICATIONS ACCEPTED

NAME INDEXשמי מפתח

116223 בע"מ די.וי. מערכות3

בנגב, הרשות בן-גוריון אוניברסיטת147199 ופיתוח למחקר140429 בע"מ יישומים אוריקל

149324 בע"מ אי.סי.איי. טלקום147169 בע"מ איי.סי. קוד

167283 כץ אליעזר בע"מ פיונירס דיסק פלאש אם-סיסטמס

148619145572 ברמן אנה

140367 רון בינימין

150880 בע"מ אימג'ינג גיוון155138 בע"מ בביולוגיה יישומים גן

133693 בע"מ די-פארם

137455 בע"מ החזקות זולי

148375 בע"מ טויטופלסט151953 בע"מ נשק טי.די.אי. מערכות

143014 בע"מ מדיקל טראנספארמה

בע"מ ופיתוח למחקר חברה ידע

143202 ,150301151000 גוילי יצחק

144966 אליעזרוב ישראל167283 מרמורשטיין ישראל

150855 בע"מ רפואיות טכנולוגיות ניטי

161917 בע"מ סולריות מערכות סולל125855 בע"מ סלריס

149823, 149822 בע"מ ספידביט150251 בע"מ ספייסלוג'יק

149439 בע"מ ישראל פוליקום

135332 בע"מ טכנולוגיות קלוקוייז153136 בע"מ מתכת תעשיות קראוס קרמיקה( בע"מ )טכנולוגיות קראל

143780

145572 ברמן ראובן בע"מ לחימה אמצעי לפיתוח רפאל-רשות

141710

3DV SYSTEMS LIMITED 116223ABBOTT GMBH & CO. KG 146232ACCENT OPTICAL TECHNOLOGIES,

INC. 157691ADSIL, LC 151390AKZO NOBEL N.V. 145483ALEXANDER BECKMANN 145362ALLA PAVLOVNA TUZOVA 154360ALOIS PICHLER 157258ALZA CORPORATION 144756ANDEROL, INC. 159091ANGIOTECH INTERNATIONAL AG. 145069ANGIOTECH PHARMACEUTICALS, INC. 145069ANNA BERMAN 145572APPLIED VISION SYSTEMS, INC. 147672ARJO WIGGINS LIMITED 165463ASAT AG APPLIED SCIENCE & TECHNOLOGY 142876ASK 141761ASTRAZENECA AB 139297ASTRAZENECA AB 141410, 150403ATHEROS COMMUNICATIONS, INC. 147916AVENTIS PHARMA S.A. 136647

BANDSPEED, INC. 145090BASF AKTIENGESELLSCHAFT 147767BASF AKTIENGESELLSCHAFT 150173, 154303BAYER AKTIENGESELLSCHAFT 149748BAYER CROPSCIENCE S.A. 148162BELDEN WIRE & CABLE COMPANY 146993BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY 147199BENYAMIN RON 140367BIOFRONTERA BIOSCIENCE GMBH 142876Biogen Idec MA Inc. 126918BIOPHYSICA, INC. 143709BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 151011BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG 149984

BOREALIS TECHNOLOGY OY 158429

CABOT CORPORATION 151825CELGENE CORPORATION 135288CELLARIS LTD. 125855CENTAUR PHARMACEUTICALS, INC. 150403CEREL (CERAMIC TECHNOLOGIES) LTD. 143780CHUGAI SEIYAKU KABUSHIKI KAISHA 136310CLEAN EARTH TECHNOLOGIES, LLC 165884, 165885, 165886CLOCKWISE TECHNOLOGIES LTD. 135332COLEY PHARMACEUTICALS, INC. 139813COMPUTER ASSOCIATES THINK, INC. 142572, 143693, 143940COMPUTER ASSOCIATES THINK, INC. 144067, 145325COULTER PHARMACEUTICAL INC. 140028CV THERAPEUTICS, INC. 146471

DEERE & COMPANY 164542, 164842DERMATRENDS, INC. 150177DONALDSON COMPANY, INC. 154569, 154570D-PHARM LIMITED 133693DSM IP ASSETS B.V. 151586

ECI TELECOM LTD. 149324EGIS GYOGYSZERGYAR RT. 146420EISAI CO.,LTD. 151314ELI LILLY AND COMPANY 146810, 155700ELIEZER KATZ 167283ENZO THERAPEUTICS, INC. 137292ETHYPHARM 142787

F. HOFFMANN-LA ROCHE AG 150549F. LLI CITTERIO S.P.A. 152305FABBRICA D'ARMI PIETRO BERETTA S.P.A. 155711FIDELINE 137257FUMAKILLA LIMITED 150888

June 3, 2007 –התשס"ז בסיון י"ז ii

GALENIX DEVELOPPEMENT 148003GALMED INTERNATIONAL LIMITED 142650GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC 150811GENE BIO-APPLICATION LTD. 155138GENENTECH, INC. 135345GENZYME CORPORATION 146211GIVAUDAN SA 137893GIVEN IMAGING LTD. 150880GLAXOSMITHKLINE S.P.A. 147012GPI NIL HOLDINGS, INC. 128792GRUNENTHAL GMBH 148406

HARRIS CORPORATION 145125HARRY CONNICK, JR. 149816HONEYWELL INC. 149730

I.C. CODE LTD. 147169IBM CORPORATION 141458, 143013IBM CORPORATION 157506IHARA CHEMICAL INDUSTRY CO., LTD. 146758IMMUGEN PHARMACEUTICALS, INC. 145470INNOVAPARK, LLC 149880INSTITUT FIZIKI TVERDOGO TELA ROSSIISKOI AKADEMII NAUK 151182INTEL CORPORATION 149538INTER IKEA SYSTEMS B.V. 155357INTERNATIONAL BUSINESS MACHINES CORPORATION 142265, 147118INTROGENE B.V. 133032ISRAEL ELIEZEROV 144966ISRAEL MARMORSTEIN 167283ITALDATA INGEGNERIA DELL'IDEA S.P.A. 155372ITZHAK GVILI 151000

JANE, S.A. 156952JANSSEN PHARMACEUTICA N.V. 147327, 147328JONATHAN DALLAS TOYE 129912

KIRIN-AMGEN INC. 140669KRAUSZ METAL INDUSTRIES LTD. 153136KREIDO LABORATORIES 157789

LABORATOIRE L. LAFON 148042LABORATOIRE THERAMEX 148953LIFESCAN, INC. 150669LILLY ICOS LLC 146098LOEB HEALTH RESEARCH INSTITUTE AT THE OTTAWA HOSPITAL 139813LONZA AG 143229LOOK DYNAMICS, INC. 146688LTS LOHMANN THERAPIE-SYSTEME AG 148568LTS LOHMANN THERAPIE-SYSTEME AG 149812

M. KAINDL 161371MASSACHUSETTS INSTITUTE OF TECHNOLOGY 137299MASSACHUSETTS INSTITUTE OF TECHNOLOGY 148137MEDA PHARMA GMBH & CO. KG 148068MERCK & CO., INC. 159109MERCK PATENT GMBH 146707MIKKEL G. MANDT 158662MILKHAUS LABORATORY, INC. 131478, 138336MOELLER GEBAUDEAUTOMATION KG 146058M-SYSTEMS FLASH DISK PIONEERS LTD. 148619

N.V. ORGANON 145483NAGRACARD S.A. 148521NDS LIMITED 126552NEOTHERMIA CORPORATION 150159NEPHROS, INC. 155408, 156103NEWMAT, S.A. 148683NEXMED HOLDINGS, INC. 150306NIKEM RESEARCH S.R.L. 147012NITI MEDICAL TECHNOLOGIES LTD. 150855NORTH CAROLINA STATE

UNIVERSITY 150560NOVAMONT S.P.A. 151212NOVEXEL 136647NOVO NORDISK A/S 124939

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "KLINIKA INSTITUTA BIOREGUL YATSII I GERONTOLOGII" 146432OCCIDENTAL CHEMICAL CORPORATION 154653OLIVER BRUESTLE 136833ORTHOFIX INTERNATIONAL B.V. 145553ORTHO-MCNEIL PHARMACEUTICAL, INC. 137954, 147510ORYCLE APPLICATIONS LTD. 140429

PHARMACIA & UPJOHN COMPANY LLC 151789POLYCOM ISRAEL LTD. 149439POWDERJECT RESEARCH LIMITED 145668PRODEMEX, S.A. DE C.V. 151586

QLT USA, INC. 155006QUALCOMM INCORPORATED 138090, 147418, 147761, 147791, 147795QUALCOMM INCORPORATED 147628

RAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD. 141710RECORDATI IRELAND LIMITED 147441RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY 147441REM TECHNOLOGIES, INC. 157290RESEARCH CORPORATION TECHNOLOGIES, INC. 140553REUBEN BERMAN 145572RHEINMETALL W & M GMBH 152972ROGER DE LATHOUWER 143886ROGUE VALLEY NATURAL

SPRINGS, INC. 153892RTP PHARMA INC. 138767

SAMSUNG ELECTRONICS CO., LTD. 141743SAMSUNG ELECTRONICS CO., LTD. 157663SANOFI AVENTIS 145150SANOFI AVENTIS 163286SANOFI-AVENTIS DEUTSCHLAND GMBH 146276, 149209SCANNEX TECHNOLOGIES, LLC 147319SCHERING AKTIENGESELLSCHAFT 136455SECURELOGIC LTD. 150251SILVERBROOK RESEARCH PTY. LTD. 146619, 164924, 166724SIMULA, INC. 154957SMITHKLINE BEECHAM CORPORATION 140028SMITHKLINE BEECHAM CORPORATION 148325SNECMA MOTEURS 149738SOCIETE DES PRODUITS NESTLE S.A. 143270SOLEL SOLAR SYSTEMS LTD. 161917SPEEDBIT LTD. 149822, 149823SPS VERPACKUNGS-SYSTEM GMBH 149898SUGEN, INC. 124728

T.D.I. ARMS SYSTEMS LTD. 151953TECHNISCHE UNIVERSITAT DRESDEN 143952THALES 149659THALES NEDERLAND B.V. 154133THE MOWER FAMILY CHF TREATMENT IRREVOCABLE TRUST 144290THE OTTAWA HEALTH RESEARCH INSTITUTE 139813THE PROCTER & GAMBLE COMPANY 147265THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 128058THE REGENTS OF THE UNIVERSITY

June 3, 2007 –התשס"ז בסיון י"ז iv

OF CALIFORNIA 143202THE REGENTS OF THE UNIVERSITY OF MICHIGAN 140028TOSHIO KITAMURA 136310TRANSPHARMA MEDICAL LTD. 143014TRIUMPH BRANDS, INC. 163624T-SYSTEMS INTERNATIONAL, INC. 143253TWITOPLAST LTD. 148375

UNITED TECHNOLOGIES CORPORATION 147091, 160163, 163398UNITED TECHNOLOGIES CORPORATION 163443UNIVERSITY OF BRITISH COLUMBIA 145069UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 144411

VACUUMSCHELZE GMBH 138199

WARCOP INVESTMENT LTD. 140367WAYPORT, INC. 149356WISCONSIN ALUMNI RESEARCH FOUNDATION 146923

WORLDWIDE COATINGS IP PTY LTD 152333WORLDWIDE FIRE RETARDANT IP PTY LTD. 152333WORLDWIDE THERMAL MANAGEMENT IP PTY LTD. 152333WYETH HOLDINGS CORPORATION 137617

YEDA RESEARCH AND DEVELOPMENT CO. LTD. 143202, 150301

ZULI HOLDINGS LTD. 137455

ענייני מפתחSUBJECT MATTER INDEX

A01G – 144701

A01J – 145605

A01H – 149773, 150925, 152186

A23N – 146356, 163176

A23J – 158263

A23K – 128541

A61B – 137514, 149645

A61F – 140059, 141980, 145629, 148121 ,150112

A61K – 123509, 130842, 131346, 134163 ,136804 ,140667 , 140670 ,140745 ,140899, 143012 ,143093 ,143234, 143294 ,143580 ,145112, 145580 ,146578 ,146974, 147212 ,147559 ,149085, 149580 ,150628 ,154975,

154976

A61J – 143119

A61M – 140475, 148609, 148636, 150960 ,151120 ,160450

A62B – 172238

A63B – 141219, 166971

A63H – 159934

B01D – 139539, 154033, 154244, 157906

B01F – 155267

B01J – 148287, 154390, 160321

B05B – 143319

B32B – 162235

B41J – 149952, 150382, 164954

B60N – 154444

B61L – 158815 B65D – 147222, 154878, 156431

C03B – 154708

C07C – 132518, 137964, 139922, 140744 ,146032 ,146372, 148111 ,148407 ,148761, 148870 ,149527 ,154974

C07D – 134787, 136717, 136827, 137828 ,139946 ,140032, 140062 ,141324 ,144026, 145375 ,145814 ,147898, 148218 ,148318 ,148782, 149063 ,149164 ,149289 ,

156943 ,157457

C07F – 145280, 145925, 150490, 158110

C07H – 144274 C07J – 149424, 150082, 153703

C07K– 110367, 123815, 127155, 128941 ,134968

C08F – 149332, 152174, 157798, 161973 ,164466

C08G – 158290

C08J – 150465, 157910

June 1, 2007 –התשס"ז בסיון ט"ו vi

C09D – 153090C12N– 107822, 127363, 128578,

129164 ,131171 ,132259, 134700 ,138353

C12P – 141645

C23C– 143076

D04H – 150139

D06B – 162231

E04C – 148699

F02K – 160696, 162142

F03B – 156993

F04B – 156196

F15D – 131589

F16J –146687

F16K – 166167

F24F – 159601

F25B – 152951

F25D – 159602

F41F – 156013

F42B – 145097, 148248, 154056

G01c – 145593, 149934

G01D – 157311

G01N – 145970, 154961

G01R – 143927

G01S – 156156

G02B – 128950, 156159, 156855

G03F – 154504 G06F – 135448, 146048, 147754,

147844

G06K –145905, 146673

G07B – 156675

G08B – 158270

G08G – 151258

H01L – 150784, 153153, 153156, 156319 ,156321 ,156523

H01R – 138621, 142552

H01T – 124696

H02G – 145847

H02H – 149861

H03F – 140564

H04B – 144258, 147792, 148207

H04H – 135184

H04J – 137058

H04L – 141464, 147513, 148037

H04N – 148356

H04Q– 135907, 147142, 147577

H05H – 152119

המשפטים, ירושלים הפטנטים, משרד רשות ע"י נערךהממשלתי, ירושלים במדפיס והודפס הופק

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEMPRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER

June 1, 2007 –התשס"ז בסיון ט"ו viii

יומן הפטנטים 2007 02 - justice.gov.il · web viewרשומות. israel state records...

Documents